Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DCWashington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Form 10-K

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2017, 2023

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-35073

GEVO, INC.

Gevo, Inc.

(Exact name of registrant as specified in its charter)

Delaware

87-0747704

(State or Other Jurisdictionother jurisdiction of

Incorporationincorporation or Organization)

organization)

(I.R.S. Employer

Identification No.)

345 Inverness Drive South,

Building C, Suite 310

Englewood, CO

80112

(Address of Principal Executive Offices)principal executive offices)

(Zip Code)

(303)

(303) 858-8358

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

    

Trading Symbol

    

Name of Each Exchange on Which Registered

Common Stock, par value $0.01 per share

NASDAQ CapitalGEVO

The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

Accelerated filer

Non-accelerated filer

Non-accelerated filer

  (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b).

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The aggregate market value of common equity held by non-affiliates of the registrant was approximately $11.2 million$0.4 billion as of June 30, 2017,2023, the last businesstrading day of the registrant’s most recently completed second fiscal quarter, based on the closing price of the common stock as reported on the NASDAQNasdaq Capital Market on June 30, 2017.2023. Shares of common stock held by each officer, director and holder of 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

As of February 28, 2018,January 31, 2024, the number of outstanding shares of the registrant’s common stock, par value $0.01 per share, was 22,600,849  240,499,833.

DOCUMENTS INCORPORATED BY REFERENCE

Part III of this Annual Report on Form 10-K incorporates certain information by reference from the registrant’s proxy statement for the 20182024 annual meeting of stockholders to be filed no later than 120 days after the end of the registrant’s fiscal year ended December 31, 2017.2023.


GEVO, INC.

FORM 10-K—ANNUAL REPORT

For the Fiscal Year Ended DecemberFOR THE FISCAL YEAR ENDED DECEMBER 31, 20172023

TABLE OF CONTENTS

Table of Contents

Page

PART I

Item 1. and 2.

Business and Properties

4

6

Item 1A.

Risk Factors

18

20

Item 1B.

Unresolved Staff Comments

46

40

Item 2.1C.

PropertiesCybersecurity

46

40

Item 3.

Legal Proceedings

47

40

Item 4.

Mine Safety Disclosures

47

40

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

48

41

Item 6.

Selected Financial Data[Reserved]

49

42

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

52

43

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

68

53

Item 8.

Financial Statements and Supplementary Data

70

54

2ItemItem 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

105

89

Item 9A.

Controls and Procedures

105

89

Item 9B.

Other Information

105

90

PART IIIItem 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

91

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

106

91

Item 11.

Executive Compensation

106

91

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

106

91

Item 13.

Certain Relationships and Related Transactions, and Director Independence

106

91

Item 14.

Principal Accountant Fees and Services

106

PART IV

Item 15.

Exhibits and Financial Statement Schedules

  107

Item 16.

Form 10-K Summary

  112  

91

SIGNATURESPART IV

  113  

Item 15.

Exhibits, Financial Statement Schedules

92

Item 16.

Form 10-K Summary

96

SIGNATURES

97


Forward-Looking Statements

This reportAnnual Report on Form 10-K (this “Report”) contains forward-looking statements within the meaning of Section 21 E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used anywhere in this Annual Report, on Form 10-K (this “Report”), the words “expect,” “believe,” “anticipate,” “estimate,” “intend,” “plan” and similar expressions are intended to identify forward-looking statements. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievementachievements to differ materially from those expressed or implied by these forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. These forward-looking statements include, among other things, statements about: our financial condition, our results of operation and liquidity, our ability to finance, develop, and construct our Net-Zero Projects (as defined below), as well as other growth projects, our ability to produce our products, our expectations regarding the demand for our products and our ability to meet such demand, our ability to meet production, financial and operational guidance, our ability to generate revenue from our executed contracts, our strategy to pursue low-carbon or “net-zero” carbon renewable fuels for sale into California and elsewhere, our ability to replace our fossil-based energy sources with renewable energy sources at our Net-Zero Projects and elsewhere, our expectations regarding the location and start-up date for our initial Net-Zero Project, our expectations regarding our ability to produce renewable liquid hydrocarbons, our expectations regarding our ability to produce protein and other products for use in the food chain, our ability and plans to construct greenfield commercial hydrocarbon facilities to produce sustainable aviation fuel (“SAF”) and other products, our ability to raise additional funds to finance our business and the sources of those funds, our ability to perform under our existing offtake agreements and other sales agreements we may enter into in the future, our ability to successfully operate our business,renewable natural gas (“RNG”), also known as biogas, facilities in Iowa, our ability to produce isobutanol onrenewable hydrocarbon products at a commercial level and at a profit, the availability of, and market prices for, government economic incentives to the renewable energy market, achievement of advances in our technology platform, the successavailability of our retrofit production model, our ability to expand our Luverne, Minnesota facility for our first commercial hydrocarbons facility,suitable and cost-competitive feedstocks, our ability to gain market acceptance for our products, our expectations regarding the demand for carbon credits, the expected cost-competitiveness and relative performance attributes of our products, our strategy to pursue alcohol-to-SAF development and production, additional competition and changes in economic conditions and the continued listingfuture price and volatility of our common stock on NASDAQ.petroleum and products derived from petroleum. Important factors could cause actual results to differ materially from those indicated or implied by forward-looking statements such as those contained in documents we have filed with the United States (“U.S.”) Securities and Exchange Commission (the “SEC”), including this Report in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” Item 1A. “Risk Factors” and subsequent reports on Form 10-Q. All forward-looking statements in this Report are qualified entirely by the cautionary statements included in this Report and such other filings. These risks and uncertainties or other important factors could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this Report. These forward-looking statements speak only as of the date of this Report. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing the Company’s views as of any date subsequent to the date of the filing of this Report.

Unless the context requires otherwise, in this Report the terms “Gevo,” “we,” “us,” “our” and “Company” refer to Gevo, Inc. and its wholly-ownedwholly owned, direct and indirect subsidiaries.

This Report contains estimates and other information concerning our target markets that are based on industry publications, surveys and forecasts, including those generated by SRI Consulting, a division

3

Risk Factors Summary

Our business is subject to a high degreenumber of uncertaintyrisks and risk due to a varietyuncertainties, many of factors,which are beyond our control, including those described in “Risk Factors.”Part I, Item 1A. Risk Factors of this annual report. These and other factors could cause actual results to differ materially from those expressed in these publications, surveys and forecasts.

Conventions that Apply to this Report

With respect to calculation of product market volumes:

product market volumes are provided solely to show the magnitude of the potential markets for isobutanol and the products derived from it. Theyrisks include, but are not intendedlimited to, be projections of our actual isobutanol production or sales;the following:

We have a history of net losses, and we may not achieve or maintain profitability.
We will require substantial additional financing to achieve our goals, and a failure to obtain this capital when needed or on acceptable terms could force us to delay, limit, reduce or terminate our development and commercialization efforts.
Our business is capital-intensive in nature, and we rely on external financing to fund our growth strategy, including the development and construction of our Net-Zero Projects and other similar growth projects. Limitations on access to external financing could adversely affect our operating results.
Our proposed growth projects may not be completed or, if completed, may not achieve profitability or perform as expected. Our project development activities may consume a significant portion of our management’s focus, and if not successful, reduce our profitability.
We may be unable to successfully perform under current or future offtake and sales agreements to provide our products, which could harm our commercial prospects.
Our offtake agreements, including our take-or-pay agreements, are subject to significant conditions precedent and, as a result, the revenues that we expect from such contracts may never be realized.
Fluctuations in the price of corn and other feedstocks may affect our cost structure.
Fluctuations in petroleum prices and customer demand patterns may reduce demand for renewable fuels.
Any decline in the value of carbon credits associated with our products could have a material adverse effect on our results of operations cash flow and financial condition.
We may not be successful in the commercialization of alcohol-to-SAF projects utilizing Axens technology.
The technological and logistical challenges associated with producing, marketing, selling and distributing renewable hydrocarbon products are complex, and we may not be able to resolve such complexities in a timely or cost-effective manner, or at all.
Our actual costs may be greater than expected in developing our growth projects, causing us to realize significantly lower profits or greater losses on our projects.
We may be unable to produce renewable hydrocarbon products in accordance with customer specifications.
Our experience may not be sufficient to operate commercial-scale facilities and we may encounter substantial difficulties operating commercial plants or expanding our business.
Even if we are successful in producing our products on a commercial scale, we may not be successful in negotiating additional fuel offtake agreements or pricing terms to support the growth of our business.
If we engage in acquisitions, we will incur a variety of costs and may potentially face numerous risks that could adversely affect our business and operations.
If we engage in joint ventures, we will incur a variety of costs and may potentially face numerous risks that could adversely affect our business and operations.
If we lose key personnel, including key management personnel, or are unable to attract and retain additional personnel, it could delay our product development programs and harm our research and development efforts, make it more difficult to pursue partnerships or develop our own products or otherwise have a material adverse effect on our business.
We may face substantial competition from companies with greater resources and financial strength, which could adversely affect our performance and growth.
Business interruptions may have an adverse impact on our business and our financial results.
Our business and operations would suffer in the event of IT system failures or a cyber-attack.
We may engage in hedging transactions, which could adversely impact our business.
Ethical, legal and social concerns about genetically engineered products and processes, and similar concerns about feedstocks grown on land that could be used for food production, could limit or prevent the use of our products, processes and technologies and limit our revenues.
As our products have not previously been used as a commercial fuel in significant amounts, their use exposes us to product liability risks.

4

product market volume calculations for fuels markets are based on data available for the year 2013;Table of Contents

We may not be able to use some or all of our net operating loss carry-forwards tax deductions to offset future taxable income.
Competitiveness of our products for fuel use (including RNG) depends in part on government economic incentives for renewable energy projects or other related policies that could change.
In order to benefit from RINs and LCFS credits, our RNG projects are required to be registered and are subject to regulatory audit.
Our RNG project has, and any future digester project may not be able to achieve the operating results we expect from these projects.
Our ability to compete may be adversely affected if we are unsuccessful in defending against any claims by competitors or others that we are infringing upon their intellectual property rights.
Our ability to compete may be adversely affected if we do not adequately protect our proprietary technologies or if we lose some of our intellectual property rights through costly litigation or proceedings.
We may not be able to enforce our intellectual property rights throughout the world.
Confidentiality agreements with employees and others may not adequately prevent disclosures of trade secrets and other proprietary information.
We have received funding from U.S. government agencies, which could negatively affect our IP rights.
The U.S. renewable fuels industry is highly dependent upon certain federal and state legislation and regulation and any changes in legislation or regulation could have a material adverse effect on our results of operations, cash flows and financial condition.
Reductions or changes to existing regulations and policies may present technical, regulatory and economic barriers, which may significantly reduce demand for renewable fuels or our ability to supply our products.
Negative attitudes toward renewable energy projects from the U.S. government, other lawmakers and regulators, and activists could adversely affect our business, financial condition and results of operations.
Any claims relating to improper handling, storage or disposal of hazardous materials or noncompliance with applicable laws and regulations could be time consuming and costly and could adversely affect our business and results of operations.
Our international activities may increase our exposure to potential liability under anti-corruption, trade protection, tax and other laws and regulations.
The market price of our common stock may be adversely affected by the future issuance and sale of additional shares of our common stock or by our announcement that such issuances and sales may occur.
Future issuances of our common stock or instruments convertible or exercisable into our common stock may materially and adversely affect the price of our common stock and cause dilution to our existing stockholders.
Raising capital at a subsidiary, or project, level would result in lower revenues attributable back to us.
Our inability to comply with applicable Nasdaq listing requirements could result in delisting of our common stock.
Our stock price may be volatile, and your investment in our securities could suffer a decline in value.
The estimates and assumptions on which our financial projections are based may prove to be inaccurate.
Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies.
We do not anticipate paying cash dividends, and accordingly, stockholders must rely on stock appreciation for any return on their investment.
If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our stock price and trading volume could decline. The trading market for our common stock may be influenced by the research and reports that securities or industry analysts publish about us or our business.
We are subject to anti-takeover provisions in our certificate of incorporation, our bylaws and under Delaware law that could delay or prevent an acquisition of the Company, even if the acquisition would be beneficial to our stockholders.
Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

5

product market volume calculations for chemicals markets are based on data available for the year 2012; and

volume data with respect to target market sizes is derived from data included in various industry publications, surveys and forecasts generated by the EIA, the IEA and Nexant.Table of Contents

We have converted these market sizes into volumes of isobutanol as follows:

we calculated the size of the market for isobutanol as a gasoline blendstock and oxygenate by multiplying the world gasoline market volume by an estimated 12.5% by volume isobutanol blend ratio;

we calculated the size of the specialty chemicals markets by substituting volumes of isobutanol equivalent to the volume of products currently used to serve these markets;

we calculated the size of the petrochemicals and hydrocarbon fuels markets by calculating the amount of isobutanol that, if converted into the target products at theoretical yield, would be needed to fully serve these markets (in substitution for the volume of products currently used to serve these markets); and

for consistency in measurement, where necessary we converted all market sizes into gallons.

Conversion into gallons for the fuels markets is based upon fuel densities identified by Air BP Ltd. and the American Petroleum Institute.


PART I

PART I

Items 1 and 2.Business and Properties.

Item 1.

Business.

Company Overview

We areGevo, Inc. (Nasdaq: GEVO), a renewable chemicals and next generation biofuelsDelaware corporation founded in 2005, is a growth-oriented, carbon abatement company targeting what we believe to be very large potential markets: thatwith the mission of low carbon fuels and chemicals that can compete directly against petro-chemical products depending on the price of oil and value of carbon.   Renewable fuels are onesolving greenhouse gas emissions for those sectors of the few markets where the value for renewable carbon has already been established, particularly in the U.S.transportation industry that are not amenable to electrification or hydrogen. We believe that the demandmarket size for low carbonhydrocarbon fuels chemicals, and plastics will continue to remain significant in the long-term even with the rapid adoption of electric vehicles and grow stronger over time.hydrogen technologies.

We are focused on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels, such as SAF, with the potential to achieve a “net-zero” greenhouse gas (“GHG”) footprint. We believe that this addresses the global need of reducing GHG emissions with “drop in” sustainable alternatives to petroleum fuels. We use the Argonne National Laboratory’s Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (the “GREET Model”) to measure, predict and verify GHG emissions across the life cycle of our products. Our “net-zero” concept means the production of drop-in hydrocarbon fuels and chemicals by using sustainably grown feedstocks (e.g., low till, no-till and dry corn cultivation, or other carbohydrate sources); renewable, substantially decarbonized energy sources; and process technologies to lower GHG emissions, resulting in an expected net-zero carbon footprint from the full life cycle of the fuel measured from the capture of renewable carbon through the burning of the fuel.

Graphic

Our primary market focus, given current demand and growing customer interest, is hydrocarbon fuels, and SAF in particular. We believe that SAF from carbohydrates to alcohol is the most economically viable approach for carbon abatement. We also have commercial opportunities for other renewable hydrocarbon products, such as RNG; hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the chemical industry, such as ethylene and butenes; plastics and materials; and other chemicals. Global fuel consumption by commercial airlines continues to remain strong, with global fuel consumption at more than 100 billion gallons per year (“BGPW”) and growing.

6

We believe that there is a growing and significant market demand for SAF production generally based on a number of factors, including:

Air transportation is considered to be a hard to decarbonize segment by governments, airlines, and others. De-fossilized jet fuel, meaning jet fuel but with a low GHG emission footprint, is expected to be important to achieve the decarbonization of the industry. The International Air Transport Association’s (“IATA”) 77th Annual General Meeting approved a resolution for the global air transport industry to achieve net-zero carbon emissions by the year 2050. Most recently, IATA presented roadmaps to achieve its 2050 Fly Net Zero commitment, which include SAF providing 62 percent of the carbon mitigation needed in 2050. IATA has 317 airline members, including Alaska Airlines, American Airlines, Delta Air Lines, FedEx Express, United Airlines and UPS Airlines, who have committed to spending significant amounts to mitigate the balance of emissions from their global businesses going forward.
The U.S. Federal government continues to advance its Sustainable Aviation Fuel Grand Challenge (the “Challenge”) to meet the demand for SAF by working with stakeholders to reduce costs, enhance sustainability, and expand production and use of SAF which achieves a minimum of a 50% reduction in life cycle GHGs compared to conventional fuel. The Challenge includes the goal of supplying at least 3 billion gallons of SAF per year by 2030 and, by 2050, sufficient SAF to meet 100% of aviation fuel demand, which is currently projected to be around 35 billion gallons per year.
Newly enacted state-based incentives for SAF in 2023, including per gallon tax credits in Illinois, Minnesota, and Washington, demonstrate growing public policy support at all levels of government for scaling SAF production and increasing SAF use in the United States.
The oneworld® alliance committed to a target of 10% SAF use across the alliance by 2030 and plans to reach net-zero emissions by 2050.

We believe that we possess the ability to convert various carbohydrate feedstocks through a fermentation process into alcohols and then transform the alcohols into renewable fuels and materials, through a combination of licensing of technology and engineering from third parties, and our own proprietary technology, know-how, and engineering. While we expect our major capital deployments to focus on the production of SAF, we recognize there are opportunities to operate in several different renewable fuels and materials markets and we will eventuallypursue those opportunities when appropriate based on customer interest, access to capital, and expected investment returns.

Our SAF production process uses carbohydrates as a feedstock. Carbohydrates are plant matter that result from photosynthesis. Photosynthesis is the natural process by which carbon dioxide is captured from the air by plants, which are very efficient at capturing carbon dioxide from the atmosphere. The carbon in carbohydrates is renewable because its source is carbon dioxide from the atmosphere. The carbohydrates are fermented to produce alcohol intermediate products (e.g., ethanol or isobutanol). The alcohol-based intermediates are then chemically processed to make renewable hydrocarbons. To achieve net-zero carbon intensity (“CI”) across the whole life cycle of the products, we believe:

carbohydrates from sustainably grown feedstocks (e.g., low till, no-till, and dry corn cultivation) or other carbohydrate sources with a low CI score should be used in production;
the energy (electricity and heat sources) used in production must be de-fossilized; and
the products cannot contain fossil-based carbon.

We believe sustainably grown industrial field corn (i.e., corn that is grown with precision agricultural techniques and low-till or no till cultivation to conserve nutrients, prevent water runoff, and erosion) is the best feedstock to commercialize our SAF with initially because:

it produces a significant amount of protein and vegetable oil for nutritional products on a per acre basis while also producing an abundance of low CI carbohydrates that can be captured and used as a feedstock for fuels and chemicals;
the protein and oil that are produced can be easily separated and sold as co-products into the food chain markets. The protein and oil revenue serves to offset the cost of the corn feedstock;

7

we believe that the carbon footprint of growing corn can be negative, according to calculations completed with the GREET Model, when a full suite of climate-smart agricultural practices is employed on appropriate acres of cropland;
we believe that corn can achieve lower CI scores when grown with climate-smart agricultural techniques than waste raw materials or wood; and
we believe that residual carbohydrates from corn are the lowest cost carbohydrates available as a renewable raw material, and the production is proven and scalable.

We believe that utilizing sustainable agriculture practices to help solve GHG problems is a breakthrough that addresses the problem of GHGs without compromising sustainability or food supply. We also believe that it will be valuedpossible to create an incentive structure that rewards farmers to lower the CI score of their agricultural products and create a cycle of continuous improvement to their overall sustainability footprint.

Building Out Production Capacity to Meet Demand

We believe that we will be able to develop the marketplace, customers and production capacity to achieve at least 1 billion gallons of sales in the next decade. Two approaches will be required to achieve this objective. The first approach, the development of greenfield sites (i.e., the development of a project on an undeveloped site), allows us to optimize production and the integration of technology. The second approach, leveraging installed alcohol production capacity, has the advantage that the fermentation capacity already exists via existing ethanol plants. Those existing ethanol plants would need to be decarbonized and hydrocarbon production capacity would need to be installed.

Our concept of “Net-Zero Projects” is a series of planned facilities to produce energy dense liquid hydrocarbons using renewable energy and our proprietary technology. The concept of a Net-Zero Project is to convert renewable energy (such as, photosynthetic, wind, renewable natural gas, and biogas) from a variety of sources into energy dense liquid hydrocarbons that when burned in traditional engines, have the potential to achieve net-zero GHG emissions across the life-cycle of the liquid fuel based on the GREET Model, the pre-eminent science-based life-cycle analysis model. The GREET Model takes into account emissions and impacts cradle-to-cradle for renewable resource-based fuels including inputs and generation of raw materials, agriculture practices, chemicals used in production processes of both feedstocks and plasticsproducts, energy sources used in production and transportation and the end use of the products, which for fuel products is usually burning to release energy.

Using sustainably grown corn or low CI corn as an input at a Net-Zero Project would comprise the following steps: (i) process the corn kernels to produce protein, oil and carbohydrate; (ii) ferment the carbohydrate into an alcohol; and (iii) convert the alcohol to SAF and other renewable hydrocarbon products. The combination of renewable carbon obtained from the carbohydrates, plus the reduction/elimination of fossil-based energy creates the advantage in driving the CI score to achieve net-zero. In addition to those practices, there is potential to sequester renewable carbon in the soil during corn production, and from capturing the CO2 from the production process, which should cause the CI scores to become negative across the whole life cycle of the product as measured by the GREET Model.

Greenfield Projects

Our initial greenfield Net-Zero Project, Net-Zero 1 (“NZ1”), is expected to be located in Lake Preston, South Dakota, and is designed to produce approximately 65 million gallons per year (“MGPY”) of total hydrocarbon volumes, including 60 MGPY of SAF. The plant is expected to be powered by wind-based electricity. The liquid hydrocarbons, when burned, are expected to have a net-zero GHG footprint. Along with the hydrocarbons, NZ1 is expected to produce approximately 695,000 tons per year of high-value protein products for use in the food chain and more than 34 million pounds per year of corn oil. Our products will be produced in three steps: the first step is milling the corn to produce the carbohydrates needed for the production of SAF while simultaneously enabling the production of protein and oil; the second step produces alcohols using carbohydrate-based fermentation; and the third step is the conversion of the alcohols into hydrocarbons.

8

We completed the value engineering on our NZ1 project and are proceeding with detailed engineering, modularization design, and capital costs updates. We are currently refining project cost estimates with engineering, procurement, and construction (“EPC”) partners to identify cost saving opportunities, and currently expect to finance the construction of NZ1 at the subsidiary level using a combination of Company equity and third-party capital, to include non-recourse debt. The Company expects to have invested a cumulative total of $236 to $286 million of cash equity in the project at financial close. Cash distributions from future NZ1 earnings would be proportionate to Gevo’s ownership in NZ1 under this expected financing structure. The use of project debt and third party equity allows us to conserve capital for use on other growth projects. We expect to apply similar development and financing strategies to future Net-Zero Projects to enable growth of SAF production to meet demand for SAF.

We have substantially completed the engineering design of NZ1. We have substantially completed value engineering and we are now focusing on detail engineering with our EPC partners, to reduce and contractually finalize a negotiated lump-sum, fixed price agreement whereby the EPC partners will build and deliver the plant. This detail engineering work is focused specifically on increasing the modularization of component parts on the NZ1 plant design, which means that we expect that the process equipment would be built into modules at a factory, then the modules would be assembled onsite at NZ1, with the goal of minimizing specialized field work typical in plant construction of this type. This approach is expected to lower the risk and cost of, and access to, skilled labor at the site and reduce the supply chain constrictions for some of our long-lead equipment. Increasing the modularization of the plant design is also expected to reduce our spend in advance of securing third-party equity and debt financing for NZ1 and increase the certainty of construction schedule for those counterparties.

In order to achieve full construction financing for NZ1, we need to secure third-party equity and debt. Upon receiving an invitation from the U.S. Department of Energy (“DOE”), we submitted a Part II Application for a DOE loan guarantee for a direct lending from Federal Financing Bank. In August 2023, Gevo was invited to enter the due diligence and term sheet negotiation phases with DOE. Given the current interest rate environment and general macroeconomic conditions, a DOE-guaranteed loan is our most attractive debt option and is expected to offer the lowest cost of debt for the project. We expect that obtaining a DOE-guaranteed loan will have the benefit of reducing the overall amount of equity required to finance NZ1 and should result in higher project equity returns for investors which should increase the likelihood of Gevo successfully financing NZ1. The DOE loan application process is expected to be complete in 2024. We expect that our NZ1 plant start-up date will occur twenty-four to thirty months after the financing of NZ1 closes, the timing of which is uncertain. In parallel with the DOE-guaranteed loan process, we continue to explore debt financing for NZ1 without the benefit of the DOE-guaranteed loan. We are also working to secure CCS access at the site.

We are evaluating and performing early site development work at several sites in the U.S. for other greenfield sites. These sites include several greenfield locations that are particularly advantageous in terms of potential economics, opportunities to decarbonize, and time to market. In addition, we are pursuing potential Net-Zero Projects with several existing ethanol plant sites. Existing ethanol plants need to be decarbonized with renewable energy or de-fossilized energy and/or carbon sequestration. Gevo has developed a preferred list of potential partners and sites with decarbonization in mind and is engaged in preliminary feasibility and development discussions with several of these potential partners. We plan to give priority to existing industrial plant sites that have attractive potential economics and high predictability of timeline for decarbonization.

Leveraging Existing Alcohol Production Capacity

Based upon what we have learned as we develop and engineer NZ1, we believe that it should be possible, practical and financially attractive to convert existing ethanol plants to allow for the production of SAF and other renewable hydrocarbon products. In order to accomplish this conversion, three critical things are required: (i) the energy for the converted plant needs to be de-fossilized to achieve the CI scores required for the market; (ii) a hydrocarbon production plant needs to be built; and (iii) the plant needs to have access to carbon capture and sequestration (“CCS”).

We believe that there are several existing ethanol plants that could be attractive for an alcohol-to-jet (“ATJ”) plant that would be largely copied from our NZ1 Project.

9

Renewable Natural Gas

Our RNG and biogas projects generate incremental profit and create a long-term option to potentially supply RNG to our Net-Zero Projects as part of our long-term strategy to decarbonize SAF and other hydrocarbon fuels.

We finished the development and construction of our first RNG facilities in northwest Iowa in 2022. RNG has value in markets such as California as well as in our hydrocarbon production process by helping us achieve carbon negative GHG emissions on our renewable hydrocarbon products. The end products resulting from such a decarbonization process have lower CI scores and increased market value, in addition to fuels.    having a more positive impact on the environment. Our initial RNG project, Gevo NW Iowa RNG, LLC (“Gevo RNG”), was developed to generate RNG captured from dairy cow manure which is supplied by three dairies located in Northwest Iowa. Animal manure is digested anaerobically to produce RNG. We financed the construction of the Gevo RNG project in April 2021 with the $68,155,000 of Solid Waste Facility Revenue Bonds (Gevo NW Iowa RNG, LLC Renewable Natural Gas Project), Series 2021 (Green Bonds) (the “2021 Bonds”) issued by the Iowa Finance Authority in a public offering for the benefit of Gevo RNG.

The challengesGevo RNG project started up and began producing and injecting initial volumes of biogas in 2022, during the project’s testing and ramp-up period. The project achieved stable production levels and surpassed our annual production target of 310,000 MMBtu for 2023. In addition, we completed an expansion to displace petrochemicalthe Gevo RNG project to increase its annual design capacity from 355,000 million British thermal units (“MMBtu”) to 400,000 MMBtu.

Gevo was granted registration approval by the U.S. Environmental Protection Agency (“EPA”) in 2022, allowing us to participate in its Renewable Fuel Standard Program (“RFS Program”) to receive renewable identification numbers (“RINs”). During the first quarter of 2023, we received approval for a temporary pathway under California’s Low Carbon Fuel Standard (“LCFS”) program. We realized substantial sales for our environmental attributes of both LCFS credits and RINs in 2023.

We believe the trust and reputation we have attained in the RNG industry, in combination with our understanding of the various and complex environmental attributes, gives us a competitive advantage. We intend to leverage our relationships to identify and execute new project opportunities. Typically, new development opportunities come from our existing relationships with dairy owners who value our reputation in the industry.

We exercise financial discipline in pursuing projects by targeting attractive risk-adjusted project returns, whether selling RNG into the markets or using it to lower CI scores at our Net-Zero Projects. We will monitor biogas supply availability across our portfolio and seek to maximize our production by expanding operations when economically feasible.

Competitive Advantages

We believe that our vertically integrated set of technologies and business systems (including our extensive portfolio of several hundred patents and patent applications, trade-secrets, and proprietary production technologies) creates competitive advantage through (i) access to multiple opportunities to drive the CI score of our products down, (ii) opportunities to address needs in the chemicals, food, feed, plastics and materials markets, (iii) to drive production costs very low to maximize margins, (iv) deploy production technology that is readily scalable and robust from an operating point of view, (v) through Verity Tracking, and (vi) modular design of production facilities which can help to facilitate rapid deployment of production assets. The vertical business systems enable Gevo to capture value from selling protein and vegetable oil, capturing biogenic carbon, and generating carbon value at state and federal levels.

10

Carbohydrates as Feedstocks

Carbohydrate feedstocks exceed all other potential renewable carbon feedstock sources by several orders of magnitude on a worldwide basis. In the Midwest region of the U.S. corn is an ideal feedstock for multiple reasons. On a per acre basis, field corn (not food corn) is one of the most productive crops to produce protein and oil, as well as carbohydrates. The non-carbohydrate co-products from the field corn kernel represent the majority of the nutritional value of the kernel and could be delivered into the food chain. By selling the protein, oil and animal feed into the food chain markets, it would offset a portion of the cost of acquiring the corn. We believe about 50% of the cost of corn can be offset by manufacturing valuable products for the food chain. The remaining carbohydrates are used as a feedstock for fermentation.

We believe that in the U.S., carbohydrates produced from corn are the most sustainable and lowest cost renewable carbon source that can be used as feedstock for alcohol to hydrocarbon processes to produce hydrocarbon fuels. In the future, we expect to evaluate the commercial use of carbohydrates from sources other than corn (e.g., of sugar cane, molasses or other cellulosic sugars derived from wood, agricultural residues and waste) as the cost to acquire those carbohydrates becomes competitive, and the sustainability profile (and related CI scores) become acceptable. We expect our future feedstocks to be chosen on the collective basis of (i) cost, (ii) carbon and/or sustainability footprint with associated value, (iii) positive contribution to food chain where possible, and (iv) availability of the feedstock at a practical scale.

Proprietary Carbohydrate Conversion Technologies

Three technologies are required to convert carbohydrates to SAF and other renewable products are enormous:hydrocarbons: (i) the products needfermentation process to meet or exceed the stringent performance requirements established by the incumbent products,convert carbohydrates to alcohols; (ii) the products needchemical processing technology to be compatible with existing distribution infrastructure,make the hydrocarbon fuel products; and (iii) the products must be economical intechnology and know-how to mitigate the market place,fossil based GHG emissions from the integrated fermentation and (iv) in most cases, the products must have a lower carbon footprint and improve the “sustainability” of the business system.   We believe we have viable technologies that produce products that address these challenges.  fuel production plants.

We have developed proprietary technology that usestwo ways of producing alcohols via fermentation from carbohydrates: (i) ethanol, which has two carbons, and (ii) isobutanol, which has four carbons. Ethanol can be a combination of synthetic biology, metabolic engineering, chemistrybuilding block for SAF, diesel fuel, naptha and chemical engineeringproducts. Isobutanol can be a building block for gasoline hydrocarbons, SAF and chemical products. Ethanol technology is well known and readily available. Isobutanol technology is relatively new and has yet to be scaled to the size of current ethanol production, but it offers long-term potential in enabling lower CI scores and allowing for the production of chemical products, and high value gasoline hydrocarbons.

We believe that we possess proprietary know-how to integrate alcohol production and chemical processing to make isobutanolSAF and other renewable hydrocarbons that should lower the CI score of our renewable hydrocarbon products, from isobutanol thatand have filed patents on the overall process.

Alcohols can displacebe converted to hydrocarbon products with catalytic chemical processing techniques analogous to those used in the petrochemical incumbent products.industry. We have been ableworking with Axens North America, Inc. (“Axens”) to genetically engineer yeast, wherebyuse their technology on this process since they have already scaled it up and they have licensed to many commercial production facilities. Axens brings technologies with over 60 related patents, engineering packages, proprietary catalysts and certain proprietary equipment required to convert alcohols into SAF and they will provide certain process guarantees to us.

Integration of the yeast produces isobutanol from carbohydrates at costs that we believeproduction systems with various renewable or de-fossilized energy sources will be essential. Our Net-Zero plant concept depends upon a variety of decarbonization methods to be commercially competitive once large production facilities are deployed that will enable economiesensure the operability of scale to be  reached.the plant while also reducing and eliminating the need for fossil-based energy. We have shown thatpartnered with companies such as Zero6 Energy, formerly Juhl Energy, to develop the isobutanol production process works in fulltechnology suite for this decarbonization.

We own and operate a development scale fermenter systems at our production facilityplant in Luverne, Minnesota (the “Luverne Facility”). This development scale plant enables us to solve the practical issues involved with scale up of new technologies and testing of new unit operations. Gevo may use the Luverne Facility in the future to prove out processes, process concepts, unit operations and for other purposes in order to optimize feedstocks and the processes used for producing hydrocarbons from alcohols. Currently, the activities at the Luverne Facility are minimized to care and maintenance, as the Company has shifted focus to the Net-Zero Projects.

11

Verity

It is critical that we can prove the CI of our products, ensuring that these values are accurate and auditable. The mission of Verity (“Verity”), including Verity Tracking and Verity Carbon Solutions, is to document CI and other sustainability attributes and apply Distributed Ledger Technology, commonly referred to as blockchain, to create a record of the products throughout the entire business system. Verity starts by calculating carbon intensity of feedstocks from data collected at the farm and field level. We also have shown thatplan to track these feedstocks through production at our plants where we intend to use a mix of renewable isobutanol canelectricity, biogas, renewable hydrogen and other potentially decarbonized energy sources in production. The CI data would then be readily convertedcombined to hydrocarbon products that address large markets.  Specifically, ourdeliver a comprehensive CI reduction in a finished renewable alcohol-to-jet fuel (“ATJ”)fuel. The resulting CI reduction value has been approved for use in commercial aviation and used multiple times for commercial flights.  In addition, our renewable isobutanol is being usedpotential to be quantified as a gasoline blendstockdigital asset and monetized in the Houston areavoluntary or compliance carbon markets, and providing compliance needs for on-road vehicles as an ethanol-free fuel option for consumers.  Our renewable isooctane meets the performance and specification requirements for use in chemicals and fuels and is currently being used in the European Union.tax incentives while preventing double-counting. We believe that there is largein the future, regenerative agricultural practices have the potential to sequester large quantities of soil organic carbon while improving soil health.

There is increasing regulatory and stakeholder pressure on global corporations to lower emissions. These trends are driving demand for carbon credits, giving rise to two sets of markets, the regulated compliance carbon market and the unregulated voluntary carbon market, both of which could grow our business, through a combination of (i) directly producing and selling our renewable isobutanol and related hydrocarbon products, and (ii) licensing our technology.

We believe that renewable isobutanol is a potentially valuable commercial product because of its versatility to address large markets either as a product directly or as a key intermediate for producing renewable carbon alternatives to mainstream fuels such as jet fuel, gasoline, plastics such as Polyethylenen Terephthalate (“PET”), and various other chemical products and materials.   Isobutanol is a four-carbon alcohol that can be sold directly for use as a specialty chemicalmeaningfully in the production of solvents, paints and coatings, or more importantly from a market size and performance value-added point of view, as a gasoline blendstock.  Because isobutanol can be readily converted to hydrocarbon products such hydrocarbon fuels, including isooctane, isooctene and ATJ, lubricants, polyester, rubber, plastics, fibers and other polymers, we believe that the addressable markets are very large; potentially being able to ultimately reach 40% of the global petrochemicals markets depending on the price of oil and the value for renewable carbon.        

Our renewable isobutanol production technology has been proven to work in a 1.5 million gallon per year (“MGPY”) capacity production line, (~265,000 gallon fermenter scale) at our Luverne Facility.  We have concluded that the technology works as we expected at this scale.  Our technology to convert our renewable isobutanol to ATJ, isooctane, isooctene, and para-xylene (building block for polyester) has been proven at our hydrocarbons demonstration plant located at South Hampton Resources located in Silsbee, TX.     In order to reduce production costs further, we need to achieve economies of scale.  We plan to do this by expanding our isobutanol and hydrocarbon capabilities once we have off-take agreements in place.

In addition to our isobutanol production line, our Luverne Facility has production capacity of about 20 MGPY of ethanol, 45-50 kilotons (“KT”) of animal feed, and 3 million pounds of corn oil.  We plan on optimizing the Luverne Facility to increase margin at the site by reducing carbohydrate feedstock costs, improving thecoming decades. The total value of animal feed and protein products, and the yield of corn oil.  These improvements are expected to benefit both ethanol and isobutanol production.  We believe that these upgrades to the Luverne Facility could prove to be a key step to reach profitability, independent of isobutanol production.  

Our technology is designed to permit (i) the retrofit of existing ethanol capacity to produce renewable isobutanol, ethanol or both products simultaneously or (ii) the addition of renewable isobutanol or ethanol production capabilities to a facility’s existing ethanol production by adding additional fermentation capacity side-by-side with the facility’s existing ethanol fermentation capacity (collectively referred to as “Retrofit”). Having the flexibility to switch between the production of isobutanol and ethanol, or produce both products simultaneously, should allow us to optimize asset utilization and cash flows at a facility by taking advantage of fluctuations in market conditions. Our technology is also designed to allow relatively low capital expenditure Retrofits of existing


ethanol facilities, enabling a relatively rapid route to isobutanol production from the fermentation of renewable feedstocks. Alternatively, our technology can be deployed at a greenfield or brownfield site to produce isobutanol and hydrocarbons without producing ethanol.  

NASDAQ Market Price Compliance

On June 21, 2017, we received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market, notifying us that, for the prior 30 consecutive business days, the closing bid price of our common stock was not maintained at the minimum required closing bid price of at least $1.00 per share as required for continued listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, we had an initialmajor compliance period of 180 calendar days, to regain compliance with this requirement. On December 20, 2017, the Nasdaq Stock Market granted us an additional 180 calendar days, or until June 18, 2018, to regain compliance. To regain compliance, the closing bid price of our common stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before June 18, 2018. The Nasdaq determination to grant the second compliance period was based on our meeting of the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Markets

Isobutanol Direct Use Markets

Without modification, isobutanol has applications in the specialty chemical and gasoline blendstock markets. Since our potential customers in thesecarbon markets would not be required to develop any additional infrastructure to use our isobutanol, we believe that selling into these markets will result in a relatively low risk profile and produce attractive margins.

Gasoline Blendstocks

Isobutanol has direct applications as a gasoline blendstock. Fuel-grade isobutanol may be used as a high energy content, low Reid Vapor Pressure (“RVP”), gasoline blendstock and oxygenate. Based on isobutanol’s low water solubility, in contrast with ethanol, we believe that isobutanol will be compatible with existing refinery infrastructure, allowing for blending at the refinery rather than blending at the terminal.

Further, based on isobutanol’s high energy content and low water solubility, as well as testing completed by the National Marine Manufacturers Association, the Outdoor Power Equipment Institute and Briggs & Stratton, we believe that isobutanol has direct applications as a blendstock in high value specialty fuels markets serving marine, off-road vehicles, small engine and sports vehicle markets.

We estimate the total addressable worldwide market for isobutanol as a gasoline blendstock to be approximately 43 billion gallons per year (“BGPY”).

The market size for ethanol free (E0) gasoline, a large niche, is estimated by the EIA to be about 5 BGPY, outside of RFG regions. RFG areas are required to sell gasoline containing an oxygenate. Up to this point, ethanol was the only gasoline oxygenate available. We believe our isobutanol enables ethanol free gasoline in RFG areas, a market estimated to be about 2BGPY. When RFG regions are included in the total US market size estimation, the total ethanol free market is expected to be about 7 BGPY.

Specialty Chemicals

Isobutanol has direct applications as a specialty chemical. High-puritygreater than $800 billion in 2023, according to Bloomberg. Verity intends to document and chemical-grade isobutanol can be used as a solvent and chemical intermediate. We plan to produce high-purity and chemical-grade isobutanol that can be usedaccount for carbon capture in the existing butanol markets as a cost-effective, environmentally sensitive alternative to petroleum-based products.

We believe that our production route will be cost-efficient and will allow for significant expansion of the historical isobutanol markets within existing butanol markets through displacing n-butanol, a related compound to isobutanol that is currently sold into butanol markets.

We estimate the total addressable worldwide market for isobutanol as a specialty chemical to be approximately 1.2 BGPY.

Butene and Hydrocarbon Markets Derived from Isobutanol


Beyond direct use as a specialty chemical and gasoline blendstock, isobutanol can be dehydrated to produce butenes which can then be converted into other products such as para-xylene, jet fuel and many other hydrocarbon fuels and specialty blendstocks, and specialty chemicals offering substantialconjunction with scientifically supported measurement techniques. The potential for additional demand. The conversionVerity is broad and could be applicable to tracking the CI of isobutanol into butenes is a fundamentally important process that enables isobutanolvarious items beyond Gevo’s internal businesses, including, but not limited to, be used as a building block chemical in multiple markets.

Jet Fuel

According to IATA, the year-on-year growth for jet fuel is about 3 BGPYrenewable fuels, food, feed and industrial products through their respective business systems and value chains. Our robust scientific measurement, reporting, and verification plan and approach is expected to continue at approximately the same growth rate for the next decade.   From 2020 onward the airlines industry has pledged to hold its annual emission of fossilprovide a high-quality credit that should meet regulated compliance and unregulated carbon constant after 2020.  By the year 2027 IATA expects that the airlines industry will have adopted penalties tied to GHG emissions.  This means that the emissions from jets need to be mitigated.  As part of the mitigation of fossil based GHG’s, IATA expects that renewable resource based low carbon fuels will be needed.   We have developedmarkets.

In March 2023, we entered into a jet fuel made from our isobutanol.  This fuel is commonly referred to as alcohol-to-jet fuel or ATJ.  

In April 2016, ASTM International completed its process of approvingjoint development framework agreement with Southwest Iowa Renewable Energy; in August 2023, we entered into a revision of ASTM D7566 (Standard Specification for Aviation Turbine Fuel Containing Synthesized Hydrocarbons) to include alcohol to jet synthetic paraffinic kerosene derived from renewable isobutanol. This allows our renewable jet fuel to be used asjoint development framework agreement with a blending component in standard Jet A-1 for commercial airline usesecond ethanol producer in the United States and around the globe.

We have delivered ATJ which was used by nine airlines for Fly Green Day, sponsored by the O’Hare Fuel Committee, at Chicago O’Hare International Airport.  This event is the first time renewable jet fuelMidwest that has been supplied at Chicago O’Hare using the existing airport fueling infrastructure, such as pipelines, terminals and tankage.

We have previously delivered ATJ to Alaska Airlines, which successfully flew multiple commercial flights using our fuel in 2016, including what we believed was the first commercial flight using a cellulosic jet fuel derived from wood waste.

We have successfully delivered to the U.S. Air Force, the U.S. Army and the U.S. Navy a combined total of approximately 90,000over 100 million gallons of our ATJ. Militarycapacity; and commercial airlines are currently looking to form strategic alliancesin October 2023 we entered into an agreement with biofuels companies to meet their renewable fuel needs.

We estimate the global market for jet fuel to be approximately 89 BGPY.

Other Hydrocarbon Fuels

Isooctane, isooctene, diesel fuel and bunker fuel may also be produced from our isobutanol. We have been producing jet fuel and isooctane for renewable gasoline at our demonstration plant located at South Hampton Resources in Silsbee, TX since 2011.   The products produced at our hydrocarbon plant are sold on a commercial basis to develop the markets.   We continue to optimize the technologies and production systems, but we believe this technology is ready to scale up on a full commercial basis.  

Para-xylene (“PX”) and Polyethylene Terephthalate (“PET”)

Isobutanol can be used to produce PX, polyester and their derivatives, which are usedthird ethanol producer in the beverage, food packaging, textileSouthwest. These agreements include commercial terms and fibers markets. PX is a key raw material in PET production.

We estimate the global market for PET to be approximately 50 million metric tons per year of which approximately 30% is used for plastic bottles and containers. We have demonstrated the conversion of our isobutanol into renewable PX at the demonstration plant in Silsbee, TX.  This demonstration plant produced renewable PX from October 2013 through March 2014, and, in May 2014,profit-sharing frameworks. As we shipped renewable PX to Toray Industries, Inc. (“Toray Industries”) under the terms of a supply agreement.

Butenes

Traditionally butenes have been producedgrow Verity as co-products from the process of cracking naphtha in the production of ethylene. Historically, lower natural gas prices and reported reductions in the use of naphtha as the feedstock for the production of ethylene have resulted in a projected reduction in the volume of available butenes. This structural shift in feedstocks increases the potential market opportunity for our isobutanol in the production of butenes.

Isobutanol can be sold to isobutylene and n-butene (butenes) chemicals users for conversion into lubricants, methyl methacrylate and rubber applications.


Our Build-Out Strategy

Wean externally facing business, we are working to secure off-takesign up additional ethanol and biofuel customers. Each of these agreements will focus on implementing Verity technology and developing the market for carbon credits to help farmers and biofuel producers quantify the CI reductions for their products.

During the second quarter of 2023, we launched the Verity Tracking platform (the “Platform”) with farmers in the Lake Preston, South Dakota area who participated in our 2022 grower program. In its initial release, the Platform allows the users to measure, report, verify, and view the CI scores at both the farm average and field-by-field levels. The Platform provides insights into the contributors and removers behind the CI, helping users to understand the factors that justifydrive differences in CI performance between fields. Users can also compare their scores with the build-outU.S. national average calculated by the GREET model.

12

Our Facilities and hydrocarbon product capacitiesProjects

Development Scale Facility

As described above, we currently own a development scale plant, the Luverne Facility. The Luverne Facility was originally constructed in 1998 and is located on approximately 55 acres of land containing approximately 50,000 square feet of building space. In 2022, the activities at our Luverne Facility or another suitable location.  We planwere transitioned to use those agreementscare and maintenance, market development, and customer education, as we shifted focus to aid inour Net-Zero Projects. The workforce adjustment allowed us to retain key personnel and redeploy some resources to our NZ1 and RNG projects to provide valuable knowledge and experience for the financing of these build-out projects.  The sizefuture strategic growth of the build-out projects will be determined by customer demand.  We currently believe that the Luverne Facility offers the best site for the build-out projects given the technology already deployed at the Luverne Facility.  However, if an opportunity arose whereby overall production cost of products (net of carbon value) or if a different location aided financing significantly, certain equipment could be moved from the Luverne Facility to a new site, and our products could be produced at a site other than the Luverne Facility instead.  Beyond the Luverne Facility, we believe that we will license our technology or partner to build additional plants, leveraging existing ethanol industry infrastructure and production capacity.  We may not be successful in our efforts to build out the Luverne Facility or license our technology.

Our Retrofit at the Luverne Facility

In September 2010, we acquired the Luverne Facility, a 22 MGPY ethanol production facility in Luverne, Minnesota.  Since 2010, we made improvements and modifications to the Luverne Facility to add isobutanol production capabilities.Company. The Luverne Facility is currently configuredwell equipped and positioned as a development site as it provides a unique opportunity to produce ethanolshowcase our decarbonization and isobutanol, side-by-side.business systems and raise awareness for future partnerships, investors, and local communities, even though operations at the site have been minimized. Future operations, if any, will be tailored to support a focus on advancing our technology, testing, optimizing alternative feedstocks and yeast strains, and unit operations as well as partnership development for fuels and specialty chemicals with integrated solutions for GHG reductions. We continue to evaluate incentive opportunities recently introduced by the Inflation Reduction Act, which may positively impact the future economics of our operation at Luverne.

Third Party RetrofitRNG Facilities

We developed Gevo’s initial RNG project, Gevo RNG, in Northwest Iowa to generate RNG captured from dairy cow manure which is supplied by three dairies located in Northwest Iowa. Gevo RNG has a designed capacity of 400,000 MMBtu of RNG per year. The RNG is sold into the California market under dispensing agreements BP Canada Energy Marketing Corp. and Construction ActivitiesBP Products North America Inc. (collectively, “BP”) have in place with Clean Energy Fuels Corp., the largest fueling infrastructure in the U.S. for RNG. We commenced construction of the Gevo RNG project in April 2021, and in the third quarter of 2022, the Gevo RNG project ramped up production of biogas, raw biogas upgrading to RNG and the injection of RNG into an interconnected natural gas pipeline.

We have commencedfour leases for land and three fuel supply agreements related to the Gevo RNG project. Under these contracts, we lease land from dairy farmers on which we have built a licensing strategy wherebygas upgrading unit, three anaerobic digesters, related equipment and pipelines. These leases expire at various dates between 2031 and 2050.

Development Properties

In July 2022, we purchased approximately 240 acres of land for NZ1 in Lake Preston, South Dakota, followed by a licensee would investgroundbreaking ceremony in Lake Preston in September 2022. Refer to the capitalsection entitled “Greenfield Projects” above for additional information about NZ1.

Headquarters

Our corporate headquarters and research and development laboratories are located in Englewood, Colorado and are leased. Our lease terminates in January 2029 and the Retrofitleased space is approximately 19,241 square feet.

Competition

We face competitors in each market that we focus on, some of its own ethanol plant orwhich are limited to individual markets, and some of which will compete with us across all of our target markets. Many of our competitors have greater financial resources, more comprehensive product lines, broader market presence, longer standing relationships with customers, longer operating histories, greater production capabilities, stronger brand recognition and greater marketing resources than we do which could make it difficult for a new greenfield build outus to compete.

13

Our renewable hydrocarbons, including SAF, compete with the licensor, would expect to receive an up-front license fee and ongoing royalty payments from the projects,incumbent petroleum-based fuels industry, as well as other potential revenue streamsrenewable fuels companies. The incumbent petroleum-based fuels industry makes the vast majority of the world’s gasoline, jet and diesel fuels and blendstocks. The petroleum-based fuels industry is mature and includes a substantial base of infrastructure for the production and distribution of petroleum-derived products, however, the industry faces challenges from its dependence on petroleum. High and volatile oil prices should provide an opportunity for renewable producers relying on biobased feedstocks like corn, which in recent years have had lower price volatility than oil, to compete.

Renewable fuels companies may provide substantial competition in the hydrocarbon fuels markets. These renewable fuel competitors are numerous and include both large established companies and numerous startups. Government tax incentives for renewable fuel producers and regulations such as yeast sales. This licensing strategy is expectedthe Inflation Reduction Act Clean Fuel Production Credit, RFS Program, California LCFS program, and programs emerging in other states such as Illinois help provide opportunities for renewable fuels producers to take some timecompete. We believe that we have the advantage of being able to develop. The abilitytarget conversion of alcohols into specific high-value molecules such as SAF, other renewable hydrocarbons and various chemical products.

Intellectual Property and Technologies

We seek protection for our intellectual property under patent, copyright, trademark and trade secret laws.

Since the Company was founded, we have submitted hundreds of patent applications in the U.S. and in various foreign jurisdictions. These patent applications are for our technologies and specific methods and products that support our business. We continue to license afile new patent applications, for which terms extend up to 20 years from the filing date in the U.S. and for various terms in international jurisdictions. We expect to continue to develop and build our intellectual property portfolio to address unmet technology is generally related to the commercial track record of the underlying technology itself. In addition, revenues from licensing our isobutanol and/or hydrocarbon technologies are expected to be directly linked to the build out of specific projects, which may take multiple years to construct.

Our Production Technology Platformand market needs going forward.

We have used tools from synthetic biology, biotechnology, chemical catalysis,filed and process engineeringprosecuted, and intend to developcontinue to file and prosecute, patent applications and maintain trade secrets, as is consistent with our business plan, in an ongoing effort to protect our intellectual property.

We have a strong proprietary set of technologies that enable the potential of cost effective production of isobutanol andtechnology position. Our technology pathway converts carbohydrates to alcohols via a fermentation process. The alcohols are then converted to hydrocarbon fuels using a catalytic chemical process. By using renewable energy across the production process, in combination with sustainable feedstocks, like low carbon non-food corn, the GHG emissions can be substantially reduced or eliminated as measured across the whole of the life cycle. The processes used to convert carbohydrates to drop in hydrocarbons using isobutanol as the intermediate alcohol is protected by a global patent portfolio with more than 300 patents, as well as proprietary processes and chemicals.  We believeknow-how. Certain production technology to convert ethanol to hydrocarbons has been exclusively licensed to Gevo in the technologiesU.S. by Axens, and incorporates more than 60 patents, as well as proprietary production technology and know-how. Additionally, we have multiple patents and patent applications covering the ethanol to be proven to work, having made and sold products using these technologies.  hydrocarbons routes.

We have a proprietary fermentation yeast biocatalyst that effectively produces isobutanol.has been designed to consume carbohydrates and produce isobutanol as a product. Our technology team developed our proprietary biocatalyst to efficiently convert fermentable sugars of all types into isobutanol by engineering isobutanol pathways into the biocatalyst. The advantage of this biocatalyst is that it (i) works in large scale fermentation systems, and (ii) can operate in complex biological mixtures such as corn mash or molasses and produce a suitable clean isobutanol product. The technology is designed to use similar carbohydrate feedstocks, similar to ethanol technology. For example, carbohydrates from non-food corn, sugar cane, molasses or cellulosic sugars each could be used depending upon cost and availability. We believe that our technology has the potential to add value to existing ethanol production sites by increasing the site profitability if our technologies are deployed.  

We have demonstrated that our isobutanol to hydrocarbon technologies for the production of jet fuel, isooctane, isooctene, and paraxylene appear to be viable from a technical and process point of view.  These catalytic technologies appear to be effective and scalable.  

Animal feed, protein, and oil are important products produced at our Luverne Facility.  Animal feed is made from the spent grain mash from isobutanol and fermentations. We market our distiller’s grains to the, beef, swine and poultry industries as a high-protein, high-energy animal feed. The spent yeast from fermentation adds protein to the mix, resulting in a higher protein content than corn itself. By selling the feed, protein, and oil products, we generate additional revenues and effectively reduce the net cost of fermentation feedstock.  Going forward we see opportunity to further add value to animal feed, protein, and oil products, thereby benefiting the site margin at the Luverne Facility, whether we produce isobutanol, ethanol, or both.

Biocatalyst Overview

Our biocatalysts are microorganisms that have been designed to consume carbohydrates and produce isobutanol as a product. Our technology team developed these proprietary biocatalysts to efficiently convert fermentable sugars of all types into isobutanol by engineering isobutanol pathways into the biocatalysts.  We designed our biocatalysts to equal or exceed the performance of the yeast currently used in commercial ethanol production in yield (percentage of the theoretical maximum percentage of isobutanol that can be made from a given amount of feedstock) and rate (how fast the sugar fed to the fermentation is converted to isobutanol). To achieve this, we believe that more than 100 genetic changes have been made to our yeast biocatalyst.  We achieved our target fermentation performance goals at our Luverne Facility, given the scale we at which we operate. We continue to seek to improve the performance


parameters of our biocatalyst with a goal of reducing projected capital and operating costs, increasing operating reliability and increasing the volume of isobutanol production.

In 2016, in a project sponsored by the USDA, we used our one MGPY demonstration facility located at ICM, Inc.’s St. Joseph, Missouri facility to convert hydrolyzed wood feedstocks into isobutanol. The isobutanol produced was converted to jet fuel and used for flights on Alaska Airlines.  

While we believe that the majority of the development work on a commercially viable isobutanol producing yeast is complete, we expect to continue to make incrementaladditional improvements targeted to improve its commercial performance.

Feedstocks

In the U.S., non-food corn is a commercially attractive feedstock for both ethanol and isobutanol, because it is abundant and readily available, but more importantly because this corn generates low cost carbohydrates, protein and feed for the food chain, and corn oil.  In other parts of the world sugar or molasses from cane, beets, or other sugar producing crops could be used.  In the future, certain types of cellulosic sugars could be used once the cost to acquire those sugars becomes cost effective.  We have designed our biocatalyst platform to be capable of producing isobutanol from any fuel ethanol feedstock currently in commercial use, which we believe, in conjunction with our proprietary isobutanol separation unit, will permit us to modify any existing fuel ethanol facility to produce our products.

Our Luverne Facility is currently set up to use non-food corn as a feedstock.   The starch is fermented to isobutanol and or ethanol, the fiber and protein are isolated from the process and sold as animal feed, and the corn oil is sold for industrial use.  

We expect that our feedstock flexibility will allow our technology to be deployed worldwide and will enable us to offer our customers protection from the raw material cost volatility historically associated with petroleum-based products.  For example, in some parts of the world, it may be that molasses is a lower cost feedstock, in others, sugar from beets or cane might be the lower cost feedstock.  As cellulosic sugars become economical, we expect that these could be viable as a feedstock too.

In the future we expect feedstocks to be chosen on the collective basis of (i) cost, (ii) carbon and or sustainability footprint with associated value, (iii) positive contribution to food chain where possible, and (iv) availability of the feedstock at a practical scale.

In June 2015, Agri-Energy, LLC, our wholly-owned subsidiary, entered into a Price Risk Management, Origination and Merchandising Agreement, as amended as of December 21, 2017 (the “Origination Agreement”) with FCStone Merchant Services, LLC (“FCStone”) and a Grain Bin Lease Agreement with FCStone, as amended as of December 21, 2107 (the “Lease Agreement”). Pursuant to the Origination Agreement, FCStone will originate and sell to Agri-Energy, the owner of the Luverne Facility, and Agri-Energy will purchase from FCStone, the entire volume of corn grain used by the Luverne Facility in Luverne, Minnesota.  For more information, see Item 7A.Quantitative and Qualitative Disclosures about Market Risk below.

Conversion of Isobutanol into Hydrocarbons

We have demonstrated conversion of our isobutanol into a wide variety of hydrocarbon products which are currently used to produce plastics, fibers, polyester, rubber and other polymers and hydrocarbon fuels. Hydrocarbon products consist entirely of hydrogen and carbon and are currently derived almost exclusively from petroleum, natural gas and coal. Importantly, isobutanol can be dehydrated to produce butenes, which are an intermediate product in the production of hydrocarbon products with many industrial uses. The straightforward conversion of our isobutanol into butenes is a fundamentally important process that enables isobutanol to be used as a building block chemical. Much of the technology necessary to convert isobutanol into butenes and subsequently into these hydrocarbon products is commonly known and practiced in the chemicals industry today.  For example, the dehydration of ethanol to ethylene, which uses a similar process and technology to the dehydration of isobutanol, is practiced commercially today to serve the ethylene market. The dehydration of isobutanol into butenes is not commercially practiced today because isobutanol produced from petroleum is not cost-competitive with other petrochemical processes for generation of butenes. We believe that our efficient fermentation technology for producing isobutanol will promote commercial isobutanol dehydration and provide us with the opportunity to access hydrocarbon markets. To assist in accessing these markets, we have developed a hydrocarbon processing demonstration plant (“Hydrocarbons Demo Plant”) near Houston, Texas, in partnership with South Hampton Resources, Inc. (“South Hampton”). The Hydrocarbon Demo Plant can process approximately 6,000 to 7,000 gallons of our isobutanol per month into a variety of renewable hydrocarbons for use as fuels and chemicals. We have been selling products from this plant since 2011.


Our ETO Technology

We have also developed new technologies using ethanol as a feedstock for the production of hydrocarbons, renewable hydrogen, and other chemical intermediates, which we describe as our ethanol-to-olefins (“ETO”) technologies. The process produces tailored mixes of isobutylene, propylene, hydrogen and acetone, which are valuable as standalone molecules, or as feedstocks to produce other chemical products and longer chain alcohols. This technology has the potential to address additional markets in the chemicals and plastics fields, such as renewable polypropylene for automobiles and packaging and renewable hydrogen for use in chemical and fuel cell markets. At this time, this technology has only been operated at a laboratory scale, but if successfully scaled up to commercial level, this technology may provide the estimated 25BGPY global ethanol industry a broader set of end-product market and margin opportunities.

Underpinning the ETO technology is our development of proprietary mixed metal oxide catalysts that produce either polymer grade propylene, isobutylene or acetone in high yields in a single processing step. One of the benefits of the technology is that we can use conventional fuel grade specification ethanol that can be sourced from a variety of feedstocks with no apparent adverse impact on end product yields. Water, which is co-fed with the ethanol, is able to be recycled resulting in a process which generates minimal waste. The ethanol and water mixture is vaporized and fed across a fixed catalyst bed resulting in a gaseous product mix consisting of the propylene, isobutylene or acetone, in addition to hydrogen and carbon dioxide, along with lesser amounts of methane and ethylene. Separation of gaseous products can be achieved via conventional process technologies and unit operations within the petroleum industry.

We have found that our ETO technology is effective at converting fusel oils into flavors, fragrances, and certain specialty solvents.  We are evaluating the business opportunities and commercial potential.

Butamax Advanced Biofuels LLC

Between 2011 and 2015, we were involved in an intellectual property dispute with Butamax Advanced Biofuels LLC (“Butamax”).  We believe the dispute was satisfactorily resolved, enabling each of our companies to pursue their respective businesses.

Cross License Agreement

On August 22, 2015, we entered into a Settlement Agreement and Mutual Release (the “Settlement Agreement”) with Butamax, E.I. du Pont de Nemours & Company (“DuPont”) and BP Biofuels North America LLC (“BP” and, together with Butamax and DuPont, the “Butamax Parties”), that resolves the various disputes, lawsuits and other proceedings between one or more of the Butamax Parties and us, as previously disclosed and as specifically identified in the Settlement Agreement (the “Subject Litigation”), and creates a new business relationship pursuant to which Butamax and we have granted rights to each other under certain patents and patent applications in accordance with the terms of a Patent Cross-License Agreement (the “License Agreement”) which was entered into by us and Butamax concurrently with the Settlement Agreement  For additional information concerning the settlement agreement, please see our Annual Report on Form 10-K for the year-ended December 31, 2015 — Item 3 Legal Proceedings.

Pursuant to the terms of the License Agreement, each party receives a non-exclusive license under certain patents and patent applications owned or licensed (and sublicensable) by the other party for the production and use of biocatalysts in the manufacture of isobutanol using certain production process technology for the separation of isobutanol, and to manufacture and sell such isobutanol in any fields relating to the production or use of isobutanol and isobutanol derivatives, subject to the customer-facing field restrictions described below. Each party also receives a non-exclusive license to perform research and development on biocatalysts for the production, recovery and use of isobutanol.

Each party may produce and sell up to 30 million gallons of isobutanol per year in any field on a royalty-free basis. Butamax will be the primary customer-facing seller of isobutanol in the field of fuel blending (subject to certain exceptions, the “Direct Fuel Blending” field) and we will be the primary customer-facing seller of isobutanol in the field of jet fuel for use in aviation gas turbines (the “Jet” field, also subject to certain exceptions). As such, subject to each party’s right to sell up to 30 million gallons of isobutanol per year in any field on a royalty-free basis, other than with Butamax’s written consent, we will only sell isobutanol through Butamax in the Direct Fuel Blending field subject to a royalty based on the net sales price for each gallon of isobutanol sold or transferred by us, our affiliates or sublicensees within the Direct Fuel Blending field (whether through Butamax or not) and on commercially reasonable terms to be negotiated between the parties and Butamax will only sell isobutanol through us in the Jet field subject to a royalty based on the net sales price for each gallon of isobutanol sold or transferred by Butamax, its affiliates or sublicensees within the Jet field (whether through us or not) and on commercially reasonable terms to be negotiated between the parties; provided, that each party may sell up to fifteen million gallons of isobutanol in a given year directly to customers in the other party’s customer-facing field on a royalty-free basis so long as the isobutanol volumes are within the permitted 30 million gallons of isobutanol sold or otherwise transferred per year in any field described above and, in certain instances, each party may then sell up to the total permitted 30 million gallons per year in the other party’s customer-facing field on a royalty-free basis. In addition, in order to maintain its status


as the primary customer-facing seller in these specific fields, each party must meet certain milestones within the first five years of the License Agreement. If such milestones are not met as determined by an arbitration panel, then a party will have the right to sell directly to customers in the other party’s customer-facing field subject to the payment of certain royalties to the other party on such sales.

In addition to the royalties discussed above for sales of isobutanol in the Direct Fuel Blending field, and subject to our right to sell up to 30 million gallons of isobutanol per year in any field on a royalty-free basis, we will pay to Butamax a royalty per gallon of isobutanol sold or transferred by us, our affiliates or sublicensees within the field of isobutylene (a derivative of isobutanol) applications (other than isobutylene for paraxylene, isooctane, Jet, diesel and oligomerized isobutylene applications). Likewise, in addition to the royalties discussed above for sales of isobutanol in the Jet field, and subject to Butamax’s right to sell up to 30 million gallons of isobutanol per year in any field on a royalty-free basis, Butamax will pay to us a royalty per gallon of isobutanol sold or transferred by Butamax, its affiliates or sublicensees within the fields of marine gasoline, retail packaged fuels and paraxylene (except for gasoline blending that results in use in marine or other fuel applications). The royalties described above will be due only once for any volume of isobutanol sold or transferred under the License Agreement, and such royalties accrue when such volume of isobutanol is distributed for end use in the particular royalty-bearing field. All sales of isobutanol in other fields will be royalty-free, subject to the potential technology fee described below.

In the event that we, our affiliates or sublicensees choose to employ a certain solids separation technology for the production of isobutanol at one of their respective plants (“Solids Separation Technology”), we are granted an option to license such technology from Butamax on a non-exclusive basis subject to the payment of a one-time technology license fee based on the rated isobutanol capacity for each such plant (subject to additional fees upon expansion of such capacity). We also receive the option to obtain an engineering package from Butamax to implement the Solids Separation Technology on commercially reasonable terms to be negotiated between the parties and subject to the technology fee described above and an additional technology licensing fee for use of the Solids Separation Technology applicable to ethanol capacity as provided in such engineering package from Butamax (which capacity is not duplicative of the rated isobutanol capacity referenced above) in instances where Butamax provides an engineering package for use at a particular plant that will run isobutanol and ethanol production side-by-side using the licensed Solids Separation Technology at such plant.

The License Agreement encompasses both parties’ patents for producing isobutanol, including biocatalysts and separation technologies, as well as for producing hydrocarbon products derived from isobutanol, including certain improvements and new patent applications filed within seven years of the date of the License Agreement. While the parties have cross-licensed their patents for making and using isobutanol, the parties will not share their own proprietary biocatalysts with each other. The parties may use third parties to manufacture biocatalysts on their behalf and may license their respective technology packages for the production of isobutanol to third parties, subject to certain restrictions. A third party licensee would be granted a sub-license, and would be subject to terms and conditions that are consistent with those under the License Agreement.

Under the License Agreement, the parties also agreed to certain limitations on the making or participating in a challenge of the other party’s patents that are at issue in the Subject Litigation. The parties have also made certain representations, warranties and covenants to each other including, without limitation, with respect to obtaining certain consents, indebtedness, rights in the licensed patents, and relationships with certain other ethanol plant process technology providers.

The License Agreement will continue in effect until the expiration of the licensed patents, unless earlier terminated by a party as provided in the License Agreement. The parties also have certain termination rights with respect to the term of the license granted to the other party under the License Agreement upon the occurrence of, among other things, a material uncured breach by the other party. In the event that a party’s license is terminated under the License Agreement, such party’s sublicense agreements may be assigned to the other party, subject to certain restrictions.

The parties may not assign the License Agreement or any right or obligation thereunder without the prior written consent of the other party. However, the parties may assign the License Agreement to an affiliate or a person that acquires all of the business or assets of such party, subject to certain restrictions.

Competition

Our isobutanol is targeted for use in the following markets: direct use as a solvent and gasoline blendstock, use in the chemicals industry for producing rubber, plastics, fibers, polyester and other polymers and use in the production of hydrocarbon fuels. We face competitors in each market, some of which are limited to individual markets, and some of which will compete with us across all of our target markets.  Many of our competitors have greater financial resources than we do.  If we fail to raise sufficient capital for our business and strategy, we may not be able to successfully compete.


Renewable isobutanol. We are a leader in the development of renewable isobutanol via fermentation of renewable plant biomass. While the competitive landscape in renewable isobutanol production is limited at this time, we are aware of other companies that are seeking to develop isobutanol production capabilities, including Butamax with whom we have entered into the License Agreement.  See above—Butamax Advanced Biofuels LLC—Cross License Agreement.

Solvent markets. We also face competition from companies that are focused on the development of n-butanol, a related compound to isobutanol. These companies include Cathay Industrial Biotech Ltd., METabolic EXplorer S.A., Eastman Chemicals Company, and Green Biologics Ltd. We understand that these companies produce n-butanol from an acetone-butanol-ethanol (“ABE”) fermentation process primarily for the small chemicals markets. ABE fermentation using a Clostridia biocatalyst has been used in industrial settings since 1919. As discussed in several academic papers analyzing the ABE process, such fermentation is handicapped in competitiveness by high energy costs due to low concentrations of butanol produced and significant volumes of water processed. It requires high capital and operating costs to support industrial scale production due to the low rates of the Clostridia fermentation, and results in a lower butanol yield because it produces ethanol and acetone as by-products. We believe our proprietary process has many significant advantages over the ABE process because of its limited requirements for new capital expenditures, its production output of only isobutanol as a primary product and its limited water usage in production. We believe these advantages will produce a lower cost isobutanol compared to n-butanol produced by ABE fermentation. N-butanol’s lower octane rating compared to isobutanol gives it a lower value in the gasoline blendstock market, but n-butanol can compete directly in many solvent markets where n-butanol and isobutanol have similar performance characteristics.

Gasoline blendstocks. In the gasoline blendstock market, isobutanol competes with non-renewable alkylate and renewable ethanol. We estimate the total potential global market for isobutanol as a gasoline blendstock to be approximately 43 BGPY. Alkylate is a premium value gasoline blendstock typically derived from petroleum. However, petroleum feeds for alkylate manufacture are pressured by continued increases in the use of natural gas to generate olefins for the production of alkylate, due to the low relative cost of natural gas compared to petroleum. Isobutanol has fuel properties similar to alkylate and, as such, we expect that isobutanol could be used as a substitute for some alkylate in fuel applications. Ethanol is renewable and has a high octane rating, and although it has a high RVP, ethanol receives a one pound RVP waiver in a large portion of the U.S. gasoline market. Renewability is important in the U.S. because the Renewable Fuels Standard program mandates that a minimum volume of renewable blendstocks be used in gasoline each year. A high octane rating is important for engine performance and is a valuable characteristic because many inexpensive gasoline blendstocks have lower octane ratings. Low RVP is important because the U.S. Environmental Protection Agency (“EPA”) sets maximum permissible RVP levels for gasoline. In markets where low RVP is important, isobutanol can enable refiners to meet fuel specifications at lower cost. Ethanol’s vapor pressure waiver is valuable because it offsets much of the negative value of ethanol’s high RVP. We believe that our isobutanol will be valued for its combination of low RVP, low water solubility, relatively high octane and renewability.

Many production and technology supply companies are working to develop ethanol production from cellulosic feedstocks, including Shell Oil Company, DuPont-Danisco Cellulosic Ethanol LLC, POET, LLC, ICM, Inc., Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Archer Daniels Midland Company, BlueFire Renewables, Inc., ZeaChem Inc., Iogen Corporation, Qteros, Inc., and many smaller startup companies. Successful commercialization by some or all of these companies will increase the supply of renewable gasoline blendstocks worldwide, potentially reducing the market size or margins available to isobutanol.

Of particular interest to us is the “ethanol free” gasoline blendstock market.  This market segment is estimated by the EIA to be approximately 5 BGPY in non RFG regions.  In the past, ethanol free gasoline could not be sold in RFG areas because RFG areas require oxygen in gasoline.  Isobutanol can now be used in the RFG areas to make an ethanol free gasoline.  The estimated potential of isobutanol blended gasoline is estimated to be about 2 BGPY.   Isobutanol containing gasoline has been successfully introduced in the Houston region. It appears that isobutanol is uniquely suited to address the market for ethanol free gasoline in RFG areas.  We are unaware of any other viable alternative.

Plastics, fibers, polyester, rubber and other polymers. Isobutanol can be dehydrated to produce butenes, hydrocarbon intermediates currently used in the production of plastics, fibers, polyester, rubber and other polymers. The straightforward conversion of our isobutanol into butenes is a fundamentally important process that enables isobutanol to be used as a building block chemical in multiple markets. These markets include butyl rubber, lubricants and additives derived from butenes such as isobutylene, poly methyl methacrylate from isobutanol, propylene for polypropylene from isobutylene, polyesters made via PX from isobutylene and polystyrene made via styrene.

In these markets, we compete with the renewable isobutanol companies and renewable n-butanol producers described previously, and face similar competitive challenges. Our competitive position versus petroleum-derived plastics, fibers, rubber and other polymers varies, but we believe that the high volatility of petroleum prices, often tight supply markets for petroleum-based petrochemical feedstocks and the desire of many consumers for goods made from more renewable sources will enable us to compete effectively. However, petrochemical companies may develop alternative pathways to produce petrochemical-based hydrocarbon


products that may be less expensive than our isobutanol or more readily available or developed in conjunction with major petrochemical, refiner or end user companies. These products may have economic or other advantages over the plastics, fibers, polyester, rubber and other polymers developed from our isobutanol. Further, some of these companies have access to significantly more resources than we do to develop products.

Additionally, Global Bioenergies, S.A. is pursuing the direct production of isobutylene from renewable carbohydrates. Through analysis of the fermentation pathway, we believe that the direct production of butenes such as isobutylene via fermentation will have higher capital and operating costs than production of butenes derived from our isobutanol.

Hydrocarbon fuels. Beyond direct use as a fuel additive, isobutanol can be converted into many hydrocarbon fuels and specialty blendstocks, offering substantial potential for additional demand in the fuels markets. We will compete with the incumbent petroleum-based fuels industry, as well as biofuels companies. The incumbent petroleum-based fuels industry makes the vast majority of the world’s gasoline, jet and diesel fuels and blendstocks. The petroleum-based fuels industry is mature, and includes a substantial base of infrastructure for the production and distribution of petroleum-derived products. However, the industry faces challenges from its dependence on petroleum. High and volatile oil prices will provide an opportunity for renewable producers relying on biobased feedstocks like corn, which in recent years have had lower price volatility than oil, to compete.

Biofuels companies will provide substantial competition in the gasoline market. These biofuels competitors are numerous and include both large established companies and numerous startups. Government tax incentives for renewable fuel producers and regulations such as the United States Renewable Fuel Standard Program or RFS Program help provide opportunities for renewable fuels producers to compete. In particular, in the gasoline and gasoline blendstock markets, Virent Energy Systems, Inc. (“Virent”) offers a competitive process for making gasoline and gasoline blendstocks. However, we have the advantage of being able to target conversion of isobutanol into specific high-value molecules such as isooctane, which can be used to make gasoline blendstocks with a higher value than whole gasoline, which we do not believe Virent’s process can match. In the jet fuel market, we may face competition from companies such as Synthetic Genomics, Inc., Sapphire Energy, Inc. and Exxon-Mobil Corporation, which are pursuing production of jet fuel from algae-based technology. Renewable Energy Group, Inc. and others are also targeting production of jet fuels from vegetable oils and animal fats. Red Rock Biofuels LLC, Fulcrum BioEnergy, Inc. and others are planning to produce jet fuel from renewable biomass.  In the diesel fuels market, competitors such as Amyris Biotechnologies, Inc. (“Amyris”) provide alternative hydrocarbon diesel fuel. We believe our technology provides a higher yield on feedstock than the isoprenoid fermentation pathway developed by Amyris, which we believe will yield a production cost advantage.

Ethanol. We compete with numerous ethanol producers located throughout the U.S., many of which have much greater resources than we do, including Archer-Daniels-Midland Company, Green Plains, Inc., POET, LLC and Valero Energy Corporation. Competition for corn supply from other ethanol plants and other corn consumers will likely exist in all areas and regions in which our current and future plants will operate.  We also face competition from foreign producers of ethanol and such competition may increase significantly in the future. Large international companies have developed, or are developing, increased foreign ethanol production capacities. Brazil is the world’s second largest ethanol producing country.  Brazil’s ethanol production is sugarcane-based, as opposed to corn-based, and has historically been less expensive to produce.

Intellectual Property

Our success depends in large part on our proprietary products and technology for which we seek protection under patent, copyright, trademark and trade secret laws. Such protection is also maintained in part using confidential disclosure agreements. Protection of our technologies is important so that we may offer our customers and partners proprietary services and products unavailable from our competitors, and so that we may exclude our competitors from using technology that we have developed or exclusively licensed. If competitors in our industry have access to the same technology, our competitive position may be adversely affected.

We have submitted hundreds of patent applications in the U.S. and in various foreign jurisdictions. These patent applications are directed to our technologies and specific methods and products that support our business in the biofuel and bioindustrial markets. We continue to file new patent applications, for which terms extend up to 20 years from the filing date in the U.S.

As of December 31, 2017, we have been issued 24 U.S. patents and 26 international patents.

In addition to the patents and applications described above, we have a global cross-license to certain patents and applications relating to the production, recovery, and use of isobutanol that are owned or licensed by Butamax.  The global cross-license allows us to freely practice the licensed inventions, subject to the terms of the cross-license. For information regarding this license, see above —Butamax Advanced Biofuels LLC—Cross License Agreement.


We intend to file and prosecute patent applications and maintain trade secrets, as is consistent with our business plan, in an ongoing effort to protect our intellectual property. It is possible that our licensors’ current patents, or patents which we may later acquire or license, may be successfully challenged or invalidated in whole or in part. It is also possible that we may not obtain issued patents from our filed applications, and may not be able to obtain patents regarding other inventions we seek to protect.  We also may not file patents in each country in which we plan to do business or actually conduct business. Under appropriate circumstances, we may sometimes permit certain intellectual property to lapse or go abandoned. Due to uncertainties inherent in prosecuting patent applications, sometimes patent applications are rejected and we may subsequently abandon them. It is also possible that we will develop products or technologies that will not be patentable or that the patents of others will limit or preclude our ability to do business. In addition, any patent issued to us may provide us with little or no competitive advantage, in which case we may abandon such patent or license it to another entity.

We have obtained registered trademarks for Gevo Integrated Fermentation TechnologyTM, GIFTTM, and Gevo® in the U.S. These registered and pending U.S. trademarks are also registered or pending in certain foreign countries.

Our means of protecting our proprietary rights may not be adequate and our competitors may independently develop technology or products that are similar to or compete with ours. Patent, trademark and trade secret laws afford only limited protection for our technology platform and products. The laws of many countries do not protect our proprietary rights to as great an extent as do the laws of the U.S. Despite our efforts to protect our proprietary rights, unauthorized parties have in the past attempted, and may in the future attempt, to operate using aspects of our intellectual property or products or to obtain and use information that we regard as proprietary. Third parties may also design around our proprietary rights, which may render our protected technology and products less valuable. In addition, if any of our products or technologies is covered by third-party patents or other intellectual property rights, we could be subject to various legal actions. We cannot assure you that our technology platform and products do not infringe patents held by others or that they will not in the future.

Litigation may be necessary to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement, invalidity, misappropriation or other allegations. Any such litigation could result in substantial costs and diversion of our resources.  We may be unable to finance litigation costs, which may harm our ability to enforce our intellectual property rights.  Any settlement of or adverse judgment resulting from such litigation could require us to obtain a license to continue to make, use or sell the products or technology that is the subject of the claim, or otherwise restrict or prohibit our use of the technology.

Customers, Partnerships and Collaborations

We commenced a limited commercial scale campaign for the production of isobutanol in 2014 at our Luverne Facility to demonstrate commercial scale capacity and sell the resulting product.  We expect initial commercial production to be directed to serve the high-purity and chemical-grade markets, to provide introductory volumes to the specialty fuel blendstock markets in the U.S. and to be further processed at a demonstration plant near Houston, Texas, to fulfill contracts for various hydrocarbons applications such as ATJ and PX. In 2014, we also began producing and selling isobutanol distiller’s grains or iDGs™, as an animal feed co-product, in a similar manner as distiller’s grains are sold in the ethanol industry today.

In 2017, 2016 and 2015, C&N Ethanol Marketing, LLC accounted for approximately 76%, 71% and 71% of our consolidated revenue, respectively.  In the same years, Land O’Lakes Purina Feed LLC accounted for approximately 17%, 17% and 19% of our consolidated revenue, respectively.  Given our production capacity compared to the overall size of the North American market and the demand for our products, we do not believe that a decline in a specific customer's purchases would have a material adverse long-term effect upon our financial results.

As of December 31, 2017, we had entered into the following key arrangements:  

HCS Holding GmbH – In May 2017, we signed a supply agreement with HCS Holding GmbH (HCS) to supply isooctane under a five-year offtake agreement. HCS is a manufacturer of specialty products and solutions in the hydrocarbons sector, operating under such brands as Haltermann Carless. In the first phase of the supply agreement, HCS will purchase isooctane produced at our demonstration hydrocarbons plant located in Silsbee, Texas, commencing in May 2017. The pricing is fixed over the first phase and Gevo estimates that this could generate up to $2-3 million of gross revenue per year.  In the second phase of the supply agreement, HCS agreed to purchase 300,000 gallons of isooctane per year, with an option to purchase an additional 100,000 gallons of isooctane per year, under a five-year offtake arrangement upon commencement of production at our first commercial hydrocarbon facility. The supply agreement contains a pricing formula which is intended to provide us a fixed margin. We expect to supply this isooctane from its first commercial hydrocarbons facility, which is likely to be built at the Luverne Facility.

Musket Corporation. In June 2016, we entered into an agreement with Musket Corporation (“Musket”) to supply isobutanol for blending with gasoline.  Musket is a national fuel distributor under the umbrella of the Love’s Family of Companies.  In

14


November 2016, we announced that we had entered the on-road automobile gasoline market in Houston in partnership with Musket.  This marked the first time that our isobutanol had been specifically targeted towards on-road vehicles, a much larger market opportunity for isobutanol than specialty segments.  On February 8, 2018, we announced that we had strengthened our existing relationship with Musket Corporation, a national fuel distributor under the umbrella of the Love’s Family of Companies, by amending our existing isobutanol supply agreement to provide Musket with the exclusive right to sell our renewable isobutanol within a 300 mile radius of Houston, Texas.  This agreement establishes a market region that encompasses Austin, Dallas, Fort Worth, Oklahoma, Louisiana, as well as the majority of South and East Texas.

C&N Ethanol Marketing, LLC. In August 2011, we entered into a renewable fuels supply chain services agreement with C&N Ethanol Marketing Corporation, later changed to C&N Ethanol Marketing, LLC by amendment (“C&N”) to provide supply chain services including logistics management, customer service support, invoicing and billing services. Substantially all ethanol sold by us since September 2010 was sold to C&N.Table of Contents

Land O’Lakes Purina Feed LLC. In December 2011, we entered into a commercial off-take and marketing agreement with Land O’Lakes Purina Feed LLC (“Land O’Lakes Purina Feed”) for the sale of iDGs™ produced by the Luverne Facility. Land O’ Lakes Purina Feed provides farmers and ranchers with an extensive line of agricultural supplies (feed, seed, and crop protection products) and services. Pursuant to the agreement, Land O’Lakes Purina Feed will be the exclusive marketer of our iDGs™ and modified wet distiller’s grains for the animal feed market. The agreement has an initial three-year term following the first commercial sales of iDGs™ with automatic one-year renewals thereafter unless terminated by one of the parties. Further, we plan to work with Land O’Lakes Purina Feed to explore opportunities to upgrade the iDGs™ for special value-added applications in feed markets. Land O’ Lakes Purina Feed also provides marketing services for the sale of our ethanol distiller grains.

BCD Chemie. In April 2015, we entered into a first purchase order to supply isooctene to BCD Chemie, a subsidiary of Brenntag AG, a leading chemical distributor based in Germany. BCD Chemie is targeting applications in Europe to replace petroleum-based hydrocarbons to enable companies to meet regulatory requirements for renewable content in fuels while satisfying the performance requirements of their customers. We subsequently entered into additional purchase orders to supply isooctene to BCD Chemie into 2016. To date, the total value of the purchase orders to BCD Chemie is over $1 million. 

Clariant Corp. Since 2016, we have been working with Clariant Corp., one of the world’s leading specialty chemical companies, to develop catalysts to enable Gevo’s “ETO” technology and improve Gevo’s other hydrocarbon technology.  Gevo’s ETO technology, which uses ethanol as a feedstock, produces tailored mixes of propylene, isobutylene and hydrogen, which are valuable as standalone molecules, or as feedstocks to produce other products such as diesel fuel and commodity plastics, that would be drop-in replacements for their fossil-based equivalents.

Northwest Advanced Renewables Alliance.  We have provided NARA with technology to enable the commercial scale processing of cellulosic sugars from wood waste into valuable products. The cellulosic jet fuel made using our technologies was used in a 1,000-gallon renewable fuel commercial flight flown by Alaska Airlines in November 2016.  Our isobutanol and ATJ technologies were both licensed by NARA as part of this project. NARA was a five-year project supported by the U.S. Department of Agriculture, National Institute of Food and Agriculture, and is comprised of 22 member organizations from industry, academia and government laboratories. Its mission was to facilitate development of biojet and bioproduct industries in the Pacific Northwest using forest residuals that would otherwise become waste products.  The NARA project ended in 2017 after a short-term extension with additional financing of approximately $50,000 was provided in the summer of 2017.

Research and Development

Our strategy depends on continued improvement of our technologies for the production of isobutanol, as well as next generation chemicals and biofuels based on our isobutanol technology. Accordingly, we annually devote significant funds to research and development. The following table shows our research and development costs by function (in thousands).  

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Biocatalyst development

$

1,991

 

 

$

2,867

 

 

$

3,435

 

Process engineering and operation of pilot and demo plants

 

2,188

 

 

 

1,714

 

 

 

1,344

 

Chemistry and applications development

 

1,003

 

 

 

635

 

 

 

1,831

 

Total Research and Development Expense

$

5,182

 

 

$

5,216

 

 

$

6,610

 


During 2017, 2016 and 2015, we recorded revenue from government grants and cooperative agreements in the amounts of $44,000, $0.5 million, and $1.2 million, respectively, which primarily related to research and development activities performed in our biocatalyst, chemistry, and applications development groups.

Our research and development activities are currently being performed primarily in our corporate headquarters located in Englewood, Colorado and the Hydrocarbons Demo Plant in Silsbee, Texas.

Government Regulation - Environmental Compliance Costs

Regulation by governmental authorities in the U.S. and other countries is a significant factor in the development, manufacture and marketing of second-generation biofuels. Our isobutanol and the next generation products isobutanol will be used to produce may require regulatory approval by governmental agencies prior to commercialization.renewable fuels. In particular, biofuelsrenewable fuels are subject to rigorous testing and premarket approval requirements by the EPA’s Office of Transportation and Air Quality and regulatory authorities in other countries. In the U.S., various federal and, in some cases, state statutes and regulations also govern or impact the manufacturing, safety, storage and use of biofuels.renewable fuels. The process of seeking required approvals and the continuing need for compliance with applicable statutes and regulations requires the expenditure of substantial resources. Regulatory approval, if and when obtained for any of the next generation products isobutanol is used to produce, may be limited in scope, which may significantly limit the uses for which our isobutanol and these next generation products may be marketed.

When built at a dry-mill facility, our GIFT™ fermentation process creates iDGs™, a potential animal feed component, as a co-product. We are currently approved to sell iDGs™ as animal feed through the self-assessed Generally Regarded as Safe (“GRAS”) process of the U.S. Food and Drug Administration (the “FDA”) via third party scientific review. While we believe we can rely on the GRAS process, as we update our biocatalysts to increase isobutanol production, for further customer assurance, we also intend to pursue approval upon a completed biocatalyst from the Center for Veterinary Medicine of the FDA. Even if we receive such approval, the FDA’s policies may change and additional government regulations may be enacted that could prevent, delay or require regulatory approval of our co-products. We cannot predict the likelihood, nature or extent of adverse governmental regulations that might arise from future legislative or administrative action, either in the U.S. or abroad.

Our process contains a genetically engineered organism which, when used in an industrial process, is considered a new chemical under the EPA’s Toxic Substances Control Act program (“TSCA”). EPA’s Biotechnology Program under TSCA requires the submission of certain information of the Office of Pollution Prevention and Toxic Substances.  Due to the nature of our microorganism we can utilize the TSCA Biotechnology Program Tier I and Tier II exemption criteria at our Luverne, Minnesota manufacturing location.  As we expand our business activities, we will pursue the EPA’s Microbial Commercial Activity Notice process for future plants.  We do not anticipate a material adverse effect on our business or financial condition as a result of our efforts to comply with these requirements. However, the TSCA new chemical submission policies may change and additional government regulations may be enacted that could prevent or delay regulatory approval of our products. We cannot predict the likelihood, nature or extent of adverse governmental regulations that might arise from future legislative or administrative action, either in the U.S. or abroad.

There are various third-party certification organizations, such as ASTM International and Underwriters’ Laboratories, Inc. (“UL”), involved in certifying the transportation, dispensing and use of liquid fuel in the U.S. and internationally. In 2013, a specification for fuel grade isobutanol titled ASTM D7862 “Standard Specification for Butanol for Blending with Gasoline for Use as Automotive Spark-Ignition Engine Fuel” was published. In April 2016, ASTM International completed its process of approving the revision of ASTM D7566 (Standard Specification for Aviation Turbine Fuel Containing Synthesized Hydrocarbons) to include alcohol to jet synthetic paraffinic kerosene (ATJ-SPK) derived from renewable isobutanol. In addition, UL has published guidance on the use of isobutanol-gasoline blends in its UL87A fuel dispensers.  When ATJ-SPK which meets the specifications of ASTM D7566 is blended at a level of 30% or lower with petroleum based jet fuel which meets the specifications of ASTM D1655, the entire blended product meets the specifications of ASTM D1655, conventional jet fuel.  In other words, the blend containing the ATJ-SPK is completely fungible with any conventional D1655 jet fuel. Voluntary standards development organizations may change and additional requirements may be enacted that could prevent or delay marketing approval of our products. The process of seeking required approvals and the continuing need for compliance with applicable statutes and regulations require the expenditure of substantial resources. We do not anticipate a material adverse effect on our business or financial conditions as a result of our efforts to comply with these requirements, but we cannot predict the likelihood, nature or extent of adverse third-party requirements that might arise from future action, either in the U.S. or abroad.

We are subject to various federal, state and local environmental laws and regulations, including those relating to the discharge of materials into the air, water and ground, the generation, storage, handling, use, transportation and disposal of hazardous materials and the health and safety of our employees. These laws and regulations require us to obtain environmental permits and comply with numerous environmental restrictions as we construct and operate isobutanol assets. They may require expensive pollution control


equipment or operationoperational changes to limit actual or potential impacts to the environment. A violation of these laws, regulations or permit conditions can result in substantial fines, natural resource damage, criminal sanctions, permit revocations andor facility shutdowns.

There is a risk of liability for the investigation and cleanup of environmental contamination at each of the properties that we own or operate and at off-site locations where we arrange for the disposal of hazardous substances. If these substances are or have been disposed of or released at sites that undergo investigation or remediation by regulatory agencies, we may be responsible under the Comprehensive Environmental Response, Compensation and Liability Act or other environmental laws for all or part of the costs of investigation and remediation. We may also be subject to related claims by private parties alleging property damage and personal injury due to exposure to hazardous or other materials at or from the properties. Some of these matters may require us to expend significant amounts for investigation and cleanup or other costs. We are not aware of any material environmental liabilities relating to contamination at or from our facilities or at off-site locations where we have transported or arranged for the disposal of hazardous substances.

In addition, new laws, new interpretations of existing laws, increased governmental enforcement of environmental laws or other developments could require us to make significant additional expenditures. Continued government and public emphasis on environmental issues can be expected to result in increased future investments in environmental controls at our facilities which cannot be estimated at this time. Present and future environmental laws and regulations applicable to our operations, more vigorous enforcement policies and discovery of currently unknown conditions could all require us to make substantial expenditures. For example, our air emissions are subject to the Clean Air Act, the Clean Air Act Amendments of 1990 and similar state and local laws and associated regulations. Under the Clean Air Act, the EPA has promulgated National Emissions Standards for Hazardous Air Pollutants (“NESHAP”), which could apply to facilities that we own or operate if the emissions of hazardous air pollutants exceed certain thresholds. If a facility we operate is authorized to emit hazardous air pollutants above the threshold level, then we might still be required to come into compliance with another NESHAP at some future time. New or expanded facilities might be required to comply with both standards upon startup if they exceed the hazardous air pollutant threshold. In addition to the costs for achieving and maintaining compliance with these laws, more stringent standards may also limit our operating flexibility.

As a condition to granting the permits necessary for operating our facilities, regulators could make demands that increase our construction and operations costs, which might force us to obtain additional financing. For example, unanticipated water discharge limits could sharply increase construction costs for our projects. Permit conditions could also restrict or limit the extent of our operations. We cannot guarantee that we will be able to obtain or comply with the terms of all necessary permits to complete the Retrofitretrofit of an ethanol plant. Failure to obtain and comply with all applicable permits and licenses could halt our construction and could subject us to future claims.

Our products benefit from the United States Renewable Fuel Standard Program or RFS Program in that our ethanol and isobutanol areRNG is currently eligible for Renewable Identification Numbers or RINS(“RINS”) that have value based on the current RFS Program. The RFS Program could change, impacting our products, positively or negatively.

15

Various systems are being put in place around the workdworld to measure carbon intensityCI and the reduction of greenhouse gas emissions,GHGs, with the intent of creating a system to monetize the value of the reduction of carbon.  LCFS in CA is a good example. In order to benefit from such systems, companies need to have their products qualified through a regulatory process. There is no guarantee that any benefit could be gained. Gevo has not yet attemptedIn 2019, we submitted a design pathway application to the California Air Resources Board to gain approval for programs suchlow-carbon intensity ethanol utilizing beef manure biogas as LCFS.  

Segmentsa process input under the LCFS, and Geographic Information

We have determined that we have two operating segments: (i) Gevo segment; and (ii) Gevo Development/Luverne segment. We organize our business segments based on the nature of the products and services offered through each of our consolidated legal entities. Transactions between segments including revenue, loss from operations and total assets by segment are eliminated in consolidation. For additional financial information related to our segments, see Note 18 Segments in Item 8. Financial Statements and Supplemental Data, of this Report

Gevo Segment. Our Gevo segment is responsible for all research and development activities related to the future production of isobutanol, including the development of our proprietary biocatalysts, the production and sale of biojet fuel, our Retrofit process and the next generation of chemicals and biofuels that will be based on our isobutanol technology. Our Gevo segmentmay also develops, maintains and protects our intellectual property portfolio, develops future markets for our isobutanol and provides corporate oversight services.

Gevo Development/Agri-Energy. Our Gevo Development/Agri-Energy segment is currently responsible for the operation of our Luverne Facility and the production of ethanol, isobutanol and related products. Substantially all of the ethanol produced from the date of the acquisition of the Luverne Facility through December 31, 2017 was sold through an ethanol marketing company. Sales of


ethanol and related products from our Gevo Development/Luverne segment comprised approximately 90% of our consolidated revenue for the fiscal year ended December 31, 2017.

The following table sets forth our revenue by reportable segment (in thousands).

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

1,097

 

 

$

2,425

 

 

$

2,911

 

Gevo Development / Agri-Energy

 

26,439

 

 

 

24,788

 

 

 

27,226

 

Consolidated

$

27,536

 

 

$

27,213

 

 

$

30,137

 

Geographic Information.  For both the Gevo and the Gevo Development/Agri-Energy, all revenue is earned and all assets are heldseek approval under similar programs in the U.S.future.

People and Culture

Higher Purpose

Our employees strive to make environmental and social impacts in the world. Our employees are also guided by our code of business conduct and ethics, which helps them to uphold and strengthen our standards of integrity and innovation while continuously improving our environment, health, safety and sustainability. Our world and business may change, but our core values are a constant in everything we do.

Employees

As of December 31, 2017,2023, we employed 51had 103 employees 22in North America. We also retain consultants, independent contractors, and temporary and part-time workers. None of whom were employedour facilities in the U.S. are covered by us in our principal offices located in Englewood, Colorado. Of our employees, 13 were engaged incollective bargaining agreements. The Gevo team is made up of scientists, research and development activities and 9 were engaged in general,experts, software developers, data engineers, operations, administrative and business development activities. Asprofessionals, skilled trades and energy technicians.

Total

Employment

Full-time

101

Part-time

2

Total

103

Department

Project Development

31

Research and Development

16

Production

13

General, administrative and business development

43

Total

103

Location

Colorado

44

Texas

11

Iowa

11

Minnesota

9

New Mexico

7

South Dakota

5

Illinois

5

Other States

8

Foreign

3

Total

103

16

Human Rights

Gevo honors human rights and respects the individual dignity of all people globally. Our commitment to human rights requires that we understand and carry out our subsidiary, Agri-Energy, employed 29responsibilities consistent with our values and practices. We strive to ensure that human rights are upheld for our employees and all of whom were locatedworkers in Luverne, Minnesota, and involvedour supply chain. Our commitment to human rights is defined in the operationscode of business conduct and ethics, our supplier code of conduct, our dealer code of conduct and related policies and practices, which establish clear guidelines for our employees, suppliers and dealers while helping to inform our business decisions. We do not tolerate human rights abuses, such as forced labor, unlawful child labor or human trafficking. We are proud to contribute to the places where we work and support the residents of these places.

Code of Business Conduct and Ethics

We are committed to conducting business in accordance with the highest ethical standards. This means how we conduct ourselves is more than just a matter of policy and law, it is a reflection of our production facility. Nonecore values. Our code of business conduct and ethics provides specific guidance to all of our employees, are represented byoutlining how they can and must uphold and strengthen the integrity that defines us. We maintain a labor union, and we consider our employee relationsglobal compliance hotline to allow for concerns to be good.brought forward.

Corporate InformationHealth and Safety

We were incorporatedstrive to achieve safety excellence through increased focus on leading indicators, risk reduction, health and safety management systems, and prevention to protect the public health and environmental quality in Delaware in June 2005our communities, as a corporation underwell as the name Methanotech, Inc.health and filed an amendmentsafety of our employees, customers and neighbors. We strive to comply with all health and safety laws and regulations that apply to our certificatebusiness. We provide site safety orientation for all employees and guests as well as periodic refresher training for employees at a level appropriate for their role. We have received no violations and are proud that we have never had a fatality at a Gevo facility. During 2023, we had one reportable injury, no lost time incidents, and a total recordable injury rate of incorporation changing our name to Gevo, Inc. on March 29, 2006. Our principal executive offices are located at 345 Inverness Drive South, Building C, Suite 310, Englewood, CO 80112, and our telephone number is (303) 858-8358.

Website Access to SEC Filings0.93.

We are subjectserious about maintaining the well-being of our employees and families, paying 100% of the premiums for health, dental and vision insurance for whole families. Despite the significant increases in premium costs, we continue to pay the reporting requirements underpremiums for disability and life insurance to assist in maintaining living standards when issues arise. We continue to be agile in addressing employee needs in the Securities Exchange Actquickly evolving environment while being transparent across the workforce.

Diversity and Inclusion

In order to ensure that each of 1934,our employees can bring their full selves to work, we strive to foster a diverse, equitable, and inclusive workplace where all voices are heard and included. We continue to champion policies, practices and behaviors that amplify innovation on behalf of people, community and the planet. Diversity, equity and inclusion (“DEI”) are critical to our success as amended (the “Exchange Act”). Consequently,an organization. Incorporating DEI into our business practices enhances innovation and enables our best talent to thrive in an environment where diverse perspectives are celebrated. This requires deliberate intention and action on the part of every employee and leader. We will continue to push forward on the path to a more diverse, equitable and inclusive culture and have committed to interview and consider at least one qualified woman and person of color for every open role, vice president and higher, including at the senior executive level and the Board of Directors.

We are proud of the vibrant tapestry of people represented within our team, including individuals of African descent, Latinx heritage, and Asian backgrounds, as well as individuals of diverse sexual orientations and gender identities.

Building a diverse and inclusive workforce is a top priority at Gevo. While we acknowledge that we have further progress to make, we are requiredproud of the significant strides we have taken in recent years. In 2023, our non-management workforce saw a surge in female representation (35%) and increased representation across several minority groups including Hispanic/Latino (10%) and Black/African American (3%). At the leadership level, female representation increased to file reports33%, and informationwe are actively developing programs to cultivate talent from diverse backgrounds for future leadership roles.

17

December 31,

Women

2022

2023

Non-Management

32

%

35

%

Women Leaders

22

%

33

%

Total

28

%

34

%

December 31,

Diversity

2022

2023

Non-Management

Asian

2

%

5

%

Black or African American

4

%

3

%

Hispanic or Latino

9

%

10

%

Two or More Races

2

%

3

%

Diversity

17

%

21

%

Management

Asian

3

%

3

%

Black or African American

8

%

5

%

Hispanic or Latino

6

%

3

%

Two or More Races

6

%

5

%

Diversity

22

%

15

%

We recognize that our diversity journey is ongoing, and we haven't yet reached our full potential. The decline in the overall diversity percentage of our leaders (from 22% in 2022 to 15% in 2023) reflects a decrease from the prior year of 7%. This shift underscores the importance of maintaining momentum in expanding representation across all backgrounds. We are transparent about our data and committed to using it to guide our progress. We will continue to hold ourselves accountable and report regularly on our diversity and inclusion efforts.

Board composition fosters diverse perspectives and strengthens the Board’s ability to understand and address the needs of a broad stakeholder base. With 33% female representation among independent directors, the Board demonstrates a dedication to gender equality and harnesses the talents of a wider pool of leadership. The inclusion of 17% Hispanic independent board directors reflects the Company's commitment to diversity in its leadership and aligns with the SEC, including reportsdemographics of its customers and communities

Attraction, Retention and Engagement

We are currently operating in an extremely challenging talent market. Market hiring surges, increased attrition and shifting work expectations have significantly impacted the attraction and retention of talent, creating a hyper-competitive marketplace. We understand that our long-term success will require a differentiated, targeted approach to talent attraction and retention. In response to these challenges, we took a number of actions in 2023 in an effort to enhance our ability to attract and retain diverse talent:

We continued the annual talent review process to advance our internal talent placements, as well as plan for succession and growth. Further, we extended our leadership development program to more managers, of which 78% of the participants identify as a woman and/or of Asian, African or Hispanic heritage.
We provide a 401(K) matching program to support employees, with a matching contribution of up to 4% of their deferral in the Company’s stock.
Our employees are enthusiastic about enriching their communities. We continued to support a program to recognize their dedication and began matching community service efforts with up to 16 hours of paid time off.

18

We are committed to providing employment opportunities for people in our local communities. We partner with local technical colleges and universities to offer scholarships, tuition reimbursement and internships to students in the Energy programs and partner with them in showcasing non-traditional careers to achieve gender equity. Our continued support of this scholarship program has awarded four scholarships to date.

Our employees are highly engaged with our mission. We promote discussion and alignment through monthly town hall sessions with all employees, led by our CEO, Patrick Gruber, as well as fostering open-door conversations with all members of management.

Further, we found that our employees could be effective while working outside the Gevo offices. Gevo’s management philosophy is to lead with trust in our employees and support a culture which enables employees to do their best work. And, as a company focused on reducing the following forms: annual reportsworld’s carbon footprint, we hold that value for our employees as well and encourage them to reduce their personal carbon footprint and work from their homes, as their respective positions allow. This policy has allowed us to attract talent we might not otherwise have if we had restricted hiring to certain geographies.

Available Information

Our Annual Reports on Form 10-K, quarterly reportsQuarterly Reports on Form 10-Q, current reports10‑Q, Current Reports on Form 8-K and any amendments to those reports (including related exhibits and supplemental schedules) filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act. These reports and other information concerning us may be accessedAct of 1934, as amended, are made available, free of charge, through the SEC’s website at http://www.sec.gov and on our website at www.gevo.com. Such filings are placed on our website, as soon as reasonably practicalpracticable after they aresuch reports have been filed with, or furnished to, the SEC. Any information contained in, or that can be accessed throughOur website address is www.gevo.com. Information on our website is not incorporated by reference into, nor is it in any wayand does not constitute a part of, this Report.report.

19

Item 1A.Risk Factors



Item 1A.

Risk Factors

You should carefully consider thesethe risk factors described below before you decide to invest in our securities. The risks described below are not the only ones facing us. Our business is also subject to the risks that affect many other companies, such as competition, technological obsolescence, labor relations, general economic conditions, geopolitical changes and international operations. Additional risks and uncertainties not presently known to us or that we currently believe are immaterial may also impair our business operations and our liquidity. The risks described below could cause our actual results to differ materially from those contained in the forward-looking statements we have made in this Report, the information incorporated herein by reference and those forward-looking statements we may make from time to time.

Risks RelatingRisk Related to our Business and Strategy

We have substantial indebtedness outstanding and may incur additional indebtedness in the future. Our indebtedness exposes us to risks that could adversely affect our business, financial condition and results of operations.

As of December 31, 2017, we had approximately $16.7 million in outstanding 12% Convertible Senior Notes, due 2020, which were issued to WB Gevo, Ltd. (“Whitebox”) in June 2017 (the “2020 Notes”). In addition, we and any current and future subsidiaries of ours may incur substantial additional debt in the future, subject to the specified limitations in our existing financing documents and the indenture governing the 2020 Notes. If new debt is added to our or any of our subsidiaries’ debt levels, the risks described in this “Certain Risks Related to Owning Our Securities” section could intensify.

Our current and future indebtedness could have significant negative consequences for our business, results of operations and financial condition, including:

increasing our vulnerability to adverse economic and industry conditions;

limiting our ability to obtain additional financing;

requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, thereby reducing the amount of our cash flow available for other purposes;

limiting our flexibility in planning for, or reacting to, changes in our business; and

placing us at a possible competitive disadvantage with less leveraged competitors and competitors that may have better access to capital resources.

We cannot assure you that we will continue to maintain sufficient cash reserves or that our business will generate cash flow from operations at levels sufficient to permit us to pay principal, premium, if any, and interest on our indebtedness, or that our cash needs will not increase. If we are unable to generate sufficient cash flow or otherwise obtain funds necessary to make required payments, or if we fail to comply with the various requirements of our existing indebtedness or any other indebtedness which we may incur in the future, we would be in default, which could permit the holders of our indebtedness, including the Convertible Notes, to accelerate the maturity of such indebtedness. Any default under such indebtedness could have a material adverse effect on our business, results of operations and financial condition.

In particular, our indebtedness with Whitebox is secured by liens on substantially all of our assets, including our intellectual property. If we are unable to satisfy our obligations under such instruments, Whitebox could foreclose on our assets, including our intellectual property. Any such foreclosure could force us to substantially curtail or cease our operations which could have a material adverse effect on our business, financial condition and results of operations.

There is substantial doubt about our ability to continue as a going concern, which may hinder our ability to obtain further financing.

Our audited financial statements for the year ended December 31, 2017, were prepared under the assumption that we would continue our operations as a going concern.  Our independent registered public accounting firm for the year ended December 31, 2017 included a “going concern” emphasis of matter paragraph in its report on our financial statements as of, and for the year ended, December 31, 2017, indicating that the amount of working capital at December 31, 2017 was not sufficient to meet the cash requirements to fund planned operations  through the period that is one year after the date our 2017 financial statements are issued without additional sources of cash, which raises substantial doubt about our ability to continue as a going concern. Uncertainty concerning our ability to continue as a going concern may hinder our ability to obtain future financing. Continued operations and our ability to continue as a going concern are dependent on our ability to obtain additional funding in the near future and thereafter, and there are no assurances that such funding will be available to us at all or will be available in sufficient amounts or on reasonable terms.


Our financial statements do not include any adjustments that may result from the outcome of this uncertainty. Based on our current operating plan, existing working capital at December 31, 2017 was not sufficient to meet the cash requirements to fund planned operations through the period that is one year after the date our 2017 financial statements are issued unless we are able to restructure and extend our debt obligations and/or raise additional capital to fund operations. Without additional funds from private and/or public offerings of debt or equity securities, sales of assets, sales of our licenses of intellectual property or technologies, or other transactions, we will exhaust our resources and will be unable to continue operations. If we cannot continue as a viable entity, our stockholders would likely lose most or all of their investment in us.

We have a history of net losses, and we may not achieve or maintain profitability.

We have incurred net losses of $24.6 million, $37.2$66.2 million and $36.2$98.0 million during the years ended December 31, 2017, 20162023 and 2015,2022, respectively. As of December 31, 2017,2023, we had an accumulated deficit of $401.4$721.6 million. We expect to incur losses and negative cash flows from operating activities for the foreseeable future. We currently derive revenue primarily from the sale of isobutanol, ethanolRNG and related productsenvironmental attributes produced at the Luverne Facility, although over certain periods of time, we may and have operated the plant for the sole production of ethanol and related products to maximize cash flows. 

Additionally, we have generated limited revenue from the sale of products such as ATJ, isooctane and isooctene produced from isobutanol that has been used for commercial flights with Alaska Airlines, jet engine qualification and flight demonstration by the U.S. Air Force and other branches of the U.S. military, as well as specialty gasoline applications such as racing fuel.  We have also generated revenue through grants and cooperative agreements.  If we are unable to obtain new grants, cooperative agreements or product supply contracts, our revenues could be adversely affected.Gevo RNG.

Furthermore, we expect to spend significant amounts on the further development and commercial implementation of our strategic plans and technology.

We also expect to spend significant amounts acquiringon (i) developing and deploying additional equipment to attain final product specifications that may be required by future customers, acquiring or otherwise gaining access to additional ethanol plantsfinancing our Net-Zero projects and Retrofitting them for isobutanol production, onother similar growth projects, (ii) marketing, general and administrative expenses associated with our planned growth, onand (iii) management of operations as a public company, and on debt service obligations. In addition, the cost of preparing, filing, prosecuting, maintaining and enforcing patent, trademark and other intellectual property rights and defending ourselves against claims by others that we may be violating their intellectual property rights may be significant.

In particular, over time, costs related to defending the validity of our issued patents and challenging the validity of the patents of others at the U.S. Patent and Trademark Office (“USPTO”) may be significant.company. As a result, even if our revenues increase substantially, we expect that our expenses will exceed revenuesto continue to incur new losses for the foreseeable future. We do not expect to achieve profitability during the foreseeable future and may never achieve it. If we fail to achieve profitability, or if the time required to achieve profitability is longer than we anticipate, we may not be able to continue our business.business operations. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.

We will require substantial additional financingfinancings to achieve our goals, and a failure to obtain this capital when needed or on acceptable terms could force us to delay, limit, reduce or terminate our development and commercialization efforts.

Significant portionsWe operate in a capital-intensive industry and will continue to need substantial amounts of capital to execute on our resources have been dedicated to research and development, as well as demonstrating the effectiveness of our technology through the Retrofit of the Luverne Facility.business plans. We believe that we will continue to expend substantial resources for the foreseeable future on further growth of our business, including developing, our technologies, developing future markets for our isobutanolconstructing, financing and accessing and Retrofittingacquiring facilities necessary for the production of isobutanolour products on a commercial scale. These expenditures may, among other things, include costs associated with our Net-Zero Projects, research and development, accessing existing ethanol plants, Retrofitting or otherwise modifying the plants to produce isobutanol,developing biogas processing projects and wind projects, obtaining government and regulatory approvals, acquiring or constructing storage facilities and negotiating supplyofftake agreements for the isobutanol we produce.our products. In addition, other unanticipated costs may arise. Because the costs of developing our technology at a commercial scale are highly uncertain, we cannot reasonably estimate the amounts necessary to successfully commercialize our production.

To date, we have funded our operations primarily through equity offerings and issuances of debt, borrowing under our secured debt financing arrangements and revenues earned primarily from the sale of ethanol.debt. Based on our current plans and expectations, we will require additional funding at the corporate and/or project level to achieve our goals. We currently expect to finance the construction of NZ1 and any other Net Zero Projects at the subsidiary level using third party capital. In addition, the cost of preparing, filing, prosecuting, maintaining and enforcing patent, trademark and other intellectual property rights and defending against claims by others that we may be violating their intellectual property rights may be significant. Moreover, our plans and expectations may change as a result of factors currently unknown to us, and we may need additional funds sooner than plannedexpected and may seek to raise additional funds through public or private debt or equity financings in the near future.financings. We may also choose to seek additional capital sooner than required due to favorable market conditions or strategic considerations.


Our future capital requirements will depend on many factors, including:

the timing of and costs involved in developingfinancing and optimizingconstructing our technologies for full-scale commercial production of isobutanol;

Net-Zero Projects, including NZ1;

the timing of and costs involved in accessing existing ethanol plants;

obtaining permits and compliance with applicable regulations;
the timing and costs associated with any future capital projects or expansions;

20

the timing of, and costs involved in Retrofitting the plants we access with our technologies;

the costs involved in establishing enhanced yeast seed trains, including atmaintaining the Luverne Facility;

the costs involved in acquiring and deploying additional equipment to attain final product specifications including at the Luverne Facility, that may be required by future customers;

the costs involved in increasing our isobutanol production capacity, including at the Luverne Facility;

the cost and timing to expand the Luverne Facility into our first commercial hydrocarbons facility;

the cost of operating, maintaining and increasing production capacity of the Retrofitted plants;

our ability to negotiate agreements supplying suitable biomass to our plants, and the timing and terms of those agreements;

the timing of, and the costs involved in developing adequate storage facilities for the isobutanol we produce;

our ability to gain market acceptance for isobutanol as a specialty chemical, gasoline blendstock and as a raw material for the production of hydrocarbons;

our products;

our ability to negotiate supplyfinanceable offtake agreements for the isobutanolproducts we produce, and the timing and terms of those agreements, including terms related to sales price;

our ability to negotiate sales of our isobutanol for full-scale production of butenes and other industrially useful chemicals and fuels,products and the timing and terms of those sales, including terms related to sales price;

our ability to sell the iDGs™ left as a co-product of fermenting isobutanol from corn as animal feedstock;

our ability to establish and maintain strategic partnerships, licensing or other arrangements and the timing and terms of those arrangements; and

the cost of preparing, filing, prosecuting, maintaining, defending and enforcing patent, trademark and other intellectual property claims, including litigation costs and the outcome of such litigation.

Additional funds may not be available when we need them, on terms that are acceptable to us, or at all. In addition, our ability to raise additional funds will be subject to certain limitations in the agreements governing our indebtedness, including the 2020 Notes. If needed funds are not available to us on a timely basis, we may be required to delay, limit, reduce or terminate:

our research and development activities;

Net-Zero Projects, including NZ1;

our plans to access and/or Retrofit existing ethanol facilities;

enter into agreements with strategic partners;

our productiondevelopment of isobutanol at Retrofitted plants, including at the Luverne Facility;

future capital projects or expansions;

any plans to further expand production of isobutanol or other products at the Luverne Facility;

our production of hydrocarbons at the demonstration plant located at the South Hampton facility near Houston, TX, or any other future facilities;

our efforts to prepare, file, prosecute, maintain and enforce patent, trademark and other intellectual property rights and defend against claims by others that we may be violating their intellectual property rights; and/or

our activities in developing storage capacitynegotiating and negotiating supplyperforming under offtake agreements that may be necessary for the commercialization of our isobutanol production.

products.

We may needOur business is capital-intensive in nature and we rely on external financing to cease production atfund our growth strategy, including the Luverne Facility due to the condition of twodevelopment and construction of our fermentation vessels.Net-Zero Projects and other similar growth projects. Limitations on access to external financing could adversely affect our operating results.

As an older production facility,We are in a capital-intensive business and we rely heavily on external financing for the Luverne Facility is more susceptible to maintenance issues that result in production challenges than newer production facilities.  In the second quartercosts of 2017, we hired a third-party engineering firm to test the structural integrity of twodevelopment and construction of our oldest fermentation vessels.  These fermentation vessels are fabricated from carbon steelgrowth projects, such as NZ1, and are dedicated to ethanol production. Currently it is estimated that these two fermentation vessels likely have approximately two yearsother projected capital expenditures. Completion of our growth projects will require significant capital expenditures and three months, respectively, of useful life remaining under the current operating strategy unless they are replaced or repaired. It is possible that the conditionconstruction costs. The recovery of the two affected fermentation vessels could force us to cease isobutanol production or to completely cease all production


activities at the Luverne Facility for an extendedcapital investment in our growth projects will generally occur over a long period of time. Any such production stoppagesAs a result, we must obtain funds from external sources to help develop and construct our existing project pipeline, to help finance the acquisition of system components, to help identify and develop new projects, to help fund research and development expenses and to help pay the general and administrative costs of operating our business. We may not be able to obtain the needed funds on terms acceptable to us, or costs incurredat all. If we are unable to repairraise additional funds when needed, we could be required to delay development and construction of projects, reduce the scope of, abandon or replace such vessels couldsell some or all of our growth projects or default on our contractual commitments in the future, any of which would have a material adverse effect on our business, financial condition and resultsoperating results.

Our proposed growth projects may not be completed or, if completed, may not perform as expected or achieve profitability. Our project development activities may consume a significant portion of operations.our management’s focus, and if not successful, reduce our profitability.

We plan to grow our business by building multiple production facilities, including greenfield and brownfield projects. Development projects may require us to spend significant sums for engineering, permitting, legal, financial advisory and other expenses before we determine whether a development project is feasible, economically attractive or capable of being financed.

Our development projects are typically planned to be large and complex, and we may not be able to complete them. There can be no assurance that we will be able to negotiate the required agreements, overcome any local opposition, or obtain the necessary licenses, permits and financing. Failure to achieve any of these elements may prevent the development and construction of a project. If that were to occur, we could lose all of our investment in development expenditures and may be required to write off project development assets.

21

We may be unable to successfully negotiate final, binding terms relatedperform under current or future offtake agreements to provide our current non-binding isobutanol, ATJ and other hydrocarbon supply and distribution agreements,products, which could harm our commercial prospects.

From time-to-time,We have entered into several offtake agreements pursuant to which we agreeagreed to preliminarysell our products. Under certain of these offtake agreements, the purchasers agreed to pay for and receive, or cause to be received by a third party, or pay for even if not taken, the renewable hydrocarbon products under contract (a “take-or-pay” arrangement). The timing and volume commitment of certain of these agreements are conditioned upon, and subject to, our ability to complete the construction of a new or expanded production facility (the “Facility”). However, in order to commence construction of and complete the Facility, we must secure third-party financing. We cannot assure you that we will be able to obtain adequate financing on favorable terms, regarding supplying isobutanol or the products derived from it to various companies for their use or further distribution. We may be unable to negotiate final terms with these or other companies in a timely manner, or at all, and there is no guarantee that the terms of any final agreement will be the same or similar to those currently contemplated in our preliminary agreements. Final terms may include less favorable pricing structures or volume commitments, more expensive delivery or purity requirements, reduced contract durations and other adverse changes. Delays in negotiating final contracts could slow our initial isobutanol commercialization, and failure to agree to definitive terms for sales of sufficient volumes of isobutanol could prevent us from growing our business. To the extent that terms in our initial supply and distribution contracts may influence negotiations regarding future contracts, the failure to negotiate favorable final terms related to our current preliminary agreements could have an especially negative impact on our growth and profitability. Additionally,all. Furthermore, we have not demonstrated that we can meet the production levels and specifications contemplated in certain of our current non-binding supplyofftake agreements, or future offtake agreements. If our production scale-up proceeds more slowlyis slower than we expect, we experience production delays, if demand decreases or if we encounter difficulties in successfully completing plant Retrofits,the Facility or producing our renewable hydrocarbon products to specification, our counterparties may terminate our existing offtake agreements and potential customers including those with whom we have current letters of intent, may be less willing to negotiate definitive supplyofftake agreements with us, which would adversely impact our performance and results of operations.

In addition, from time to time, we may enter into letters of intent, memoranda of understanding and other largely non-binding agreements or demandunderstandings with potential customers or partners in order to develop our business and the markets that we serve. We can make no assurance that legally binding, definitive agreements reflecting the terms less favorable to us, and our performance may suffer.of such non-binding agreements will be completed with such customers or partners, or at all.

Our Retrofit of the Luverne Facility isofftake agreements, including our first commercial Retrofittake-or-pay purchase agreements, are subject to significant conditions precedent and, as a result, the revenues that we expect from such contracts may never be realized.

Our ability to realize revenue under our full-scale commercial production of isobutanol at the Luverne Facility could be delayed or we could experienceofftake agreements, including our take-or-pay purchase agreements, is not guaranteed and is subject to significant cost overruns in comparison to our current estimates.

conditions precedent. In September 2010, we acquired ownership of the Luverne Facility in Luverne, Minnesota. To date, we have successfully demonstrated fermentation operations at commercial scale combined with the use of our GIFTseparation system using corn mash feedstock at the Luverne Facility. We may incur additional costs in order to further optimizeactually realize revenue under such contracts, we are required to, among other things, complete the production of isobutanol, or both isobutanol and ethanol simultaneously, at the Luverne Facility.  We may determine that it is necessary to incur additional costs to further optimize the Luverne Facility or to increaseacquire, construct or retrofit a production of isobutanol or other productsfacility at the Luverne Facility, but the funds necessary may not be available when we need them,another suitable location, which is, in turn, dependent on terms that are acceptable to us or at all. In addition, our ability to secure adequate financing. If we are unable to raise additional fundssufficient capital on acceptable terms, or at all, the revenues under such contracts may never be achieved. Our ability to obtain adequate financing will be subject to certain limitationsdepend on, among other things, the status of our product development, market conditions for our products, our financial condition and general conditions in the agreements governing our indebtedness, including the 2020 Notes. If additional funding is not available to us, or not available on terms acceptable to us, our ability to optimize the isobutanol production technology currently in placecapital, financial and debt markets at the Luverne Facility and achieve full-scale commercial production at this facility may be limited. Such atime such financing is sought. In addition, any further equity or debt financings could result could reducein the scopedilution of ownership interests of our business plan and have an adverse effect onthen-current stockholders. Furthermore, even if we are able to satisfy all conditions precedent to our resultstake-or-pay contracts, including completion of operations.

The Luvernethe Facility is our first commercial isobutanolor acquiring, constructing or retrofitting a production facility at another suitable location and assecuring adequate funding, we still may never realize the full amount of revenue that we expect or project to earn from such we may be unablecontracts. In any event, our failure to produce planned quantities of isobutanol and any such production may be more costly than we anticipate.

Since commencing initial startup operations forrealize the production of isobutanol at the Luverne Facility in May 2012, we have encountered some production challenges, including contamination issues, which have resulted in lower than planned isobutanol production.  While we have resumed production of isobutanol at the Luverne Facility, this isexpected revenue under our first commercial isobutanol production facility and we may encounter further production challenges, including, but not limited to, being unable to manage plant contamination, and we may add additional processing steps or incur additional capital expenditures to achieve our target customers’ product specifications and/or to increase production levels at the facility. In addition, the Luverne Facility was constructed in 1998.  As an older production facility, the Luverne Facility may be more susceptible to maintenance issues that result in production challenges than newer production facilities.  Any such production challenges may delay our ramp up of production capacity, prevent us from producing significant quantities of isobutanol, significantly increase our cost to produce isobutanol, or cause us to switch to producing ethanol or produce both products simultaneously, which couldofftake agreements would have a material adverse effect on our business, financial condition, and results of operations.  

Some of our Retrofits, including the Retrofit of the Luverne Facility, may include additional equipment that we believe will allow us to switch between ethanoloperation and isobutanol production, or produce both products simultaneously, but we cannot guarantee that we will be successful in switching between isobutanol and ethanol production, or producing both products simultaneously, in a timely or efficient manner at these facilities.

In July 2014, we began more consistent co-production of isobutanol and ethanol at our Luverne Facility with one fermenter utilized for isobutanol production and three fermenters utilized for ethanol production.  We believe that the capability to switch between ethanol and isobutanol production, or produce both products simultaneously (as evidenced by our Luverne Facility) will, subject to regulatory factors and depending on market conditions, mitigate certain significant risks associated with startup operations for isobutanol production, but there can be no assurance that we will be able to revert to ethanol production, or produce both products


simultaneously at future plants, or that it will make sense, based on the then-current economic conditions for the production of ethanol, to do so. Even if we are able to revert to ethanol production, or produce both products simultaneously at certain facilities, those facilities may produce ethanol less efficiently or in lower volumes than they did prior to the Retrofit and such ethanol production may not generate positive economic returns. If we are unable to produce isobutanol at the volumes, rates and costs that we expect and are unable to revert to ethanol production at full capacity, or produce both products simultaneously, we would be unable to match the facility’s historical economic performance and our business, financial condition and results of operations would be materially adversely affected.liquidity.

Fluctuations in the price of corn and other feedstocks may affect our cost structure.

Our approach to the biofuelsrenewable fuels and chemicals markets will beis dependent on the price of corn and other feedstocks that will be used to produce ethanol and isobutanol.our products. A decrease in the availability of plant feedstocks or an increase in the price may have a material adverse effect on our financial condition and operating results. At certain levels, prices may make these products uneconomical to use and produce asand we may be unable to pass the full amount of feedstock cost increases on to our customers.customers, which would make it unprofitable for us to operate in these markets. In addition, passing along increased pricing to our customers could result in fewer or reduced orders or customer loss altogether. No assurance can be given that we will be able to purchase corn and other feedstocks at or near prices which would provide us with positive margins.

The price and availability of corn and other plant feedstocks may be influenced by general economic, market and regulatory factors. These factors include weather conditions, pests, global or regional growing conditions, including plant disease, farming decisions, government policies and subsidies with respect to agriculture and international trade, increasing input costs, prices for alternative crops, global political or economic issues and conflicts and shifts in global

22

demand and supply. For example, corn prices may increase significantly in response to drought conditions in the Midwesternmidwestern region of the U.S. and any resulting decrease in the supply of corn could lead to the restriction of corn supplies, which in turn could cause further increases in the price of corn. The significance and relative impact of these factors on the price of plant feedstocks is difficult to predict, especially without knowing what types of plant feedstock materials we may need to use.

Fluctuations in the price and availability of natural gas may harm our performance.

The ethanol facilities that we have Retrofitted or plan to Retrofit to produce isobutanol use significant amounts of natural gas to produce ethanol. After Retrofit with our GIFT technology, these facilities will continue to require natural gas to produce isobutanol and/or ethanol. Accordingly, our business is dependent upon natural gas supplied by third parties. The prices for and availability of natural gas are subject to volatile market conditions. These market conditions are affected by factors beyond our control, such as weather conditions, overall economic conditions and governmental regulations. Should the price of natural gas increase, our performance could suffer. Likewise, disruptions in the supply of natural gas could have a material impact on our business and results of operations.predict.

Fluctuations in petroleum prices and customer demand patterns may reduce demand for biofuels and bio-based chemicals.renewable fuels.

We anticipate marketing our biofuel asOur renewable fuels may be considered an alternative to petroleum-based fuels. Therefore, if the price of oil falls, any revenues that we generate from biofuelrenewable fuel products could decline and we may be unable to produce products that are a commercially viable alternative to petroleum-based fuels. In such cases, we may not be able to offer our customers an attractive price for our fuels, market adoption of our fuels could be slowed or limited and/or we may be forced to reduce the prices at which we sell our fuels in order to try to attract new customers or prevent the loss of demand from existing customers. Additionally, demand for liquid transportation fuels, including biofuels,renewable fuels, may decrease due to economic conditions or otherwise. We will encounter similar risksother factors outside of our control, which could have a material adverse impact on our business and results of operations.

Any decline in the chemicals industry, where declines in the pricevalue of oil may make petroleum-based hydrocarbons less expensive, which could reduce the competitiveness ofcarbon credits associated with our bio-based alternatives.

Changes in the prices of distiller’s grains and iDGs™products could have a material adverse effect on our results of operations, cash flow and financial condition.

We sell distiller’s grains as a co-product from the production of ethanol at the Luverne Facility during any period in which the production of isobutanol is temporarily paused and our management decides that the Luverne Facility will be temporarily reverted to ethanol production, or during periods in which we produce both isobutanol and ethanol simultaneously. We may also sell distiller’s grains produced by other ethanol facilities that we acquire, enter into a joint venture or tolling arrangement with, or license to in the future. We also sell the iDGs™ that are produced as a co-productThe sale of our commercial isobutanol production. Distiller’s grainsproducts is often dependent on the value of carbon credits under the RFS Program, LCFS and iDGs™ compete with other animal feed products, and decreases in the pricessimilar regulatory regimes. The value of these other products could decrease the demand for and pricecredits fluctuates based on market forces outside of distiller’s grains and iDGs™. Additionally, we have produced limited quantities of commercial iDGs™ and, as such, thereour control. There is a risk that the supply of low-carbon alternative fuels outstrips demand, resulting in the value of carbon credits declining. Any decline in the value of carbon credits associated with our iDGs™ may not meet market requirements. If the price of distiller’s grains and iDGs™ decreases or our iDGs™ do not meet market requirements, our revenue from the sale of distiller’s grains and future revenue from the sale of iDGs™ could suffer, whichproducts could have a material adverse effect on our financial condition.

To the extent that we produce ethanol before commencing isobutanol production, or during periods in which we make the strategic decision to revert to ethanol production, or produce both products simultaneously, we will be vulnerable to fluctuations in the price of and cost to produce ethanol.

We believe that, like the Luverne Facility, the other third-party ethanol production facilities we access can continue to produce ethanol during most of the Retrofit process. In certain cases, we may obtain income from this ethanol production. Further, we have


designed our isobutanol production technology (including the Retrofit of the Luverne Facility) to allow us to revert to ethanol production at certain facilities, or produce both products simultaneously, when the economic conditions for ethanol production make such production desirable. Our earnings from ethanol revenue will be dependent on the price of, demand for and cost to produce ethanol. Decreases in the price of ethanol, whether caused by decreases in gasoline prices, changes in regulations, seasonal fluctuations or otherwise, will reduce our revenues, while increases in the cost of production will reduce our margins. To the extent that ethanol production costs increase or price decreases, earnings from ethanol production could suffer, which could have a material adverse effect on our business.

Sustained narrow commodity margins may cause us to operate at a loss or to reduce or suspend production of ethanol and/or isobutanol at the Luverne Facility, and we may or may not be able to recommence production when margins improve.

Our results from operations will be substantially dependent on commodity prices. Many of the risks associated with volatile commodity prices, including fluctuations in feedstock costs and natural gas costs, apply both to the production of ethanol and isobutanol. Sustained unfavorable commodity prices may cause our combined revenues from sales of ethanol, isobutanol and related co-products to decline below our marginal cost of production. As market conditions change, our management may decide to reduce or suspend production of ethanol and/or isobutanol at the Luverne Facility.

The decision to reduce or suspend production at a facility may create additional costs related to continued maintenance, termination of staff, certain unavoidable fixed costs, termination of customer contracts and increased costs to increase or recommence production in the future. These costs may make it difficult or impractical to increase or recommence production of ethanol and/or isobutanol at the Luverne Facility even if margins improve. In addition, any reduction or suspension of the production of ethanol and/or isobutanol at the Luverne Facility may slow or stop our commercialization process, which could have a material adverse effect on our business, financial condition and results of operations.operations, cash flow and financial condition.

We may not be successful in the developmentcommercialization of individual steps in, or an integrated process for, the production of commercial quantities of isobutanol from plant feedstocks in a timely or economic manner, or at all.alcohol-to-SAF projects utilizing Axens technology.

As of the date of this filing, we have produced only limited quantities of isobutanol at commercial scale and we may not be successful in increasing our production from these limited production levels. The production of isobutanol requires multiple integrated steps, including:

obtaining the plant feedstocks;

treatment with enzymes to produce fermentable sugars;

fermentation by organisms to produce isobutanol from the fermentable sugars;

distillation of the isobutanol to concentrate and separate it from other materials;

purification of the isobutanol; and

storage and distribution of the isobutanol.

Our future success on alcohol-to-SAF projects depends on, among other things, our ability to produce commercial quantities of isobutanolSAF from ethanol using Axens technology. We may encounter challenges in a timely and economic manner. While we have produced isobutanol using our biocatalystsscaling up the Axens technology and/or the technology may not work as expected, or at the Luverne Facility in commercial-scale fermenters, our biocatalysts have not yet produced isobutanol at fully optimized levels atall on a commercial facility. The riskscale. In addition, the cost to construct commercial alcohol-to-SAF facilities or the production costs associated with the operation of contamination and other problems rises assuch facilities may be higher than we increase the scale of our isobutanol production.project. If we are unable to successfully manage these risks, we may encounter such difficulties in achievingscaling or constructing alcohol-to-SAF projects, it could significantly affect our target isobutanol production yield, rate, concentration or purity atprofitability and have a commercial scale, which could delay or increase the costs involved in commercializingmaterial adverse impact on our isobutanol production. In addition, we have limited experience sourcing large quantitiesbusiness and results of feedstocks and in storing and/or distributing significant volumes of isobutanol. operations.

The technological and logistical challenges associated with each of the processes involved in production, saleproducing, marketing, selling and distribution of isobutanoldistributing renewable hydrocarbon products are extraordinary,complex, and we may not be able to resolve any difficulties that arise in a timely or cost effectivecost-effective manner, or at all. Even if we are successful in developing an economical process for converting first generation carbohydrate feedstocks such as corn

We have limited experience operating, and sugar cane into commercial quantities of isobutanol, we may not be able to adapt such process to other biomass raw materials, including cellulosic biomass.

Prior to commencement of the Luverne Facility Retrofit, we hadhave never built, (through Retrofit or otherwise) or operated a commercial isobutanolrenewable hydrocarbon facility. We believe that we understand the engineering and process characteristics necessary to successfully build the additional facilities that we are contemplating and to scale up to larger facilities, and we expect to incur additional capital expenditures to increase isobutanol production levels at the Luverne Facility, but thesefacilities. Our assumptions, however, may prove to be incorrect. Accordingly, we cannot be certain that we canwill be able to consistently produce isobutanolrenewable hydrocarbon products in an economical manner in commercial quantities. If our costsIn addition, we expect to incur significant capital expenditures to build large-scale commercial isobutanol facilities are significantly higher than we expect or ifout our Net-Zero projects and produce renewable hydrocarbon products. If we fail to build or scale up the facilities required to produce our renewable hydrocarbon products or are unable to consistently produce isobutanolrenewable hydrocarbon products economically on a commercial scale or in


commercial volumes, our commercialization of isobutanolrenewable hydrocarbon products and our business, financial condition and results of operations will be materially adversely affected.

Our actual costs may be greater than expected in developing our growth projects, causing us to realize significantly lower profits or greater losses on our projects.

We have entered intogenerally must estimate the costs of completing a licensing agreement with Porta Hnos S.A. (“Porta”)specific project to Retrofit their facility in Argentina,prior to the construction of the project. The actual cost of labor and the production of isobutanol at the Porta facility could be delayedmaterials and as a result, any royalties or other revenues expected to be derivedimportant costs may vary from the licensing agreementcosts we originally estimated. These

23

variations may be delayed.

In January 2016,cause the gross profit of a project to materially differ from what we entered intooriginally estimated. Cost overruns on our growth projects could occur due to changes in a license agreementvariety of factors such as:

failure to properly estimate costs of engineering, materials, equipment, labor or financing;
unanticipated technical problems with the structures, materials or services;
unanticipated project modifications;
changes in the costs of equipment, materials, labor or contractors;
our suppliers’ or contractors’ failure to perform;
changes in laws and regulations; and
delays caused by weather conditions.

As projects grow in size and joint development agreement with Portacomplexity, multiple factors may contribute to construct multiple isobutanol plants in Argentina using corn as a feedstock,reduced profit or greater losses, and depending on the firstsize of which is expected to be wholly owned by Porta (the “Porta Facility”).  The plant is expected to have a production capacity of up to five million gallons of isobutanol per year. Once the plant is operational, Gevo expects to generate revenues from this licensing arrangement, through royalties, sales and marketing fees, and other revenue streams such as yeast sales.  The agreements also contemplate Porta constructing at least three additional isobutanol plants for certain of their existing ethanol plant customers. For these projects, Gevo would be the direct licensor of its technology and the marketer for any isobutanol produced, and would expect to receive all royalties and sales and marketing fees generated from these projects. Porta would provide the engineering, procurement and construction (“EPC”) services for the projects. The production capacity of these additional plants is still to be determined.

Although we will be able to apply our experienceparticular project, variations from the Retrofit of the Luverne Facility, no two ethanol facilities are exactly alike, and each Retrofit or constructionestimated project will require individualized engineering and design work.  Unexpected difficulties unique to the Porta Facility may cause delays in commencing production, and there is no guarantee that we will be successful in properly completing the project. Any such unexpected difficulties could delay or limit the revenues that we are able to derive from the licensing arrangement with Porta.  Moreover, there can be no assurances that the Retrofit of the Porta facility will ever be completed or Porta will construct other isobutanol plants as contemplated.  If the Porta Facility project is not completed or if Porta does not construct additional isobutanol facilities, Gevo will not generate any revenue.  In addition, if Porta experiences delays or is unsuccessful in completing the Porta Facility project, this may limit Gevo’s ability to license its technology to others, which could reduce the scope of Gevo’s business plan and have a material adverse effect on Gevo’s results of operations. In addition, if we experience delays or are unsuccessful in completing the Porta Facility project, this may limit our ability to license our technology to others, which could reduce the scope of our business plan and have a material adverse effect on our results of operations.

Our development strategy relies on our relationships with partners such as Praj Industries Limited (“Praj”) and Porta.

In November 2015, we entered into a joint development agreement and a development license agreementwith Praj with the goal for Praj to adapt our isobutanol technology to using non-corn based sugars and lignocellulose feedstocks. Praj is one of the leading suppliers of EPC services to the ethanol industry globally, having provided such services to approximately 350 ethanol plants across 65 countries. As a result, we believe that our alliance with Praj will allow us to more quickly achieve commercial-scale production of isobutanol derived from feedstock outside of the U.S. Porta is a leading supplier of EPC services to the ethanol industry in South America. As a result, we believe that our alliance with Porta will allow us to more quickly achieve commercial-scale production of isobutanol in Argentina and potentially elsewhere in South America. However, Praj and Porta may fail to fulfill their obligations to us under our agreements with them such as failing to meet milestones associated with our joint development agreement. If Praj and Porta fail to fulfill their obligations to us under our agreements, our ability to realize continued development and commercial benefits from our alliance could be affected and our business and prospects could be harmed.

In addition, we may be unable to secure other partners beyond Praj and Porta to assist us in developing commercial isobutanol projects globally. If we are unable to secure such additional partnerships, our business and prospects could be harmed.

We may not be able to successfully identify and acquire access to additional ethanol production facilities suitable for efficient Retrofitting, or acquire access to sufficient capacity to be commercially viable or meet customer demand.

Our strategy currently includes accessing and Retrofitting, either independently or with potential development partners or licensees, existing ethanol facilities for the production of large quantities of isobutanol for commercial distribution and sale. In addition to the Luverne Facility, we have signed licensing agreements with Porta and Praj. However, we may not find future development partners with whom we can implement this growth strategy, and we may not be able to identify facilities suitable for joint venture, acquisition, lease or license.

Even if we successfully identify a facility suitable for efficient Retrofitting, we may not be able to acquire access to such facility in a timely manner, if at all. The owners of the ethanol facility may reach an agreement with another party, refuse to consider a joint venture, acquisition, lease or license, or demand more or different consideration than we are willing to provide. In particular, if the profitability of ethanol production increases, plant owners may be less likely to consider modifying their production, and thus may be less willing to negotiate with us or agree to allow us to Retrofit their facilities for isobutanol production. We may also find that it is necessary to offer special terms, incentives and/or rebates to owners of ethanol facilities that allow us to access and Retrofit their


facilities while our production technology is being proven on a commercial scale. Even if the owners of a facility are interested in reaching an agreement that grants us access to the plant, negotiations may take longer or cost more than we expect, and we may never achieve a final agreement. Further, our ability to raise additional funds will be subject to certain limitations in the agreements governing our indebtedness, including our secured indebtedness with Whitebox, and we may not be able to raise capital on acceptable terms, or at all, to finance our joint venture, acquisition, participation or lease of facilities.

Even if we are able to access and Retrofit several facilities, we may fail to access enough capacity to be commercially viable or meet the volume demands or minimum requirements of our customers, including pursuant to definitive supply or distribution agreements that we may enter into, which may subject us to monetary damages. Failure to acquire access to sufficient capacity in a timely manner and on favorable terms may slow or stop our commercialization process, whichcosts could have a material adverse effect on our business, financial condition and results of operations.

Once we acquire accessbusiness. For example, if project costs exceed our estimates, it could cause us to ethanol facilities, we may be unable to successfully Retrofit them to produce isobutanol,realize significantly lower profits or we may not be able to Retrofit them in a timely and cost-effective manner.

For each ethanol production facility to which we acquire access, we will be required to obtain numerous regulatory approvals and permits to Retrofit and operate the facility. In the U.S., these include such items as a modification to the air permit, fuel registration with the EPA, ethanol excise tax registration and others. These requirements may not be satisfied in a timely manner, or at all. Later-enacted federal and state governmental requirements may also substantially increase our costs or delay or prevent the completion of a Retrofit, which could have a material adverse effectgreater losses on our business, financial condition and results of operations.

No two ethanol facilities are exactly alike, and each Retrofit will require individualized engineering and design work. There is no guarantee that we or any contractor we retain will be able to successfully design a commercially viable Retrofit, or properly complete the Retrofit once the engineering plans are completed. Prior to commencement of the Luverne Facility Retrofit, we had never built, via Retrofit or otherwise, a full-scale commercial isobutanol facility. Despite our experience with the Retrofit of the Luverne Facility, our estimates of the capital costs that we will need to incur to Retrofit a commercial-scale ethanol facility may prove to be inaccurate, and each Retrofit may cost materially more to engineer and build than we currently anticipate. For example, our estimates assume that each plant we Retrofit will be performing at full production capacity, and we may need to expend substantial sums to repair or modify underperforming facilities prior to Retrofit.

Furthermore, the Retrofit of acquired facilities will be subject to the risks inherent in the build-out of any manufacturing facility, including risks of delays and cost overruns as a result of factors that may be out of our control, such as delays in the delivery of equipment and subsystems or the failure of such equipment to perform as expected once delivered. In addition, we will depend on third-party relationships in expanding our isobutanol production capacity and such third parties may not fulfill their obligations to us under our arrangements with them. Delays, cost overruns or failures in the Retrofit process will slow our commercial production of isobutanol and harm our performance.

Though our Retrofit design for certain facilities will include the capability to switch between isobutanol and ethanol production, or produce both products simultaneously (as demonstrated by our Luverne Facility), we may be unable to successfully revert to ethanol production, or produce both products simultaneously at certain facilities, or such facilities may produce ethanol less efficiently or in lower volumes than they did before the Retrofit. In addition, we may be unable to secure the necessary regulatory approvals and permits to switch between isobutanol and ethanol production, or produce both products simultaneously, in a timely manner, or at all. Thus, if we fail to achieve commercial levels of isobutanol production at a Retrofitted facility, we may be unable to rely on ethanol production as an alternative or additional revenue source, which could have a material adverse effect on our prospects.

Our facilities and process may fail to produce isobutanol at the volumes, rates and costs we expect.

Some or all of the facilities we choose to Retrofit may be in locations distant from corn or other feedstock sources, which could increase our feedstock costs or prevent us from acquiring sufficient feedstock volumes for commercial production. General market conditions might also cause increases in feedstock prices, which could likewise increase our production costs.

Even if we secure access to sufficient volumes of feedstock, the facilities we Retrofit for isobutanol production may fail to perform as expected. The equipment and subsystems installed during the Retrofit may never operate as planned. Our systems may prove incompatible with the original facility, or require additional modification after installation. Our biocatalyst may perform less efficiently than it did in testing, if at all. Contamination of plant equipment may require us to replace our biocatalyst more often than expected, require unplanned installation or replacement of equipment, or cause our fermentation process to yield undesired or harmful by-products. Likewise, our feedstock may contain contaminants like wild yeast, which naturally ferments feedstock into ethanol. The presence of contaminants, such as wild yeast, in our feedstock could reduce the purity of the isobutanol that we produce and require us to invest in more costly isobutanol separation processes or equipment. Unexpected problems may force us to cease or delay production and the time and costs involved with such delays may prove prohibitive. Any or all of these risks could prevent us from achieving the


production throughput and yields necessary to achieve our target annualized production run rates and/or to meet the volume demands or minimum requirements of our customers, including pursuant to definitive supply or distribution agreements that we may enter into, which may subject us to monetary damages. Failure to achieve these rates or meet these minimum requirements, or achieving them only after significant additional expenditures, could substantially harm our commercial performance.projects.

We may be unable to produce isobutanol, ATJ or otherrenewable hydrocarbon products in accordance with customer specifications.

Even if we produce isobutanol, ATL or other products at our targeted rates, weWe may be unable to produce theserenewable hydrocarbon products to meet customer specifications, including those defined in ASTM D7862 “Standard Specification for Butanol for Blending with Gasoline for Use as Automotive Spark-Ignition Engine Fuel’ orFuel,” ASTM D7566 “Standard Specifications for Aviation Turbine Fuel Containing Synthesized Hydrocarbons”. or specifications to carbon intensity standards. We may need to add additional processing steps or incur capital expenditures in order to meet customer specifications which could add significant costs to our production process. For example, at the Luverne Facility we intend to acquire and install a product purification column, which we believe will allow us to achieve our target customers’ product specifications without continuing to rely on third-party contract tolling providers. If we fail to meet specific product or volume specifications contained in a supplyan offtake agreement, the customer may have the right to seek an alternate supply of isobutanolrenewable hydrocarbon products and/or terminate the agreement completely, and we could be required to pay shortfall fees or otherwise be subject to damages. A failure to successfully meet the specifications of our potential customers could decrease demand, and significantly hinder market adoption of our products.products, and harm our reputation, thus having a material adverse impact on our business and results of operations.

We lack significantOur experience operatingmay not be sufficient to operate commercial-scale ethanol and isobutanol facilities and we may encounter substantial difficulties operating commercial plants or expanding our business.

We have very limited experience operating commercial-scale ethanolRNG and isobutanol facilities.renewable hydrocarbon facilities concurrently. Accordingly, we may encounter significant difficulties operating at a commercial scale. We believe thatscale once we expand our future facilities will, like the Luverne Facility, be able to continue producing ethanol during much of the Retrofit process. We will need to successfully administerproduction capabilities, including at our Gevo RNG and manage this production. Although Porta and the employees at the Luverne facility are experienced in the operation of ethanol facilities, and our future development partners or the entities that we acquire may likewise have such experience, we may be unable to manage ethanol-producing operations, especially given the possible complications associated with a simultaneous Retrofit. Once we complete a commercial Retrofit, operational difficulties may increase, because neither we nor anyone else has significant experience operating a pure isobutanol fermentation facility at a commercial scale.Net-Zero Projects. The skills and knowledge gained in operating commercial ethanolour current facilities or small-scale isobutanol plants may prove insufficientnot be sufficient to support the for successful operation of a large-scale isobutanolproduction facility or the Facility, and we may be required to expend significant time and money to develop our capabilities in isobutanollarge-scale facility operation. We may also need to hire new employees or contract with third parties to help manage our operations, and our performance will suffer if we are unable to hire qualified parties or if they perform poorly. Any production delays or volume or other issues resulting from our inability to operate at a commercial scale could result in additional capital expenditures and investment, reduced sales volumes, loss of customers, harm to our reputation and could have a material adverse impact on our financial condition and results of operations.

We may face additional operational difficulties as we further expand our production capacity. IntegratingIn addition, integrating new facilities with our existing operations may prove difficult. Rapid growth, resulting from our operation of, or other involvement with, isobutanolrenewable hydrocarbon facilities or otherwise, may impose a significant burden on our administrative and operational resources. To effectively manage our growth and execute our expansion plans, we will need to expand our administrative and operational resources substantially and attract, train, manage and retain qualified management, technicians and other personnel. We may be unable to do so. Failure to meet the operational challenges of developing and managing increased production, of isobutanol and/or ethanol, or failure to otherwise manage our growth, may have a material adverse effect on our business, financial condition and results of operations.

We may have difficulty adapting our technology to commercial-scale fermentation, which could delay or prevent our commercialization24

Table of isobutanol.Contents

While we have demonstrated the ability to produce isobutanol under the demonstration plant operating conditions and under commercial scale operating conditions at the Luverne Facility, and we have succeeded in reaching our commercial fermentation performance targets for isobutanol concentration, fermentation productivity and isobutanol yield in laboratory tests, we have not yet reached all performance targets in a commercial plant environment. Ultimately, our yeast biocatalyst may not be able to meet the commercial performance targets in a timely manner, or ever. In addition, the risk of contamination and other problems may increase as we seek to ramp up our production capacity, which could negatively impact our cost of production or require additional capital expenditures to solve for these problems. If we encounter difficulties in optimizing our production, our commercialization of isobutanol and our business, financial condition and results of operations will be materially adversely affected.

We may have difficulties gaining market acceptance and successfully marketing our isobutanol and other hydrocarbon products to customers, including chemical producers, fuel distributors and refiners.

A key component of our business strategy is to market our isobutanol and other hydrocarbon products to chemical producers, fuels distributors, refiners and other fuel and chemical industry market participants. We have no experience marketing isobutanol on a commercial scale and we may fail to successfully negotiate marketing agreements in a timely manner or on favorable terms. If we fail


to successfully market our isobutanol to refiners, fuels distributors, chemical producers and others, our business, financial condition and results of operations will be materially adversely affected.

We also intend to market our isobutanol to chemical producers for use in making various chemicals such as isobutylene, a type of butene that can be produced through the dehydration of isobutanol. Although a significant market currently exists for isobutylene produced from petroleum, which is widely used in the production of plastics, specialty chemicals, alkylate for gasoline blending and high octane aviation gasoline, no one has successfully created isobutylene on a commercial scale from bio-isobutanol. Therefore, to gain market acceptance and successfully market our isobutanol to chemical producers, we must show that our isobutanol can be converted into isobutylene at a commercial scale. As no company currently dehydrates commercial volumes of isobutanol into isobutylene, we must demonstrate the large-scale feasibility of the process and potentially reach agreements with companies that are willing to invest in the necessary dehydration infrastructure. Failure to reach favorable agreements with these companies, or the inability of their plants to convert isobutanol into isobutylene at sufficient scale, may slow our development in the chemicals market and could significantly affect our profitability.

Obtaining market acceptance in the chemicals industry is complicated by the fact that many potential chemicals industry customers have invested substantial amounts of time and money in developing petroleum-based production channels. These potential customers generally have well-developed manufacturing processes and arrangements with suppliers of chemical components, and may display substantial resistance to changing these processes. Pre-existing contractual commitments, unwillingness to invest in new infrastructure, distrust of new production methods and lengthy relationships with current suppliers may all slow market acceptance of isobutanol.

A very limited market currently exists for isobutanol as a fuel or as a gasoline blendstock. Therefore, to gain market acceptance and successfully market our isobutanol to fuels distributors and refiners, we must effectively demonstrate the commercial advantages of using isobutanol over other biofuels and blendstocks, as well as our ability to produce isobutanol reliably on a commercial scale at a sufficiently low cost. We must show that isobutanol is compatible with existing infrastructure and does not damage pipes, engines, storage facilities or pumps. We must also overcome marketing and lobbying efforts by producers of other biofuels and blendstocks, including ethanol, many of whom may have greater resources than we do. If the markets for isobutanol as a fuel or as a gasoline blendstock do not develop as we currently anticipate, or if we are unable to penetrate these markets successfully, our revenue and growth rate could be materially and adversely affected.

We believe that consumer demand for environmentally sensitive products will drive demand among large brand owners for isobutanol and renewable hydrocarbon sources. One of our marketing strategies is to leverage this demand to obtain commitments from large brand owners to purchase products made from our isobutanol by third parties. We believe these commitments will, in turn, promote chemicals industry demand for our isobutanol and hydrocarbon products. If consumer demand for environmentally sensitive products fails to develop at sufficient scale or if such demand fails to drive large brand owners to seek sources of renewable isobutanol or hydrocarbons, our revenue and growth rate could be materially and adversely affected.

We may have difficulties scaling up our hydrocarbon technology, and, as such, we may be unable to produce commercial quantities of our hydrocarbons, and any such production may be more costly than we anticipate

We have developed a hydrocarbon processing demonstration plant (“Hydrocarbons Demo Plant”) in Silsbee, Texas, in partnership with South Hampton Resources, Inc. The Hydrocarbon Demo Plant can process approximately 6,000 to 7,000 gallons of our isobutanol per month into a variety of renewable hydrocarbons for use as fuels and chemicals. We have demonstrated the ability to convert our isobutanol at this level into products such as ATJ, isooctane, isooctene and par-xylene.

The production and sale of commercial volumes of hydrocarbons such as ATJ, isooctane and isooctene, produced from our isobutanol is anticipated to be an important part of our future business plans. However, we may encounter challenges in scaling up our process to convert isobutanol into hydrocarbon products successfully. In addition, the cost to construct commercial hydrocarbons facilities or the production costs associated with the operation of such facilities may be higher than we project. If we encounter such difficulties, this may significantly impact the development of the markets for our hydrocarbon products and could significantly affect our profitability.

We may be reliant on Butamax to develop certain markets for isobutanol.

As part of the License Agreement entered into with Butamax, it was agreed that Butamax would take the lead in developing the markets for on-road gasoline blendstocks. This would entail progressing the required approvals for these markets, as well as managing the marketing and distribution of our isobutanol and our potential licensee’s isobutanol in these markets beyond certain minimum volumes. If Butamax is unable to obtain the necessary approvals to sell isobutanol into the on-road gasoline blendstock markets, or if it is unsuccessful in building market demand for isobutanol as an on-road gasoline blendstock, our revenue and growth rate could be materially and adversely affected.


We may be required to pay Butamax royalties for selling isobutanol into certain markets, which could hinder our ability to competitively sell our isobutanol into those markets.

As part of the License Agreement entered into with Butamax, it was agreed that we, and our potential licensees, may be required to pay Butamax royalties for selling isobutanol into the on-road gasoline blendstock markets and the chemical isobutylene applications markets beyond certain minimum volumes. The addition of these royalties may make our isobutanol uncompetitive from a price perspective, which may hinder our ability to sell into these markets. If this is the case, our revenue and growth rate could be materially and adversely affected.

Even if we are successful in consistently producing isobutanol and our hydrocarbon products on a commercial scale, we may not be successful in negotiating sufficient supplyadditional fuel offtake agreements foror pricing terms to support the growth of our production.business.

We expect that many of our customers will be large companies with extensive experience operating in the fuels or chemicals markets. As an early stage company, weWe lack significant commercial operating experience and may face difficulties in developing marketing expertise in these fields. Our business model relies upon our ability to successfully negotiate, structure and structurefulfill long-term supplyofftake agreements for the isobutanol and other products we produce.our products. Certain agreements with existing and potential customers may initially only provide for the purchase of limited quantities from us. For example, our agreement with Alaska Airlines entered into in May 2015 provides for the initial purchase of a limited quantity of our ATJ fuel, and does not obligate Alaska Airlines to purchase any additional quantity of jet fuel in addition to the amount to be initially purchased. Our ability to increase our sales will depend in large part upon our ability to retain existing customers and expand these existing customer relationships into long-term supplyofftake agreements. Maintaining and expanding our existing relationships and establishing new ones can require substantial investment without any assurance from customers that they will place significant orders. In addition, many of our potential customers may be more experienced in these matters than we are, and we may fail to successfully negotiate these agreements in a timely manner or on favorable terms which, in turn, may force us to slow our production, delay our acquiring and Retrofitting of additional plants, dedicate additional resources to increasing our storage capacity and/or dedicate resources to sales in spot markets. Furthermore, should we become more dependent on spot market sales, our profitability will become increasingly vulnerable to short-term fluctuations in the price and demand for petroleum-based fuels and competing substitutes.

Even if we are successful in consistently producing isobutanol and our hydrocarbon products on a commercial scale, we may not be successful in negotiating pricing terms sufficient to generate positive results from operations at the Luverne Facility.

We expect that many of our customers will be large companies with extensive experience operating in the fuels or chemicals markets. As an early stage company, we lack commercial operating experience, and may face difficulties in developing marketing expertise in these fields. Our business model relies upon our ability to negotiate pricing terms for the isobutanol and other products we produce that generate positive results from the operations of the Luverne Facility. Many of our potential customers may be more experienced in these matters than we are. We may fail to negotiate these agreements in a timely manner, which may force us to dedicate resources to sales in spot markets. If we become more dependent on spot market sales our profitability will become increasingly vulnerable to short-term fluctuations in the price and demand for our products.

Our isobutanol may be less compatible with existing refining and transportation infrastructure than we believe, which may hinder our ability to market our product on a large scale.

We developed our business model based on our belief that our isobutanol is fully compatible with existing refinery infrastructure. For example, when making isobutanol blends, we believe that gasoline refineries will be able to pump our isobutanol through their pipes and blend it in their existing facilities without damaging their equipment. If our isobutanol proves unsuitable for such handling, it will be more expensive for refiners to use our isobutanol than we anticipate, and they may be less willing to adopt it as a gasoline blendstock, forcing us to seek alternative purchasers.

Likewise, our plans for marketing our isobutanol are based upon our belief that it will be compatible with the pipes, tanks and other infrastructure currently used for transporting, storing and distributing gasoline. If our isobutanol or products incorporating our isobutanol cannot be transported with this equipment, we will be forced to seek alternative transportation arrangements, which will make our isobutanol and products produced from our isobutanol more expensive to transport and less appealing to potential customers. Reduced compatibility with either refinery or transportation infrastructure may slow or prevent market adoption of our isobutanol, which could substantially harm our performance.

A sustained low oil price environment may negatively impact the price we receive for the sale of our isobutanol, ethanol and hydrocarbon products.

Many of our end-products such as isobutanol, ethanol and hydrocarbon products have some level of price correlation with crude oil. If crude oil prices were to remain at low levels over a sustained period of time, this may have an impact on the pricing that we are


able to achieve in the marketplace for many of those end-products. This may cause us to operate at a lower, or negative, operating margins and, as a result, our management may decide to reduce or suspend production of ethanol and/or isobutanol at the Luverne Facility. Unfavorable operating margins may also impact our ability to access and Retrofit, either independently or with potential development partners or licensees, existing ethanol facilities for the production of isobutanol for commercial distribution and sale.

If we engage in additional acquisitions, we will incur a variety of costs and may potentially face numerous risks that could adversely affect our business and operations.

If appropriate opportunities become available, we may acquire businesses, assets, technologies or products to enhance our business in the future. In connection with any future acquisitions, we could, subject to certain limitations in the agreements governing our indebtedness including our secured indebtedness with Whitebox:at such time:

issue additional equity securities which would dilute our current stockholders;

incur substantial debt to fund the acquisitions; or

assume significant known or unknown liabilities.

Acquisitions involve numerous risks, including problems integrating the purchased operations, technologies or products, unanticipated costs and other liabilities, diversion of management’s attention from our core business, adverse effects on existing business relationships with current and/or prospective partners, customers and/or suppliers, risks associated with entering markets in which we have no or limited prior experience and potential loss of key employees. Other than our acquisition of the Luverne Facility, we have not engaged in acquisitions in the past, and do not have experience in managing the integration process. Therefore, we may not be able to successfully integrate any businesses, assets, products, technologies or personnel that we might acquire in the future without a significant expenditure of operating, financial and management resources, if at all. The integration process could divert management time from focusing on operating our business, result in a decline in employee morale and cause retention issues to arise from changes in compensation, reporting relationships, future prospects or the direction of the business. In addition, we may acquire companies that have insufficient internal financial controls, which could impair our ability to integrate the acquired company and adversely impact our financial reporting. If we fail in our integration efforts with respect to acquisitions and are unable to efficiently operate as a combined organization, our business, financial condition and results of operations may be materially adversely affected.

If we engage in additional joint ventures, we will incur a variety of costs and may potentially face numerous risks that could adversely affect our business and operations.

If appropriate opportunities become available, we may enter into joint ventures with the owners of existing ethanol production facilities in order to acquire access to additional isobutanol production capacity. We currently anticipate that in each such joint venture, the ethanol producer would contribute access to its existing ethanol production facility and we would be responsible for Retrofitting such facility to produce isobutanol. Upon completion of the Retrofit, and in some cases the attainment of certain performance targets, both parties to the joint venture would receive a portion of the profits from the sale of isobutanol, consistent with our business model. In connection with these joint ventures, we could incur substantial debt to fund the Retrofit of the accessed facilities and we could assume significant liabilities.

various parties. Realizing the anticipated benefits of joint ventures including projected increases to production capacity and additional revenue opportunities, involves a number of potential challenges. The failure to meet these challenges could seriously harm our financial condition and results of operations. JointIn addition, these arrangements typically involve restrictions on actions that the joint venture may take without the approval of the other parties, which could limit our ability to manage the joint venture in a manner that serves our best interests. Finally, joint ventures are complex and time-consumingtime

25

consuming and we may encounter unexpected difficulties or incur unexpected costs related to such arrangements, including:

difficulties negotiating joint venture agreements with favorable terms and establishing relevant performance metrics;

difficulties completing the Retrofits of the accessed facilities using our integrated fermentation technology;

the inability to meet applicable performance targets related to the production of isobutanol;

targets;

difficulties obtaining the permits and approvals required to produce and sell our products in different geographic areas;

complexities associated with managing the potential geographic separation of accessed facilities;

diversion of management attention from ongoing business concerns to matters related to the joint ventures;

difficulties maintaining effective relationships with personnel from different corporate cultures; and

the inability to generate sufficient revenue to offset Retrofitretrofit costs.

Additionally, our joint venture partners may have liabilities or adverse operating issues that we fail to discover through due diligence prior to entering into the joint ventures. In particular, to the extent that our joint venture partners failed to comply with or


otherwise violated applicable laws or regulations, or failed to fulfill their contractual obligations, we may suffer financial harm and/or reputational harm for these violations or otherwise be adversely affected.

Our joint venture partners may have significant amounts of existing debt and may not be able to service their existing debt obligations, which could cause the failure of a specific project and the loss by us of any investment we have made to Retrofit the facilities owned by the joint venture partner. In addition, if we are unable to meet specified performance targets related to the production of isobutanol at a facility owned by one of our joint venture partners, we may never become eligible to receive a portion of the profits of the joint venture and may be unable to recover the costs of Retrofitting the facility.

Additionally, we plan to be a leading marketer for all isobutanol and co-products produced using our proprietary technology and sold in markets other than on-road gasoline blendstocks including, without limitation, all isobutanol that is produced by any facilities that we access via joint venture. Marketing agreements can be very complex and the obligations that we assume as a leading marketer of isobutanol may be time consuming. We have no experience marketing isobutanol on a commercial scale and we may fail to successfully negotiate marketing agreements in a timely manner or on favorable terms. If we fail to successfully market the isobutanol produced using our proprietary technology to refiners and chemical producers, our business, financial condition and results of operations will be materially adversely affected.

If we lose key personnel, including key management personnel, or are unable to attract and retain additional personnel, it could delay our product development programs and harm our research and development efforts, make it more difficult to pursue partnerships or develop our own products or otherwise have a material adverse effect on our business.

Our business is complex and we intend to target a variety of markets. Therefore, it is critical that our management team and employee workforce are knowledgeable in the areas in which we operate. The lossdeparture, illness or absence of any key members of our management, including our named executive officers, or the failure to attract or retain other key employees who possess the requisite expertise for the conduct of our business, could prevent us from developing and commercializing our products for our target markets and entering into partnerships or licensing arrangements to execute our business strategy. In addition,strategy, as could the loss of any key scientific staff, or the failure to attract or retain other key scientific employees, could prevent us from developing and commercializing our products for our target markets and entering into partnerships or licensing arrangements to execute our business strategy.employees. We may not be able to attract or retain qualified employees in the future due to the intense competition for qualified personnel among biotechnology and other technology-based businesses, particularly in the advanced biofuelsrenewable fuels area, or due to the limited availability of personnel with the qualifications or experience necessary for our renewable chemicals and advanced biofuelsrenewable fuels business. If we are not able to attract and retain the necessary personnel to accomplish our business objectives, we may experience staffing constraints that will adversely affect our ability to meet the demands of our partners and customers in a timely fashion or to support our internal research and development programs. In particular, our product and process development programs are dependent on our ability to attract and retain highly skilled scientists. Competition for experienced scientists and other technical personnel from numerous companies and academic and other research institutions may limit our ability to do so on acceptable terms. All of our employees are at-will employees, meaning that either the employee or we may terminate their employment at any time.

Our planned activities will require additional expertise in specific industries and areas applicable to the products and processes developed through our technology platform or acquired through strategic or other transactions, especially in the end markets that we seek to penetrate. These activities will require the addition of new personnel, and the development of additional expertise by existing personnel. The inability to attract personnel with appropriate skills or to develop the necessary expertise could impair our ability to grow our business.

Our government grants are subject to uncertainty, which could harm our business and results of operations.

We have received various government grants, including a cooperative agreement, to complement and enhance our own resources. We may seek to obtain government grants and subsidies in the future to offset all or a portion of the costs of Retrofitting existing ethanol manufacturing facilities and the costs of our research and development activities. We cannot be certain that we will be able to secure any such government grants or subsidies. Any new grants that we may obtain may be terminated, modified or recovered by the granting governmental body under certain conditions.

We may also be subject to audits by government agencies as part of routine audits of our activities funded by our government grants. As part of an audit, these agencies may review our performance, cost structures and compliance with applicable laws, regulations and standards. Funds available under grants must be applied by us toward the research and development programs specified by the granting agencies, rather than for all of our programs generally. If any of our costs are found to be allocated improperly, the costs may not be reimbursed and any costs already reimbursed may have to be refunded. Accordingly, an audit could result in an adjustment to our revenues and results of operations.


We may face substantial competition from companies with greater resources and financial strength, which could adversely affect our performance and growth.

We may face substantial competition in the markets for isobutanol, ethanol, polyester, rubber, plastics, fibers, other polymers andrenewable hydrocarbon fuels.products. Our competitors include companies in the incumbent petroleum-based industry as well as those in the nascent biorenewablerenewable fuels industry. The incumbent petroleum-based industry benefits from a large established infrastructure, production capability and business relationships. The incumbents’ greater resources and financial strength provide significant competitive advantages that we may not be able to overcome in a timely manner. Academic and government institutions may also develop technologies which will compete with us in the chemicals, solvents and blendstock markets.us.

Our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner and are technologically superior to and/or are less expensive than other products on the market. Many of our competitors have substantially greater production, financial, research and development, personnel

26

and marketing resources than we do. In addition, certain of our competitors may also benefit from local government subsidies and other incentives that are not available to us. As a result, our competitors may be able to develop competing and/or superior technologies and processes, and compete more aggressively and sustain that competition over a longer period of time than we could. Our technologies and products may be rendered obsolete or uneconomical by technological advances or entirely different approaches developed by one or more of our competitors. As more companies develop new intellectual property in our markets, the possibility of a competitor acquiring patent or other rights that may limit our products or potential products increases, which could lead to litigation. Furthermore, to secure purchase agreements from certain customers, we may be required to enter into exclusive supply contracts, which could limit our ability to further expand our sales to new customers. Likewise, major potential customers may be locked into long-term, exclusive agreements with our competitors, which could inhibit our ability to compete for their business.

In addition, various governments have recently announced a number of spending programs focused on the development of clean technologies, including alternatives to petroleum-based fuels and the reduction of carbon emissions. Such spending programs could lead to increased funding for our competitors or a rapid increase in the number of competitors within those markets.

Our limited resources relative to many of our competitors may cause us to fail to anticipate or respond adequately to new developments and other competitive pressures. This failure could reduce our competitiveness and market share, adversely affect our results of operations and financial position and prevent us from obtaining or maintaining profitability.

Our future success will dependBusiness interruptions may have an adverse impact on our ability to maintain a competitive position with respect to technological advances.

The biorenewable industry is characterized by rapid technological change. Our future success will depend on our ability to maintain a competitive position with respect to technological advances. Technological development by others may impact the competitiveness of our products in the marketplace. Competitorsbusiness and potential competitors who have greater resources and experience than we do may develop products and technologies that make ours obsolete or may use their greater resources to gain market share at our expense.

We may face significant and substantial competition as it relates to our proprietary biofuels which could adversely affect our performance and growth.

In the production of isobutanol, we face competition from Butamax. Additionally, a number of companies including Cathay Industrial Biotech, Ltd., Green Biologics Ltd., METabolic Explorer, S.A. and Eastman Chemical Company (which acquired TetraVitae Bioscience, Inc. in November 2011) are developing n-butanol production capability from a variety of renewable feedstocks.

In the ethanol market, we operate in a highly competitive industry in the U.S. According to the Renewable Fuels Association, there are over 200 ethanol facilities in the U.S. with an installed nameplate capacity of almost 15 billion gallons. Some of the key competitors in the U.S. include Archer-Daniels-Midland Company, Green Plains, Inc., POET, LLC and Valero Energy Corporation. We also face competition from foreign producers of ethanol. Brazil is believed to be the world’s second largest ethanol producing country. Many producers have much larger production capacities and operate at a lower cost of production than we do. As a result, these companies may be able to compete more effectively in narrower commodity margin environments.

In the gasoline blendstock market, we will compete with our isobutanol against renewable ethanol producers (including those working to produce ethanol from cellulosic feedstocks), producers of alkylate from petroleum and producers of other blendstocks, all of whom may reduce our ability to obtain market share or maintain our price levels.  If any of these competitors succeed in producing blendstocks more efficiently, in higher volumes or offering superior performance than our isobutanol, our financial performance may suffer. Furthermore, if our competitors have more success marketing their products or reach development or supply agreements with major customers, our competitive position may also be harmed.


In the production of other biofuels, including our hydrocarbon products, key competitors include Shell Oil Company, BP, Neste Corporation, Altair Engineering, Inc., Fulcrum Bioenergy, Inc., Red Rocks Biofuels LLC,  POET, LLC, ICM, Inc., Mascoma Corporation, Inbicon A/S, INEOS New Planet BioEnergy LLC, Archer Daniels Midland Company, BlueFire Renewables, Inc., Iogen Corporation, and many smaller startup companies. If these companies are successful in establishing low cost cellulosic ethanol or other fuel production, it could negatively impact the market for our isobutanol as a gasoline blendstock. In the markets for the hydrocarbon fuels that we plan to produce from our isobutanol, we will face competition from the incumbent petroleum-based fuels industry. The incumbent petroleum-based fuels industry makes the vast majority of the world’s gasoline, jet and diesel fuels and blendstocks. It is a mature industry with a substantial base of infrastructure for the production and distribution of petroleum-derived products. The size, established infrastructure and significant resources of many companies in this industry may put us at a substantial competitive disadvantage and delay or prevent the establishment and growth of our business in the market for hydrocarbon fuels.

Biofuels companies may also provide substantial competition in the hydrocarbon fuels market. With respect to production of renewable gasoline, biofuels competitors are numerous and include both large established companies and numerous startups. For example, Virent Energy Systems, Inc. has developed a process for making gasoline and gasoline blendstocks. Many other competitors may do so as well. In the jet fuel market, we will face competition from companies such as Synthetic Genomics, Inc., and Exxon-Mobil Corporation that are pursuing production of jet fuel from algae-based technology.  Renewable Energy Group, Inc. and others are also targeting production of jet fuels from vegetable oils and animal fats.  Red Rock Biofuels LLC and others are planning to produce jet fuel from renewable biomass. We may also face competition from companies working to produce jet fuel from hydrogenated fatty acid methyl esters. In the diesel fuels market, competitors such as Amyris Biotechnologies, Inc., Renewable Energy Group, Inc., Fulcrum Bioenergy, Inc., Neste Corporation and Altair Engineering, Inc.,  have developed technologies for production of alternative hydrocarbon diesel fuel.

Our competitive position in the polyester, rubber, plastics, fibers and other polymers markets versus the incumbent petroleum-derived products and other renewable butanol producers may not be favorable.

In the polyester, rubber, plastics, fibers and other polymers markets, we face competition from incumbent petroleum-derived products, other renewable isobutanol producers and renewable n-butanol producers. Our competitive position versus the incumbent petroleum-derived products and other renewable butanol producers may not be favorable. Petroleum-derived products have dominated the market for many years and there is substantial existing infrastructure for production from petroleum sources, which may impede our ability to establish a position in these markets. Other isobutanol and n-butanol companies may develop technologies that prove more effective than our isobutanol production technology, or such companies may be more adept at marketing their production. Additionally, one company in France, Global Bioenergies, S.A., is pursuing the production of isobutylene from renewable carbohydrates directly. Since conversion of isobutanol to butenes such as isobutylene is a key step in producing many polyester, rubber, plastics, fibers and other polymers from our isobutanol, this direct production of renewable isobutylene, if successful, could limit our opportunities in these markets.

In the polyester, rubber, plastics, fibers and other polymers markets, we expect to face vigorous competition from existing technologies. The companies we may compete with may have significantly greater access to resources, far more industry experience and/or more established sales and marketing networks. Additionally, since we do not plan to produce most of these products directly, we will depend on the willingness of potential customers to purchase and convert our isobutanol into their products. These potential customers generally have well-developed manufacturing processes and arrangements with suppliers of the chemical components of their products and may have a resistance to changing these processes and components. These potential customers frequently impose lengthy and complex product qualification procedures on their suppliers, influenced by consumer preference, manufacturing considerations such as process changes and capital and other costs associated with transitioning to alternative components, supplier operating history, regulatory issues, product liability and other factors, many of which are unknown to, or not well understood by, us. Satisfying these processes may take many months or years. If we are unable to convince these potential customers that our isobutanol is comparable or superior to the alternatives that they currently use, we will not be successful in entering these markets and our business will be adversely affected.

Business interruptions could delay us in the process of developing our products and could disrupt our sales.results.

We are vulnerable to natural disasters and other events that could disrupt our operations, such as riots, civil disturbances, war, terrorist acts, pandemics and other public health crises, weather conditions, electricity rationing, floods, infections in our laboratory or production facilities or those of our contract manufacturers and other events beyond our control. We do not have a detailed disaster recovery plan. In addition, we may not carry sufficient business interruption insurance to compensate us for losses that may occur. Any losses or damages we incur could have a material adverse effect on our cash flows and success as an overall business.


Our business and operations would suffer in the event of IT system failures.failures or a cyber-attack.

Despite the implementationOur business is dependent on proprietary technologies, processes and information that we have developed, much of security measures,which is stored on our internal computer systems. We also have entered into agreements with third parties for hardware, software, telecommunications and other information technology (“IT”) services in connection with our operations. Our operations depend, in part, on how well we and our vendors protect networks, equipment, IT systems are vulnerable toand software against damage from computer viruses, human error, unauthorized access,a number of threats, including, but not limited to, cable cuts, damage to physical plants, natural disasters, intentional actsdamage and destruction, fire, power loss, hacking, computer viruses, vandalism, theft, malware, ransomware and phishing attacks. Any of vandalism, terrorism, warthese and telecommunication and electrical failures. Any system failure, accident or security breach that causes interruptions in our operationsother events could result in IT system failures, delays, a material disruption of our business. Tobusiness or increases in capital expenses. Our operations also depend on the extent that any disruption or security breach resultstimely maintenance, upgrade and replacement of networks, equipment and IT systems and software, as well as preemptive expenses to mitigate the risks of failures.

Furthermore, the importance of such information technology systems and networks and systems has increased due to many of our employees working remotely. Additionally, if one of our service providers were to fail and we were unable to find a suitable replacement in a losstimely manner, we could be unable to properly administer our outsourced functions.

As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or damageenhance our protective measures or to investigate and remediate any information security vulnerabilities. While we have implemented security resources to protect our data security and information technology systems, such measures may not prevent such events. Significant disruption to our IT system or breaches of data or inappropriate disclosure of confidential or proprietary information, we may incur liability, reputation damage and harm tosecurity could have a material adverse effect on our business, financial condition and results of operations.

27

We may engage in hedging transactions, which could harmadversely impact our business.

We have historically engagedIn the future, we may engage in hedging transactions to offset some of the effects of volatility in commodity prices. We have generally followed a policy of using exchange-traded futures contracts to reduce our net position in agricultural commodity inventories and forward purchase contracts to manage price risk. Hedging activities may cause us to suffer losses, such as if we purchase a position in a declining market or sell a position in a rising market. Furthermore, hedging exposeswould expose us to the risk that we may have under- or over-estimated our need for a specific commodity or that the other party to a hedging contract may default on its obligation. If there are significant swings in commodity prices, or if we purchase more corn for future delivery than we can process, we may have to pay to terminate a futures contract, resell unneeded corn inventory at a loss or produce our products at a loss, all of which would have a material adverse effect on our financial performance. We may vary the hedging strategies we undertake, which could leave us more vulnerable to increases in commodity prices or decreases in the prices of isobutanol, distiller’s grains, iDGs™ or ethanol. Lossesour products. Future losses from hedging activities and changes in hedging strategy could have a material adverse effect on our operations.

Ethical, legal and social concerns about genetically engineered products and processes, and similar concerns about feedstocks grown on land that could be used for food production, could limit or prevent the use of our products, processes and technologies and limit our revenues.

Some of our processes involve the use of genetically engineered organisms or genetic engineering technologies. Additionally, our feedstocks may be grown on land that could be used for food production, which subjects our feedstock sources to “food versus fuel” concerns. If we are not able to overcome the ethical, legal and social concerns relating to genetic engineering or food versus fuel, our products and processes may not be accepted.accepted widely enough for our business to be profitable, or at all. Any of the risks discussed below could result in increased expenses, delays or other impediments to our programs or the public acceptance and commercialization of products and processes dependent on our technologies or inventions.

Our ability to develop and commercialize one or more of our technologies, products or processes could be limited by the following factors:

public attitudes about the safety and environmental hazards of, and ethical concerns over, genetic research and genetically engineered products and processes, which could influence public acceptance of our technologies, products and processes;

public attitudes regarding and potential changes to laws governing ownership of genetic material, which could harm our intellectual property rights with respect to our genetic material and discourage others from supporting, developing or commercializing our products, processes and technologies;

public attitudes and ethical concerns surrounding production of feedstocks on land which could be used to grow food, which could influence public acceptance of our technologies, products and processes;

governmental reaction to negative publicity concerning genetically engineered organisms, which could result in greater government regulation of genetic research and derivative products; and

governmental reaction to negative publicity concerning feedstocks produced on land which could be used to grow food, which could result in greater government regulation of feedstock sources.

The subjects of genetically engineered organisms and food versus fuel have received negative publicity, which has aroused public debate. Any negative publicity (even if relating to the actions or products of a competitor or partner) could have a negative impact on our business and/or perceptions of our products. This could result in lower revenue and profits. This adverse publicity could also lead to greater regulation and trade restrictions on imports of genetically engineered products or feedstocks grown on land suitable for food production. Additionally, the use of social media platforms and similar devices, provide an opportunity for the immediate and far-reaching dissemination of information, including inaccurate information. Information concerning us or our products may be posted on such platforms at any time, and such information may be adverse to our interests or may be inaccurate, each of which may harm our performance, prospects, or business. The harm may be immediate without affording us an opportunity for redress or correction.

The biocatalysts that we develop have significantly enhanced characteristics compared to those found in naturally occurring enzymes or microbes. While we produce our biocatalysts only for use in a controlled industrial environment, the release of such biocatalysts into uncontrolled environments could have unintended consequences. Any

28

adverse effect resulting from such a release could have a material adverse effect on our business and financial condition, and we may be exposed to liability for any resulting harm.


As isobutanol hasour products have not previously been used as a commercial fuel in significant amounts, itstheir use subjects us to product liability risks, and we may have difficulties obtaining product liability insurance.risks.

IsobutanolSAF has not previously been used as a commercial fuel in large quantities or for a long period of time. Research regarding SAF and research regarding its impact on engines and distribution infrastructure is ongoing. Though we intend to test our isobutanol further before its commercialization,Although SAF has been tested on some engines, there is a risk that itSAF may damage engines or otherwise fail to perform as expected. If isobutanolSAF degrades the performance or reduces the lifecyclelife-cycle of engines, or causescause them to fail to meet emissions standards, market acceptance could be slowed or stopped, and we could be subject to product liability claims. Furthermore, due to isobutanol’s lack of commercial history as a fuel, we are uncertain as to whether we will be able to acquire product liability insurance on reasonable terms, or at all. A significant product liability lawsuit could substantially impair our production efforts and could have a material adverse effect on our business, reputation, financial condition and results of operations.

We may not be able to use some or all of our net operating loss carry-forwards to offset future income.

We have net operating loss carryforwards due to prior period losses generated before January 1, 2023, which if not utilized will begin to expire at various times over the next 20 years. If we are unable to generate sufficient taxable income to utilize our net operating loss carryforwards, these carryforwards could expire unused and be unavailable to offset future income tax liabilities.

In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”), a corporation that undergoes an “ownership change” (generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period) is subject to limitation on its ability to utilize its pre-change net operating loss carry-forwards, or net operating losses, to offset future taxable income. We mayundertook a detailed study of our net operating loss carryforwards through December 31, 2023 to determine whether such amounts are likely to be limited by Section 382 of the Code. As a result of this analysis, we currently believe any Section 382 of the Code limitations will significantly impact our ability to offset income with available net operating loss carryforwards. We have experienced more than one or more ownership changeschange in prior years, and the issuance of shares in connection with our initial public offering may itself have triggered an ownership change. In addition, future changes in our stock ownership, which may be outside of our control, may trigger an ownership change, as may future equity offerings or acquisitions that have equity as a component of the purchase price. If an ownership change has occurred or does occur in the future, our ability to utilize our net operating losses to offset income if we attain profitability may be limited.

If we fail to maintain an effective systemCompetitiveness of internal controls, we might not be able to report our financial results accurately or prevent fraud; in that case, our stockholders could lose confidence in our financial reporting, which would harm our business and could negatively impact the price of our stock.

Effective internal controls are necessary for us to provide reliable financial reports and prevent fraud. In addition, Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) requires us to evaluate and report on our internal control over financial reporting and have our principal executive officer and principal financial officer certify as to the accuracy and completeness of our financial reports. The process of maintaining our internal controls and complying with Section 404 is expensive and time consuming, and requires significant attention of management. We cannot be certain that these measures will ensure that we maintain adequate controls over our financial processes and reporting in the future. Even if we conclude that our internal control over financial reporting provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, because of their inherent limitations, our internal controls over financial reporting may not prevent or detect fraud or misstatements. Failure to maintain required controls or implement new or additional controls as circumstances warrant, or difficulties encountered in maintaining or implementing controls, could harm our results of operations or cause us to fail to meet our reporting obligations.

Our management has concluded that there are no material weaknesses in our internal controls over financial reporting as of December 31, 2017. However, there can be no assurance that our controls over financial processes and reporting will be effective in the future or that additional material weaknesses or significant deficiencies in our internal controls will not be discovered in the future. If we, or our independent registered public accounting firm, discover a material weakness, the disclosure of that fact, even if quickly remedied, could reduce the market’s confidence in our financial statements and harm our stock price. In addition, a delay in compliance with Section 404 could subject us to a variety of administrative sanctions, including SEC action, ineligibility for short form resale registration, the suspension or delisting of our common stock from the stock exchange on which it is listed and the inability of registered broker-dealers to make a market in our common stock, which would further reduce our stock price and could harm our business.

We may enter into letters of intent, memoranda of understanding and other largely non-binding agreements with potential customers or partners that may not result in legally binding, definitive agreements.

From time to time, we may enter into letters of intent, memoranda of understanding and other largely non-binding agreements or understandings with potential customers or partners in order to develop our business and the markets that we serve. We can make no assurance that legally binding, definitive agreements reflecting the terms of such non-binding agreements will be completed with such customers or partners, or at all.


Competiveness for our products for fuel use in the U.S.(including RNG) depends in part on the United States Renewable Fuel Standard Programgovernment economic incentives for renewable energy projects or RFS Program at the federal level, and the benefits to our products derived from the RFS Programother related policies that could change.

The RFS Program and policy are currently being discussed by policy makers.  The RFS Program and policy could change impacting the RIN benefits our products could receive, making our products less competitive to the incumbent products made from petroleum.

We maydepend, in part, on international, federal, state and local government incentives, including but not qualify for significant carbon value benefit in those states, regions, and countries where renewable carbon value in fuel products is being assigned.  

The possibility exists that our products may not qualify for benefits of the Low Carbon Fuel Standard Program (LCFS)limited to RINs, LCFS credits in California, Clean Fuel Program credits in Oregon, Renewable Energy Credits (“RECs”), rebates, tax credits and other incentives to end users, distributors, system integrators and manufacturers of renewable energy projects, that promote the use of renewable energy. These government economic incentives could be reduced or similar programseliminated altogether, or the categories of renewable energy qualifying for such government economic incentives could be changed. These renewable energy program incentives are subject to regulatory oversight and could be administratively or legislatively changed in other states and countries.  Failure of our products to qualify for LCFS or other similar programsa manner that could have a material adverse effect on our operations. Reductions in, changes to, or eliminations or expirations of governmental incentives could result in decreased demand for, and lower revenues from, our projects and products. Further, our ability to generate revenue from the various government economic incentives depends on our strict compliance with the applicable federal and state programs, which are complex and can involve a significant degree of judgment. If the agencies that administer and enforce these programs disagree with our judgments, otherwise determine that we are not in compliance, conduct reviews of our activities or make changes to the programs, then our ability to generate revenue from the economic incentives could be temporarily restricted pending completion of reviews or as a penalty, permanently limited or lost entirely, and we could also be subject to fines or other sanctions.

In addition, we may be required to register our projects or qualify our products with the federal government, various states or other countries. Delays in obtaining registration or qualification of our projects or products could delay future revenues and could adversely affect our cash flows. Further, we typically make a large investment in our projects

29

prior to receiving registration and/or qualification. Failure of our projects or products to qualify for government economic incentives could have a material adverse effect on our business.

In order to benefit from RINs and LCFS credits, our RNG projects are required to be registered and are subject to regulatory audit.

We are required to register an RNG project with the EPA and relevant state regulatory agencies. Further, we qualify our RINs through a voluntary Quality Assurance Plan. By registering our RNG project with the EPA’s voluntary Quality Assurance Plan, we are subject to quarterly third-party audits and semi-annual on-site visits of our projects to validate generated RINs and overall compliance with the RFS program. We are also subject to a separate third party’s annual attestation review. The Quality Assurance Plan provides a process for RIN owners to follow, for an affirmative defense to civil liability, if used or transferred Quality Assurance Plan verified RINs were invalidly generated. A project’s failure to comply could result in remedial action by the EPA, including penalties, fines, retirement of RINs, or termination of the project’s registration, any of which could adversely affect our business, financial condition and results of operations.

Our RNG project has, and any future digester project may not be able to achieve the operating results we expect from these projects.

Our RNG project is dependent on the LCFS credits and RINs produced at the dairy farms that make up part of our RNG project. In the event that CARB reduces the CI score that it applies to waste conversion projects, such as dairy digesters, the number of LCFS credits for RNG generated at our RNG project will decline. Additionally, revenue from LCFS credits also depends on the price per LCFS credit, which is driven by various market forces, including the supply of and demand for LCFS credits, which in turn depends on the demand for traditional transportation fuel and the supply of renewable fuel from other renewable energy sources, and mandated CI targets, which determine the number of LCFS credits required to offset LCFS deficits, and which increase over time. A significant decline in the value of LCFS credits could require us to incur an impairment charge on our RNG project and could adversely affect our business, financial condition and results of operations.

Risks Related to Intellectual Property

Our ability to compete may be adversely affected if we are unsuccessful in defending against any claims by competitors or others that we are infringing upon their intellectual property rights.

The various bioindustrial markets in which we operate or plan to operate are subject to frequent and extensive litigation regarding patents and other intellectual property rights. In addition, many companies in intellectual property-dependent industries, including the renewable energy industry, have employed intellectual property litigation as a means to gain an advantage over their competitors. As a result, we may be required to defend against claims of intellectual property infringement that may be asserted by our competitors against us and, if the outcome of any such litigation is adverse to us, it may affect our financial condition and our ability to compete effectively.

Litigation, interferences, opposition proceedings or other intellectual property proceedings inside and outside of the U.S. may divert management time from focusing on business operations, could cause us to spend significant amounts of money and may have no guarantee of success. Any future intellectual property litigation could also force us to do one or more of the following:

stop selling, incorporating, manufacturing or using our products that use the subject intellectual property;

obtain from a third party asserting its intellectual property rights, a license to sell or use the relevant technology, which license may not be available on reasonable terms, or at all;

redesign those products or processes such as our process for producing isobutanol, that use any allegedly infringing or misappropriated technology, which may result in significant cost or delay to us, or which redesign could be technically infeasible;

pay attorneys’ fees and expenses; or

pay damages, including the possibility of treble damages in a patent case if a court finds us to have willfully infringed certain intellectual property rights.

30

We are aware of a significant number of patents and patent applications relating to aspects of our technologies filed by, and issued to, third parties. We cannot assure you that we will ultimately prevail if any of this third-party intellectual property is asserted against us.

Our ability to compete may be adversely affected if we do not adequately protect our proprietary technologies or if we lose some of our intellectual property rights through costly litigation or administrative proceedings.

Our success will depend in part on our ability to obtain patents and maintain adequate protection of our intellectual property covering our technologies and products and potential products in the U.S. and other countries. We have adopted a strategy of seeking patent protection in the U.S. and in certain foreign countries with respect to certain of the technologies used in or relating to our products and processes. We own rights to hundreds of issued patents and filed patent applications in the U.S. and in various foreign jurisdictions. When and if issued, patents would expire at the end of their term and any patent would only provide us commercial advantage for a limited period of time, if at all. Our patent applications are directed to our enabling technologies and to our methods and products which support our business in the advanced biofuelsrenewable fuels and renewable chemicals markets. We intend to continue to apply for patents relating to our technologies, methods and products as we deem appropriate.

Only some of the patent applications that we have filed in the U.S. or in any foreign jurisdictions, and only certain of the patent applications filed by third parties in which we own rights, have been issued. A filed patent application does not guarantee a patent will issue and a patent issuing does not guarantee its validity, nor does it give us the right to practice the patented technology or commercialize the patented product. Third parties may have or obtain rights to “blocking patents” that could be used to prevent us from commercializing our products or practicing our technology. The scope and validity of patents and success in prosecuting patent


applications involve complex legal and factual questions and, therefore, issuance, coverage and validity cannot be predicted with any certainty. Patents issuing from our filed applications may be challenged, invalidated or circumvented. Moreover, third parties could practice our inventions in secret and in territories where we do not have patent protection. Such third parties may then try to sell or import products made using our inventions in and into the U.S. or other territories and we may be unable to prove that such products were made using our inventions. Additional uncertainty may result from implementation of the Leahy-Smith America Invents Act, enacted in September 2011, as well as other potential patent reform legislation passed by the U.S. Congress and from legal precedent handed down by the Federal Circuit Court and the U.S. Supreme Court, as they determine legal issues concerning the scope, validity and construction of patent claims. Because patent applications in the U.S. and many foreign jurisdictions are typically not published until 18 months after filing, or in some cases not at all, and because publication of discoveries in the scientific literature often lags behind the actual discoveries, there is additional uncertainty as to the validity of any patents that may issue and the potential for “blocking patents” coming into force at some future date. Accordingly, we cannot ensure that any of our currently filed or future patent applications will result in issued patents, or even if issued, predict the scope of the claims that may issue in our and other companies’ patents. Currently, one ofAny proceedings challenging our issued patents is being challenged in regulatory proceedings before the USPTO. These proceedings may result in the claims being amended or canceled. If the claims are amended or canceled, the scope of our patentspatent claims may be narrowed, which may reduce the scope of protection afforded by our patent portfolio. Given that the degree of future protection for our proprietary rights is uncertain, we cannot ensure that (i) we were the first to make the inventions covered by each of our filed applications, (ii) we were the first to file patent applications for these inventions, (iii) the proprietary technologies we develop will be patentable, (iv) any patents issued will be broad enough in scope to provide commercial advantage and prevent circumvention, and (v) competitors and other parties do not have or will not obtain patent protection that will block our development and commercialization activities.

These concerns apply equally to patents we have licensed, which may likewise be challenged, invalidated or circumvented, and the licensed technologies may be obstructed from commercialization by competitors’ “blocking patents.” In addition, we generally do not control the patent prosecution and maintenance of subject matter that we license from others. Generally, the licensors are primarily or wholly responsible for the patent prosecution and maintenance activities pertaining to the patent applications and patents we license, while we may only be afforded opportunities to comment on such activities. Accordingly, we are unable to exercise the same degree of control over licensed intellectual property as we exercise over our own intellectual property and we face the risk that our licensors will not prosecute or maintain it as effectively as we would like.

31

In addition, unauthorized parties may attempt to copy or otherwise obtain and use our products or technology. Monitoring unauthorized use of our intellectual property is difficult, particularly where, as here, the end products reaching the market generally do not reveal the processes used in their manufacture, and particularly in certain foreign countries where the local laws may not protect our proprietary rights as fully as in the U.S., so we cannot be certain that the steps we have taken in obtaining intellectual property and other proprietary rights will prevent unauthorized use of our technology. If competitors are able to use our technology without our authorization, our ability to compete effectively could be adversely affected.affected and our business could be harmed. Moreover, competitors and other parties such as universities may independently develop and obtain patents for technologies that are similar to or superior to our technologies. If that happens, the potential competitive advantages provided by our intellectual property may be adversely affected. We may then need to license these competing technologies, and we may not be able to obtain licenses on reasonable terms, if at all, which could cause material harm to our business. Accordingly, litigation may be necessary for us to assert claims of infringement, enforce patents we own or license, protect trade secrets or determine the enforceability, scope and validity of the intellectual property rights of others.

Our commercial success also depends in part on not infringing patents and proprietary rights of third parties, and not breaching any licenses or other agreements that we have entered into with regard to our technologies, products and business. We cannot be certain that patents have not or will not issuebe issued to third parties that could block our ability to obtain patents or to operate our business as we would like, or at all. There may be patents in some countries that, if valid, may block our ability to commercialize products in those countries if we are unsuccessful in circumventing or acquiring rights to these patents. There may also be claims in patent applications filed in some countries that, if granted and valid, may also block our ability to commercialize products or processes in these countries if we are unable to circumvent or license them.

As is commonplace in the biotechnology industries, some of our directors, employees and consultants are or have been employed at, or associated with, companies and universities that compete with us or have or will develop similar technologies and related intellectual property. While employed at these companies, these employees, directors and consultants may have been exposed to or involved in research and technology similar to the areas of research and technology in which we are engaged. Though we have not received such a complaint, we may be subject to allegations that we, our directors, employees or consultants have inadvertently or otherwise used, misappropriated or disclosed alleged trade secrets or confidential or proprietary information of those companies. Litigation may be necessary to defend against such allegations and the outcome of any such litigation would be uncertain.

Under some of our research agreements, our partners share joint rights in certain intellectual property we develop. Such provisions may limit our ability to gain commercial benefit from some of the intellectual property we develop and may lead to costly or time-consuming disputes with parties with whom we have commercial relationships over rights to certain innovations.


If any other party has filed patent applications or obtained patents that claim inventions also claimed by us, we may have to participate in interference, derivation or other proceedings declared by the USPTO to determine priority of invention and, thus, the right to the patents for these inventions in the U.S. These proceedings could result in substantial cost to us even if the outcome is favorable. Even if successful, such a proceeding may result in the loss of certain claims. Even successful outcomes of such proceedings could result in significant legal fees and other expenses, diversion of management time and efforts and disruption in our business. Uncertainties resulting from initiation and continuation of any patent or related litigation could harm our ability to compete.

Ifcompete and have an adverse impact on our biocatalysts, or the genes that code for our biocatalysts, are stolen, misappropriated or reverse engineered, others could use these biocatalysts or genes to produce competing products.

Third parties, including our contract manufacturers, customers and those involved in shipping our biocatalysts, may have custody or control of our biocatalysts. If our biocatalysts, or the genes that code for our biocatalysts, were stolen, misappropriated or reverse engineered, they could be used by other parties who may be able to reproduce these biocatalysts for their own commercial gain. If this were to occur, it would be difficult for us to discover or challenge this type of use, especially in countries with limited intellectual property protection.

During the ordinary course of business, we may become subject to lawsuits or indemnity claims, which could materially and adversely affect our business and results of operations.

From time to time, we may in the ordinary course of business be named as a defendant in lawsuits, claims and other legal proceedings. These actions may seek, among other things, compensation for alleged personal injury, worker’s compensation, employment discrimination, breach of contract, property damages, civil penalties and other losses of injunctive or declaratory relief. In the event that such actions or indemnities are ultimately resolved unfavorably at amounts exceeding our accrued liability, or at material amounts, the outcome could materially and adversely affect our reputation, business and results of operations. In addition, payments of significant amounts, even if reserved, could adversely affect our liquidity position.financial condition.

We may not be able to enforce our intellectual property rights throughout the world.

The laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Many companies have encountered significant problems in protecting and enforcing intellectual property rights in certain foreign jurisdictions, and, particularly as we move forward in our partnerships with Porta, Praj, andany future international partners, we may face new and increased risks and challenges in protecting and enforcing our intellectual property rights abroad. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to bioindustrial technologies. This could make it difficult for us to stop the infringement of our patents or misappropriation of our other intellectual property rights. Proceedings to enforce our patents and other proprietary rights in foreign jurisdictions could result in substantial costs and divert our

32

efforts and attention from other aspects of our business. Accordingly, our efforts to enforce our intellectual property rights in such countries may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop.

Confidentiality agreements with employees and others may not adequately prevent disclosures of trade secrets and other proprietary information.

We rely in part on trade secret protection to protect our confidential and proprietary information and processes. However, trade secrets are difficult to protect. We have taken measures to protect our trade secrets and proprietary information, but these measures may not be effective. We require new employees and consultants to execute confidentiality agreements upon the commencement of an employment or consulting arrangement with us. These agreements generally require that all confidential information developed by the individual or made known to the individual by us during the course of the individual’s relationship with us be kept confidential and not disclosed to third parties. These agreements also generally provide that know-how and inventions conceived by the individual in the course of rendering services to us shall be our exclusive property. Nevertheless, these agreements may not be enforceable, our proprietary information may still be disclosed, third parties could reverse engineer our biocatalysts and others may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position. In addition, an unauthorized breach in our information technology systems may expose our trade secrets and other proprietary information to unauthorized parties. Any exposure of our trade secrets or other proprietary information could harm our competitive position and have an adverse impact on our financial condition.

We have received funding from U.S. government agencies, which could negatively affect our intellectual property rights.

Some of our research has been funded by grants from U.S. government agencies. When new technologies are developed with U.S. government funding, the government obtains certain rights in any resulting patents and technical data, generally including, at a


minimum, a nonexclusive license authorizing the government to use the invention or technical data for noncommercial purposes. U.S. government funding must be disclosed in any resulting patent applications, and our rights in such inventions will normally be subject to government license rights, periodic progress reporting, foreign manufacturing restrictions and march-in rights. March-in rights refer to the right of the U.S. government, under certain limited circumstances, to require us to grant a license to technology developed under a government grant to a responsible applicant or, if we refuse, to grant such a license itself. March-in rights can be triggered if the government determines that we have failed to work sufficiently towards achieving practical application of a technology or if action is necessary to alleviate health or safety needs, to meet requirements of federal regulations or to give preference to U.S. industry. If we breach the terms of our grants, the government may gain rights to the intellectual property developed in our related research. The government’s rights in our intellectual property may lessen its commercial value, which could adversely affect our performance.

Risks Related to Legal and Regulatory Risks

We may face substantial delaysThe U.S. renewable fuels industry is highly dependent upon certain federal and state legislation and regulation and any changes in obtaining regulatory approvalslegislation or regulation could have a material adverse effect on our results of operations, cash flows and financial condition.

The EPA has implemented the RFS Program pursuant to the Energy Policy Act of 2005 (the “Energy Policy Act”) and the Energy Independence and Security Act of 2007. The RFS Program sets annual quotas for usethe quantity of our isobutanol and hydrocarbon productsrenewable fuels that must be blended into motor fuels consumed in the U.S. The domestic market for renewable fuels is significantly impacted by federal mandates under the RFS Program for volumes of renewable fuels required to be blended with gasoline. Future demand for renewable fuels will be largely dependent upon incentives to blend renewable fuels into motor fuels, including the price of renewable fuels relative to the price of gasoline, the relative octane value of the renewable fuel, constraints in the ability of vehicles to use higher renewable fuel blends, the RFS Program and chemicals markets, which could substantially hinder our ability to commercialize our products.other applicable environmental requirements. Any significant increase in production capacity above the RFS Program

Large-scale commercialization33

minimum requirements may require approvals from state and federal agencies. Before we can sell isobutanol as ahave an adverse impact on renewable fuel or as a gasoline blendstock directly to large petroleum refiners, we must receive EPA fuel certification. On March 15, 2018,prices. Any change in government policies regarding the EPA published a notice for public comment on the EPA’s intent to register isobutanol for blending into gasoline which would allow us to sell isobutanol as a fuel or as a gasoline blendstock directly to large petroleum refiners and would move our small business registration to a full registration (including Tier 1 EPA testing. Final approval has not yet occurred,  and there is no guarantee of receiving it.

Additionally, California requires that fuels meet both its fuel certification requirements and a separate state low-carbon fuel standard. Any delay in receiving approval will slow or prevent the commercialization of our isobutanol for fuel markets, whichRFS Program could have a material adverse effect on our business financial condition and the results of our operations.

With respect toWaivers of the chemicals markets, we plan to focus on isobutanol production and sell to companies that can convert our isobutanol into other chemicals, such as isobutylene. However, should we later decide to produce these other chemicals ourselves, we may face similarRFS minimum levels of renewable fuels included in motor fuels or of the requirements for EPA and other regulatory approvals. Approval, if ever granted, could be delayed for substantial amounts of time, which could significantly harm the development of our business and prevent the achievement of our goals.

Our isobutanol fermentation process utilizes a genetically modified organism which, when used in an industrial process, is considered a new chemical under the EPA’s Toxic Substances Control Act (“TSCA”). The TSCA requires usby obligated parties to comply with the EPA’s Microbial Commercial Activity Notice process to operate plants producing isobutanol using our biocatalysts. The TSCA’s new chemicals submission policies may change and additional government regulations may be enacted that could prevent or delay regulatory approval of our isobutanol production.

There are various third-party certification organizations, such as ASTM and Underwriters’ Laboratories, Inc., involved in standard-setting regarding the transportation, dispensing and use of liquid fuel in the U.S. and abroad. These organizations may change the current standards and additional requirements may be enacted that could prevent or delay approval of our products. The process of seeking required approvals and the continuing need for compliance with applicable standards may require the expenditure of substantial resources, and there is no guarantee that we will satisfy these standards in a timely manner, if ever.

In addition, to Retrofit or otherwise modify ethanol facilities and operate the Retrofitted and modified plants to produce isobutanol, we will need to obtain and comply with a number of permit requirements. As a condition to granting necessary permits, regulators may make demands that could increase our Retrofit, modification or operations costs, and permit conditions could also restrict or limit the extent of our operations, which could delay or prevent our commercial production of isobutanol. We cannot guarantee that we will be able to meet all regulatory requirements or obtain and comply with all necessary permits to complete our planned ethanol plant Retrofits, and failure to satisfy these requirements in a timely manner, or at all, could have a substantial negativematerial adverse effect on our performance.results of operations. Under the Energy Policy Act, the U.S. Department of Energy, in consultation with the Secretary of Agriculture and the Secretary of Energy, may waive the renewable fuels mandate with respect to one or more states if the Administrator of the EPA determines that implementing the requirements would severely harm the economy or the environment of a state, a region or the nation, or that there is inadequate supply to meet the requirement. Additionally, the EPA has exercised the authority to waive the requirements of the RFS minimum levels for certain small refiners. Any waiver of the RFS minimum levels with respect to one or more states would reduce demand for renewable fuels and could cause our results of operations to decline and our financial condition to suffer. Further activity by the EPA to waive the requirements for small refiners could cause softening of pricing in the industry and cause our results of operations to similarly decline.

JetA critical state program is California’s LCFS program, which is designed to reduce GHG emissions associated with transportation fuels must meet various statutory and regulatory requirements before they may be used in commercial aviation, including regulations ofCalifornia by ensuring that the Federal Aviation Administration (“FAA”) and specifications determinedfuel sold in California meets declining targets for such emissions. The regulation quantifies life-cycle GHG emissions by ASTM International. Currently, our renewable jetassigning a CI score to each transportation fuel based on that fuel’s life-cycle assessment. Each petroleum fuel provider, generally the fuel’s producer or importer (the “Regulated Party”), is required to ensure that the overall CI score for its fuel pool meets the FAA regulationsannual CI target for a given year. A Regulated Party’s fuel pool can include gasoline, diesel and their blend stocks and substitutes. This obligation is tracked through credits and deficits. Fuels with a CI score lower than the ASTM International specifications.  However,annual standard earn a credit, and fuels that are higher than the standard result in a deficit. Several other states also have or are considering adopting this model. Oregon’s Clean Fuels Program, enacted in 2009 and implemented in 2016, operates using a credit system similar to the California LCFS program. Any changes to applicable regulations and specifications.in the future mightCalifornia’s LCFS program or failure of other states to implement similar programs could have a material adverse effect on our business if such changes resulted in our renewable jet fuel not being eligible for use in commercial aviation.  


Our isobutanol and hydrocarbon products may encounter physical or regulatory issues, which could limit its usefulness as a gasoline blendstock.

In the gasoline blendstock market, isobutanol can be used in conjunction with, or as a substitute for, ethanol and other widely used fuel oxygenates, and we believe our isobutanol will be physically compatible with typical gasoline engines. However, there is a risk that under actual engine conditions, isobutanol will face significant limitations, making it unsuitable for use in high percentage gasoline blends. Additionally, current regulations limit gasoline blends to low percentages of isobutanol, and also limit combination isobutanol-ethanol blends. Government agencies may maintain or even increase the restrictions on isobutanol gasoline blends. As we believe that the potential to use isobutanol in higher percentage blends than is feasible for ethanol will be an important factor in successfully marketing isobutanol to refiners, a low blend wall could significantly limit commercialization of isobutanol as a gasoline blendstock.

We may be required to obtain additional regulatory approvals for useresults of our iDGs™ as animal feed, which could delay our ability to sell iDGs™ increasing our net cost of production and harming our operating results.

Many of the ethanol plants we initially plan to Retrofit use dry-milled corn as a feedstock. We plan to sell, as animal feed, the iDGs™ left as a co-product of fermenting isobutanol from dry-milled corn. We believe that this will enable us to offset a significant portion of the expense of purchasing corn for fermentation. We are currently approved to sell iDGs™ as animal feed through the self-assessed Generally Regarded as Safe (“GRAS”) process of the U.S. Federal Drug Administration (the “FDA”) via third party scientific review.  In order to improve the value of our iDGs™, we are working with The Association of American Feed Control Officials (“AAFCO”) to establish a formal definition for our iDGs™ as well as clearance for the materials into animal feed.  We believe obtaining AAFCO approval will increase the value of our iDGs™ by offering customers of our iDGs™ further assurance of the safety of our iDGs™. If we make certain changes in our biocatalyst whereby we can no longer rely on our GRAS process, we would be required to obtain FDA approval for marketing our iDGs™.  While we believe we can rely on the GRAS process, as we update our biocatalysts to increase isobutanol production, for further customer assurance, we also intend to pursue approval upon a completed biocatalyst from the Center for Veterinary Medicine of the FDA.  FDA testing and approval can take a significant amount of time, and there is no guarantee that we will ever receive such approval. While we have sold initial quantities of our iDGs TM  from the Luverne Facility, if FDA or AAFCO approval is delayed or never obtained, or if we are unable to secure market acceptance for our iDGs™, our net cost of production will increase, which may hurt our operating results.operations.

Reductions or changes to existing regulations and policies may present technical, regulatory and economic barriers, all of which may significantly reduce demand for biofuelsrenewable fuels or our ability to supply isobutanol.our products.

The market for biofuelsrenewable fuels is heavily influenced by foreign, federal, state and local government laws, regulations and policies. For example,Changes in 2007, the U.S. Congress passed an alternative fuels mandate that required nearly 14 billion gallons of liquid transportation fuels sold in 2011 to come from alternative sources, including biofuels, a mandate that grows to 36 billion gallons by 2022. Of this amount, a minimum of 21 billion gallons must be advanced biofuels as defined by the U.S. Congress. In the U.S., and in a number of other countries, these laws, regulations and policies have been modified in the pastor how these laws, regulations and may be modified again in the future. Any reduction in mandated requirements for fuel alternativespolicies are implemented and additives to gasoline mayenforced could cause the demand for biofuelsrenewable fuels to decline and deter investment in the research and development of biofuels. For example, the Energy and Commerce Committee of the U.S. House of Representatives has undertaken an assessment of the Renewable Fuel Standard program and has published five white papers on the subject during the current congressional period. The EPA has also said that it plans to assess the E10 blendwall and current infrastructure and market-based limitations to the consumption of ethanol in gasoline-ethanol blends above E10. In particular, the EPA is proposing to cut the volume requirements for advanced biofuels by more than 40% when compared to the requirements currently written into the statute. This proposal has created significant concerns throughout the biofuels industry, many of which were voiced by the biofuels industry during the public comment period. This type of legislative activity can create concern in the marketplace about the long-term sustainability of governmental policies. The absence of tax credits, subsidies and other incentives in the U.S. and foreign markets for biofuels, or any inability of our customers to access such credits, subsidies and incentives, may adversely affect demand for our products, which would adversely affect our business. The resulting market uncertainty regarding current and future standards and policies may also affect our ability to develop new renewable products or to license our technologies to third parties and to sell products to our end customers.fuels.

Concerns associated with biofuels,renewable fuels, including land usage, national security interests and food crop usage, continue to receive legislative, industry and public attention. This attention could result in future legislation, regulation and/or administrative action that could adversely affect our business. Any inability to address these requirements and any regulatory or policy changes could have a material adverse effect on our business, financial condition and results of operations.

Additionally, like the ethanol facilities that we Retrofit, our isobutanolrenewable hydrocarbon plants willmay emit greenhouse gases.GHG. Any changes in state or federal emissions regulations, including the passage of cap-and-trade legislation or a carbon tax, could limit our production of


isobutanol and iDGs™ renewable hydrocarbon products and increase our operating costs, which could have a material adverse effect on our business, financial condition and results of operations.

The recentresults of U.S. elections could lead to changes in federal or state laws and regulations that could have a material adverse effect on our business, prospects, financial condition and results of operations.

We use hazardous materials inNegative attitudes toward renewable energy projects from the U.S. government, other lawmakers and regulators, and activists could adversely affect our business, financial condition and results of operations.

Parties with an interest in other energy sources, including lawmakers, regulators, policymakers, environmental and advocacy organizations or other activists may invest significant time and money in efforts to delay, repeal or otherwise negatively influence regulations and programs that promote renewable energy. Many of these parties have substantially greater resources and influence than we must comply with environmental lawshave. Further, changes in U.S. federal, state or local political, social or economic conditions, including a lack of legislative focus on these programs and regulations. regulations, could result in their

34

modification, delayed adoption or repeal. Any failure to adopt, delay in implementing, expiration, repeal or modification of these programs and regulations, or the adoption of any programs or regulations that encourage the use of other energy sources over renewable energy, could adversely affect our business, financial condition and results of operations.

Any claims relating to improper handling, storage or disposal of thesehazardous materials or noncompliance with applicable laws and regulations could be time consuming and costly and could adversely affect our business and results of operations.

Our research and development processes involve the use of hazardous materials, including chemical, radioactive and biological materials. Our operations also produce hazardous waste. We cannot eliminate entirely the risk of accidental contamination or discharge and any resultant injury from these materials. Federal, state and local laws and regulations govern the use, manufacture, storage, handling and disposal of, and human exposure to, these materials. We may be sued for any injury or contamination that results from our use or the use by third parties of these materials, and our liability may exceed our total assets. Although we believe that our activities conform in all material respects with environmental laws, there can be no assurance that violations of environmental, health and safety laws will not occur in the future as a result of human error, accident, equipment failure or other causes. Compliance with applicable environmental laws and regulations may be expensive, and the failure to comply with past, present or future laws could result in the imposition of fines, third-party property damage, product liability and personal injury claims, investigation and remediation costs, the suspension of production or a cessation of operations, and our liability may exceed our total assets. Liability under environmental laws can be joint and several and without regard to comparative fault. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations, which could impair our research, development or production efforts and harm our business.

Our expanded international activities may increase our exposure to potential liability under anti-corruption, trade protection, tax and other laws and regulations.

In the course of our relationships with Praj, Porta and future international partners, we may become subject to certain foreign tax, environmental and health and safety regulations that did not previously apply to us or our products. Such regulations may be unclear, not consistently applied and subject to sudden change. Implementation of compliance policies could result in additional operating costs, and our failure to comply with such laws, even inadvertently, could result in significant fines and/or penalties.

Additionally, the Foreign Corrupt Practices Act and other anti-corruption laws and regulations (“Anti-Corruption Laws”) prohibit corrupt payments by our employees, vendors or agents. Even with implementation of policies, training and internal controls designed to reduce the risk of corrupt payments, our employees, vendors or agents may violate our policies. Our international partnerships may significantly increase our exposure to potential liability. Our failure to comply with Anti-Corruption Laws could result in significant fines and penalties, criminal sanctions against us, our officers or our employees, prohibitions on the conduct of our business, and damage to our reputation.


Risks Related to Owning Our Securities.Securities

We may not be able to comply with all applicable listing requirements or standards of theThe Nasdaq Capital Market and Nasdaq could delist our common stock.

Our common stock is listed on theThe Nasdaq Capital Market. InMarket, and in order to maintain that listing, we must satisfy minimum financial and otherapplicable Nasdaq continued listing requirements. The inability to comply with applicable listing requirements and standards.

On June 21, 2017, we received a deficiency letter from the Listing Qualifications Departmentor standards of theThe Nasdaq Stock Market notifying usLLC (“Nasdaq”) could result in the delisting of our common stock, which could have a material adverse effect on our financial condition and could cause the value of our common stock to decline. Delisting of our common stock could also adversely affect our ability to raise additional financing, could significantly affect the ability of our investors to trade our securities and could negatively affect the value and liquidity of our common stock. Delisting could also have other negative results, including the potential loss of confidence by employees and fewer business development opportunities.

35

On February 29, 2024, we received notice from Nasdaq that for the prior 30 consecutive business days,Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the closingminimum bid price of our common stock was not maintained at the minimum required closing bid price of at leasthad been below $1.00 per share as required for continued listingthe previous 30 consecutive business days. The notice has no immediate effect on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, we had an initial compliance periodlisting or trading of 180 calendar days, to regain compliance with this requirement. On December 20. 2017, the Nasdaq Stock Market granted us an additionalour common stock.

We have 180 calendar days, or until June 18, 2018,August 27, 2024, to regain compliance.compliance with the Minimum Bid Price Requirement. To regain compliance, the closingminimum bid price of our common stock must bemeet or exceed $1.00 per share or more for a minimum of 10ten consecutive business days at any time before June 18, 2018. The Nasdaq determination to grant the second compliance period was based on our meeting of the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

We cannot provide any assurance that our stock price will recover within the permittedthis 180-calendar day grace period. In the event thatwe do not regain compliance with the Minimum Bid Price Requirement by August 27, 2024, we may be eligible for an additional 180-calendar day compliance period. If we do not qualify for the second compliance period or fail to regain compliance during the second 180-day period, then Nasdaq will notify us of its determination to delist our common stock, is not eligible for quotation on another market or exchange, trading of our common stock could be conducted inat which point we will have an opportunity to appeal the over-the-counter market or on an electronic bulletin board established for unlisted securities such asdelisting determination to a hearings panel.

We intend to actively monitor the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of, or obtain accurate price quotations for, our common stock, and there would likely be a reduction in our coverage by security analysts and the news media, which could cause thebid price of our common stock and may, if appropriate, consider implementing available options to decline further. In addition, it mayregain compliance with the Minimum Bid Price Requirement. There can be difficult for us to raise additional capital ifno assurance that we are not listed on a major exchange.will regain compliance with the Minimum Bid Price Requirement or maintain compliance with any of the other Nasdaq continued listing requirements.

Furthermore, it would be a fundamental change under the indenture governing our 2020 Notes ifThe market price of our common stock is not listedmay be adversely affected by the future issuance and sale of additional shares of our common stock or by our announcement that such issuances and sales may occur.

We cannot predict the size of future issuances or sales of shares of our common stock in connection with future acquisitions or capital raising activities, or the effect, if any, that such issuances or sales may have on a national securities exchange. Inthe market price of our common stock. The issuance and sale of substantial amounts of shares of our common stock, or the announcement that such circumstance we would be required to offer to repurchaseissuances and sales may occur, could adversely affect the 2020 Notes at 100%market price of principal plus accrued and unpaid interest to, but not including, the repurchase date. We would also be required to pay the holders of the 2020 Notes a fundamental change make-whole payment equal to the aggregate amount of interest that would have otherwise been payable on such 2020 Notes, to, but not including, the maturity date of such 2020 Notes.our common stock.

Future issuances of our common stock or instruments convertible or exercisable into our common stock including in connection with conversions of 2020 Notes or exercises of warrants, may materially and adversely affect the price of our common stock and cause dilution to our existing stockholders.

In order to fund our business over the past few years,Historically, we have raised capital by issuing common stock and warrants in underwritten public offerings because no other reasonable sources of capital were available. These underwritten public offerings of common stock and warrants have materially and adversely affected the prevailing market prices of our common stock and caused significant dilution to our stockholders. We anticipate that forhave also historically raised capital or refinanced outstanding debt through the foreseeable future we will continueissuance of convertible notes.

We may need to raise capital through these dilutive underwritten public offerings of common stock, warrants and warrants.convertible debt in the future.

We may obtain additional funds through public or private debt or equity financings, in the near future, subject to certain limitations in the agreements governing our indebtedness, including our secured indebtedness with Whitebox.indebtedness. If we issue additional shares of common stock or instruments convertible into common stock, it may materially and adversely affect the price of our common stock.

Raising capital at a subsidiary, or project, level would result in lower revenues attributable back to us.

We operate in a capital-intensive business and in order to construct our facilities, we need to raise large amounts of capital. In addition,order to finance the conversionconstruction of some or all of the 2020 Notes and/or the exercise of some or all of the warrants may dilute the ownership interests of our stockholders,NZ1 and any salesother Net-Zero Projects, we currently expect to raise capital at the subsidiary level using third party capital. By raising capital at a project level, any equity in that project that is sold to a third party would result in lower ownership of that project by us. Thus, we would only be entitled to the revenues and expenses that are proportionate to our level of ownership in the public market of any of our common stock issuable upon such conversion or exercise could adversely affect prevailing market prices of our common stock. Additionally, under the terms of certain warrants in the event thatproject. If we are required to sell a warrant is exercised at a time when we do not have an effective registration statement covering the underlying shares of common stock on file with the SEC, such warrant may be net exercised, which will dilute the ownership interests of existing stockholders without any corresponding benefit of a cash payment for the exercise price of such warrant.

As of December 31, 2017, we had approximately $16.7 million in outstanding 2020 Notes, which were convertible into 28.8 million shares of our common stock at the conversion rate in effect on December 31, 2017. The 28.8 million shares includes 6.1 million shares of common stock that may be issuable from time to time in the event that we pay alarge portion of the interestequity in our projects to third parties, it may have a material adverse effect on the 2020 Notes in kind or elects to pay make-whole payments due upon conversionour business, financial condition and operating results.

36


stock to any converting holder in lieu of making any required make-whole payment in cash. If we elect to issue our common stock for such payment, it will be at the same conversion rate that is applicable to conversions of the principal amount of the 2020 Notes. If we elect to issue additional shares of our common stock for such payments, this may cause significant additional dilution to our existing stockholders.

Our stock price may be volatile, and your investment in our securities could suffer a decline in value.

The market price of shares of our common stock has experienced significant price and volume fluctuations.

We cannot predict whether the price of our common stock will rise or fall. A variety of factors may have a significant effect on our stock price, including:

actual or anticipated fluctuations in our liquidity, financial condition and operating results;

the position of our cash and cash equivalents;

the capital costs required to construct our Net-Zero Projects;

our ability to obtain certain regulatory permits or approvals for our production facilities, including our Net-Zero Projects;

actual or anticipated changes in our growth rate relative to our competitors;

actual or anticipated fluctuations in our competitors’ operating results or changes in their growth rate;

announcements of technological innovations by us, our partners or our competitors;

announcements by us, our partners or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;

the entry into, modification or termination of licensing arrangements, marketing arrangements, and/or research, development, commercialization, supply, off-take or distribution arrangements;

our ability to consistently produce commercial quantities of isobutanol at the Luverne Facility and ramp up production to nameplate capacity;

our products;

additions or losses of customers or partners;

our ability to obtain certain regulatory approvals for the use of our isobutanolproducts in various fuels and chemicals markets;

commodity prices, including oil, ethanol and corn prices;

additions or departures of key management or scientific personnel;

competition from existing products or new products that may emerge;

issuance of new or updated research reports by securities or industry analysts;

fluctuations in the valuation of companies perceived by investors to be comparable to us;

litigation involving us, our general industry or both;

disputes or other developments related to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;

announcements or expectations of additional financing efforts or the pursuit of strategic alternatives;

changes in existing laws, regulations and policies applicable to our business and products, including the Renewable Fuel Standard program, and the adoption of or failure to adopt carbon emissions regulation;

sales of our common stock or equity-linked securities, such as warrants, by us or our stockholders;

share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;

general market conditions in our industry; and

general economic and market conditions.

Furthermore, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions, interest rate changes or international currency fluctuations, may negatively impact the market price of shares of our common stock, regardless of our operating performance, and cause the value of your investment to decline. Because our 2020 Notes are convertible into our common stock and our warrants are exercisable into our common stock, volatility or a reduction in the market price of our common stock could have an adverse effect on the trading price of our 2020 Notes and our warrants. Holders who receive common stock upon exercise of the warrants will also be subject to the risk of volatility and a


reduction in the market price of our common stock. In addition, the existence of our 2020 Notes and our outstanding warrants may encourage short selling in our common stock by market participants because the conversion of the 2020 Notes or exercise of the warrants could depress the price of our common stock.

Additionally, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation or other derivative shareholder lawsuits. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business regardless of the outcome.

The price of our common stock could also be affected by possible sales of common stock by investors who view our 2020 Notes or warrants as a more attractive means of equity participation in us and by hedging or engaging in arbitrage

37

activity involving our common stock. The hedging or arbitrage could, in turn, affect the trading prices of theour warrants, if any trading market becomes established, or any common stock that holders receive upon exercise of thesuch warrants.

Sales of a substantial number of shares of our common stock or securities linked to our common stock, such as our 2020 Notes and warrants (should an established market for such securities then exist), in the public market could occur at any time. These sales, or the perception in the market that such sales may occur, could reduce the market price of our common stock.

In addition, certain holders of our outstanding common stock (including shares of our common stock issuable upon the conversion of certain 2020 Notes or upon exercise of certain outstanding warrants) have rights, subject to certain conditions, to require us to file registration statements covering their shares and to include their shares in registration statements that we may file for ourselves or other stockholders.

Our quarterly operating resultsThe estimates and assumptions on which our financial projections are based may fluctuate in the future. As a result, we may failprove to meet or exceed the expectations of investment research analysts or investors, which could cause our stock price to decline.be inaccurate.

Our financial condition and operating results have varied significantly in the past and may continue to fluctuate from quarter to quarter and year to year in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations are described elsewhere in this report and other reportsprojections, including any projected investment returns on projects, sales or earnings guidance or outlook that we have filed with the SEC. Accordingly, the resultsmay provide from time to time, are dependent on estimates and assumptions related to, among other things, industry growth, product and plant development, estimated capital expenses for growth development projects, market share projections, product pricing and sale, customer interest in our products, availability of any prior quarterly or annual periods should not be relied upon as indications of our future operating performance.

The indebtedness under our 2020 Notes are secured by substantially all of our assets. As a result of these security interests, such assets would only be available to satisfy claims of our general creditors or to holders of our equity securities if we were to become insolvent to the extent the value of such assets exceeded the amount of our indebtednessgovernment incentives, tax rates, accruals for estimated liabilities, and other obligations.

Indebtedness under our 2020 Notes is secured by a first lien, on substantially all of our assets. Accordingly, if an event of default were to occur under our credit facilities, holders of our 2020 Notes would have a priority right to our assets, to the exclusion of our general creditors, in the event of our bankruptcy, insolvency, liquidation, or reorganization. In that event, our assets would first be used to repay in full all indebtedness and other obligations secured by them, resulting in all or a portion of our assets being unavailable to satisfy the claims of our unsecured indebtedness. Only after satisfying the claims of our unsecured creditors and our subsidiaries’ unsecured creditors would any amount be available for distribution to holders of our equity securities

The terms of the agreements governing our indebtedness, including our secured indebtedness with Whitebox and the indenture governing the 2020 Notes, may restrict our ability to engage in certain transactions.

The terms of the agreements governing our indebtedness, including our secured indebtedness with Whitebox and the indenture governing the 2020 Notes, may prohibit us from engaging in certain actions, including disposing of certain assets, granting or otherwise allowing the imposition of a lien against certain assets, incurring certain kinds of additional indebtedness, acquiring or merging with other entities, or making dividends and other restricted payments unless we receive the prior approval of the requisite lenders or the requisite holders of the 2020 Notes. If we are unable to obtain such approval, we could be prohibited from engaging in transactions which could be beneficial to our business and our stockholders or could be forced to repay such indebtedness in full.

The indenture governing the 2020 Notes may prohibit us from engaging in certain mergers or acquisitions and if a fundamental change of the Company occurs prior to the maturity date of the 2020 Notes, holders of the 2020 Notes will have the right, at their option, to require us to repurchase all or a portion of their 2020 Notes and, in certain circumstances, to pay the holders of 2020 Notes a make-whole payment equal to the aggregate amount of interest that would have been payable on such 2020 Notes from the repurchase date through the maturity date of such 2020 Notes.. With respect to the 2020 Notes, the Company has the right to increase the conversion rate of the 2020 Notes by any amount for a period of at least 20 business days if the Company’s board of directors


determines that such increase would be in the Company’s best interest. In addition, if a fundamental transaction occurs, some holders of warrants will have the right, at their option, to require us to repurchase the unexercised portion of such warrants for an amount in cash equal to the value of the warrants, as determined in accordance with the Black Scholes option pricing model and the terms of the warrants. These and other provisions could prevent or deter a third party from acquiring us, even where the acquisition could be beneficial to you.

The conversion or exercise prices, as applicable, of the 2020 Notes and warrants can fluctuate under certain circumstances which, if triggered, can result in potentially material further dilution to our stockholders.

The conversion price of the 2020 Notes can fluctuate in certain circumstances, including in the event that there is a dividend or distribution paid on shares of our common stock or a subdivision, combination or reclassification of our common stock. In such instances, the conversion price of the 2020 Notes can fluctuate materially lower than the current conversion price of $0.7359 per share or 1.3589 shares per $1.00 of principal.

The number of shares of common stock for which certain of our warrants, are exercisable may be adjusted in the event that we undertake certain stock dividends, splits, combinations, distributions, and the price at which such shares of common stock may be purchased upon exercise of the warrants may be adjusted in the event that we undertake certain issuances of common stock or convertible securities at prices lower than the then-current exercise price for the warrants. These provisions could result in substantial dilution to investors in our common stock.

The interest rates of the 2020 Notes can fluctuate under certain circumstances which, if triggered, can result in potentially material further dilution to our stockholders.

The interest rates of the 2020 Notes can fluctuate in certain circumstances, including in the event of a default of our obligations under the indenture governing the 2020 Notes or the registration rights agreements, if any, entered into in connection with such notes. In addition, the interest on the 2020 Notes may be payable in-kind. As the Company may pay a portion of the interest on the 2020 Notes in kind, by either increasing the principal amount of the outstanding 2020 Notes or issuing additional 2020 Notes, any increase to the interest rate applicable to the 2020 Notes could result in additional dilution to investors in our common stock.

We may not have the ability to pay interest on the 2020 Notes or to repurchase or redeem the 2020 Notes.

If a fundamental change (as defined in the indenture governing the 2020 Notes) occurs, holders of the 2020 Notes may require us to repurchase, for cash, all or a portion of their 2020 Notes. In such circumstance we would be required to offer to repurchase the 2020 Notes at 100% of principal plus accrued and unpaid interest to, but not including, the repurchase date. We would also be required to pay the holders of the 2020 Notes a fundamental change make-whole payment equal to the aggregate amount of interest that would have otherwise been payable on such notes to, but not including, the maturity date of such notes. If we elect to redeem the 2020 Notes prior to their maturity, the redemption price of any 2020 Notes redeemed by us will be paid for in cash. Our ability to pay the interest on the 2020 Notes, to repurchase or redeem the 2020 Notes, to refinance our indebtedness and to fund working capital needs and planned capital expenditures depends on our ability to generate cash flow in the future. To some extent, this is subject to general economic, financial, competitive, legislative and regulatory factors and other factors that are beyond our control. We cannot assure you that we will maintain sufficient cash reserves or that our business will generate cash flow from operations at levels sufficient to permit us to pay the interest on the 2020 Notes, to repurchase or redeem the 2020 Notes or to pay any cash amounts that may become due upon conversion of the 2020 Notes, or that our cash needs will not increase. In addition, any such repurchase or redemption of the 2020 Notes, even if such action would be in our best interests, may result in a default under the agreements governing our indebtedness unless we are able to obtain the applicable lender’s consent prior to the taking of such action.

Our failure to repurchase tendered 2020 Notes at a time when the repurchase is required by the indenture governing such notes would constitute a default under such notes and would permit holders of such notes to accelerate our obligations under such notes. Such default may also lead to a default under the agreements governing any of our current and future indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not haveraise sufficient funds to repay such indebtedness and repurchase the 2020 Notes or make cash payments upon conversions thereof.

If we are unable to generate sufficient cash flow fromto continue operations in the future to serviceand/or expand our indebtednessproduction capabilities. Our financial projections are based on historical experience and meet ouron various other needs, we may have to refinance all or a portion of our indebtedness, obtain additional funds through public or private debt or equity financings, reduce expenditures or sell assetsestimates and assumptions that we deem necessarybelieve to be reasonable under the circumstances and at the time they are made, and our business. Our ability to take some or all of these actions will be subject to certain limitations in the agreements governing our indebtedness, including our secured indebtedness with Whitebox, and we cannot assure you that any of these measures would be possible or that any additional financing could be obtained on favorable terms, or at all. The inability to obtain additional financing on commercially reasonable terms could have a material adverse effect onactual results may differ materially from our financial condition, which could cause the value of your investment to decline. Additionally, if we were to conduct a public or private offering of securities, any new offering would be likely to dilute our stockholders’ equity ownership.projections.


Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies.

We may subject to certain limitations in the agreements governing our indebtedness, including our secured indebtedness with Whitebox, seek additional capital through a combination of public and private equity offerings, debt financings, strategic partnerships and licensing arrangements. To the extent that we raise additional capital through the sale or issuance of equity, warrants or convertible debt securities, the ownership interest of our existing shareholders will be diluted, and the terms of such securities may include liquidation or other preferences that adversely affect theiryour rights as a stockholder. If we raise capital through debt financing, it may involve agreements that include covenants further limiting or restricting our ability to take certain actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through strategic partnerships or licensing agreements with third parties, we may have to relinquish valuable rights to our technologies or grant licenses on terms that are not favorable to us. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce or terminate our development and commercialization efforts.

The issuance of share-based payment awards under our stock incentive plan may cause dilution to our existing stockholders and may affect the market price of our common stock.

We have used, and in the future we may continue to use, stock options, stock grants and other equity-based incentives, either pursuant to the 2010 Plan, or outside of the 2010 Plan, to provide motivation and compensation to our directors, officers, employees and key independent consultants. The award of any such incentives will result in an immediate and potentially substantial dilution to our existing shareholders and could result in a decline in the value of our stock price.

As of December 31, 2017, there were 46,431 shares subject to outstanding options that are or will become eligible for sale in the public market to the extent permitted by any applicable vesting requirements and Rules 144 and 701 under the Securities Act. The exercise of these options and the sale of the underlying shares of common stock and the sale of stock issued pursuant to stock grants may have an adverse effect upon the price of our common stock, which in turn may have an adverse effect upon the trading price of the warrants.

As of December 31, 2017, there were 133,607 shares of common stock available for future grant under our 2010 Plan and 3,802 shares of common stock reserved for issuance under our Employee Stock Purchase Plan. These shares can be freely sold in the public market upon issuance and once vested.

We may pay vendors in stock as consideration for their services; this may result in additional costs and may cause dilution to our existing stockholders.

In order for us to preserve our cash resources, we may in the future pay vendors, including technology partners, in shares, warrants or options to purchase shares of our common stock rather than cash. Payments for services in stock may materially and adversely affect our stockholders by diluting the value of outstanding shares of our common stock. In addition, in situations where we agree to register the shares issued to a vendor, this will generally cause us to incur additional expenses associated with such registration.

Except as set forth in the applicable warrant, holders of our warrants will have no rights as common stockholders until such holders exercise their warrants and acquire our common stock.

Until you acquire shares of our common stock upon exercise of your warrants, you will have no rights with respect to the shares of our common stock underlying such warrants, except for those rights set forth in the applicable warrant. Upon exercise of your warrants, you will be entitled to exercise the rights of a common stockholder only as to matters for which the record date occurs after the exercise date.

The exercise prices for our warrants will not be adjusted for all dilutive events.

The exercise prices of certain warrants are subject to adjustment for certain events, including the issuance of stock dividends on our common stock and, in certain instances, the issuance of our common stock at a price per share less than the exercise price of such warrants. However, the exercise prices will not be adjusted for other events, including the issuance of certain rights, options or warrants, distributions of capital stock, indebtedness, or assets and cash dividends. Accordingly, an event that adversely affects the value of the warrants may occur, and that event may not result in an adjustment to the exercise prices.


We may not be permitted by the agreements governing our indebtedness, including our secured indebtedness with Whitebox, to repurchase our warrants, and we may not have the ability to do so.

Under certain circumstances, if a “fundamental transaction” or “extraordinary transaction” (as such terms are defined in our various warrants) occurs, holders of our warrants may require us to repurchase, for cash, the remaining unexercised portion of such warrants for an amount of cash equal to the value of the warrant as determined in accordance with the Black Scholes option pricing model and the terms of the warrants. Our ability to repurchase the warrants depends on our ability to generate cash flow in the future. To some extent, this is subject to general economic, financial, competitive, legislative and regulatory factors and other factors that are beyond our control. We cannot assure you that we will maintain sufficient cash reserves or that our business will generate cash flow from operations at levels sufficient to permit us to repurchase the warrants. In addition, any such repurchase of the warrants may result in a default under the agreements governing our indebtedness, including our secured indebtedness with Whitebox, unless we are able to obtain such lender’s consent prior to the taking of such action. If we were unable to obtain such consent, compliance with the terms of the warrants would trigger an event of default under such agreements.

We do not anticipate paying cash dividends, and accordingly, stockholders must rely on stock appreciation for any return on their investment.

We have never paid cash dividends on our common stock and we do not expect to pay cash dividends on our common stock at any time in the foreseeable future. The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements and other factors that our board of directors will consider. As a result, only appreciation of the price of our common stock, which may never occur, will provide a return to stockholders. Investors seeking cash dividends should not invest in our common stock.

If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our stock price and trading volume could decline. The trading market for our common stock will be influenced by the research and reports that securities or industry analysts publish about us or our business.

We do not have any control over thesesecurities or industry analysts. If one or more of the analysts who cover us downgrade our common stock or change their opinion of our common stock, our common stock price would likely decline which in turn would likely cause a decline in the value of the warrants and 2020 Notes.our warrants. If one or more of these analysts cease coverage of the Companyus or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our common stock price and the price of theour warrants to decline or the trading volume of such securitiesour common stock to decline.

38

We are subject to anti-takeover provisions in our amended and restated certificate of incorporation, our amended and restated bylaws and under Delaware law that could delay or prevent an acquisition of the Company, even if the acquisition would be beneficial to our stockholders.

Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws may delay or prevent an acquisition of the Company. Among other things, our amended and restated certificate of incorporation and amended and restated bylaws provide for a board of directors that is divided into three classes with staggered three-year terms, provide that all stockholder action must be effected at a duly called meeting of the stockholders and not by a consent in writing, and further provide that only our board of directors may call a special meeting of the stockholders. These provisions may also frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, who are responsible for appointing the members of our management team. Furthermore, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (the “DGCL”), which prohibits, with some exceptions, stockholders owning in excess of 15% of our outstanding voting stock from merging or combining with us. Finally, our charter documents establish advance notice requirements for nominations for election to our board of directors and for proposing matters that can be acted upon at stockholder meetings. Although we believe these provisions together provide an opportunity to receive higher bids by requiring potential acquirers to negotiate with our board of directors, they would apply even if an offer to acquire the Company may be considered beneficial by some stockholders.

Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.

Our certificate of incorporation provides that the Court of Chancery of the State of Delaware shall, unless we consent in writing to the selection of an alternative forum, be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or its stockholders, (iii) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

The exclusive forum provision may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and our directors, officers, employees and agents. Stockholders who do bring a claim in the Court of Chancery could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near the State of Delaware. The Court of Chancery may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. Alternatively, if a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition. Notwithstanding the foregoing, the exclusive forum provision shall not preclude or contract the scope of exclusive federal or concurrent jurisdiction for actions brought under the Exchange Act or the Securities Act, or the respective rules and regulations promulgated thereunder.

Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to these provisions. This exclusive forum provision may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees.

If a court were to find the exclusive forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations and financial condition. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management and other employees.

39

Item 1B.Unresolved Staff Comments

None.

Item 1B.1C.

Cybersecurity

We have an information security program designed to identify, protect, detect and respond to and manage reasonably foreseeable cybersecurity risks and threats. To protect our information systems from cybersecurity threats, we use various security tools that help prevent, identify, escalate, investigate, resolve and recover from identified vulnerabilities and security incidents in a timely manner. These include, but are not limited to, internal reporting, monitoring and detection tools.

We regularly assess risks from cybersecurity and technology threats and monitor our information systems for potential vulnerabilities. We use a widely-adopted risk quantification model to identify, measure and prioritize cybersecurity and technology risks and develop related security controls and safeguards. We conduct regular reviews and tests of our information security program and also leverage other exercises (e.g., penetration and vulnerability testing) to evaluate the effectiveness of our information security program and improve our security measures and planning. The results of these reviews and exercises are reported to the Audit Committee.

While we have not, as of the date of this Form 10-K, experienced a cybersecurity threat or incident that resulted in a material adverse impact to our business or operations, there can be no guarantee that we will not experience such an incident in the future. Such incidents, whether or not successful, could result in our incurring significant costs related to, for example, rebuilding our internal systems, implementing additional threat protection measures, defending against litigation, responding to regulatory inquiries or actions, paying damages, providing customers with incentives to maintain a business relationship with us, or taking other remedial steps with respect to third parties, as well as incurring significant reputational harm. In addition, these threats are constantly evolving, thereby increasing the difficulty of successfully defending against them or implementing adequate preventative measures.

Our Chief People Officer oversees our information security program. Team members who support our information security program have relevant educational and industry experience. The team provides regular reports to senior management on various cybersecurity threats, assessments and findings.

The Board oversees our enterprise risk assessment, where we assess key risks within the company, including security and technology risks and cybersecurity threats. The Audit Committee oversees our cybersecurity risk and receives regular reports from our Chief People Officer on various cybersecurity matters, including risk assessments, mitigation strategies, areas of emerging risks, incidents and industry trends, and other areas of importance.

Unresolved Staff Comments

None.

Item 2.

Properties

Our corporate headquarters and research and development laboratories, included in our Gevo, Inc. segment, are located in Englewood, Colorado. In January 2016, we amended our lease to extend the term until July 2021 and to reduce the amount of leased space from 29,865 square feet to approximately 19,241 square feet, effective July 2016.  We believe that the facility with the reduced


square footage will be adequate for our needs for the immediate future and that, should it be needed, additional space can be leased to accommodate any future growth.

Our subsidiary, Luverne, included in our Gevo Development/Luverne segment, owns and operates an ethanol and isobutanol production facility in Luverne, Minnesota on approximately 55 acres of land and contains approximately 50,000 square feet of building space. The production facility was originally constructed in 1998. The land and buildings are owned by Luverne, which granted to Whitebox a mortgage lien and security interest in such property to secure its obligations under Whitebox Notes Indenture.

Item 3.

Legal Proceedings

From time to time, we have been and may again become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any litigation that we believe to be material and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results, financial condition or cash flows.

Item 4.

Mine Safety Disclosures

Not Applicable.

40

Table of Contents


PART II

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market for Common Stock

Market Information

The Company'sCompany’s common stock is listed and traded on the NASDAQThe Nasdaq Capital Market under the symbol 'GEVO'“GEVO”.

The following table sets forth, for the period indicated, the high and low sales prices for our common stock, as reported by the NASDAQ Stock Market, for the periods indicated below. The table below has been adjusted to reflect the January 5, 2017 one-for-twenty reverse stock split.

 

Common Stock

 

 

2017

 

 

2016

 

 

High

 

 

Low

 

 

High

 

 

Low

 

First Quarter

$

4.09

 

 

$

0.93

 

 

$

13.33

 

 

$

5.20

 

Second Quarter

 

1.13

 

 

 

0.58

 

 

 

19.19

 

 

 

4.46

 

Third Quarter

 

0.81

 

 

 

0.56

 

 

 

16.00

 

 

 

9.11

 

Fourth Quarter

 

0.72

 

 

 

0.59

 

 

 

9.63

 

 

 

3.46

 

Holders of Record

As of March 6, 2018,January 31, 2024, there were approximately 3069 holders of record of our common stock. We believe that the number of beneficial owners is substantially greater than the number of record holders because a large portion of our common stock is held of record through brokerage firms in “street name.”

Dividends

No cash dividends have been paid on our common stock to date, nor do we anticipate paying dividends in the foreseeable future. Any future determination to declare cash dividends on our common stock will be made at the discretion of our Board of Directors, subject to compliance and limitations under our debt arrangements.

Performance Graph

Set forth below is a graph comparing the annual changearrangements in the cumulative total return of Gevo’s common stock with the cumulative total return of the Standard & Poor’s SmallCap 600 Value Index and with the NASDAQ Clean Edge Green Energy Index over the period from the initiation of public trading of the Company’s common stock in December 31, 2011 through December 31, 2017.

It is assumed in the graph that $100 was invested (i) in our common stock; (ii) in the stocks of the companies in the Standard & Poor’s SmallCap 600 Value Index; and (iii) in the stocks of the NASDAQ Clean Edge Green Energy Index.


The stock price performance shown on the following graph is not indicative of future price performance

effect at such time.

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

None.

Purchases of Equity Securities by the Issuer

None.On May 30, 2023, the Board authorized a stock repurchase program, under which the Company may repurchase up to $25 million of its common stock. The primary goal of the repurchase program is to allow the Company to opportunistically repurchase shares, while maintaining its ability to fund development projects. Under the stock repurchase program, the Company may repurchase shares from time to time in the open market or through privately negotiated transactions. The timing, volume and nature of stock repurchases, if any, will be in the Company’s sole discretion and will be dependent on market conditions, applicable securities laws, and other factors. The stock repurchase program may be suspended or discontinued at any time and does not have an expiration date.

The Company did not repurchase any shares of common stock under the stock repurchase program during the three months or fiscal year ended December 31, 2023.

Performance Graph

The following information is not deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C under the Exchange Act or to the liabilities of Section 18 of the Exchange Act, and will not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except to the extent the Company specifically incorporates it by reference into such a filing.

41

Table of Contents

The following line graph compares the cumulative total shareowner return on our common stock against the cumulative total return of the S&P Smallcap 600 Index and the NASDAQ Clean Edge Green Energy Index for the each of the five years ended December 31, 2023. The graph assumes a $100 investment in our common stock and each index at December 31, 2018.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN

Among Gevo, Inc., The S&P Smallcap 600 Index

and the NASDAQ Clean Edge Green Energy Index

Graphic

    

December 31, 

    

December 31, 

    

December 31, 

    

December 31, 

    

December 31, 

    

December 31, 

    

2018

    

2019

    

2020

    

2021

    

2022

    

2023

Gevo, Inc.

$

100.00

$

117.86

$

216.84

$

218.37

$

96.94

$

59.18

S&P Smallcap 600

 

100.00

 

122.78

 

136.64

 

173.29

 

145.39

 

168.73

NASDAQ Clean Edge Green Energy

 

100.00

 

142.67

 

406.35

 

395.62

 

276.35

 

248.97

The information in the graph will not be considered solicitation material, nor will it be filed with the SEC or incorporated by reference into any future filing under the Securities Act or the Exchange Act, unless we specifically incorporate it by reference into our filing.

Item 6.

Selected Financial Data[Reserved]

42

The following selected historical consolidated financial data should be read together with our consolidated financial statements and the accompanying notes appearing in Part II, Item 8Table of this Report, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The selected historical consolidated financial data in this section is not intended to replace our historical consolidated financial statements and the accompanying notes. Our historical results are not necessarily indicative of our future results.Contents

We derived the consolidated statements of operations data for the years ended December 31, 2017, 2016, and 2015 and the consolidated balance sheet data as of December 31, 2017 and 2016 from our audited consolidated financial statements in Part II, Item 8 of this Report. The consolidated statements of operations data for the years ended December 31, 2013 and 2012 and the consolidated balance sheet data as of December 31, 2014, 2013 and 2012 has been derived from our audited consolidated financial statements not included in this Report. The data should be read in conjunction with the consolidated financial statements, related notes, and other financial information included herein.  


On December 21, 2016, the Board of Directors of the Company approved a reverse split of the Company’s common stock, par value $0.01, at a ratio of one-for-twenty.   This reverse stock split became effective on January 5, 2017 and, unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted retroactively to reflect this reverse stock split.

(In thousands except share and per share amounts)

Years Ended December 31,

 

Consolidated statement of operations data:

2017

 

 

2016

 

 

2015

 

 

2014

 

 

2013

 

Total revenue (1) (2) (3)

$

27,536

 

 

$

27,213

 

 

$

30,137

 

 

$

28,266

 

 

$

8,224

 

Costs of goods and corn sold

 

38,165

 

 

 

37,017

 

 

 

38,762

 

 

 

35,582

 

 

 

17,913

 

Operating expenses

 

12,653

 

 

 

14,181

 

 

 

23,302

 

 

 

32,461

 

 

 

45,826

 

Loss from operations

 

(23,282

)

 

 

(23,985

)

 

 

(31,927

)

 

 

(39,777

)

 

 

(55,515

)

Net loss (4) (5) (6) (7) (8) (9)

 

(24,630

)

 

 

(37,228

)

 

 

(36,194

)

 

 

(41,145

)

 

 

(66,806

)

Net loss per share - basic and diluted

 

(1.51

)

 

 

(9.68

)

 

 

(51.61

)

 

 

(153.35

)

 

 

(444.67

)

Weighted-average number of common shares

   outstanding - basic and diluted

 

16,295,937

 

 

 

3,847,421

 

 

 

701,252

 

 

 

268,308

 

 

 

150,239

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31,

 

Consolidated balance sheet data:

2017

 

 

2016

 

 

2015

 

 

2014

 

 

2013

 

Cash and cash equivalents

$

11,553

 

 

$

27,888

 

 

$

17,031

 

 

$

6,359

 

 

$

24,625

 

Total assets

 

88,853

 

 

 

112,324

 

 

 

102,831

 

 

 

98,928

 

 

 

116,355

 

Derivative warrant liability

 

1,951

 

 

 

2,698

 

 

 

10,493

 

 

 

3,114

 

 

 

7,243

 

Secured debt

 

-

 

 

 

-

 

 

 

483

 

 

 

773

 

 

 

10,127

 

2017 Notes recorded at fair value

 

-

 

 

 

25,769

 

 

 

21,565

 

 

 

25,460

 

 

 

-

 

2020 Notes, net

 

13,491

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

2022 Notes, net

 

515

 

 

 

8,221

 

 

 

14,341

 

 

 

13,679

 

 

 

14,501

 

Total liabilities

 

25,322

 

 

 

43,060

 

 

 

54,505

 

 

 

51,964

 

 

 

45,380

 

Accumulated deficit

 

(401,350

)

 

 

(376,720

)

 

 

(339,492

)

 

 

(303,298

)

 

 

(262,153

)

Total stockholders’ equity

 

63,531

 

 

 

69,264

 

 

 

48,326

 

 

 

46,964

 

 

 

70,975

 

(1)

Throughout 2013, we made modifications to our Luverne Facility designed to increase the isobutanol production rates.  As a result, we produced very limited quantities of isobutanol and no ethanol at the Luverne Facility in 2013.

(2)

In March 2014, we decided to leverage the flexibility of our GIFT™ technology and further modify the Luverne Facility in order to enable the simultaneous production of isobutanol and ethanol, and in July 2014, we began more consistent co-production of isobutanol and ethanol at the Luverne Facility, with one fermenter utilized for isobutanol production and three fermenters utilized for ethanol production.

(3)

We recognized gains of $0.0 million, $0.0 million, $0.0 million, $3.5 million, and $3.1 million during the years ended December 31, 2017, 2016, 2015, 2014, and 2013, respectively, associated with a change in the fair value of the derivatives embedded in our 2022 Notes.

(4)

We recognized gains of $5.1 million, $1.8 million, $0.6 million and $6.5 million during the years ended December 31, 2017, 2016, 2015 and 2014, respectively, and a loss of $3.2 million during the year ended December 31, 2013 associated with a change in the fair value of Warrants to purchase our common stock that were issued in February 2017, September 2016, April 2016, December 2015, May 2015, February 2015, August 2014, and December 2013 in conjunction with our offering of common stock units.

(5)

We recognized a loss of $0.3 million and $4.2 million during the years ended December 31, 2017 and 2016, respectively, and gains of $3.9 million and $0.6 million during the years ended December 31, 2015 and 2014, respectively, associated with a change in the fair value of the 2017 Notes.  

(6)

We recognized a loss of $1.0 million and $0.8 million during the years ended December 31, 2017 and 2016, respectively, and a gain of $0.2 million during the year ended December 31, 2015, no gain or loss during the year ended December 31, 2014 and a loss of $2.0 million during the year ended December 31, 2013 associated with the exchange or conversion of our 2022 Notes.

(7)

We recognized a loss of $0.0 million and $0.9 million during the years ended December 31, 2017 and 2016, respectively, and a gain of $1.8 million during the year ended December 31, 2015 associated with the extinguishment of certain of our warrant liabilities.

(8)

We recognized losses of $0.0 million, $1.5 million and $2.5 million during the years ended December 31, 2017, 2016 and 2015, respectively, associated with issuances of equity in those years.

(9)

We recognized a loss of $3.9 million related to the exchange of the 2017 notes to the 2020 notes during the year ended December 31, 2017.


The following table reflects our unaudited summarized quarterly consolidated financial statements for each of the twelve months ended December 31, 2017 and 2016. This information has been derived from unaudited consolidated financial statements that, in the opinion of management, include all recurring adjustments necessary for a fair statement of such information (in thousands except share and per share amounts).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter

 

2017

First

 

 

Second

 

 

Third

 

 

Fourth

 

Revenue

$

5,616

 

 

$

7,542

 

 

$

7,699

 

 

$

6,679

 

Gross loss

 

(3,792

)

 

 

(2,163

)

 

 

(2,010

)

 

 

(2,664

)

Loss from operations (1)

 

(7,182

)

 

 

(6,177

)

 

 

(5,113

)

 

 

(4,810

)

Gain (Loss) from change in fair value of derivative warrant

   liability

 

3,259

 

 

 

2,260

 

 

 

(413

)

 

 

(5

)

Selling, general and administrative expense

 

2,173

 

 

 

2,123

 

 

 

1,893

 

 

 

1,282

 

Net loss

 

(5,934

)

 

 

(10,158

)

 

 

(4,153

)

 

 

(4,385

)

Net loss per share  - basic and diluted

$

(0.51

)

 

$

(0.66

)

 

$

(0.25

)

 

$

(0.20

)

Weighted-average number of common shares outstanding - basic

   and diluted

 

11,584,595

 

 

 

15,372,485

 

 

 

16,508,158

 

 

 

21,606,051

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quarter

 

2016

First

 

 

Second

 

 

Third

 

 

Fourth

 

Revenue

$

6,320

 

 

$

8,113

 

 

$

6,944

 

 

$

5,836

 

Gross loss

 

(2,903

)

 

 

(1,876

)

 

 

(2,706

)

 

 

(2,319

)

Loss from operations (1)

 

(5,866

)

 

 

(5,492

)

 

 

(6,135

)

 

 

(6,492

)

Gain (Loss) from change in fair value of derivative warrant

   liability

 

5,248

 

 

 

(10,573

)

 

 

1,154

 

 

 

5,954

 

Loss from change in fair value of 2017 Notes

 

(836

)

 

 

(940

)

 

 

(1,854

)

 

 

(573

)

Net loss

 

(3,605

)

 

 

(21,487

)

 

 

(9,849

)

 

 

(2,287

)

Net loss per share  - basic and diluted

$

(3.13

)

 

$

(8.75

)

 

$

(2.04

)

 

$

(0.33

)

Weighted-average number of common shares outstanding - basic

   and diluted

 

1,150,816

 

 

 

2,454,282

 

 

 

4,837,698

 

 

 

6,840,316

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1)Loss from operations during 2017 and 2016 primarily relates to costs associated with conducting research and development, business development, business and financial planning, continued improvement of facilities and operations for the co-production of isobutanol and ethanol at the Luverne Facility.


Item 7.

Management’s Discussion and AnalysisAnalysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidatedaudited financial statements and related notes that appearappearing elsewhere in this Annual Report on Form 10-K (this “Report”Annual Report). In additionSome of the information contained in this discussion and analysis and set forth elsewhere in this Annual Report, including information with respect to historical financial information, the following discussion containsour plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should review the section titled Risk Factors in Part I, Item 1A of this Annual Report for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Company Overview

We are a growth-oriented, carbon abatement company with the mission of solving greenhouse gas emissions for those sectors of the transportation industry that are not amenable to electrification or hydrogen. We believe that the market size for hydrocarbon fuels will continue to remain significant in the long-term even with the rapid adoption of electric vehicles and hydrogen technologies.

We are focused on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels, such as sustainable aviation fuel (“SAF”), with the potential to achieve a “net-zero” greenhouse gas (“GHG”) footprint. We believe that this addresses the global need of reducing GHG emissions with “drop in” sustainable alternatives to petroleum fuels. We use the Argonne National Laboratory’s Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (the “GREET Model”) to measure, predict and verify GHG emissions across the life cycle of our products. The “net-zero” concept means Gevo expects that by using sustainably grown feedstock (e.g., low till, no-till and dry corn cultivation), renewable and substantially decarbonized energy sources, drop-in hydrocarbon fuels can be produced that have a net-zero, full life cycle footprint measured from the capture of renewable carbon through the burning of the fuel.

Our primary market focus, given current demand and growing customer interest, is hydrocarbon fuels, and SAF in particular. We believe that SAF from carbohydrates to alcohol is the most economically viable approach for carbon abatement. We also have commercial opportunities for other renewable hydrocarbon products, such as RNG; hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the chemical industry, such as ethylene and butenes; plastics and materials; and other chemicals. Global fuel consumption by commercial airlines continues to remain strong, with global fuel consumption of more than 100 MGPY and growing.

Project Updates

Net-Zero Projects. Our concept of “Net-Zero Projects” is a series of planned facilities to produce energy dense liquid hydrocarbons using renewable energy and our proprietary technology. Our initial Net-Zero Project, Net-Zero 1 (“NZ1”), is expected to be located in Lake Preston, South Dakota, and is being currently designed to produce approximately 65 million gallons per year (“MGPY”) of total hydrocarbon volumes, including 60 MGPY of SAF, which would fulfill part of our approximately 350 MGPY of SAF and hydrocarbon supply agreements. The liquid hydrocarbons, when burned, are expected to have a “net-zero” GHG footprint. Along with the hydrocarbons, NZ1 is expected to produce approximately 695,000 tons per year of high-value protein products for use in the food chain and more than 34 million pounds per year of corn oil. Our products will be produced in three steps: the first step is milling the corn to produce the carbohydrates needed for the production of SAF while simultaneously enabling the production of protein and oil; the second step produces alcohols using carbohydrate-based fermentation; and the third step is the conversion of the alcohols into hydrocarbons.

43

Table of Contents

We work with several technology, design and equipment partners, most notably Fluid Quip Technologies (FQT), Axens, and Praj. FQT and Axens provide area operation designs which have been incorporated into Gevo’s proprietary overall design of low CI carbohydrate-to-hydrocarbon plants, such as NZ1 plant. Praj is working with us on the proprietary design and construction of prefabricated process modules for our plants. Our partners are working with us on proprietary process designs that have the potential to lower capital and operating cost in the future. The advantage of utilizing Fluid Quip and Axens area operation and related process designs which are well proven in other applications, we believe we have chosen technology which is substantially de-risked.

We completed the value engineering on our NZ1 project and are proceeding with detailed engineering, modularization design, and capital costs updates. We are currently refining project cost estimates with engineering, procurement, and construction (“EPC”) partners to identify cost saving opportunities, and currently expect to finance the construction of NZ1 at the subsidiary level using a combination of Company equity and third-party capital, to include non-recourse debt. The Company expects to have invested a cumulative total of $236 to $286 million of cash equity in the project at financial close. Cash distributions from future NZ1 earnings would be proportionate to Gevo’s ownership in NZ1 under this expected financing structure. The use of project debt and third party equity allows us to conserve capital for use on other growth projects. We expect to apply similar development and financing strategies to future Net-Zero Projects to enable growth of SAF production to meet demand for SAF.

We have substantially completed the engineering design of NZ1. We have substantially completed value engineering and we are now focusing on detail engineering with an EPC partner, to reduce and contractually finalize a negotiated lump-sum, fixed price agreement whereby the EPC will build and deliver the plant. This detail engineering work is focused specifically on increasing the modularization of component parts on the NZ1 plant design, which means that we expect that the process equipment would be built into modules at a factory, then the modules would be assembled onsite at NZ1, with the goal of minimizing specialized field work typical in plant construction of this type. This approach is expected to lower the risk and cost of, and access to, skilled labor at the site and reduce the supply chain constrictions for some of our long-lead equipment. Increasing the modularization of the plant design is also expected to reduce our spend in advance of securing third-party equity and debt financing for NZ1 and increase the certainty of construction schedule for those counterparties.

In order to achieve full construction financing for NZ1, we need to secure third-party equity and debt. Upon receiving an invitation from the U.S. Department of Energy (“DOE”), we submitted a Part II Application for a DOE loan guarantee for a direct lending from Federal Financing Bank. In August 2023, Gevo was invited to enter the due diligence and underwriting phases with DOE. Given the current interest rate environment and general macroeconomic conditions, a DOE-guaranteed loan is our most attractive debt option and is expected to offer the lowest cost of debt for the project. We expect that obtaining a DOE-guaranteed loan will have the benefit of reducing the overall amount of equity required to finance NZ1 and should result in higher project equity returns for investors which should increase the likelihood of Gevo successfully financing NZ1. The DOE loan application process is targeted to be complete in 2024. We expect that our NZ1 plant start-up date will occur twenty-four to thirty months after the NZ1 financing closes, the timing of which is uncertain. In parallel with the DOE-guaranteed loan process, we continue to explore debt financing for NZ1 without the benefit of the DOE-guaranteed loan. We are also working to secure access to carbon capture and sequestration at the site.

We are evaluating and performing early site development work at several sites in the U.S. for other greenfield sites. These sites include several greenfield locations that are particularly advantageous in terms of potential economics, opportunities to decarbonize, and time to market. In addition, we are pursuing potential Net-Zero Projects with several existing ethanol plant sites. Existing ethanol plants need to be decarbonized with renewable energy or de-fossilized energy and/or carbon sequestration. Gevo has developed a preferred list of potential partners and sites with decarbonization in mind and is engaged in preliminary feasibility and development discussions with several of these potential partners. We plan to give priority to existing industrial plant sites that have attractive potential economics and high predictability of timeline for decarbonization.

Renewable Natural Gas Project. The Gevo RNG project started up and began producing and injecting initial volumes of biogas in 2022, during the project’s testing and ramp-up period. The project achieved stable production levels and surpassed our annual production target of 310,000 MMBtu for 2023. In addition, we completed an expansion to the Gevo RNG project to increase its annual design capacity from 355,000 MMBtu to 400,000 MMBtu.

44

Table of Contents

Gevo’s revenue from the RNG project in Northwest Iowa (the “RNG Project”) stems from sales of RNG and from the environmental attributes associated with its RNG sales, including the attributes available from California’s Low Carbon Fuel Standard (“LCFS”) program and the U.S. Environmental Protection Agency (“EPA”) Renewable Fuels Standard (“RFS”) program to receive renewable identification numbers (“RINs”). Gevo was granted registration approval by the EPA in 2022, allowing us to participate in its Renewable Fuel Standard Program (“RFS Program”) to receive renewable identification numbers (“RINs”).

During the first quarter of 2023, we received approval for a temporary pathway under California’s Low Carbon Fuel Standard (“LCFS”) program. We continue to realize substantial sales for our environmental attributes of both LCFS credits and RINs in 2023.

Verity. It is critical that we can prove the CI of our products, ensuring that these values are accurate and auditable. The mission of Verity (“Verity”), including Verity Tracking and Verity Carbon Solutions, is to document CI and other sustainability attributes and apply Distributed Ledger Technology, commonly referred to as blockchain, to create a record of the products throughout the entire business system. Verity starts by calculating carbon intensity of feedstocks from data collected at the farm and field level. We plan to track these feedstocks through production at our plants where we intend to use a mix of renewable electricity, biogas, renewable hydrogen and other potentially decarbonized energy sources in production. The CI data would then be combined to deliver a comprehensive CI reduction in a finished renewable fuel. The resulting CI reduction value has potential to be quantified as a digital asset and monetized in voluntary or compliance carbon markets, and providing compliance needs for tax incentives while preventing double-counting. We believe that in the future, regenerative agricultural practices have the potential to sequester large quantities of soil organic carbon while improving soil health.

There is increasing regulatory and stakeholder pressure on global corporations to lower emissions. These trends are driving demand for carbon credits, giving rise to two sets of markets, the regulated compliance carbon market and the unregulated voluntary carbon market, both of which could grow meaningfully in the coming decades. The total value of major compliance carbon markets is expected to be greater than $800 billion in 2023, according to Bloomberg. Verity intends to document and account for carbon capture in conjunction with scientifically supported measurement techniques. The potential for Verity is broad and could be applicable to tracking the CI of various items beyond Gevo’s internal businesses, including, but not limited to, renewable fuels, food, feed and industrial products through their respective business systems and value chains. Our robust scientific measurement, reporting, and verification plan and approach is expected to provide a high-quality credit that should meet regulated compliance and unregulated carbon markets.

In March 2023, we entered into a joint development framework agreement with Southwest Iowa Renewable Energy; in August 2023, we entered into a joint development framework agreement with a second ethanol producer in the Midwest that has over 100 million gallons of capacity; and in October 2023, we entered into an agreement with a third ethanol producer in the Southwest. These agreements include commercial terms and profit-sharing frameworks. As we grow Verity as an externally facing business, we are working to sign up additional ethanol and biofuel customers. Each of these agreements will focus on implementing Verity technology and developing the market for carbon credits to help farmers and biofuel producers quantify the CI reductions for their products.

During the second quarter of 2023, we launched the Verity Tracking platform (the “Platform”) with farmers in the Lake Preston, South Dakota area who participated in our 2022 grower program. In its initial release, the Platform allows the users to measure, report, verify, and view the CI scores at both the farm average and field-by-field levels. The Platform provides insights into the contributors and removers behind the CI, helping users to understand the factors that drive differences in CI performance between fields. Users can also compare their scores with the U.S. national average calculated by the GREET model.

Key Verity project highlights include:

Verity Carbon Solution began development in 2020 as a necessary and value-added services for our SAF production;
3 ethanol producer customers contracted, and growing;
2% of the total US ethanol market or more than 300 million gallons per year;

45

Table of Contents

100% farmer retention in the grower program comprising 65,000 acres and growing;
Total value pool of all major global compliance carbon markets in 2023 was $800 billion;
Capital light, fee-based, industry agnostic business

Luverne Facility. In 2022, the activities at our Luverne Facility were transitioned to care and maintenance, market development, and customer education, as we shifted focus to our Net Zero Projects. The workforce adjustment which resulted allowed us to retain key personnel and redeploy some resources to our NZ1 and RNG projects to provide valuable knowledge and experience for the future strategic growth of the Company. The Luverne Facility is well equipped and positioned as a development site as it provides a unique opportunity to showcase our decarbonization and business systems and raise awareness for future partnerships, investors, and local communities, even though operations at the site have been minimized. Future operations, if any, will be tailored to support a focus on advancing our technology, testing, optimizing alternative feedstocks and yeast strains, and unit operations as well as partnership development for fuels and specialty chemicals with integrated solutions for GHG reductions. We continue to evaluate incentive opportunities recently introduced by the Inflation Reduction Act, which may positively impact the future economics of our operation at Luverne.

U.S. Department of Agriculture. In September 2023, we executed a Notice of Grant and Agreement Award with the U.S. Department of Agriculture (“USDA”) for a Partnerships for Climate-Smart Commodities grant of up to $30.0 million for Gevo’s Climate-Smart Farm-to-Flight Program, with project activity beginning for the 2023 crop year. The project expects to create critical structural climate-smart market incentives for low CI corn as well as to accelerate the production of SAF to reduce the sector’s dependency on fossil-based fuels. In addition, this program will help provide support and incentive payments for farmers to produce, measure, report and verify low CI corn using climate smart agricultural practices, as well as accelerate development of the low-CI corn supply chain for low-carbon ethanol and SAF.

LG Chem Agreement. In April 2023, we entered into a joint development agreement with LG Chem, Ltd. (“LG Chem”) a leading global chemical company to develop bio-propylene for renewable chemicals using our Ethanol-to-Olefins (“ETO”) technology. Gevo’s proprietary ETO technology can target carbon neutral or carbon negative drop-in replacements for traditional petroleum-based building blocks called olefins, including bio-propylene, which can be used for renewable chemicals or fuels including sustainable aviation fuel. These plant-based, renewable olefins would be derived from atmospheric CO2 captured through photosynthesis and are expected to deliver the same performance in final products on the market today. Under the terms of the agreement, we will provide the core enabling technology it has developed for renewable olefins to be produced from low-carbon ethanol and together the parties will collaborate to accelerate the pilot research, technical scale-up, and commercialization of bio-propylene. LG Chem is expected to bear all scale-up costs for chemicals and make certain payments to Gevo. We received $1.1 million, net of foreign taxes of $0.2 million, in the second quarter of 2023 under the agreement, and we expect to receive an additional $1.2 million over the next two years to help defray costs associated with the joint development efforts. In addition, LG Chem agreed to make certain payments to us upon commencement of commercialization as follows:

$5.0 million upon commencement of commercialization, to be paid ratably over a period of five years.
1% royalty on Net Sales for the first production facility beginning six years from commercial operation.
1% royalty on Net Sales for all subsequent production facilities upon commencement of operations.

Nasdaq Listing Rules Compliance

On February 29, 2024, we received notice from Nasdaq that we were not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the minimum bid price of our common stock had been below $1.00 per share for the previous 30 consecutive business days. We have 180 calendar days, or until August 27, 2024, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the minimum bid price of our common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during the compliance grace period. In the event we do not regain compliance with the Minimum Bid Price Requirement by August 27, 2024, we may be eligible for an additional 180-calendar day compliance period. Our failure to regain compliance during the compliance period could result in delisting.

46

Table of Contents

Key Operating Metrics

Total operating revenues reflect both sales of RNG and sales of related environmental attributes. As a result, our revenues are primarily affected by unit production of RNG, production of environmental attributes, and the prices at which we monetize such production. The following table summarizes the key operating metrics described above, which metrics we use to measure performance:

Year Ended December 31, 

(in thousands, unless otherwise indicated)

    

2023

    

2022

    

Change

    

Change %

    

Revenues

 

  

 

  

 

  

 

  

 

Natural gas commodity

$

659

$

640

$

19

3

%

Natural gas environmental attributes - RINs

 

9,888

 

214

 

9,674

4,521

%

Natural gas environmental attributes - LCFS

 

4,910

 

 

4,910

100

%

Total revenues

$

15,457

$

854

$

14,603

Production expenses (1)

$

11,481

$

2,626

$

8,855

337

%

RNG metrics

 

  

 

  

 

  

  

RNG production volumes (MMBtu)

 

314

 

125

 

189

151

%

Plus: prior period RNG volumes dispensed in current period

 

116

 

 

116

100

%

Less: RNG production volumes not dispensed

 

(34)

 

(116)

 

82

(71)

%

Total RNG volumes available for RIN and LCFS generation (2)

 

396

 

9

 

387

4,300

%

RIN metrics

 

  

 

  

 

  

  

RIN generation (3)

 

4,639

 

101

 

4,538

4,493

%

Plus: Prior period RINs

 

 

 

%

Total RINs available for sale

 

4,639

 

101

 

4,538

4,493

%

Less: RINs sold

 

(4,639)

 

(101)

 

(4,538)

4,493

%

RIN inventory

 

 

 

RNG volumes not dispensed for RINs (MMBtu) (4)

 

34

 

116

 

(82)

(71)

%

Average realized RIN price (5)

$

2.13

$

2.13

$

%

LCFS metrics

 

  

 

  

 

  

  

LCFS generation (6)

76

76

100

%

Less: LCFS sold

(76)

(76)

100

%

LCFS inventory

RNG volumes not dispensed for LCFS (MMBtu)

 

34

 

116

 

(82)

(71)

%

Average realized LCFS price (5)

$

64.79

$

$

64.79

100

%

(1)The higher per unit cost reflects lower production volumes during the commissioning and ramp-up phase, which was substantially completed by the end of Q3 2023.
(2)Represents gas production which has not been dispensed to generate RINs and LCFS.
(3)RINs are generally generated in the month following the gas being dispensed.
(4)One MMBtu of RNG has approximately the same energy content as 11.727 gallons of ethanol, and thus may generate 11.727 RINs under the RFS Program.
(5)Realized prices for environmental attributes are net of third-party commissions and thus do not correspond directly to index prices.
(6)LCFS credits are generally generated in the calendar quarter following the gas being dispensed.

47

Table of Contents

Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our Consolidated Financial Statements and the notes to those Consolidated Financial Statements appearing in this Annual Report. This discussion contains forward-looking statements that involve significant risks and uncertainties. As a result of many factors, such as those set forth under “Risk Factors” in Part I, Item 1A of this Annual Report, our actual results may differ materially from those discussed below. Factors that could cause or contribute toanticipated in these differences include those discussed below and elsewhere inforward-looking statements.

This section of this Report particularly in “Risk Factors.”

Overview

We are a renewable chemicalsdiscusses year-to-year comparisons between 2023 and next generation biofuels company, targeting what we believe to be very large potential markets: that2022. The complete Management’s Discussion and Analysis of low carbon fuelsFinancial Condition and chemicals that can compete directly against petro-chemical products depending on the priceResults of oilOperations for year-to-year comparisons between 2022 and value2021 and other discussions of carbon.   Renewable fuels are one of the few markets where the value for renewable carbon has already been established, particularly in the U.S.  We believe that the demand for low carbon fuels, chemicals, and plastics will continue and grow stronger over time.  We believe that renewable carbon will eventually be valued in chemicals and plastics in addition to fuels.    

The challenges to displace petrochemical products with renewable products are enormous:  (i) the products need to meet or exceed the stringent performance requirements established by the incumbent products, (ii) the products need to be compatible with existing distribution infrastructure, (iii) the products must be economical in the market place, and (iv) in most cases, the products must have a lower carbon footprint and improve the “sustainability” of the business system.   We believe we have viable technologies that produce products that address these challenges.  

We have developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to make isobutanol and hydrocarbon products from isobutanol that can displace petrochemical incumbent products.    We have been able to genetically engineer yeast, whereby the yeast produces isobutanol from carbohydrates at costs that we believe to be commercially competitive once large production facilities are deployed that will enable economies of scale to be  reached.  We have shown that the isobutanol production process works in full scale fermenter systems at our production facility in Luverne, Minnesota (the “Luverne Facility”). We also have shown that our renewable isobutanol2021 items can be readily converted to hydrocarbon products that address large markets.  Specifically, our renewable alcohol-to-jet fuel (“ATJ”) has been approved for use in commercial aviation and used multiple times for commercial flights.  In addition, our renewable isobutanol is being used as a gasoline blendstock in the Houston area for on-road vehicles as an ethanol-free fuel option for consumers.  Our renewable isooctane meets the performance and specification requirements for use in chemicals and fuels and is currently being used in the European Union.  We believe that there is large potential to grow our business, through a combination of (i) directly producing and selling our renewable isobutanol and related hydrocarbon products, and (ii) licensing our technology.

We believe that renewable isobutanol is a potentially valuable commercial product because of its versatility to address large markets either as a product directly or as a key intermediate for producing renewable carbon alternatives to mainstream fuels such as jet fuel, gasoline, plastics such as PET, and various other chemical products and materials.   Isobutanol is a four-carbon alcohol that can be sold directly for use as a specialty chemical in the production of solvents, paints and coatings, or more importantly from a market size and performance value-added point of view, as a gasoline blendstock.  Because isobutanol can be readily converted to hydrocarbon products such hydrocarbon fuels, including isooctane, isooctene and ATJ, lubricants, polyester, rubber, plastics, fibers and other polymers, we believe that the addressable markets are very large; potentially being able to ultimately reach 40% of the global petrochemicals markets depending on the price of oil and the value of renewable carbon.    

2017 Production and Sales

During 2017, we produced 15.6 million gallons of ethanol, 47 thousand tons of animal feed, and 1,050 tons of corn oil resulting in revenue of $26.3 million. Consistent with our market development efforts, during 2017, we produced approximately 206,000 gallons of isobutanol at the Luverne Facility.  During 2017, we sold the equivalent of approximately 49,368 gallons of isobutanol, either directly as isobutanol or as renewable hydrocarbons (jet fuel, isooctane and isooctene) resulting in revenue of $1.1 million.

As we continue our market development efforts and increase our isobutanol production levels at our Luverne Facility, there will likely continue to be a mismatch in timing between isobutanol production and sales. As a result, at times we will likely build isobutanol inventory levels. Currently, our alcohol storage capacity is limited at our Luverne Facility, and our isobutanol inventory, together with our ethanol inventory, may exceed such storage capacity. This will cause us to seek other forms of storage, such as railcars, customer sites or investing in additional storage capabilities.


Market Development, Sales and Production Strategy for 2018

In 2018, we intend to continue to develop the markets for our isobutanol, jet fuel, isooctane, and other products made from isobutanol and ethanol.  Ultimately, our primary target is to enter into binding supply contracts for isobutanol and related hydrocarbon products that represent the majority of the production volumes to be produced at the expanded Luverne Facility that we plan to construct (the “Luverne Facility Expansion”).  The focus for market development continues to be:

Isobutanol for the ethanol free gasoline market, primarily in Reformulated Gasoline or RFG areas.  We plan to increase our distribution network, and add additional regions, broadening our distribution footprint.  The isobutanol in our inventory would be used in part to develop these sales.  

Isooctane for gasoline and chemicals are expected to continue to be a priority.  The vast majority of sales are expected to go into the European Union.  We expect that the demand for this product will continue to grow, and we may expand or modify the hydrocarbon demonstration plant at South Hampton Resources in Silsbee, Texas to increase capacity for isooctane.  We plan use the renewable isobutanol in inventory for the feedstock for this product.  We expect to continue to work on securing a set of offtake contracts that would support the Luverne Facility Expansion.

ATJ.  We plan to sell ATJ for market development purposes and demonstrations.  In certain niche markets, we may begin commercial sales, depending on price and volumes that can be supported from the hydrocarbon demonstration plant at South Hampton Resources in Silsbee, Texas.  We expect to continue to work on securing a set of offtake contracts that would support the Luverne Facility Expansion.

In 2018, we expect to sell approximately 19 million gallons or more of ethanol, and approximately 56 thousand tons of its animal feed product.  As previously announced, in 2018, we expect to improve the cash flow out of the Luverne Facility by optimizing the ethanol production processes, developing value added products for ethanol, animal feed, and corn oil produced at the Luverne Facility plant and further reducing the cost of the Luverne Facility’s carbohydrates.

We expect to use our inventory of isobutanol to meet our market development needs in 2018.  In 2017, we ran up an inventory of isobutanol.  During the production runs at the Luverne Facility in 2017, we also met our variable cost production targets for isobutanol.  As previously disclosed, running isobutanol at a scale of 1.5 MGPY, the current capacity of the Luverne Facility, costs us cash because not all of the fixed costs are covered given the relatively low run rate.  We are prepared to ramp-up isobutanol production in response to positive demand and price appreciation.   We will be focused on developing markets and generating cash using the current inventory.  We expect to be selling isobutanol into the gasoline blendstock market, as well as selling isooctane, jet fuel and other products made from inventoried isobutanol.

Path to Profitability

We believe that there are two paths by which we can become profitable.  First, as described above, together with the initiatives to improve the cash flow profilefound within Part II, Item 7, of our business in 2018 compared to 2017, we believe that by optimizing the Luverne Facility’s ethanol production processes, developing value added products for ethanol and animal feed produced at the plant and further reducing the cost of the plant’s carbohydrate feedstock, we could become profitable in the near future, independent of isobutanol production.

Second, we believe that we could become profitable if we are able to obtain binding offtake agreements for our isobutanol and related hydrocarbon products that justify the Luverne Facility Expansion, along with adequate financing for such expansion, whereby we would convert the Luverne Facility primarily to the production of isobutanol, with some percentage of such isobutanol volumes to be further processed into hydrocarbons such as ATJ and isooctane.  

Luverne Facility Update

In 2018, as previously announced, we expect to undertake initiatives to improve the profitability of the Luverne Facility.

We currently have five fermentation vessels at its Luverne Facility.   Three fermentation vessels are made from carbon steel.  Two fermentation vessels are newer and made from stainless steel.  The two stainless steel fermentation vessels and one of the three


carbon steel fermentation vessels are expected to be used for ethanol production during 2018.  The remaining two carbon steel fermentation vessels are not expected to be needed for production in 2018.  If we were to run isobutanol production in side by side mode of operation with ethanol production, we would need one of the two other carbon steel fermentation vessels to be put back into operation, along with the other three fermentation vessels that we plan to use for ethanol production during 2018.

During 2017, we hired a third-party engineering firm to test the structural integrity of the carbon steel fermentation vessels. The results of the testing indicate that one of these fermentation vessels has at least one more year of life before needed repair, and the other one has approximately 2 months of life remaining.  If we were to start up and run isobutanol for an extended period of time, at least one of these carbon steel fermentation vessels would need to be repaired prior to being put back into service.  Repair costs are estimated to be approximately $250,000 per fermentation vessel.

Ultimately, we anticipate that as we build out, or expands the Luverne Facility to increase capacity, we might repair both carbon steel fermentation vessels, and/or install additional fermentation vessels dependingAnnual Report on the need for capacity for isobutanol and/or ethanol at that time.  

NASDAQ Market Price Compliance

On June 21, 2017, we received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market, notifying us that, for the prior 30 consecutive business days, the closing bid price of our common stock was not maintained at the minimum required closing bid price of at least $1.00 per share as required for continued listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, we had an initial compliance period of 180 calendar days, to regain compliance with this requirement. On December 20, 2017, the Nasdaq Stock Market granted us an additional 180 calendar days, or until June 18, 2018, to regain compliance. To regain compliance, the closing bid price of our common stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before June 18, 2018. The Nasdaq determination to grant the second compliance period was based on our meeting of the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Recent Highlights and Developments

On February 8, 2018, we announced that we had strengthened our existing relationship with Musket Corporation, a national fuel distributor under the umbrella of the Love’s Family of Companies, by amending our existing isobutanol supply agreement to provide Musket with the exclusive right to sell our renewable isobutanol within a 300 mile radius of Houston, Texas.  This agreement establishes a market region that encompasses Austin, Dallas, Fort Worth, Oklahoma, Louisiana, as well as the majority of South and East Texas.

In January 2018, we entered into a private exchange agreement with a holder of our 7.5% convertible senior notes due July 2022 (the “2022 Notes”) to exchange the remaining $515,000 of outstanding principal amount of the 2022 Notes for 780,303 shares of our common stock. Upon completion of this exchange, the 2022 Notes were satisfied in their entirety and there are no remaining obligations under the 2022 Notes.

On December 11, 2017, we announced that GE Aviation had commenced jet engine combustor component testing with a jet fuel comprised 100% of our renewable ATJ. The testing is being performed as part of the Federal Aviation Authority’s (FAA) Continuous Lower Energy, Emissions and Noise Program (CLEEN). CLEEN is the FAA’s principal environmental effort to accelerate the development of new aircraft, engine technologies, and to advance sustainable alternative jet fuels, in conjunction with aviation industry leaders such as GE Aviation. Specifically, this testing is designed to enable the greater displacement of petroleum-based jet fuel by bio-based alternative products. Bio-based hydrocarbon fuels have similar performance characteristics to the petroleum-based fuels used today, albeit with reductions in particulate matter and other air quality related emissions. Some bio-based jet fuels, such as our ATJ, have the potential to improve performance, such as providing greater energy density which translates into better mileage.

On November 8, 2017, we announced that our ATJ derived from renewable isobutanol was used by nine airlines for Fly Green Day, sponsored by the O’Hare Fuel Committee, at Chicago O’Hare International Airport. This event was the first time renewable jet fuel has been supplied at Chicago O’Hare using the existing airport fueling infrastructure, such as pipelines, terminals and tankage. To date, airlines and airports have generally relied on alternative means of supplying renewable jet fuel to the wing, usually trucking jet fuel on site for blending and fueling. For Fly Green Day, Air BP blended Gevo’s ATJ with regular fossil-based Jet A fuel, certified its quality and then supplied its customers through the airport’s main fuel hydrant system. Airlines that participated in Fly Green Day included Lufthansa, United Airlines, Etihad, Cathay Pacific Airways, Emirates, Japan Airlines, Korean Air, Atlas Air and FedEx.


On October 9, 2017, we announced that the U.S. Department of Energy’s Chemical Catalysis for Bioenergy Consortium (ChemCatBio) had awarded funding to Los Alamos National Laboratory, National Renewable Energy Laboratory, Argonne National Laboratory and Oak Ridge National Laboratory in support of two collaboration projects with us. The first project is focused on improving the energy density of certain of our hydrocarbon products, such as its alcohol-to-jet-fuel (ATJ), to meet product specifications for tactical missile fuels, which are currently purchased by the US Department of Defense (DoD). The goal of the second project is to fine-tune the composition of the catalyst used in our proprietary Ethanol-to-Olefins (ETO) process, in order to improve performance and accelerate scale-up efforts.

On October 3, 2017, we announced that we expect to supply our renewable ATJ to the Virgin Australia Group, a leading Australian airline group.  The Virgin Australia Group will be responsible for coordinating the purchase, supply and blending of the ATJ into the fuel supply system at Brisbane Airport in Queensland, Australia. Our ATJ is expected to be blended with traditional jet fuel and supplied on flights departing Brisbane Airport, including Virgin Australia flights. The Queensland government is supporting the arrangement as a first step in the development of a renewable jet fuel production industry in the state. Queensland is looking to leverage carbohydrate-based feedstocks, abundant to its local agricultural sector, to support the build-out of renewable jet fuel production plants in the future. We are well positioned to play a role in this growth, as we believe our ATJ is cost advantaged in comparison to other renewable jet alternatives derived from carbohydrate-based feedstocks.  

In September 2017, our Board of Directors approved voluntarily reductions of the exercise price of a portion of the Series M Warrants exercisable into 3,945,000 shares of our common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock. In October, our Board of Directors approved voluntarily reductions of the exercise price of a portion of the Series M Warrants exercisable into 1,185,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.65 per share of common stock, and Series M Warrants exercisable into 300,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock. In September and October 2017, all 5,430,000 of these Series M Warrants were exercised, resulting in proceeds to the Company of approximately $3.3 million.

On July 25, 2017, we announced, in conjunction with Praj Industries Ltd. (“Praj”) that our proprietary isobutanol technology will now be available for licensing to processors of sugar cane juice and molasses. This follows on the back of Praj’s development work, adapting our technology to sugar cane and molasses feedstocks. A Joint Development Agreement and a Development License Agreement were entered into between Praj and us in November 2015. The goal of these agreements was for Praj to adapt our isobutanol technology to using non-corn based sugars and lignocellulose feedstocks. In the first phase of development, Praj worked with our technology using sugar cane and molasses feedstocks, developed a process design package that will now be offered for commercialization to cane juice and molasses-based ethanol plants, as licensees of our isobutanol technology. Licensing is expected to be focused on Praj plants located in India, South America and South East Asia, with initial capacity targeted to come on-line in the 2019/2020 timeframe.

On June 20, 2017, we announced that WB Gevo, Ltd. (the “Holder”), the holder of the Company’s issued and outstanding Senior Secured Convertible Notes, due June 23, 2017 (the “2017 Notes”), exchanged (the “Exchange”) all $16.5 million of the existing 2017 Notes for $16.5 million of our newly created 12.0% Convertible Senior Secured Notes due March 15, 2020 (the “2020 Notes”).

On June 9, 2017, we entered into a private exchange agreement with a holder of our 2022 Notes to exchange an aggregate of $485,000 in principal amount of 2022 Notes for an aggregate of 736,671 shares of common stock.  On July 3, 2017, we repurchased $175,000 of its outstanding 7.5% convertible senior notes due July 2022 (the “2022 Notes”) pursuant to a one-time repurchase option under the 2022 Notes.    

In May 2017, we signed a supply agreement with HCS Holding GmbH (HCS) to supply isooctane under a five-year offtake agreement. HCS is a manufacturer of specialty products and solutions in the hydrocarbons sector, operating under such brands as Haltermann Carless. In the first phase of the supply agreement, HCS will purchase isooctane produced at our demonstration hydrocarbons plant located in Silsbee, Texas, commencing in May 2017. The pricing is fixed over the first phase and Gevo estimates that this could generate up to $2-3 million of gross revenue per year.  In the second phase of the supply agreement, HCS agreed to purchase 300,000 gallons of isooctane per year, with an option to purchase an additional 100,000 gallons of isooctane per year, under a five-year offtake arrangement upon commencement of production at our first commercial hydrocarbon facility. The supply agreement contains a pricing formula which is intended to provide us a fixed margin. We expect to supply this isooctane from its first commercial hydrocarbons facility, which is likely to be built at the Luverne Facility (the “Luverne Facility Expansion”).

On February 23, 2017, we paid down the principal balance on the 2017 Notes with 15% of the net proceeds from the offering referred to immediately above,  along with the $8.0 million in prepayments under the supplemental indenture, for an aggregate total payment of $9.6 million, which reduced the principal balance on the 2017 Notes to approximately $16.5 million.

In February 2017, we sold 5,680,000 Series G units, with each Series G unit consisting of one share of common stock, a Series K warrant to purchase one share of common stock and a Series M warrant to purchase one share of common stock, at a public offering price of $1.90 per Series G unit. We also sold 570,000 Series H units, with each Series H unit consisting of a


pre-funded Series L warrant to purchase one share of common stock, a Series K warrant to purchase one share of common stock and a Series M warrant to purchase one share of common stock, at a public offering price of $1.89 per Series H unit.  The Series K warrants have an exercise price of $2.35 per share, are exercisable beginning the date of original issuance and will expire on February 17, 2022. The Series L warrants have an exercise price of $1.90 per share, which are pre-paid upon issuance, except for a nominal exercise price of $0.01 per share and, consequently, no additional payment or other consideration (other than the nominal exercise price of $0.01 per share) will be required to be delivered to us by the holder upon exercise of the Series L warrants. The Series L warrants will be exercisable from the date of original issuance and will expire on February 17, 2018. The Series M warrants will have an exercise price of $2.35 per share, are exercisable beginning on the date of original issuance and will expire on November 17, 2017. The shares of common stock and the warrants are immediately separable and were issued separately.  The gross proceeds to us from this offering were approximately $11.9 million, not including any future proceeds from the exercise of the warrants.

Effective January 5, 2017, we effected a one-for-twenty reverse split of the Company’s issued and outstanding common stock (the “Reverse Stock Split”).  Upon the effectiveness of the stock split, every twenty shares of the Company’s common stock issued and outstanding were automatically combined into one share of common stock, without any change in the par value per share.

Debt Maturities and Exchanges

In June 2017, we issued our 12% convertible senior secured notes due 2020 (the “2020 Notes”) in exchange for our outstanding 12.0% convertible senior secured notes due 2017 (“2017 Notes”). As of December 31, 2017, the outstanding principal on our 2020 Notes was $16.7 million. The 2020 Notes are scheduled to mature on March 15, 2020.

In January 2018, we entered into a private exchange agreement with a holder of our 2022 Notes to exchange the remaining $515,000 of outstanding principal amount of the 2022 Notes for 780,303 shares of our common stock. Upon completion of this exchange, the 2022 Notes were satisfied in their entirety and there are no remaining obligations under the 2022 Notes.

Financial Condition

For the year ended December 31, 2017, we incurred a consolidated net loss of $24.6 million and had an accumulated deficit of $401.4 million. Our cash and cash equivalents at December 31, 2017 totaled $11.5 million which is primarily being used for the following: (i) operating activities of our Luverne Facility; (ii) operating activities at our corporate headquarters in Colorado, including research and development work; (iii) capital improvements primarily associated with the Luverne Facility; (iv) costs associated with optimizing isobutanol production technology; and (v) debt service obligations.

The continued operation of our business is dependent upon raising additional capital through future public and private equity offerings, debt financings or through other alternative financing arrangements. In addition, successful completion of our research and development programs and the attainment of profitable operations are dependent upon future events, including our ability to raise sufficient capital to expand our commercial production facility, completion of our development activities resulting in sales of isobutanol or isobutanol-derived products and/or technology, achieving market acceptance and demand for our products and services and attracting and retaining qualified personnel.

We expect to incur future net losses as we continue to fund the development and commercialization of our products and product candidates.  We have primarily relied on raising capital to fund our operations and debt service obligations by issuing common stock and warrants in underwritten public offerings.  Those issuances have caused significant dilution to our existing stockholders. While we have sought, and will continue to seek, other, less dilutive forms financing to fund our operations and debt service obligations, there is no assurance that we will be successful in doing so.

Based on our current operating plan, existing working capital at December 31, 2017 was not sufficient to meet the cash requirements to fund planned operations through the period that is one year after the date our 2017 financial statements are issued unless we are able to raise additional capital to fund operations.  Our audited financial statementsForm 10-K for the year ended December 31, 2017, were prepared under2022, filed with the assumption that we would continueSEC on March 9, 2023, which is available free of charge on the SEC’s website at www.sec.gov and our operations as a going concern.  Our independent registered public accounting firm forcorporate website at www.gevo.com.

Comparison of the Years Ended December 31, 2023 and 2022

(in thousands)

    

Year Ended December 31, 

    

    

    

 

    

2023

    

2022

    

Change ($)

    

Change (%)

 

Total operating revenues

$

17,200

$

1,175

$

16,025

1,364

%

Operating expenses:

 

  

 

  

 

  

Cost of production

 

11,991

 

8,698

 

3,293

38

%

Depreciation and amortization

19,007

7,887

11,120

141

%

Research and development expense

 

6,637

 

7,427

 

(790)

(11)

%

General and administrative expense

 

42,628

 

39,941

 

2,687

7

%

Project development costs

 

14,732

 

10,061

 

4,671

46

%

Facility idling costs

 

4,040

 

4,599

 

(559)

(12)

%

Impairment loss

 

 

24,749

 

(24,749)

(100)

%

Loss on disposal of assets

 

 

499

 

(499)

(100)

%

Total operating expenses

 

99,035

 

103,861

 

(4,826)

(5)

%

Loss from operations

 

(81,835)

 

(102,686)

 

20,851

(20)

%

Other income (expense)

 

  

 

  

 

  

Interest expense

 

(2,161)

 

(1,167)

 

(994)

85

%

Interest and investment income

 

19,090

 

3,481

 

15,609

448

%

Other income (expense), net

 

(1,309)

 

2,365

 

(3,674)

(155)

%

Total other income, net

 

15,620

 

4,679

 

10,941

234

%

Net loss

$

(66,215)

$

(98,007)

$

31,792

(32)

%

Operating revenue. During the year ended December 31, 2017 included a “going concern” emphasis of matter paragraph in its report on our financial statements as of, and for2023, revenue increased $16.0 million compared to the year ended December 31, 2017. These conditions raise substantial doubt about2022, primarily due to sales of RNG and environmental attributes from our ability to continue as a going concern. Our inability to continue as a going concern may potentially affect our rights and obligationsRNG project. Sales under our debt obligations.

Our transition to profitability is dependent upon, among other things,RNG project commenced in the successful development and commercializationthird quarter of our products and product candidates,2022. During the achievement of a level of revenues adequate to support our cost structure and securing sufficient financing for the build-out and Retrofit of the Luverne Facility or a facility at another suitable location.  We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise additional cash. We intend to fund future operations through additional private and/or public offerings of debt or equity securities. In addition, we may seek additional capital through arrangements with strategic partners or from other sources, may seek to restructure our debt and we will continue to address our cost structure. Notwithstanding, there can be no assurance that we will be able to raise additional funds, or achieve or sustain profitability or positive cash flows from operations.


Results of Operations

Comparison of the yearsyear ended December 31, 20172023, we sold 313,572 MMBtu of RNG from our RNG project, resulting in biogas commodity sales of $0.7 million and 2016 (in thousands)  

 

Years Ended December 31,

 

 

 

 

 

 

2017

 

 

2016

 

 

Change

 

Revenue and cost of goods sold

 

 

 

 

 

 

 

 

 

 

 

Ethanol sales and related products, net

$

26,279

 

 

$

24,613

 

 

$

1,666

 

Hydrocarbon revenue

 

1,029

 

 

 

1,929

 

 

 

(900

)

Grant and other revenue

 

228

 

 

 

671

 

 

 

(443

)

Total revenues

 

27,536

 

 

 

27,213

 

 

 

323

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

38,165

 

 

 

37,017

 

 

 

1,148

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross loss

 

(10,629

)

 

 

(9,804

)

 

 

(825

)

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

Research and development expense

 

5,182

 

 

 

5,216

 

 

 

(34

)

Selling, general and administrative expense

 

7,471

 

 

 

8,965

 

 

 

(1,494

)

Total operating expenses

 

12,653

 

 

 

14,181

 

 

 

(1,528

)

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(23,282

)

 

 

(23,985

)

 

 

703

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (expense) income

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(2,951

)

 

 

(7,837

)

 

 

4,886

 

Loss on exchange or conversion of debt

 

(4,933

)

 

 

(763

)

 

 

(4,170

)

Loss on extinguishment of warrant liability

 

-

 

 

 

(918

)

 

 

918

 

Gain from change in fair value of derivative warrant liability

 

5,101

 

 

 

1,783

 

 

 

3,318

 

Gain from change in fair value of 2020 Notes embedded derivative

 

1,751

 

 

 

-

 

 

 

1,751

 

Loss from change in fair value of 2017 Notes

 

(339

)

 

 

(4,204

)

 

 

3,865

 

Loss on issuance of equity

 

-

 

 

 

(1,519

)

 

 

1,519

 

Other income

 

23

 

 

 

215

 

 

 

(192

)

Total other (expense) income

 

(1,348

)

 

 

(13,243

)

 

 

11,895

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(24,630

)

 

$

(37,228

)

 

$

12,598

 

Revenues. Duringenvironmental attribute sales of $14.8 million, see Key Operating Metrics above. Additionally, we recognized $1.3 million of licensing and development revenue from the twelve monthsagreement with LG Chem as well as $0.4 million from the sale of isooctane during the year ended December 31, 2017, we recognized revenue2023.

Cost of $26.3production. Cost of production increased $3.3 million associated withduring the sale of 15.6 million gallons of ethanol,year ended December 31, 2023, compared to the year ended December 31, 2022, primarily due to the production and sales from our RNG project, which significantly increased in 2023, after the ramp-up phase, as well as isobutanollower costs at the idling Luverne Facility in 2023.

Depreciation and related products, an increase of $1.7amortization. Depreciation and amortization increased $11.1 million fromduring the twelve monthsyear ended December 31, 2016 primarily related2023, compared to increased production at the Luverne Facility.  Hydrocarbon revenue decreased during the 12 monthsyear ended December 31, 2017 primarily as a result of lower shipments of finished products from our demonstration plant located at the South Hampton Facility. Hydrocarbon revenues are comprised of ATJ, isooctane and isooctene sales. Grant and other revenue was $0.2 million during the 12 months ended December 31, 2017, down $0.4 million on as compared to the same period in 2016, primarily as a result of the Company’s contract with the Northwest Advanced Renewables Alliances ending in 2017.

Cost of goods sold. Our cost of goods sold during the twelve months ended December 31, 2017 included $32.0 million associated with the production of ethanol, isobutanol and related products and $6.2 million in depreciation expense. Cost of goods sold increased during the twelve months ended December 31, 2017 2022, primarily due to increased productiona full three quarters of ethanol as comparedadditional depreciation expense in 2023 for RNG assets placed into service in Q3 2022 and accelerated depreciation on Agri-Energy segment assets due to shorter lives stemming from the impairment assessment during the third quarter of 2022. See Note 4 to the prior year.Consolidated Financial Statements for additional information.

48

Table of Contents

Research and development expense. Research and development expensesexpense decreased $0.8 million during the twelve monthsyear ended December 31, 20172023, compared to the year ended December 31, 2022, primarily due to a $0.3 million decrease in depreciation expenses.

Selling, general and administrative expense. The decrease in selling, general and administrative expenses during the twelve months ended December 31, 2017 primarily resulted from decreasesreduction of $0.6 million in salary related expenses, $0.2 million in legal expenses, and $0.5 million in consulting expenses.


Loss on exchange or conversion of debt. During the twelve months ended December 31, 2017, we incurred a loss of $0.9 million resulting from the exchange of a portion of our 2022 Notes for our common stock and a $3.9 million loss on the exchange of our 2017 Notes for our 2020 Notes.

Gain from change in fair value of derivative warrant liability. In December 2013, August 2014, February 2015, May 2015, December 2015, April 2016, September 2016 and February 2017, we issued warrants to purchase our common stock which are recorded at fair value each reporting period. During the twelve months ended December 31, 2017, the estimated fair value of the derivative warrant liability decreased primarily due to a decline in the price of our common stock, and as a result, the Company reported a $5.1 million gain for 2017.

Gain from change in fair value of 2020 Notes embedded derivative. During the twelve months ended December 31, 2017, the estimated fair value of the 2020 Notes embedded derivative liability decreased, resulting in a non-cash gain of $1.8 million primarily due to the decrease in the price of the Company’s stock from the June 20, 2017 issuance date.

Loss from change in fair value of the 2017 Notes. During the twelve months ended December 31, 2017, we reported a $0.3 million loss associated with the increase in fair value of the 2017 Notes, primarily as a result of the decrease in the time to maturity during the period of time the 2017 Notes were still outstanding in 2017.

Comparison of the years ended December 31, 2016 and 2015 (in thousands)  

 

Years Ended December 31,

 

 

 

 

 

 

2016

 

 

2015

 

 

Change

 

Revenue and cost of goods sold

 

 

 

 

 

 

 

 

 

 

 

Ethanol sales and related products, net

$

24,613

 

 

$

27,125

 

 

$

(2,512

)

Hydrocarbon revenue

 

1,929

 

 

 

1,694

 

 

 

235

 

Grant and other revenue

 

671

 

 

 

1,318

 

 

 

(647

)

Total revenues

 

27,213

 

 

 

30,137

 

 

 

(2,924

)

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

37,017

 

 

 

38,762

 

 

 

(1,745

)

 

 

 

 

 

 

 

 

 

 

 

 

Gross loss

 

(9,804

)

 

 

(8,625

)

 

 

(1,179

)

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

Research and development expense

 

5,216

 

 

 

6,610

 

 

 

(1,394

)

Selling, general and administrative expense

 

8,965

 

 

 

16,692

 

 

 

(7,727

)

Total operating expenses

 

14,181

 

 

 

23,302

 

 

 

(9,121

)

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(23,985

)

 

 

(31,927

)

 

 

7,942

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (expense) income

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(7,837

)

 

 

(8,243

)

 

 

406

 

(Loss)/Gain on exchange or conversion of debt

 

(763

)

 

 

232

 

 

 

(995

)

(Loss)/Gain on extinguishment of warrant liability

 

(918

)

 

 

1,775

 

 

 

(2,693

)

Gain from change in fair value of derivative warrant liability

 

1,783

 

 

 

577

 

 

 

1,206

 

(Loss)/Gain  from change in fair value of 2017 Notes

 

(4,204

)

 

 

3,895

 

 

 

(8,099

)

Loss on issuance of equity

 

(1,519

)

 

 

(2,523

)

 

 

1,004

 

Other income

 

215

 

 

 

20

 

 

 

195

 

Total other (expense) income

 

(13,243

)

 

 

(4,267

)

 

 

(8,976

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(37,228

)

 

$

(36,194

)

 

$

(1,034

)

Revenues. During the twelve months ended December 31, 2016, we recognized revenue of $24.6 million associated with the sale of 14.2 million gallons of ethanol, as well as isobutanol and related products, a decrease of $2.5 million from the twelve months ended December 31, 2015 primarily related to decreased production at the Luverne Facility. Hydrocarbon revenue increased during the twelve months ended December 31, 2016 primarily as a result of increased shipments of isooctane and isooctene during the year.


Cost of goods sold. Our cost of goods sold during the twelve months ended December 31, 2016 included $31.0 million associated with the production of ethanol, isobutanol and related products and $6.0 million in depreciation expense. Cost of goods sold decreased during the twelve months ended December 31, 2016 primarily due to decreased production of ethanol as compared to the prior year.

Research and development expense. Research and development expenses decreased during the twelve months ended December 31, 2016 primarily due to a $1.3 million decrease in employee compensation expense.

Selling, general and administrative expense. The decrease in selling, general and administrative expenses during the twelve months ended December 31, 2016 primarily resulted from decreases of $1.5 million in employee compensation expense, $6.9 million in professional and legal expenses, partially offset by an increase in $0.6personnel related costs due to additional headcount added during the year ended December 31, 2023.

General and administrative expense. General and administrative expense increased $2.7 million during the year ended December 31, 2023, compared to the year ended December 31, 2022, primarily due to increases in other general expenses, includingpersonnel costs associatedrelated to the hiring of highly qualified and skilled professionals, professional consulting fees, and stock-based compensation. On a periodic basis, we assess our Corporate cost allocation estimates. During the year ended December 31, 2023, we performed an assessment which resulted in the implementation of Corporate cost allocations across all segments to reflect the use of centralized administrative functions as well as the allocation of personnel costs related to our project development efforts. If we had applied the most recent cost allocation estimate to the year ended December 31, 2023, it would have resulted in a decrease in General and administrative expense of approximately $28.4 million, with restructuringa corresponding increase primarily to Project development costs, representing the nature of the Company’s debt obligations.

Gain / (Loss) on exchangeexpenditures related to those growth projects: namely our view that substantial portions of these expenditures may be reimbursed to us upon financial close of NZ1, and their growth-oriented non-recurring and discretionary nature. The allocations did not impact the Company’s operating loss or conversion of debt. Duringnet loss for the twelve monthsyear ended December 31, 2016, we incurred a loss2023.

Project development costs. Project development costs are related to our future Net-Zero Projects and Verity which consist primarily of $0.8employee expenses, preliminary engineering costs, and technical consulting costs. Project development costs increased $4.7 million resulting fromduring the exchange of a portion of our 2022 Notes for our common stock.

Loss on extinguishment of warrant liability. During the twelve monthsyear ended December 31, 2016, we incurred a loss of $0.9 million resulting from exercises of warrants2023, compared to purchase our common stock. This is the result of the fair value of the derivative warrant liability for the warrants and the cash received being less than the fair value of the shares issued upon exercise.

Gain (loss) from change in fair value of derivative warrant liability. In December 2013, August 2014, February 2015, May 2015, December 2015, April 2016 and September 2016, we issued warrants to purchase our common stock which are recorded at fair value each reporting period. During the twelve monthsyear ended December 31, 2016, the estimated fair value of the derivative warrant liability decreased 2022, primarily due to a declineincreases in the pricepersonnel costs and consulting fees.

Facility idling costs. Facility idling costs are related to care and maintenance of our common stock, and as a result,Luverne Facility. Facility idling costs decreased by $0.6 million for the Company reported a $1.8 million gain for 2016.

Gain (Loss) from change in fair value of the 2017 Notes. During the twelve monthsyear ended December 31, 2016,2023, compared to the year ended December 31, 2022, primarily due to one-time charges recorded during 2022 related to removing flammable and other hazardous items from the site, writing off certain patents, and reduction in the workforce.

Impairment loss. No impairment loss was recorded during the year ended December 31, 2023. During the year ended December 31, 2022, the Company recorded a $24.7 million impairment loss on long-lived assets, which reduced the carrying value of certain property, plant, and equipment, and a leased right of use asset, at the Agri-Energy segment to its fair value. The impairments recorded relate to the determination to suspend production at the Luverne Facility and shift the plant into an idled, care and maintenance status during the third quarter of 2022. The impact of the one-time impairment charge of $24.7 million was $0.11 of basic and diluted impairment loss per share for the year ended December 31, 2022. See Note 4 to the Consolidated Financial Statements for additional information.

Loss on disposal of assets. The Company did not record a loss on disposal of assets for the year ended December 31, 2023. As a result of suspending the production of ethanol at the Luverne Facility, we reported a $4.2wrote-off $0.5 million of costs during the year ended December 31, 2022, related to ancillary equipment and spare parts that are no longer expected to be utilized at the Luverne Facility. The equipment and spare parts had been planned to be used in ethanol production.

Loss from operations. The Company’s loss associated withfrom operations decreased by $20.9 million during the year ended December 31, 2023, compared to the year ended December 31, 2022, primarily due to increased revenue from RNG operations and LG Chem licensing in 2023, as well as the prior year impairment loss, partially offset by the increase in fair valuecosts for our Net-Zero, Verity, and USDA Climate-Smart Grant projects.

Interest expense. Interest expense increased by $1.0 million during the year ended December 31, 2023, compared to the year ended December 31, 2022, primarily due to the interest on the 2021 Bonds, which was capitalized into construction in process during the construction phase of our RNG Project in the 2017 Notes,prior periods.

Interest and investment income. Interest and investment income increased $15.6 million during the year ended December 31, 2023, compared to the year ended December 31, 2022, primarily due to an increase in interest earned on our cash equivalent investments as a result of the decrease in the time to maturityhigher interest rates.

49

Table of Contents

Other income. Other income decreased $3.7 million during the twelve-months-ended December 31, 2016.

Loss on issuance of equity. During the twelve monthsyear ended December 31, 2016, we reported a $1.52023, compared to the year ended December 31, 2022, primarily due to the receipt of $0.4 million loss associated withfrom the April 2016 equity issuance primarily as a resultUSDA's Biofuel Producer Program in 2023 compared to $2.9 million in 2022. In addition, our termination of the estimated fair valueexpediting procurement agreement with a local utility resulted in a one-time charge of the common stock$1.6 million in 2023.

Sources of Our Revenues

Our current and warrants issued being greater than the consideration received in exchange.

Revenues, Cost of Goods Sold and Operating Expenses

Revenues

During 2017, 2016 and 2015, we generated revenuehistoric revenues are primarily derived from: (i) the sale of ethanol, isobutanolRNG commodities and the related products;environmental attributes; (ii) licensing and development sales; (iii) hydrocarbon sales consisting primarily of the sale of biojet fuel, isooctane and bio-PX derived from our isobutanol for purposesand SAF; and (iv) the sale of certificationisobutanol and testing; and (iii) government grants and research and development programs.related products.

Principal Components of Our Cost Structure

Cost of Goods Sold and Gross Loss

Production. Our cost of goods sold during the years ended December 31, 2017, 2016 and 2015production consists primarily includesof costs directly associated with ethanol production and initial operations for the production of RNG and other renewable hydrocarbon products, including isobutanol, at the Luverne Facility such asSAF, and isooctane. Such costs forinclude direct materials, direct labor, depreciation, other operating costs and certain plant overhead costs. Direct materials include corn feedstock, denaturant and process chemicals. Direct labor includes compensation (including stock-based compensation) of personnel directly involved in production operations at the Luverne Facility.operations. Other operating costs include utilities and natural gas and wind power usage.

Our gross loss is defined as our total revenues less our cost of goods sold.

Research and Development

Development. Our research and development costs consistexpense consists of expensescosts incurred to identify, develop and test our technologies for the production of isobutanolrenewable hydrocarbon products and the development of downstream applications thereof. Research and development expenses includeexpense includes personnel costs (including stock-based compensation), consultants and related contract research, facility costs, supplies, depreciation and amortization expense on property, plant and equipment used in product development, license fees paid to third parties for use of their intellectual property and patent rights and other overhead expenses incurred to support our research and development programs.


Research and development expenses also include upfront fees and milestone payments made under licensing agreements and payments for sponsored research and university research gifts to support research at academic institutions.

Selling, General and Administrative

Selling, generalAdministrative. General and administrative expenses consistexpense consists of personnel costs (including stock-based compensation), consulting and service provider expenses (including patent counsel-related costs), legal fees, marketing costs, corporate insurance costs, occupancy-related costs, depreciation and amortization expenses on property, plant and equipment not used in our product development programs or recorded in cost of goods sold, travel and relocation expenses and hiring expenses.

We also record selling, general Our corporate personnel, consisting of subject matter experts, including chemists, engineers, and administrative expensessustainability experts, dedicate the majority of their time and efforts for the operationsdevelopment of our growth projects. Costs incurred have not yet been allocated to the Luverne Facility that include administrativespecific growth projects on the face of our financial statements.

Project Development Costs. Project development costs consist of consulting, preliminary engineering costs, personnel expenses (including stock-based compensation) and oversightresearch and development expenses certain personnel-related expenses, insuranceto support the business activities of our Net-Zero Projects.

Depreciation and Amortization. Depreciation and amortization relates to property, plant and equipment associated with the production of RNG and other operating expenses.renewable hydrocarbon products, including isobutanol, SAF, and isooctane, as well as that used in product development.

Liquidity and Capital Resources

As of December 31, 2023, we had cash and cash equivalents of $298.3 million and current restricted cash of $77.3 million, totaling $375.6 million in cash, cash equivalents, and restricted cash. As of December 31, 2023, we had net working capital of $295.0 million, with $91.4 million of current liabilities. Our cash equivalents primarily consist of investments in U.S. government money market funds. We expect to use our cash, cash equivalents, and restricted cash for the following purposes: (i) identification, development, engineering, licensing, acquisition and construction of production facilities and the Company’s other Net-Zero Projects; (ii) potential investment in RNG projects; (iii) potential development of the Luverne Facility; (iv) operating activities at the Company’s corporate headquarters in Colorado, including research and development work; (v) exploration of strategic alternatives and additional financing, including project financing; and (vi) future debt service obligations. We believe as a result of our cash and cash equivalents balances, and the performance of our current and expected operations, we will be able to meet our obligations and other potential cash requirements during the next 12 months from the date of this report.

50

Table of Contents

Since our inception in 2005, we have devoted most of our cash resources to manufacturing, research andthe development and selling, general and administrative activities related to the commercialization of isobutanol,routes to efficiently produce fuels and chemicals from carbohydrates, such as wellrenewable feedstock, using alcohols (isobutanol and ethanol) as related products from renewable feedstocks.intermediates. We have incurred losses since inception, have a significant accumulated deficit, and expect to incur losses through at least 2020. Wefor the foreseeable future. Historically we have financed our operations primarily with proceeds from multiple salesthe issuance of equity, andwarrants, debt securities, and borrowings under debt facilities and product sales.

The continued operationfacilities. Our current sources of our business is dependent upon raising additional capital through future public and private equity offerings, debt financings or through other alternative financing arrangements. In addition, successful completion of our research and development programs and the attainment of profitable operations are dependent upon future events, including our ability to raise sufficient capital to expand our commercial production facility, completion of our development activities resulting incash include sales of isobutanol or isobutanol-derived products and/or technology, achieving market acceptanceRNG, environmental attributes, and demand for our products and services and attracting and retaining qualified personnel.

We expect to incur future net losses as we continue to fund the development and commercialization of our products and product candidates. We have primarily relied on raising capital to fund our operations and debt service obligations by issuing common stock and warrants in underwritten public offerings.  Those issuances have caused significant dilution to our existing stockholders. While we have sought, and will continue to seek, other, less dilutive forms financing to fund our operations and debt service obligations, there is no assurance that we will be successful in doing so.

Based on our current operating plan, existing working capital at December 31, 2017 was not sufficient to meet the cash requirements to fund planned operations through the period that is one year after the date our 2017 financial statements are issued unless we are able to raise additional capital to fund operations. These conditions raise substantial doubt about our ability to continue as a going concern. Our inability to continue as a going concern may potentially affect our rights and obligations under our debt obligations.

Our transition to profitability is dependent upon, among other things, the successful development and commercialization of our products and product candidates, the achievement of a level of revenues adequate to support our cost structure and securing sufficient financing for the build-out and Retrofit of the Luverne Facility or a facility at another suitable location.licensing fees. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise additional cash. We intend toalso fund future operations through additional private and/or public offerings of debtequity or equitydebt securities. In addition, we may seek additional capital, on acceptable terms, through arrangements with strategic partners or from other sources, may seek to restructure our debt and we will continue to address our cost structure.sources. Notwithstanding, there can be no assurance that we will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.

Our transition to profitability is dependent upon, among other things, the successful development and commercialization of our product candidates, the development, licensing, acquisition and construction of commercial level production facilities to support our offtake agreements, the achievement of a level of revenues adequate to support the Company’s cost structure, and the ability to raise capital to finance the development, licensing, acquisition, and construction of additional productions facilities.

The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):

 

Year Ended December 31,

 

 

2017

 

 

2016

 

Net cash used in operating activities

$

(20,626

)

 

$

(20,516

)

Net cash used in investing activities

 

(1,906

)

 

 

(5,938

)

Net cash provided by financing activities

 

6,197

 

 

 

37,311

 

Year Ended December 31, 

    

2023

    

2022

Net cash used in operating activities

    

$

(53,719)

    

$

(44,311)

Net cash provided by investing activities

$

114,129

$

85,092

Net cash (used in) provided by financing activities

$

(189)

$

138,562

Operating Activities

Our primary uses of cash from operating activities are personnel-related expenses, and research and development-related expenses, including costs incurred under development agreements, costs forof licensing of technology, legal-related costs, and expenses


for the productiondevelopment and commercialization of isobutanol, ethanolroutes to efficiently produce fuels and related products, logisticschemicals from renewable feedstock carbohydrates using alcohols (isobutanol and further processing of ethanol and isobutanol at the Luverne Facility and for the operation of our hydrocarbon demonstration production facility.ethanol) as an intermediate.

During the year ended December 31, 2017, we used $20.6 million in cash for operating activities due to a net loss of $24.6 million, excluding the impact of $6.4 million in non-cash expenses, and $2.4 million2023, net cash used associated with an increase in working capital primarily a result of a pay down of accounts payable coupled with an increase in both accounts receivable and inventory.

Duringoperating activities was $53.7 million compared to $44.3 million for the year ended December 31, 2016, we used $20.52022. Non-cash charges primarily consisted of depreciation and amortization of $19.0 million, stock-based compensation expense of $17.1 million, which reflects higher amortization expense for the stock awards issued in cashthe prior period with higher market value, see Note 16 to the Consolidated Financial Statements for operating activities dueadditional information, and non-cash expense of $0.1 million related to a net lossthe amortization of $37.3 million, offset by the impact of $17.2 million in non-cash expenses, and $0.5 millionmarketable securities premiums. The net cash usedoutflow from changes in operating assets and liabilities increased $23.9 million, primarily due to an increase in working capital primarilycash outflows of $23.0 million related to prepaid expenses and other current assets, deposits and other assets, $2.6 million related to increases in accounts receivable as a result of the pay down ofwell as $0.9 million related to accounts payable coupledand accrued liabilities. These were partially offset by $2.7 million of decreased costs associated with an increase in accounts receivable.the sale of environmental attribute inventory.

Investing Activities

During the year ended December 31, 2017,2023, we used $1.9had $114.1 million in cash forprovided by investing activities, of which $168.6 million related to proceeds from sales and maturities of marketable securities, partially offset by $54.5 million of investments in our capital expendituresprojects, including $28.2 million in NZ1, $6.4 million in the RNG Project, and $19.9 million in other projects.

51

Table of Contents

We completed the value engineering on our NZ1 project and are proceeding with detailed engineering, modularization design, and capital costs updates. We are currently refining project cost estimates with engineering, procurement, and construction (“EPC”) partners to identify cost saving opportunities, and currently expect to finance the construction of NZ1 at out Luverne Facility.the subsidiary level using a combination of Company equity and third-party capital, to include non-recourse debt. The Company expects to have invested a cumulative total of $236 to $286 million of cash equity in the project at financial close. Cash distributions from future NZ1 earnings would be proportionate to Gevo’s ownership in NZ1 under this expected financing structure. The use of project debt and third party equity allows us to conserve capital for use on other growth projects. We expect to apply similar development and financing strategies to future Net-Zero Projects to enable growth of SAF production to meet demand for SAF.

In 2022, we allocated approximately $25.0 million to develop our next Net-Zero Project, of which we have spent approximately $15.0 million. Gevo is in the process of identifying and performing early site development work for additional Net-Zero production locations. These potential sites include greenfield and brownfield (i.e., at an existing ethanol plant) locations that are advantageous in terms of potential economics, opportunities to decarbonize, and time to market.

During the year ended December 31, 2016,2022, we used $5.9had $85.1 million in cash forprovided by investing activities, all of which was$299.6 million related to proceeds from sales and maturities of marketable securities, partially offset by the reinvestment of $130.4 million in marketable securities, and $84.1 million of investments in our capital expenditures at our Luverne Facility.  projects, including $34.7 million in the RNG Project, $43.3 million in NZ1 and $2.0 million in other Net-Zero Projects, as well as $4.1 million in other isobutanol related projects.

Financing Activities

During the year ended December 31, 2017,2023, we generated $6.2had $0.2 million inof net cash fromused in financing activities, primarily relateddue to payments for equipment loans and finance lease liabilities.

We currently expect to finance the $11.0 millionconstruction of NZ1 at the subsidiary level using a combination of our own, third-party, and debt capital. The Company expects to retain an equity interest in proceeds from issuance of common stock, the $2.6 million release of restricted cash,project and may invest equity in the $3.4 million inproject using the proceeds from the exercisereimbursement of warrants, These gainsthe Company’s NZ1 development expenditures. Cash distributions from future NZ1 earnings would be proportionate to Gevo’s ownership in cash were offset by $9.8 million in principal paymentsNZ1 under this expected financing structure which would allow us to Whitebox,conserve and $1.1 million in equityredeploy our capital on other growth projects, including our Net-Zero 2 project (“NZ2”). We expect to apply similar development and debt offering costs.financing strategies to NZ2 and future Net-Zero Projects to enable growth of SAF production to meet demand for SAF.

During the year ended December 31, 2016,2022, we accumulated $37.3had $138.6 million inof net cash fromprovided by financing activities, primarily relateddue to the$139.0 million of net proceeds from public offeringsthe issuance of common stock and common stock warrants in April,a registered direct offering in June and September 20162022, offset by our pay down$0.4 million of the remaining balance of our secured long-term debt in September 2016.

2020 Notes

On April 19, 2017, we entered into the Purchase Agreement with the Holder of the 2017 Notes, and Whitebox Advisors LLC, in its capacity as representative of the Holder (“Whitebox”). Pursuant to the terms of the Purchase Agreement, the Holder, subject to certain conditions, including approval of the transaction by our stockholders (which was received on June 15, 2017), agreed to exchange all of the outstanding principal amount of the 2017 Notespayments primarily for an equal principal amount of our newly created 2020 Notes, plus an amount in cash equal to the accrued and unpaid interest (other than interest paid in kind) on the 2017 Notes (the “Exchange”). As noted above, on June 20, 2017, we completed the Exchange, terminated the 2017 Notes Indenture and cancelled the 2017 Notes. As of December 31, 2017, the outstanding principal on the 2020 Notes was $16.7 million, including paid-in-kind interest.

The 2020 Notes will mature on March 15, 2020. The 2020 Notes bear interest at a rate equal to 12% per annum (with 2% potentially payable as PIK Interest (as defined and described below) at our option), payable on March 31, June 30, September 30, and December 31 of each year. Under certain circumstances, we have the option to pay a portion of the interest due on the 2020 Notes by either (a) increasing the principal amount of the 2020 Notes by the amount of interest then due or (b) issuing additional 2020 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”).

The 2020 Notes are convertible into shares of our common stock, subject to certain terms and conditions. The initial conversion price of the 2020 Notes is equal to $0.7359 per sharenet settlement of common stock or 1.3589 sharesunder stock plans and certain equipment loans.

Critical Accounting Estimates

Our Consolidated Financial Statements are based on the application of common stock per $1 principal amountU.S. GAAP, which requires us to make estimates and assumptions about future events that affect the amounts reported in our Consolidated Financial Statements and the accompanying notes. Future events and their effects cannot be determined with certainty; therefore, the determination of 2020 Notes (the “Conversion Price”). In addition, upon certain equity financing transactions by us,estimates requires the Holders will have a one-time right to reset the Conversion Price (the “Reset Provision”) (i) in the first ninety (90) days following the Exchange Date, at a 25% premium to the common stock price in the equity financing and (ii) after ninety (90) and to and including one hundred eighty (180) days following the closing of the Exchange, at a 35% premium to the common stock share price in the equity financing. Following an exercise of judgment. We believe our judgments related to these accounting estimates are appropriate. However, if different assumptions or conditions were to prevail, the Reset Provision,results could be materially different from the Holders will alsoamounts recorded. We have a right to consent to certain equity financings by us during the one hundred eighty (180) days following the closing of the Exchange.

See Note 8, Debt,determined that we have no critical accounting estimates material to our consolidated financial statements included herein for further discussionposition, results of the 2020 Notes.


2022 Notes

In July 2012, we sold $45.0 million in aggregate principal amount of 2022 Notes, for net proceeds of $40.9 million, after accounting for $2.7 million and $1.4 million ofoperations or cash discounts and issue costs, respectively. The 2022 Notes bear interest at 7.5% which is to be paid semi-annually in arrears on January 1 and July 1 of each year commencing on January 1, 2013.  As a result of certain conversion and exchanges, the principal balance of the 2022 Notes was $515,000 as of December 31, 2017.

 In the first quarter of 2018, we issued 780,303 shares in exchange for the redemption of the remaining $515,000 in outstanding 2022 Notes.  As a result of this exchange, all obligations under the 2022 Notes have been fully satisfied.

Contractual Obligations and Commitments

The following summarizes the future commitments arising from our contractual obligations at December 31, 2017 (in thousands).

 

 

Less than 1 year

 

 

1-3 years

 

 

4 - 5 years

 

 

Thereafter (4)

 

 

Total

 

Principal debt payments (1)

 

$

-

 

 

$

17,408

 

 

$

-

 

 

$

515

 

 

$

17,923

 

Interest payments on debt (2)

 

 

1,717

 

 

 

2,155

 

 

 

77

 

 

 

-

 

 

 

3,949

 

Operating leases (3)

 

 

1,421

 

 

 

1,302

 

 

 

200

 

 

 

-

 

 

 

2,923

 

Insurance and Maintenance

 

 

223

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

223

 

Total

 

$

3,361

 

 

$

20,865

 

 

$

277

 

 

$

515

 

 

$

25,018

 

(1)

Principal debt payments include the principal amounts of the outstanding 2020 Notes and 2022 Notes.

(2)

Interest payments due to holders of the 2020 Notes and 2022 Notes.

(3)

Commitments for operating leases primarily relate to our leased facility in Englewood, Colorado and our lease for rail cars for ethanol and isobutanol shipments.

(4)

In January 2018, the Company exchanged the remaining $0.5 million of outstanding 2022 Notes for common stock.

The table above reflects only payment obligations that are fixed and determinable. The above amounts exclude potential payments to be made under our license and other agreements that are based on the achievement of future milestones or royalties on product sales.

Off-Balance Sheet Arrangements

As of December 31, 2017, we did not have any off-balance sheet arrangements, or relationships with unconsolidated entities, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with generally accepted accounting principles, or GAAP, in the U.S. requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management bases its estimates, assumptions and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our consolidated financial statements, which in turn, could change the results from those reported. Our management evaluates its estimates, assumptions and judgments on an ongoing basis.

While our significant accounting policies are more fully described in Note 2flow related to our consolidated financial statements included in this Report, we believe that the following accounting policies are the most critical to aid you in fully understanding and evaluating our reported financial results and reflect the more significant judgments and estimates that we use in the preparation of our consolidated financial statements.

Accounting for Senior Secured Debt, Convertible Notes and Embedded Derivative

2020 Notes

On April 19, 2017, we entered into the Purchase Agreement with the Holder of the 2017 Notes, and Whitebox Advisors LLC, in


its capacity as representative of the Holder (“Whitebox”). Pursuant to the terms of the Purchase Agreement, the Holder, subject to certain conditions, including approval of the transaction by our stockholders (which was received on June 15, 2017), agreed to exchange all of the outstanding principal amount of the 2017 Notes for an equal principal amount of our newly created 2020 Notes, plus an amount in cash equal to the accrued and unpaid interest (other than interest paid in kind) on the 2017 Notes (the “Exchange”). As noted above, on June 20, 2017, we completed the Exchange, terminated the 2017 Notes Indenture and cancelled the 2017 Notes. As of December 31, 2017, the outstanding principal on the 2020 Notes was $16.7 million.

The 2020 Notes will mature on March 15, 2020. The 2020 Notes bear interest at a rate equal to 12% per annum (with 2% potentially payable as PIK Interest (as defined and described below) at our option), payable on March 31, June 30, September 30, and December 31 of each year. Under certain circumstances, we have the option to pay a portion of the interest due on the 2020 Notes by either (a) increasing the principal amount of the 2020 Notes by the amount of interest then due or (b) issuing additional 2020 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”).

The 2020 Notes are convertible into shares of our common stock, subject to certain terms and conditions. The initial conversion price of the 2020 Notes is equal to $0.7359 per share of common stock, or 1.3589 shares of common stock per $1 principal amount of 2020 Notes (the “Conversion Price”). In addition, upon certain equity financing transactions by us, the Holders will have a one-time right to reset the Conversion Price (the “Reset Provision”) (i) in the first ninety (90) days following the Exchange Date, at a 25% premium to the common stock price in the equity financing and (ii) after ninety (90) and to and including one hundred eighty (180) days following the closing of the Exchange, at a 35% premium to the common stock share price in the equity financing. Following an exercise of the Reset Provision, the Holders will also have a right to consent to certain equity financings by us during the one hundred eighty (180) days following the closing of the Exchange.

See Note 8, Debt, to our consolidated financial statements included herein for further discussion of the 2020 Notes.

2022 Notes and Embedded Derivative

In July 2012, we sold $45.0 million in aggregate principal amount of 2022 Notes. Terms of the 2022 Notes, include, among others: (i) rights to convert into shares of our common stock, including upon a Fundamental Change (as defined in the 2022 Notes Indenture); and (ii) a Coupon Make-Whole Payment (as defined in the 2022 Notes Indenture) in the event of a conversion by the holders of the 2022 Notes prior to July 1, 2017. The embedded derivative is separated from the host contract, the 2022 Notes, and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. The Company has concluded that the embedded derivative within the 2022 Notes meet these criteria and, as such, must be valued separate and apart from the 2022 Notes as an embedded derivative and recorded at fair value each reporting period. The fair value of the embedded derivative is included as a component of the 2022 Notes on our consolidated balance sheets.

We used a binomial lattice model in order to estimate the fair value of the embedded derivative in the 2022 Notes. A binomial lattice model generates two probable outcomes, whether up or down, arising at each point in time, starting from the date of valuation until the maturity date. A lattice was initially used to determine if the 2022 Notes would be converted, called or held at each decision point. Within the lattice model, the following assumptions are made: (i) the 2022 Notes will be converted early if the conversion value is greater than the holding value; and (ii) the 2022 Notes will be called if the holding value is greater than both (a) the Redemption Price (as defined in the 2022 Notes Indenture) and (b) the conversion value plus the Coupon Make-Whole Payment at the time. If the 2022 Notes are called, then the holders will maximize their value by finding the optimal decision between (1) redeeming at the Redemption Price and (2) converting the 2022 Notes.

Using this lattice, we valued the embedded derivative using a “with-and-without method,” where the value of the 2022 Notes including the embedded derivative is defined as the “with,” and the value of the 2022 Notes excluding the embedded derivative is defined as the “without.” This method estimates the value of the embedded derivative by looking at the difference in the values between the 2022 Notes with the embedded derivative and the value of the 2022 Notes without the embedded derivative. The lattice model requires the following inputs: (i) price of our common stock; (ii) Conversion Rate (as defined in the 2022 Notes Indenture); (iii) Conversion Price (as defined in the 2022 Notes Indenture); (iv) maturity date; (v) risk-free interest rate; (vi) estimated stock volatility; and (vii) estimated credit spread for the Company.

Changes in certain inputs into the lattice model can have a significant impact on changes in the estimated fair value of the embedded derivative. For example, the estimated fair value of the embedded derivative will generally decrease with: (i) a decline in the stock price; (ii) decreases in the estimated stock volatility; and (iii) a decrease in the estimated credit spread. From the date the 2022 Notes were issued through December 31, 2016, we observed a significant decline in the market price of our common stock which resulted in a $28.0 million decrease in the estimated fair value of our embedded derivative from issuance through December 31,


2016.  These changes in the estimated fair value of the embedded derivative represent unrealized gains, which have been recorded as gains from change in fair value of embedded derivative in the consolidated statements of operations.

Derivative Warrant Liability

The following warrants were sold by the Company:

In December 2013, the Company sold warrants to purchase 71,013 shares of the Company’s common stock (the “2013 Warrants”).

In August 2014, the Company sold warrants to purchase 50,000 shares of the Company’s common stock (the “2014 Warrants”).

In February 2015, the Company sold Series A warrants to purchase 110,833 shares of the Company’s common stock (the “Series A Warrants”) and Series B warrants to purchase 110,833 shares of the Company’s common stock (the “Series B Warrants”).

In May 2015, the Company sold Series C warrants to purchase 21,500 shares of the Company’s common stock (the “Series C Warrants”).

In December 2015, the Company sold Series D warrants to purchase 502,500 shares of the Company’s common stock (the “Series D Warrants”) and Series E warrants to purchase 400,000 shares of the Company’s common stock (the “Series E Warrants”).

In April 2016, the Company sold 514,644 Series F warrants to purchase one share of common stock (each a “Series F Warrant”) and 1,029,286 Series H warrants, each to purchase one share of common stock (each, a “Series H Warrant”), and 328,571 pre-funded Series G warrants (“Series G Warrants”) to purchase one share of common stock, pursuant to an underwritten public offering.

In September 2016, the Company sold 712,503 Series I warrants to purchase one share of common stock (each a “Series I Warrant”) and 185,000 pre-funded Series J warrants (“Series J Warrants”) to purchase one share of common stock, pursuant to an underwritten public offering.

In February 2017, the Company sold Series K warrants to purchase 6,250,000 shares of the Company’s common stock (the “Series K Warrants”) and Series M warrants to purchase 6,250,000 shares of the Company’s common stock (the “Series M Warrants”), and pre-funded Series L warrants (the “Series L Warrants”) to purchase 570,000 shares of the Company’s common stock, pursuant to an underwritten public offering.


The following table sets forth information pertaining to shares issued upon the exercise of Warrants as of December 31, 2017:

 

 

Issuance

Date

 

Expiration

Date

 

Exercise

Price as of December 31, 2017

 

 

Shares

Underlying

Warrants on

Issuance Date

 

 

Shares Issued

upon Warrant

Exercises as of

December 31,

2017

 

 

Shares

Underlying

Warrants

Outstanding as of

December 31,

2017 (4)

 

2013 Warrants

 

12/16/2013

 

12/16/2018

 

$

8.99

 

 

 

71,013

 

 

 

15,239

 

 

 

55,774

 

2014 Warrants

 

8/5/2014

 

8/5/2019

 

$

6.83

 

 

 

50,000

 

 

 

30,538

 

 

 

19,462

 

Series A Warrants

 

2/3/2015

 

2/3/2020

 

$

0.68

 

 

 

110,833

 

 

 

99,416

 

 

 

11,417

 

Series B Warrants

 

2/3/2015

 

8/3/2015

 

 

-

 

(1)

 

110,833

 

 

 

110,833

 

 

 

-

 

Series C Warrants

 

5/19/2015

 

5/19/2020

 

$

5.50

 

 

 

21,500

 

 

 

-

 

 

 

21,500

 

Series D Warrants

 

12/11/2015

 

12/11/2020

 

$

2.00

 

 

 

502,500

 

 

 

501,570

 

 

 

930

 

Series E Warrants

 

12/11/2015

 

12/11/2020

 

 

-

 

(1)

 

400,000

 

 

 

400,000

 

 

 

-

 

Series F Warrants

 

4/1/2016

 

4/1/2021

 

$

2.00

 

 

 

514,644

 

 

 

233,857

 

 

 

280,787

 

Series G Warrants

 

4/1/2016

 

4/1/2017

 

 

-

 

(1)

 

328,571

 

 

 

328,571

 

 

 

-

 

Series H Warrants

 

4/1/2016

 

10/1/2016

 

 

-

 

(1)

 

1,029,286

 

 

 

1,029,286

 

 

 

-

 

Series I Warrants

 

9/13/2016

 

9/13/2021

 

$

11.00

 

 

 

712,503

 

 

 

-

 

 

 

712,503

 

Series J Warrants

 

9/13/2016

 

9/13/2017

 

 

-

 

 

 

185,000

 

 

 

185,000

 

 

 

-

 

Series K Warrants

 

2/17/2017

 

2/17/2022

 

$

0.60

 

 

 

6,250,000

 

 

 

160,000

 

 

 

6,090,000

 

Series L Warrants

 

2/17/2017

 

2/17/2018

 

 

-

 

(1)

 

570,000

 

 

 

570,000

 

 

 

-

 

Series M-A Warrants

 

2/17/2017

 

11/17/2017

 

 

-

 

(1), (2)

 

2,305,000

 

 

 

1,485,000

 

 

 

-

 

Series M-B Warrants

 

2/17/2017

 

11/17/2017

 

 

-

 

(1), (3)

 

3,945,000

 

 

 

3,945,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

17,106,683

 

 

 

9,094,310

 

 

 

7,192,373

 

(1)

Warrants have either been fully exercised and/or expired as of December 31, 2017.    

(2)

In October 2017, 1,485,000 Series M warrants were repriced between $0.60 and $0.65 per warrant. Of those warrants that were repriced, all were exercised in the fourth quarter of 2017, providing proceeds of $950 thousand.

(3)

In September 2017, 3,945,000 Series M warrants were repriced to $0.60. Of those warrants that were repriced, all were exercised in the second half of 2017, providing proceeds of $2.4 million.

(4)

This table does not include 1,393 equity-classified warrants, issued between 2008 through 2012, with strike prices between $17.70 and $24.45 per share.

The agreements governing the above Warrants include the following terms:

certain warrants have exercise prices which are subject to adjustment for certain events, including the issuance of stock dividends on our common stock and, in certain instances, the issuance of our common stock or instruments convertible into the Company’s common stock at a price per share less than the exercise price of the respective warrants;

warrant holders may exercise the warrants through a cashless exercise if, and only if, we do not have an effective registration statement then available for the issuance of the shares of our common stock. If an effective registration statement is available for the issuance of its common stock, a holder may only exercise the warrants through a cash exercise;

the exercise price and the number and type of securities purchasable upon exercise of the warrants are subject to adjustment upon certain corporate events, including certain combinations, consolidations, liquidations, mergers, recapitalizations, reclassifications, reorganizations, stock dividends and stock splits, a sale of all or substantially all of our assets and certain other events; and

in the event of an extraordinary transaction (as defined in the respective warrant agreements), generally including any merger with or into another entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of its common stock, in which the successor entity (as defined in the respective warrant agreements) that assumes the warrant is not a publicly traded company, we or any successor entity will pay the warrant holder, at such holder’s option, exercisable at any time concurrently with or within 30 days after the consummation of the extraordinary transaction, an amount of cash equal to the value of such holder’s warrants as determined in accordance with an appropriate valuation model and the terms of the respective warrant agreement.


Based on these terms, we have determined that the warrants issued since 2013 (the “Warrants”) qualify as derivatives and, as such, are presented as a derivative warrant liability on the consolidated balance sheets and recorded at fair value each reporting period. The fair value of the Warrants was estimated to be $2.0 million and $2.7 million  as of December 31, 2017 and December 31, 2016, respectively. The decrease in the estimated fair value of the Warrants represents an unrealized gain which has been recorded as a gain from the change in fair value of derivative warrant liability in the consolidated statements of operations.

During the twelve months ended December 31, 2017, our common stock was issued as a result of exercise of Warrants as described below:

 

Twelve Months Ended

December 31, 2017

 

 

Common Stock

Issued

 

 

Proceeds

 

Series K Warrants

 

160,000

 

 

 

106,000

 

Series L Warrants

 

570,000

 

 

 

5,700

 

Series M-A Warrants

 

1,485,000

 

 

 

950,250

 

Series M-B Warrants

 

3,945,000

 

 

 

2,367,000

 

 

 

6,160,000

 

 

$

3,428,950

 

  During the twelve months ended December 31, 2017, we issued 160,000 shares of common stock as a result of the exercise of Series K Warrants, 570,000 shares of common stock as a result of the exercise of Series L Warrants and 5,430,000 shares of common stock as a result of the exercise of Series M Warrants, resulting in a total proceeds of approximately $3.4 million.

     In addition, in September 2017, as permitted by Section 2(a) of the Series M Warrants agreement the Board of Directors of the Company approved a voluntarily reduction of the exercise price of the Series M Warrants exercisable into 3,945,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock, for the remaining term of these warrants (The Series “M-B” Warrants). Except for the reduction in exercise price, the terms of these Series M-B Warrants remained unchanged. In September 2017, the Company issued 3,500,000 shares of common stock as a result of the exercise of these Series M-B Warrants. In the fourth quarter of 2017, the remaining 445,000 Series M-B Warrants for which the exercise price had been adjusted to $0.60 were exercised.

   In October 2017, the Board of Directors of the Company approved voluntarily reductions of the exercise price of additional Series M Warrants exercisable into 1,185,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.65 per share of common stock, and Series M Warrants exercisable into 300,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock. These, along with the remainder of the Series M Warrants for which the original exercise price was not reduced comprise the Series M-A Warrants.   Except for the reduction in exercise price, the terms of these Series M Warrants remained unchanged. During the fourth quarter of 2017, all Series M-A warrants for which the exercise price was reduced were exercised. The remaining Series M-A warrants expired during the fourth quarter of 2017.

As of December 31, 2017, all of the Series B, E, G, H, J and M Warrants for which the exercise price had been adjusted were fully exercised or expired

Impairment of Property, Plant and Equipment

Our property, plant and equipment consist primarily of assets associated with the acquisition and Retrofit of the Luverne Facility. We assess impairment of property, plant and equipment for recoverability when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances applicable to our current stage of operations which could trigger a review include, but are not limited to: (i) significant decreases in the market price of the asset; (ii) significant adverse changes in the business climate or legal or regulatory factors; (iii) accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; and (iv) expectations that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life. The carrying amount of a long-lived asset is considered to be impaired if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.


We evaluated our long-lived assets for impairment as of December 31, 2017. This evaluation included comparing the carrying amount our long-lived assets to the undiscounted future cash flows of our consolidated net assets as this represents the lowest level of identifiable cash flows. Significant assumptions included in the estimated undiscounted future cash flows include, among others, estimates of the:

sales price of isobutanol, hydrocarbons, ethanol and by-products such as dried distiller’s grains;

purchase price of corn;

production levels of isobutanol;

capital and operating costs to produce isobutanol; and

estimated useful life of the primary asset.

Factors which can impact these assumptions include, but are not limited to;

effectiveness of our technology to produce isobutanol at targeted margins;

demand for isobutanol, hydrocarbon and oil prices; and

harvest levels of corn.

Based upon our evaluation at December 31, 2017, we concluded that the estimated undiscounted future cash flows from Luverne exceeded the carrying value of the Luverne Facility and, as such, these assets were not impaired. Although our cash flow forecasts are based on assumptions that are consistent with our planned use of the assets, these estimates required significant exercise of judgment and are subject to change in future reporting periods as facts and circumstances change. Additionally, we may make changes to our business plan that could result in changes to the expected cash flows. As a result, it is possible that a long- lived asset may be impaired in future reporting periods.

Stock-Based Compensation

Our stock-based compensation expense includes expenses associated with share-based awards granted to employees and board members and expenses associated with our employee stock purchase plan (“ESPP”). The estimated fair value of stock options and ESPP awards is determined on the date of grant and recorded to expense over the requisite service period, generally the vesting period. We estimate the fair value of stock option awards using the Black-Scholes option-pricing model which requires judgments to be made, including estimating: (i) the expected life of an award; (ii) stock price volatility; and (iii) prior to our initial public offering in February 2011, the fair value of our common stock.

The Black-Scholes option-pricing model calculates the estimated fair value of stock options using the following inputs: (i) expected stock option life; (ii) expected volatility; (iii) risk-free interest rate; (iv) expected dividend yield rate; (v) exercise price; and (vi) closing price of our common stock on the date of grant.

Due to our limited history of grant activity, we use the “simplified method” permitted by the SEC to estimate the expected stock option life as the arithmetic average of the total contractual term of the option and its vesting period. We calculate the estimated volatility rate based on selected comparable public companies, due to a lack of historical information regarding the volatility of our stock price. We will continue to analyze the historical stock price volatility assumption as more historical data for our common stock becomes available. The risk-free interest rate assumption is based on the U.S. Treasury yield curve in effect on the date of grant for instruments with a term similar to the expected life of the related option. No dividends are expected to be paid.

The estimated fair value of a stock option using the Black-Scholes option-pricing model is impacted significantly by changes in a company’s stock price. For example, all other assumptions being equal, the estimated fair value of a stock option will increase as the closing price of a company’s stock increases, and decrease as the closing price of a company’s stock decreases. Prior to the closing of our initial public offering, we were a private company and, as such, we were required to estimate the fair value of our common stock. In the absence of a public trading market, we determined a reasonable estimate of the then-current fair value of our common stock for purposes of granting stock-based compensation based on multiple criteria. We determined the fair value of our common stock utilizing methodologies, approaches and assumptions consistent with the American Institute of Certified Public Accountants Practice Aid, “Valuation of Privately-Held-Company Equity Securities Issued as Compensation.” After the closing of our initial public offering in February 2011, the fair value of our common stock is no longer an estimate as it is based upon the closing price of our stock on the date of grant.


Revenue Recognition

Following our acquisition of Luverne on September 22, 2010, we have primarily derived revenue from the sale of ethanol, distiller’s grains and other related products produced as part of the ethanol production process at the Luverne Facility. The production of ethanol alone is not our intended business and our future strategy is expected to depend on our ability to produce and market isobutanol and products derived from isobutanol. Revenue from the sale of ethanol, hydrocarbons or excess corn inventory is recognized when all of the following criteria are satisfied: persuasive evidence of an arrangement exists; risk of loss and title is transferred to the customer; the price is fixed or determinable; and collectability is reasonably assured. Ethanol and related products are generally shipped free on board shipping point. Collectability of revenue is reasonably assured based on historical evidence of collectability between us and our customers.

Lease revenue related to the contractual agreements for utilization of the Luverne storage facilities is recognized on a straight line basis over the term of the lease.

Revenue related to our government research grants and cooperative agreements is recognized in the period during which the related costs are incurred or over the contract period, provided that the conditions under the awards have been met and only perfunctory obligations are outstanding.Report.

Recent Accounting Pronouncements

See Note 2, Summary of Significant Accounting Policies, in Item 8. “Financial Statements and Supplemental Data,,” of this Report, for a discussion of recent accounting pronouncements.

52

Table of Contents

Item 7A.

Item 7A.Quantitative and Qualitative Disclosures about Market Risk

Commodity Price Risk

We are exposed to market risks related to environmental attribute pricing, commodity pricing, interest rate, credit risk with our contract counterparties, and equity price risks. We currently have produced isobutanol, ethanolno foreign exchange risk and distiller’s grains from corn anddo not use derivative financial instruments as part of an overall strategy to manage market risk; however, we may consider such arrangements in the future as we evaluate our business is sensitiveand financial strategy.

Environmental Attribute and Commodity Pricing Risk

We attempt to changesnegotiate the best prices for our environmental attributes and to competitively price our products to reflect the fluctuations in market prices. Reductions in the market prices of environmental attributes may have a material adverse effect on our revenues and profits as they directly reduce our revenues. We have prepared a sensitivity analysis to estimate our exposure to market risk with respect to RIN and LCFS prices. Our analysis, which may differ from actual results, based on our actual 2023 RINs and LCFS sold of approximately $2.08 and $64.79 respectively. The estimated annual impact of a hypothetical 10% decrease in the average realized price per RIN and per LCFS credit would have a negative effect on our operating profit of corn. approximately $1.0 million and $0.5 million, respectively.

The price of corn is subject to fluctuations due to unpredictable factors such as weather, corn planted and harvested acreage,RNG changes in national and global supply and demand and government programs and policies. We use natural gas during the production of isobutanol and ethanol and, as a result, our business is also sensitive to changes in the price of natural gas. The price of natural gas is influenced by such weather factors as extreme heat or cold in the summer and winter, or other natural events like hurricanes in the spring, summer and fall. Other natural gas price factors include North American exploration and production, and the amount of natural gas in underground storage during both the injection and withdrawal seasons. Ethanol, isobutanol and hydrocarbon prices are sensitive to world crude oil supply and demand, crude oil refining capacity and utilization, government regulation and consumer demand for alternative fuels. Distiller’s grains prices are sensitive to various demand factors such as numbers of livestock on feed, prices for feed alternatives and supply factors, primarily production by ethanol plants and other sources.

Historically, we have attempted to reduce the market risk associated with fluctuations in the price of corn by employing a variety of risk management and economic hedging strategies. Strategies include the use of forward purchase contracts and exchange-traded futures contracts. Exchange-traded futures contracts for corn are recorded as a derivative asset or liability on our consolidated balance sheets at fair value. Changes in the fair value during a reporting period are recognized as cost of goods sold in our consolidated statements of operations.  

In June 2015, Agri-Energy, LLC, our wholly-owned subsidiary, entered into a Price Risk Management, Origination and Merchandising Agreement, as amended as of December 21, 2017 (the “Origination Agreement”) with FCStone Merchant Services, LLC (“FCStone”) and a Grain Bin Lease Agreement with FCStone, as amended as of December 21, 2017 (the “Lease Agreement”). Pursuantrelation to the Origination Agreement, FCStone will originate and sell to Agri-Energy, the owner of the Luverne Facility, and Agri-Energy will purchase from FCStone, the entire volume of corn grain used by the Luverne Facility in Luverne, Minnesota. The initial term of the Origination Agreement will continue for a period of eighteen months and will automatically renew for additional terms of one year unless Agri-Energy gives notice of non-renewal to FCStone. FCStone will receive an origination fee for purchasing and supplying Luverne with all of the corn used by the Luverne Facility. As security for the payment and performance of all indebtedness, liabilities and obligations of Agri-Energy to FCStone, Agri-Energy granted to FCStone a security interest in the corn grain stored in grain storage bins owned and operated by Agri-Energy (“Storage Bins”) and leased to FCStone pursuant to the Lease Agreement. Pursuant to the Lease Agreement, FCStone will lease Storage Bins from Agri-Energy to store the corn grain prior to title of the corn grain transferring to Agri-Energy upon Agri-Energy’s purchase of the corn grain. FCStone agrees to lease Storage Bins sufficient to store 700,000 bushels of corn grain. The term of the Lease Agreement will run concurrently with the Origination Agreement, and will be extended, terminated, or expire in accordance with the Origination Agreement. Gevo also entered into an unsecured guaranty (the “Guaranty”) in favor of FCStone whereby Gevo guaranteed the obligations of Agri-Energy to FCStone under the Origination Agreement. The Guaranty shall terminate on the earlier to occur of (i) April 15, 2020 or (ii) termination of the Origination Agreement.


Equity Price Risk

2020 Notes Embedded Derivative. As of December 31, 2017, we had $16.7 million in principal amount of the 2020 Notes, due March 15, 2020. A component of the 2020 Notes includes an embedded holder conversion option, which has been accounted for as a separate instrument from the host 2020 Notes, representing a $5.2 million liability as of 12/31/2017. The change in the estimated fair value, which is determined in part based upon the quoted market prices of the underlying common stock of the Company, represents an unrealized gain or loss included in our consolidated statement of operations. Accordingly, our results of operations are subjectwholesale gas. Pricing for wholesale gas is volatile and we expect this volatility to exposure associated with increases or decreasescontinue in the estimated fair valuefuture. Further, volatility of the 2020 Notes embedded derivative.

Warrants. As of December 31, 2017, there were 55,774 shares underlying the 2013 Warrants, 19,462 shares underlying the 2014 Warrants, 11,417 shares underlying the Series A Warrants, 21,500 shares underlying the Series C Warrants, 930 shares underlying the Series D Warrants, 280,787 shares underlying the Series F Warrants, 712,503 shares underlying the Series J Warrants, 6,090,000 shares underlying the Series J Warrants, respectively that are derivative instruments and are recorded at an estimated fair value each reporting period. The changewholesale gas also creates volatility in the estimated fair value, which is determined in part based upon the quoted market prices of environmental attributes. We have prepared a sensitivity analysis to estimate our exposure to market risk with respect to the Warrants, represents an unrealized gainmarket price of wholesale gas. Our analysis. which may differ from actual results, was based on our actual 2023 gas production sold pursuant to contracts that do not provide for a fixed or loss included in our consolidated statementfloor price of operations. Accordingly, our resultsapproximately $2.10/MMBtu. The estimated annual impact of operations are subject to exposure associated with increases or decreasesa hypothetical 10% decrease in the estimated fair valuemarket price of the Warrants.

Refer to “Critical Accounting Policies and Estimates” included in this Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for an additional discussion on thewholesale gas would not have a material impact on our financial condition or results of operations associated with the embedded derivative and derivative instruments described above.operations.

Interest Rate Risk

We hadare exposed to market risk related to changes in interest rates. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates, particularly because our investments, including cash equivalents, are invested in U.S. treasury or government money market funds. Our analysis. which may differ from actual results, was based on our actual 2023 effective interest rate earned on our cash and cash equivalents totaling $11.6 million at December 31, 2017. These amounts were invested primarilyequivalents. The estimated annual impact of a hypothetical 0.25% decrease in demand deposit checking and savings accounts andmarket interest rates would have a negative impact on our interest income of approximately $2.8 million.

We are held for working capital purposes. The primary objective of our investment activities isexposed to preserve our capital for the purpose of funding our operations and we do not enter into investments for trading or speculative purposes. Accordingly, we believe we do not have material exposurefurther market risk related to changes in fair value as a result of changes in interest rates.

The terms ofrates through our 2020 Notes provide2021 Bonds, see Footnote 15 to the Consolidated Financial Statements for fixed rates of interest, and are therefore not subject to fluctuations in market interest rates.

The valuations ofadditional information. Our analysis, which may differ from actual results, was based on the embedded derivative within our 2020 Notes use the risk-freeanticipated future interest rate that is expected to be entered into under the 2021 Bond remarketing under a Trust Indenture dated April 1, 2021 (the “Indenture”) between the Authority and Citibank, N.A. as trustee (the “Trustee”), which is expected to occur no later than April 1, 2024. We anticipate an input, so the valuationsincrease in our interest rates to 4.5%, with a resulting negative impact on our annual interest expense of $2.0 million.

Credit Risk

We are subject to interest rate risk.credit risk due to the concentration of our RNG receivables with a limited number of significant customers. This concentration increases our exposure to credit risk on our receivables, since the financial insolvency of these customers could have a significant impact on our results of operations.

Equity Price Risk

We have in the past, and may in the future, seek to acquire additional funding by sale of common stock and other equity. The price of our common stock has been volatile in the past and may also be volatile in the future. As a result, there is a risk that we may not be able to sell our common stock at an acceptable price should the need for new equity funding arise.


53

Table of Contents

Item 8.

Financial Statements and Supplementary Data

Index to Gevo, Inc. Consolidated Financial Statements

Page

Report of Independent Registered Public Accounting Firm (PCAOB ID Number 248)

7155

Consolidated Balance Sheets

7257

Consolidated Statements of Operations

7358

Consolidated Statements of Comprehensive Income (Loss)

59

Consolidated Statements of Stockholders’ Equity

7460

Consolidated Statements of Cash Flows

7561

Notes to Consolidated Financial Statements

7863


54

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders

Gevo, Inc.

Opinion on the financial statements

We have audited the accompanying consolidated balance sheets of Gevo, Inc. (a Delaware corporation) and subsidiaries (the “Company”) as of December 31, 20172023 and 2016,2022, the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the threetwo years in the period ended December 31, 2017,2023, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20172023 and 2016,2022, and the results of its operations and its cash flows for each of the threetwo years in the period ended December 31, 2017,2023, in conformity with accounting principles generally accepted in the United States of America.

Going concern uncertainty

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has suffered recurring losses from operations and incurred a net loss of $25 million during the year ended December 31, 2017. As of December 31, 2017 and the date of this report, the Company’s existing working capital is not sufficient to meet the cash requirements to fund operations through March 28, 2019 without additional sources of debt or equity. These conditions, along with other matters as set forth in Note 1, raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. As described in Note 8 to the consolidated financial statements, these matters may also potentially affect the Company’s rights and obligations under certain of its debt agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supportingregarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical audit matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Consolidation – Variable interest model

As described in Notes 2 and 22 to the consolidated financial statements, the Company enters into agreements with special purpose entities (“SPEs”), some of which are variable interest entities (“VIEs”). The Company consolidates a VIE if it is deemed to be the primary beneficiary. The Company determines it is the primary beneficiary if it has the power to direct the activities that most significantly impact the VIEs’ economic performance and has the obligation to absorb losses or has the right to receive benefits of the VIE that could potentially be significant to the VIE. During September 2022 and February 2023, the Company entered into agreements with Zero6 Energy Development, Inc. (“ZEDI”) to develop and construct facilities to provide carbon neutral power to their Net Zero 1 project via the two Project LLCs: Kingsbury County Wind Fuel, LLC and Dakota Renewable Hydrogen, LLC, respectively. In December

55

Table of Contents

2023 the agreements with ZEDI related to the two Project LLCs were amended to remove certain kickout rights that previously existed. Each Project LLC is a VIE, and the Company holds an implicit variable interest in each Project LLC. As of December 2023, the Company has concluded that the removal of the kickout rights from the agreements has resulted in a loss of control and that, therefore, the Company is no longer the primary beneficiary of the Project LLCs. We identified the Company’s assessment of the primary beneficiary of the Project LLCs as a critical audit matter.

The principal considerations for our determination that performing procedures relating to the deconsolidation of the Project LLCs as VIEs is a critical audit matter are that (i) there is significant judgment by management when determining whether the Company is the primary beneficiary of the VIEs based on the purpose and design of the project LLCs and other legal rights of the parties, including the determination of which party has power to direct the activities that most significantly affect the economic performance of the VIE, as well as the substance of the arrangements, the right to receive potentially significant benefits, indicators if the parties in the arrangements were acting in the role of agents or de facto agents, and (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating audit evidence related to the purpose of each Project LLCs rights and obligations of the variable interest holders, mechanisms for the resolution of disputes among variable interest holders, and other agreements with the legal entity and its variable interest holders.

Our audit procedures related to the assessment of the primary beneficiary of the Project LLCs included the following, among others.

discussing with management the purpose and design of each VIE
reading the operating agreements and other related legal documents to understand the rights of each party, including the ability to remove the entity that has the power to direct the activities of the VIE
evaluating management’s analysis of significant activities of each VIE such as capital decisions, financing decisions and operating decisions, and which party, if any, has the power to direct such activities. In our evaluation, we considered the purpose and design of the Project LLCs and other legal rights of the parties, including the significance of the decision-making rights of each party in assessing which party has power to direct the activities that most significantly affect the economic performance of the VIE, as well as the substance of the arrangements. We also considered whether there were indicators that parties to the arrangements were acting in the role of agents or de facto agents.

/s/ GRANT THORNTON LLP

We have served as the Company’s auditor since 2015.

Denver, Colorado

March 28, 20187, 2024

56


Table of Contents

GEVO, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

 

 

December 31,

 

 

 

2017

 

 

2016

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

11,553

 

 

$

27,888

 

Accounts receivable

 

 

1,054

 

 

 

1,122

 

Inventories

 

 

4,362

 

 

 

3,458

 

Prepaid expenses and other current assets

 

 

712

 

 

 

850

 

Total current assets

 

 

17,681

 

 

 

33,318

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

70,369

 

 

 

75,592

 

Restricted deposits

 

 

-

 

 

 

2,611

 

Deposits and other assets

 

 

803

 

 

 

803

 

Total assets

 

$

88,853

 

 

$

112,324

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

4,011

 

 

$

6,193

 

Current Portion of 2017 Notes recorded at fair value

 

 

-

 

 

 

25,769

 

2020 Notes embedded derivative liability

 

 

5,224

 

 

 

-

 

Derivative warrant liability

 

 

1,951

 

 

 

2,698

 

Total current liabilities

 

 

11,186

 

 

 

34,660

 

 

 

 

 

 

 

 

 

 

2020 Notes, net

 

 

13,491

 

 

 

-

 

2022 Notes, net

 

 

515

 

 

 

8,221

 

Other long-term liabilities

 

 

130

 

 

 

179

 

Total liabilities

 

 

25,322

 

 

 

43,060

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (see Note 18)

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Stockholders' Equity

 

 

 

 

 

 

 

 

Common stock, $0.01 par value per share; 250,000,000 authorized; 21,811,059 and

   7,074,246 shares issued and outstanding at December 31, 2017 and 2016,

   respectively. (See Note 2)

 

 

218

 

 

 

71

 

Additional paid-in capital

 

 

464,663

 

 

 

445,913

 

Accumulated deficit

 

 

(401,350

)

 

 

(376,720

)

Total stockholders' equity

 

 

63,531

 

 

 

69,264

 

Total liabilities and stockholders' equity

 

$

88,853

 

 

$

112,324

 

    

Note

December 31, 2023

    

December 31, 2022

Assets

 

  

  

 

  

Current assets

 

  

  

 

  

Cash and cash equivalents

 

  

$

298,349

$

237,125

Marketable securities

 

6

 

 

167,408

Restricted cash

 

7

 

77,248

 

1,032

Trade accounts receivable, net

 

  

 

2,623

 

476

Inventories

 

10

 

3,809

 

6,347

Prepaid expenses and other current assets

 

8

 

4,353

 

3,034

Total current assets

 

  

 

386,382

 

415,422

Property, plant and equipment, net

 

11, 23

 

211,563

 

185,174

Restricted cash

 

7

 

 

77,219

Operating right-of-use assets

 

9

 

1,324

 

1,331

Finance right-of-use assets

 

9

 

210

 

219

Intangible assets, net

 

12

 

6,524

 

7,691

Deposits and other assets

 

13

 

44,319

 

13,692

Total assets

 

$

650,322

$

700,748

Liabilities

 

  

 

  

 

  

Current liabilities

 

  

 

  

 

  

Accounts payable and accrued liabilities

 

14, 23

$

22,752

$

24,760

Operating lease liabilities

 

9

 

532

 

438

Finance lease liabilities

 

9

 

45

 

79

Loans payable

 

15

 

130

 

159

2021 Bonds payable, net

15

67,967

Total current liabilities

 

  

 

91,426

 

25,436

2021 Bonds payable, net

 

15

 

 

67,223

Loans payable

 

15

 

21

 

159

Operating lease liabilities

 

9

 

1,299

 

1,450

Finance lease liabilities

 

9

 

187

 

183

Other liabilities

 

  

 

 

820

Total liabilities

 

  

 

92,933

 

95,271

Commitments and Contingencies

 

19

 

  

 

  

Stockholders' Equity

 

  

 

  

 

  

Common stock, $0.01 par value per share; 500,000,000 shares authorized; 240,499,833 and 237,166,625 shares issued and outstanding at December 31, 2023, and December 31, 2022, respectively.

 

  

 

2,405

 

2,372

Additional paid-in capital

 

  

 

1,276,581

 

1,259,527

Accumulated other comprehensive loss

 

  

 

 

(1,040)

Accumulated deficit

 

  

 

(721,597)

 

(655,382)

Total stockholders' equity

 

  

 

557,389

 

605,477

Total liabilities and stockholders' equity

 

  

$

650,322

$

700,748

See the accompanying Notes to the Consolidated Financial Statements.

57


Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share amounts)

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Revenue and cost of goods sold

 

 

 

 

 

 

 

 

 

 

 

Ethanol sales and related products, net

$

26,279

 

 

$

24,613

 

 

$

27,125

 

Hydrocarbon revenue

 

1,029

 

 

 

1,929

 

 

 

1,694

 

Grant and other revenue

 

228

 

 

 

671

 

 

 

1,318

 

Total revenues

 

27,536

 

 

 

27,213

 

 

 

30,137

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

38,165

 

 

 

37,017

 

 

 

38,762

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross loss

 

(10,629

)

 

 

(9,804

)

 

 

(8,625

)

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

Research and development expense

 

5,182

 

 

 

5,216

 

 

 

6,610

 

Selling, general and administrative expense

 

7,471

 

 

 

8,965

 

 

 

16,692

 

Total operating expenses

 

12,653

 

 

 

14,181

 

 

 

23,302

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(23,282

)

 

 

(23,985

)

 

 

(31,927

)

 

 

 

 

 

 

 

 

 

 

 

 

Other (expense) income

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(2,951

)

 

 

(7,837

)

 

 

(8,243

)

(Loss)/Gain on exchange or conversion of debt

 

(4,933

)

 

 

(763

)

 

 

232

 

(Loss)/Gain on extinguishment of warrant liability

 

-

 

 

 

(918

)

 

 

1,775

 

Gain from change in fair value of 2020 Notes embedded derivative

 

1,751

 

 

 

-

 

 

 

-

 

Gain from change in fair value of derivative warrant liability

 

5,101

 

 

 

1,783

 

 

 

577

 

(Loss)/Gain from change in fair value of 2017 Notes

 

(339

)

 

 

(4,204

)

 

 

3,895

 

Loss on issuance of equity

 

-

 

 

 

(1,519

)

 

 

(2,523

)

Other income

 

23

 

 

 

215

 

 

 

20

 

Total other (expense) income

 

(1,348

)

 

 

(13,243

)

 

 

(4,267

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(24,630

)

 

$

(37,228

)

 

$

(36,194

)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share - basic and diluted

$

(1.51

)

 

$

(9.68

)

 

$

(51.61

)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding - basic and diluted

 

16,295,937

 

 

 

3,847,421

 

 

 

701,252

 

    

    

Year Ended December 31, 

    

Note

    

2023

    

2022

Total operating revenues

 

3, 23

$

17,200

$

1,175

Operating expenses:

 

  

 

  

 

  

Cost of production

 

16

 

11,991

 

8,698

Depreciation and amortization

 

11, 12

 

19,007

 

7,887

Research and development expense

 

16

 

6,637

 

7,427

General and administrative expense

42,628

39,941

Project development costs

 

16

 

14,732

 

10,061

Facility idling costs

 

 

4,040

 

4,599

Impairment loss

 

4

 

 

24,749

Loss on disposal of assets

 

11, 12

 

 

499

Total operating expenses

 

16

 

99,035

 

103,861

Loss from operations

 

 

(81,835)

 

(102,686)

Other income (expense)

 

  

 

  

 

  

Interest expense

 

  

 

(2,161)

 

(1,167)

Interest and investment income

 

6, 7, 20

 

19,090

 

3,481

Other income (expense), net

 

  

 

(1,309)

 

2,365

Total other income, net

 

  

 

15,620

 

4,679

Net loss

 

  

$

(66,215)

$

(98,007)

Net loss per share - basic and diluted

 

5

$

(0.28)

$

(0.44)

Weighted-average number of common shares outstanding - basic and diluted

 

5

 

238,687,621

 

221,537,262

See the accompanying Notes to the Consolidated Financial Statements.

58


Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITYCOMPREHENSIVE INCOME (LOSS)

(In thousands, except share amounts)in thousands)

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

Stockholders’

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity

 

BALANCE—December 31, 2014

 

332,094

 

 

$

3

 

 

$

350,259

 

 

$

(303,298

)

 

$

46,964

 

Shares issued upon reverse stock split

 

34

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of restricted stock

 

23,791

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock, net of issue costs and warrants

 

428,333

 

 

 

4

 

 

 

22,442

 

 

 

-

 

 

 

22,446

 

Cancellation of restricted stock

 

(37

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock for services, upon exercise of stock options and

   pursuant to an employee stock purchase plan

 

38

 

 

 

-

 

 

 

3

 

 

 

-

 

 

 

3

 

Non-cash stock-based compensation

 

-

 

 

 

-

 

 

 

2,647

 

 

 

-

 

 

 

2,647

 

Issuance of common stock upon exercise of warrants

 

232,205

 

 

 

2

 

 

 

10,164

 

 

 

-

 

 

 

10,166

 

Issuance of common stock upon conversion of debt

 

8,502

 

 

 

-

 

 

 

714

 

 

 

-

 

 

 

714

 

Issuance of common stock upon exchange of debt

 

55,392

 

 

 

1

 

 

 

1,579

 

 

 

-

 

 

 

1,580

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(36,194

)

 

 

(36,194

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE—December 31, 2015

 

1,080,352

 

 

$

10

 

 

$

387,808

 

 

$

(339,492

)

 

$

48,326

 

Shares issued upon reverse stock split

 

4

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock under stock plans, net

 

2,782

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Cancellation of restricted stock

 

(4

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock, net of issue costs & warrants

 

2,480,094

 

 

 

25

 

 

 

34,199

 

 

 

-

 

 

 

34,224

 

Non-cash stock-based compensation

 

-

 

 

 

-

 

 

 

886

 

 

 

-

 

 

 

886

 

Issuance of common stock upon exercise of warrants

 

2,559,218

 

 

 

26

 

 

 

12,272

 

 

 

-

 

 

 

12,298

 

Issuance of common stock upon exchange of debt

 

951,800

 

 

 

10

 

 

 

10,748

 

 

 

-

 

 

 

10,758

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(37,228

)

 

 

(37,228

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE—December 31, 2016

 

7,074,246

 

 

$

71

 

 

$

445,913

 

 

$

(376,720

)

 

$

69,264

 

Issuance of common stock under stock plans, net

 

3,000

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock, net of issue costs & warrants

 

5,680,000

 

 

 

56

 

 

 

6,339

 

 

 

-

 

 

 

6,395

 

Non-cash stock-based compensation

 

-

 

 

 

-

 

 

 

421

 

 

 

-

 

 

 

421

 

Issuance of common stock upon exercise of warrants

 

6,160,000

 

 

 

62

 

 

 

3,367

 

 

 

-

 

 

 

3,429

 

Issuance of common stock upon exchange of debt

 

2,893,813

 

 

 

29

 

 

 

8,623

 

 

 

-

 

 

 

8,652

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(24,630

)

 

 

(24,630

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BALANCE—December 31, 2017

 

21,811,059

 

 

$

218

 

 

$

464,663

 

 

$

(401,350

)

 

$

63,531

 

Year Ended December 31, 

    

Note

  

2023

    

2022

Net loss

    

  

$

(66,215)

$

(98,007)

Other comprehensive income (loss):

  

 

Unrealized gain (loss) on available-for-sale securities

6

 

1,040

 

(426)

Comprehensive loss

  

$

(65,175)

$

(98,433)

See the accompanying Notes to the Consolidated Financial Statements.

59


Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWSSTOCKHOLDERS’ EQUITY

(In thousands)  thousands, except share amounts)

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(24,630

)

 

$

(37,228

)

 

$

(36,194

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

(Gain) from the change in fair value of derivative warrant liability

 

(5,101

)

 

 

(1,783

)

 

 

(577

)

(Gain) from the change in fair value of the embedded derivative to the

   2020 Notes

 

(1,751

)

 

 

-

 

 

 

-

 

Loss from the change in fair value of 2017 Notes

 

339

 

 

 

4,204

 

 

 

(3,895

)

Loss/(Gain) on exchange or conversion of debt

 

4,933

 

 

 

763

 

 

 

(232

)

Loss/(Gain) on extinguishment of warrant liability

 

-

 

 

 

918

 

 

 

(1,775

)

Loss on issuance of equity

 

-

 

 

 

1,519

 

 

 

2,523

 

Stock-based compensation

 

421

 

 

 

886

 

 

 

2,647

 

Depreciation and amortization

 

6,641

 

 

 

6,747

 

 

 

6,573

 

Non-cash interest expense

 

962

 

 

 

3,977

 

 

 

3,772

 

Other non-cash expenses

 

-

 

 

 

(1

)

 

 

(7

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

68

 

 

 

269

 

 

 

970

 

Inventories

 

(904

)

 

 

29

 

 

 

805

 

Prepaid expenses and other current assets

 

137

 

 

 

(119

)

 

 

1

 

Accounts payable, accrued expenses, and long-term liabilities

 

(1,742

)

 

 

(697

)

 

 

(2,771

)

Net cash used in operating activities

 

(20,627

)

 

 

(20,516

)

 

 

(28,160

)

 

 

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

Acquisitions of property, plant and equipment

 

(1,906

)

 

 

(5,938

)

 

 

(1,464

)

Proceeds from sales tax refund for property, plant and equipment

 

-

 

 

 

-

 

 

 

144

 

Net cash used in investing activities

$

(1,906

)

 

$

(5,938

)

 

$

(1,320

)

Common Stock

Accumulated Other

Accumulated 

Stockholders’

    

Note

    

Shares

    

Amount

    

Paid-In Capital

    

Comprehensive Loss

    

Deficit

    

Equity

Balance, December 31, 2021

    

  

    

201,988,662

    

$

2,020

    

$

1,103,224

    

$

(614)

    

$

(557,375)

    

$

547,255

Issuance of common stock and common stock warrants, net of issuance costs

 

21

 

33,333,336

 

333

 

138,675

 

 

 

139,008

Issuance of common stock upon exercise of warrants

 

21

 

4,677

 

 

3

 

 

 

3

Non-cash stock-based compensation

 

16

 

 

 

17,419

 

 

 

17,419

Stock-based awards and related share issuances, net

 

21

 

1,839,950

 

19

 

206

 

 

 

225

Other comprehensive loss

 

  

 

 

 

 

(426)

 

 

(426)

Net loss

 

  

 

 

 

 

 

(98,007)

 

(98,007)

Balance, December 31, 2022

 

  

 

237,166,625

$

2,372

$

1,259,527

$

(1,040)

$

(655,382)

$

605,477

Non-cash stock-based compensation

 

16

 

 

 

17,087

 

 

 

17,087

Stock-based awards and related share issuances, net

 

21

 

3,333,208

 

33

 

(33)

 

 

 

Other comprehensive income

 

  

 

 

 

 

1,040

 

 

1,040

Net loss

 

  

 

 

 

 

 

(66,215)

 

(66,215)

Balance, December 31, 2023

 

  

 

240,499,833

$

2,405

$

1,276,581

$

$

(721,597)

$

557,389

See the accompanying Notes to the Consolidated Financial Statements.

60


Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS—(Continued)FLOWS

(In thousands)

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

Payments on secured debt

$

(9,791

)

 

$

(504

)

 

$

(318

)

Debt and equity offering costs

 

(1,095

)

 

 

(3,144

)

 

 

(3,519

)

Proceeds from issuance of common stock upon exercise of stock options

   and employee stock purchase plan

 

-

 

 

 

-

 

 

 

3

 

Proceeds from issuance of common stock and common stock warrants

 

11,044

 

 

 

28,661

 

 

 

33,820

 

Release of restricted cash held as collateral on 2017 notes

 

2,611

 

 

 

-

 

 

 

-

 

Proceeds from the exercise of warrants

 

3,429

 

 

 

12,298

 

 

 

10,166

 

Net cash provided by financing activities

 

6,198

 

 

 

37,311

 

 

 

40,152

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

(16,335

)

 

 

10,857

 

 

 

10,672

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Beginning of year

 

27,888

 

 

 

17,031

 

 

 

6,359

 

Ending of year

$

11,553

 

 

$

27,888

 

 

$

17,031

 

Year Ended December 31, 

    

Note

2023

    

2022

Operating Activities

    

  

  

    

  

Net loss

 

  

$

(66,215)

$

(98,007)

Adjustments to reconcile net loss to net cash used in operating activities:

 

  

 

  

 

  

Impairment loss

 

4

 

 

24,749

Loss on disposal of assets

 

23

 

 

499

Stock-based compensation

 

16

 

17,087

 

17,419

Depreciation and amortization

 

11, 12

 

19,007

 

7,887

Amortization of marketable securities (discount) premium

 

6

 

(102)

 

2,723

Other noncash expense (income)

 

  

 

908

 

877

Changes in operating assets and liabilities:

 

  

 

Accounts receivable

 

  

 

(2,147)

 

502

Inventories

 

10

 

670

 

(2,004)

Prepaid expenses and other current assets, deposits and other assets

 

8, 13

 

(25,620)

 

(2,591)

Accounts payable, accrued expenses and non-current liabilities

 

14

 

2,693

 

3,635

Net cash used in operating activities

 

  

 

(53,719)

 

(44,311)

Investing Activities

 

  

 

  

 

  

Acquisitions of property, plant and equipment

 

11, 23

 

(54,455)

 

(84,077)

Acquisition of patent portfolio

 

12

 

 

(10)

Proceeds from maturity of marketable securities

 

6

 

168,550

 

299,581

Purchase of marketable securities

 

6

 

 

(130,402)

Proceeds from sale of property, plant and equipment

11

34

Net cash provided by investing activities

 

  

 

114,129

 

85,092

Financing Activities

 

  

 

  

 

  

Debt and equity offering costs

 

21

 

 

(10,993)

Proceeds from issuance of common stock and common stock warrants

 

21

 

 

150,000

Proceeds from exercise of warrants

 

21

 

 

3

Net settlement of common stock under stock plans

 

16

 

 

(286)

Payment of loans payable

 

15

 

(167)

 

(150)

Payment of finance lease liabilities

 

9

 

(22)

 

(12)

Net cash (used in) provided by financing activities

 

  

 

(189)

 

138,562

Net increase in cash and cash equivalents

 

  

 

60,221

 

179,343

Cash, cash equivalents and restricted cash at beginning of period

 

  

 

315,376

 

136,033

Cash, cash equivalents and restricted cash at end of period

 

  

$

375,597

$

315,376

See the accompanying Notes to the Consolidated Financial Statements.

61


Table of Contents

GEVO, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS—(Continued)

(In thousands)

Supplemental disclosures of cash and non-cash investing

Year Ended December 31,

 

and financing transactions

2017

 

 

2016

 

 

2015

 

Conversion and exchanges of convertible debt for common stock

$

8,652

 

 

$

10,758

 

 

$

2,294

 

Cash paid for interest

 

2,554

 

 

 

3,694

 

 

 

4,642

 

Non-cash purchase of property, plant and equipment

 

27

 

 

 

513

 

 

 

890

 

Discount due to exchange of 2017 Notes for 2020 Notes

 

3,009

 

 

 

-

 

 

 

-

 

Fair value of 2020 Notes embedded derivative upon exchange

 

6,975

 

 

 

-

 

 

 

-

 

Accrued offering costs

 

-

 

 

 

-

 

 

 

648

 

Fair value of warrants at issuance and upon exercise, net

 

(4,353

)

 

 

6,668

 

 

 

(7,951

)

Year Ended December 31, 

Schedule of cash, cash equivalents and restricted cash

2023

    

2022

Cash and cash equivalents

$

298,349

$

237,125

Restricted cash (current)

 

77,248

 

1,032

Restricted cash (non-current)

 

 

77,219

Total cash, cash equivalents and restricted cash

$

375,597

$

315,376

Year Ended December 31, 

Supplemental disclosures of cash and non-cash investing and financing transactions

2023

    

2022

Cash paid for interest, net of amounts capitalized

$

1,029

$

522

Non-cash purchase of property, plant and equipment

 

8,174

 

13,837

Right-of-use asset purchased with operating lease

 

199

 

See the accompanying Notes to the Consolidated Financial Statements.

62

Table of Contents

77


GEVO, INC.

Notes to Consolidated Financial Statements

1. Nature of Business, and Financial Condition and Basis of Presentation

Nature of Business. business. Gevo, Inc. (Nasdaq: GEVO) (“Gevo”, “we”, “us”, “our”, or the “Company,” which, unless otherwise indicated, refers to Gevo, Inc. and its subsidiaries), a Delaware corporation founded in 2005, is a renewable chemicals and next generation biofuelsgrowth-oriented, carbon abatement company focused onwith the development and commercializationmission of alternativessolving greenhouse gas (“GHG”) emissions for those sectors of the transportation industry that are not amenable to petroleum-based products using isobutanol produced from renewable feedstocks. Gevo was incorporated in Delaware on June 9, 2005. Gevo formed Gevo Development, LLC (“Gevo Development”) in September 2009 to finance and develop biorefineries through joint venture, licensing arrangements, tolling arrangementselectrification or direct acquisition (see Note 8 Gevo Development). Gevo Development became a wholly-owned subsidiary of Gevo in September 2010. Gevo Development purchased Agri-Energy, LLC (“Agri-Energy”) in September 2010.hydrogen.

The Company is focused on transforming renewable energy into energy-dense liquid drop-in hydrocarbons that can be used as renewable fuels, such as sustainable aviation fuel (“SAF”) and other fuels and chemicals, with the potential to achieve a “net-zero” GHG, or even carbon negative footprint measured by the Argonne National Laboratory’s GREET (Greenhouse gases, Regulated Emissions, and Energy use in Transportation) model (the “GREET Model”) to measure, predict and verify GHG emissions across the life-cycle. Our “net-zero” concept means production of drop-in hydrocarbon fuels by using sustainably grown feedstocks (e.g., low till, no-till and dry corn cultivation), renewable and substantially decarbonized energy sources, resulting in a net-zero carbon footprint from the full life cycle of the fuel measured from the capture of renewable carbon through the burning of the fuel.

Gevo’s primary market focus, given current demand and growing customer interest, is SAF. The Company believes that SAF from carbohydrates to alcohol is the most economically viable approach for carbon abatement. The Company also has commercial opportunities for other renewable hydrocarbon products, such as (i) renewable natural gas, also known as biogas (“RNG”), (ii) hydrocarbons for gasoline blendstocks and diesel fuel, and (iii) plastics, materials and other chemicals. We are engaged in technology, process and intellectual property development targeted to large scale deployment of net-zero hydrocarbon fuels and chemicals. We are developing the marketplace and customers for SAF and other related products. We also are engaged as a developer and enabler/licensor for large scale commercial production, and we expect to be a co-investor on certain projects. Gevo’s business model is that of a developer of projects, a licensor, process technology developer, and operator of certain assets in the future.

Net-Zero Projects

In early 2021, we announced our proprietary “Net-Zero Projects” that we developed and engineered as a series of planned facilities to produce energy dense liquid hydrocarbons using renewable energy and our proprietary technologytechnology. Our Net-Zero Projects will convert renewable energy (e.g., photosynthetic, wind, RNG) from a variety of sources into energy dense liquid hydrocarbons that, uses a combinationwhen burned in traditional engines, has the potential to achieve net-zero GHG emissions across the whole lifecycle of synthetic biology, metabolic engineering, chemistry and chemical engineeringthe liquid fuel: from the way carbon is captured from the atmosphere, processed to make isobutanolliquid fuel products, and burned as a fuel for planes, cars, trucks, and ships. Gevo has engineered, developed, and owns our Net-Zero plant designs, and the overall Gevo Net-Zero process (i.e., the process to enable carbon-negative olefins, and hydrocarbon fuels with an anticipated net-zero or better carbon footprint measured across the lifecycle of the whole processes). The proprietary Gevo Net-Zero processes and plant designs are based upon the conversion of carbohydrates to alcohols, then the conversion of the alcohols to olefins (i.e., building blocks for chemicals, plastics, and fuels), and then the conversion of the olefins into fuels, all optimized and integrated to achieve a net-zero carbon footprint. In the fermentation section of our plant design, we work with Fluid Quip Technologies, LLC and PRAJ Industries Limited (“PRAJ”), as well as other suppliers of unit operations, and using Axens North America, Inc. (“Axens”) as the unit operation technology supplier for producing olefins and fuels. Gevo has developed and owns the overall proprietary plant designs, engineering details, integration technologies, and has filed patents on several process improvements.

In November 2021, Gevo entered into an agreement to exclusively utilize Axens’ technology for isobutanol conversion into hydrocarbons. In February of 2022, Gevo and Axens entered into a second exclusive agreement to specifically cover the process steps for ethanol to finished jet fuel.

63

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Our initial Net-Zero Project, Net-Zero 1 (“NZ1”), is expected to be located in Lake Preston, South Dakota, and is being currently designed to produce approximately 65 million gallons per year (“MGPY”) of total hydrocarbon volumes, including 60 MGPY of SAF. Along with the hydrocarbons, NZ1 is being currently designed to produce approximately 1,390 million pounds per year of high-value protein products from isobutanol that can displace petrochemical incumbent products. The Company has been able to genetically engineer yeast, whereby the yeast produces isobutanol from carbohydrates. Through May 2012, Agri-Energy was engagedfor use in the food chain and more than 34 million pounds per year of corn oil. Our products will be produced in three steps; the first step is milling the corn and the production of protein, oil, and carbohydrates, the second step produces alcohols using fermentation and the third step is the conversion of the alcohols into hydrocarbons.

We also are developing other commercial production projects for SAF at other locations in the United States where we expect to use our Net-Zero plant designs based on work done for NZ1 at Lake Preston. Gevo expects to play the role of project developer, plant design and technology licensor, and investor, based on traditional developer business models where the developer gets a partial ownership stake for developing the project. We may also co-invest in projects to increase our equity ownership in those projects.

Renewable Natural Gas Project

Gevo’s RNG facilities in Northwest Iowa (“NW Iowa RNG”) are owned by Gevo NW Iowa RNG, LLC, and produces RNG captured from dairy cow manure supplied by three local dairies. Animal manure can be digested anaerobically to produce biogas, which is then upgraded to pipeline quality gas referred to as RNG. The original design capacity for this project was 355,000 MMBtu. Gevo NW Iowa RNG, LLC sells the produced RNG to the California market through an agreement with BP Canada Energy Marketing Corp. and BP Products North America Inc. (collectively, “BP”). In addition, NW Iowa RNG generates and sells Low Carbon Fuel Standard (“LCFS”) credits as well as D3 Renewable Identification Numbers (“RINs”) through the production of producing and selling ethanol and related products produced at its production facility locatedRNG (collectively, “environmental attributes”).

Luverne Facility

Gevo’s development plant in Luverne, Minnesota (the “Luverne Facility”). The Company commenced, recorded in the retrofitAgri-Energy segment, was originally constructed in 1998 and is located on approximately 55 acres of land, which contains approximately 50,000 square feet of building space. Gevo may use the Luverne Facility in 2011the future to prove our processes, process concepts, unit operations and commenced initial startup operations for other purposes in order to optimize feedstocks and the commercial production of isobutanol at this facility in May 2012.  In September 2012,processes used for producing hydrocarbons from alcohols. Currently, the Company made the strategic decision to pause isobutanol productionactivities at the Luverne Facility are minimized to focus on optimizing specific parts of the process to further enhance isobutanol production rates.  care and maintenance, market development, and customer education.

In 2013, theFinancial Condition. The Company modified the Luverne Facility in order to (i) significantly reduce previously identified infections, (ii) demonstrate that its biocatalyst performs in the one million liter fermenters at the Luverne Facility,has incurred consolidated net losses since inception and (iii) confirm GIFT efficacy at commercial scale at the Luverne Facility.  

In 2014, the Company further reconfigured the Luverne Facility to enable the co-production of both isobutanol and ethanol, leveraging the flexibility of its GIFT™ technology, with one fermenter utilized for isobutanol production and three fermenters utilized for ethanol production. In line with the Company’s strategy to maximize asset utilization and site cash flows, the Company believes that this configuration of the Luverne Facility should allow it to continue to optimize its isobutanol technology athad a commercial scale, while taking advantage of potentially superior ethanol contribution margins. As a result, during certain periods the Company may only produce ethanol at the Luverne Facility. In addition, the condition of two of the Luverne Facility’s oldest fermentation vessels may limit the Company’s ability to co-produce isobutanol and ethanol. Therefore, the Company expects to focus on the production of ethanol and produce limited volumes of isobutanol until one or both of these fermentation vessels have been repaired or replaced.

The Company’s technology converts its renewable isobutanol to alcohol-to-jet (“ATJ”), isooctane, isooctene, and para-xylene (building block for polyester) at its hydrocarbons demonstration plant located at South Hampton Resources located in Silsbee, TX. In addition the Company’s Luverne Facility has production capacity of about 20 MGPY of ethanol, 45-50 kilotons (“KT”) of animal feed, and 3 million pounds of corn oil.

Assignificant accumulated deficit as of December 31, 2017, the Company continues to engage in research and development, business development, business and financial planning, optimizing operations for isobutanol, hydrocarbon and ethanol production and raise capital to fund future expansion of its Luverne Facility for increased isobutanol and hydrocarbon production. Ultimately, the Company believes that the attainment of profitable operations is dependent upon future events, including (i) completing its development activities resulting in commercial production and sales of isobutanol or isobutanol-derived products and/or technology, (ii) obtaining adequate financing to complete its development activities, (iii) obtaining adequate financing to build out further isobutanol and hydrocarbon production capacity, (iv) gaining market acceptance and demand for its products and services, and (v) attracting and retaining qualified personnel.

Financial Condition. For the twelve months ended December 31, 2017 and 2016, the Company incurred a consolidated net loss of $24.6 million and $37.2 million, respectively, and had an accumulated deficit of $401.4 million at December 31, 2017.2023. The Company’s cash and cash equivalents attotaled $298.3 million, and short-term restricted cash totaled $77.2 million as of December 31, 2017 totaled $11.6  million and are expected to be used for the following purposes: (i) operating activities of the Luverne Facility; (ii) operating activities at the Company’s corporate headquarters in Colorado, including research and development work; (iii) capital improvements primarily associated with the Luverne Facility; (iv) costs associated with optimizing isobutanol production technology; (v) exploration of strategic alternatives and new financings; and (vi) debt service  and repayment obligations.

The Company expects to incur future net losses as it continues to fund the development and commercialization of its product candidates. To date, the Company has financed its operations primarily with proceeds from multiple sales of equity and debt securities, borrowings under debt facilities and product sales. The Company’s transition to profitability is dependent upon, among other things, the successful development and commercialization of its product candidates and the achievement of a level of revenues adequate to support the Company’s cost structure. The Company may never achieve profitability or positive cash flows, and unless

78


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

and until it does, the Company will continue to need to raise additional cash. Management intends to fund future operations through additional private and/or public offerings of debt or equity securities.  In addition, the Company may seek additional capital through arrangements with strategic partners or from other sources, it may seek to restructure its debt and it will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds, or achieve or sustain profitability or positive cash flows from operations. Existing working capital was not sufficient to meet the cash requirements to fund planned operations through the period that is one year after the date the Company’s audited 2017 year-end financial statements were issued.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s inability to continue as a going concern may potentially affect the Company’s rights and obligations under its senior secured debt and issued and outstanding convertible notes. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include adjustments that might result from the outcome of this uncertainty. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of liabilities in the normal course of business.

Reverse Stock Split. On December 21, 2016, the Board of Directors approved an amendment to its Amended and Restated Certificate of Incorporation to effect a one-for-twenty reverse stock split of the Company’s common stock, par value $0.01 per share. The reverse stock split became effective January 5, 2017. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted retroactively to reflect this reverse stock split.

NASDAQ Market Price Compliance. On June 21, 2017, the Company received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market, notifying us that, for the prior 30 consecutive business days, the closing bid price of our common stock was not maintained at the minimum required closing bid price of at least $1.00 per share as required for continued listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, the Company had an initial compliance period of 180 calendar days, to regain compliance with this requirement. On December 20, 2017, the Nasdaq Stock Market granted us an additional 180 calendar days, or until June 18, 2018, to regain compliance. To regain compliance, the closing bid price of our common stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before June 18, 2018. The Nasdaq determination to grant the second compliance period was based on our meeting of the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

2023.

2. Summary of Significant Accounting Policies

Principles of Consolidation. The consolidated financial statementsConsolidated Financial Statements of Gevo include the accounts of its wholly-ownedwholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Basis of Presentation. The consolidated financial statementsConsolidated Financial Statements of the Company (which include the accounts of its wholly-owned subsidiaries Gevo DevelopmentAsset, LLC, Gevo RNG Holdco, LLC, Gevo NW Iowa RNG, LLC, Gevo Net-Zero HoldCo, LLC, Gevo Net-Zero 1, LLC, Gevo Net-Zero Operations, LLC, Gevo Net-Zero Asset Management, LLC, and Agri-Energy, LLC) have been prepared pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) and accounting principles generally accepted in the U.S. (“U.S. GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company at December 31, 20172023.

64

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Reclassifications. The Company reclassified certain prior period amounts to conform to the current period presentation. The reclassifications included the categorization of depreciation and amortization on the Consolidated Statements of Operations and had no impact on total revenues, total operating expenses, net loss or stockholders’ equity for any period.

Use of Estimates. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”)U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Concentrations of Credit Risk and Major Customers. The Company’s financial instruments that are exposed to concentrations of credit risk consist of cash and cash equivalents in excess of the federally insured limits. The Company’s cash and cash equivalents are deposited with high credit-quality financial institutions and are primarily in demand deposit accounts.accounts and money market funds. As of December 31, 2023, and 2022, one customer accounted for 100% of trade accounts receivable, net, and 90% and 73% of total revenue, respectively.

Cash, and Cash Equivalents and Restricted Cash. The Company maintains its cash and cash equivalents in highly liquid interest bearinginterest-bearing money market accounts or non-interest bearingnon-interest-bearing demand accounts. The Company considers all highly liquid investments purchased with a maturity of three months or less at the date of acquisition to be cash equivalents. Restricted cash is classified as current or non-current based on the terms of the underlying agreements and represents cash held as deposits and cash collateral for financial letters of credit.

Marketable Securities. The Company’s marketable securities consist of marketable debt securities and have been classified and accounted for as available-for-sale. Management determines the appropriate classification of its investments at the time of purchase and reevaluates the classifications at each balance sheet date. The Company classifies its marketable securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Marketable securities with maturities of 12 months or less are classified as short-term and marketable securities with maturities greater than 12 months are classified as long-term. The Company’s marketable securities are carried at fair value, with unrealized gains and losses, net of taxes, reported as a component of accumulated other comprehensive loss in shareholders’ equity, with the exception of unrealized losses believed to be other-than-temporary, which are reported in earnings in the current period.

Trade Accounts Receivable, net. The Company records receivables for products shipped and services provided but for which payment has not yet been received. As of December 31, 2017 and 2016, noIn evaluating its allowance for doubtful accounts has been recorded, based uponfor accounts receivable, the Company performs ongoing reviews of its outstanding receivables to determine if any amounts are uncollectible and adjusts the allowance for doubtful accounts accordingly.

79


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

expected full collection of the accounts receivable. As of December 31, 2017 and 2016, one customer, C&N Ethanol Marketing, LLC comprised 78% and 53%, respectively, of our outstanding trade accounts receivable.

Inventories. Inventory is recorded at net realizable value per ASU 2015-11value. Isobutanol and cost of goods sold is determined by average cost method. Ethanol and isobutanolethanol inventory cost consists of the applicable share of raw material, direct labor and manufacturing overhead costs.overhead. Work in process inventory includes unfinished SAF, isooctane and isooctene inventory. Spare Parts inventory consists of the parts required to maintain and operate the Company’s Luverne Facility and is recorded at cost.


 

Derivative Instruments. For each reporting period, the Company reviews the value of inventories on hand to estimate the recoverability through future sales. The Company evaluatesreduces its contractsinventories with adjustments for potential derivatives which Gevo, Inc. useslower of cost or net realizable value, with cost determined by the average cost method.

65

Table of Contents

GEVO, INC.

Notes to raise capital. See Note 6Consolidated Financial Statements (Continued)

Environmental Attribute Inventory. The Company generates D3 Renewable Identification Numbers (“RINs”) and Low Carbon Fuel Standard (“LCFS”) credits (collectively, “environmental attributes”) through the production of RNG used for transportation purposes as prescribed under the Renewable Fuels Standard program (“RFS”). Environmental attribute inventory is included as a descriptioncomponent of “Inventories” on the Consolidated Balance Sheets. The Company considers environmental attributes to be a distinguishable product that is generated as an integral component of the Company’s accounting for embedded derivativesproduction process of RNG as the environmental attributes that are generated can be separated from the underlying commodity and Note 7 formay be sold independently from the RNG produced. As such, the Company considers environmental attributes to be a descriptionco-product of the Company’s derivative warrant liability. At issuance date, derivative warrant liabilities are initially recognized as a liability with a corresponding reduction in stockholders’ equity. Changes inproduction of RNG and accordingly allocates the estimated faircosts of production based on the relative sales value of all revenue items for the NW Iowa RNG operations. The value of the derivative warrant liability between issuance date and exercise/expiration date represents an unrealized (gain)/loss andenvironmental attributes is reviewed for potential write-downs based on the net realizable value methodology. Revenue is recognized on these environmental attributes when there is an agreement in place to monetize the credits at an agreed upon price with a customer based upon defined third party market prices and recorded in the Consolidated Statementa transfer of Operations.  The fair value of the derivative warrant liability is ultimately either re-classed into equity upon either exercise or, if expired, a realized (gain)/loss is recognized and recorded in the Consolidated Statement of Operation.control has occurred.

As of December 31, 2017 and 2016, the Company did not have any forward purchase contracts or exchange-traded futures contracts.

Property, Plant and Equipment. Property, plant and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the assets’ estimated useful lives. Leasehold improvements are amortized over the term of the lease agreement or the service lives of the improvements, whichever is shorter. Assets under construction are depreciated when they are placed into service. Maintenance and repairs are charged to expense as incurred and expenditures for major improvements are capitalized.

Impairment of Property, PlantConstruction in Progress. Construction in progress represents expenditures necessary to bring an asset, project, new facilities or equipment to the condition and Equipment. The Company’slocation necessary for its intended use and are capitalized and recorded at cost. Once completed and ready for its intended use, the asset is transferred to property, plant and equipment consist primarilyto be depreciated or amortized.

Depreciation and Amortization. Capitalized costs are depreciated or amortized using the straight-line method at rates sufficient to depreciate such costs over the shorter of estimated productive lives of such assets associated withor the acquisition and retrofituseful life of the Luverne Facility.individual assets. The estimates of productive lives may change, possibly in the near term, resulting in changes to depreciation and amortization rates in future reporting periods.

Impairment of Long-Lived Assets. The Company assesses impairmentevaluates the recoverability of the recorded amount of long-lived assets, including property, plant and equipment, for recoverabilitylicenses, patents, operating lease right-of-use assets, and finance lease right-of-use assets when events or changes in circumstances indicate that their carrying amount may not be recoverable. Circumstances which could trigger a review include, but are not limited to: significant decreases in the market price of the asset; significant adverse changes in the business climate, or legal or regulatory factors; accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset; or expectations that the asset will more likely than not be sold or disposed of significantly before the end of its estimated useful life. The carrying amount of a long-lived asset is considered to be impaired if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the assets.

The If the Company evaluated its Luverne Facility fordetermines that an asset is impaired, it measures the impairment to be recognized as of December 31, 2017 and 2016. These evaluations included comparing the carryingamount by which the recorded amount of the acquisitionasset exceeds its fair value. A summary of impairment losses on tangible and retrofitintangible assets for the years ended December 31, 2023, and 2022, is included in Note 4, Asset Impairment.

Leases, Right-of-Use Assets and Related Liabilities. The Company enters into various arrangements which constitute a lease as defined by Accounting Standards Codification (“ASC”) 842, Leases, as part of its ongoing business activities and operations. Leases represent a contract or part of a contract that conveys the right to control the use of identified property, plant or equipment (an identified asset) for a period of time in exchange for consideration. Such contracts result in both (a) right-of-use assets, which represent the Company’s right to use an underlying asset for the term of the Luverne Facility to the estimated undiscounted future cash flows at the Luverne Facility as thiscontract; and (b) a corresponding lease liability which represents the lowest levelCompany’s obligation to make the lease payments arising from the contract. The Company has elected not to recognize a right-of-use asset and lease liability for any lease with an original lease term of identifiable cash flows. Significant assumptions included in12 months or less. Lease expense for such leases is recognized on a straight-line basis over the estimated undiscounted future cash flows include, among others, estimates of the:lease term.

sales price of isobutanol, hydrocarbons, ethanol and by-products such as dried distiller’s grains;66

purchase price of corn;

capital and operating costs to produce isobutanol; and

estimated useful life of the primary asset.

Factors which can impact these assumptions include, but are not limited to;

effectiveness of the Company’s technology to produce isobutanol at targeted margins;

demand for isobutanol and oil prices; and

harvest levels of corn.

80


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

A lease is classified as a finance lease when one or more of the following criteria are met: (i) the lease transfers ownership of the asset by the end of the lease term, (ii) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (iii) the lease term is for a major part of the remaining useful life of the asset, (iv) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset, or (v) the asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term. If a lease does not meet any of these criteria, the lease is classified as an operating lease.

Based uponLease liabilities are initially measured at the lease commencement date based on the present value of lease payments over the lease term, discounted using an estimate of the Company’s evaluationincremental borrowing rate for a collateralized loan with the same term and payment as the lease. Right-of-use assets are measured based on the amount of the lease liability adjusted for any lease payments made to the lessor at December 31, 2017or before the lease commencement date less any lease incentives received. All right-of-use assets are evaluated for impairment in accordance with accounting standards applicable to long-lived assets.

Renewal options are included in the calculation of our right-of-use assets and 2016,lease liabilities when the Company concludeddetermines that the estimated undiscounted future cash flowsoption is reasonably certain of exercise based on an analysis of the relevant facts and circumstances. Certain of the Company’s leases require variable lease payments that do not depend on an index or rate and such payments are excluded from the Luverne Facility exceededcalculation of the right-of-use asset and lease liability and are recognized as variable lease cost when incurred.

Lease cost for operating leases consists of the fixed lease payments recognized on a straight-line basis over the lease term plus variable lease payments as incurred. Lease cost for finance leases consists of amortization of the right-of-use assets on a straight-line basis over the lease term, interest expense on the lease liability and variable lease payments as incurred.

The Company has elected the practical expedient to account for the lease and non-lease components as a single lease component for its corporate office lease asset class.

Intangible assets. Intangible assets consist of patents. Costs related to patents, including legal fees, are capitalized and amortized over the estimated useful lives using the straight-line method. Amortization expense is recorded in “Depreciation and amortization” in the Operating expenses section of the Consolidated Statements of Operations. For patents purchased in an asset acquisition, the useful life is determined by valuation estimates of remaining economic life. The patents are included in “Intangible assets, net” on the Consolidated Balance Sheets. The Company periodically evaluates the amortization period and carrying value and, as such, these assets were not impaired. Although the Company’s cash flow forecasts are based on assumptionsof its patents to determine whether any events or circumstances warrant revised estimated useful life or reduction in value.

Borrowing Costs. The borrowing costs that are consistent withdirectly attributable to the acquisition and construction of an asset that needs a substantially long period of time for its plannedintended use to begin are capitalized and recorded as part of the assets, these estimates required significant exercisecost of judgmentthe asset when expenditures for the asset and are subject to change in future reporting periods as factsborrowing costs have been incurred, and circumstances change. Additionally, the Company may make changes to its business plan that could result in changesactivities relating to the expected cash flows. As a result, itacquisition and construction that are necessary to prepare the asset for its intended use have commenced. The capitalization of borrowing costs ceases when the asset under acquisition or construction becomes ready for its intended use and the borrowing costs incurred thereafter are recognized in profit or loss for the current period. The capitalization of borrowing costs is possible that a long-livedsuspended during periods in which the acquisition or construction of an asset may be impaired in future reporting periods.is interrupted abnormally and the interruption lasts for more than three months, until the acquisition or construction is resumed.

Debt IssueIssuance Costs and Debt Discounts/Premiums. Debt issueissuance costs are costs with third parties incurred in connection with the Company’s debt financings that have been capitalized and are being amortized over the stated maturity period or estimated life of the related debt using the effective interest method. Debt issuance costs are presented as a direct reduction of the carrying amount of the related debt. Debt discounts, including fees paid to lenders, and debt premiums are amortized over the life of the related debt using the effective interest method. Debt discounts and premiums are presented as a reduction and increase, respectively, in the carrying amount of the related debt. Amortization of debt issuance costs, discounts and premiums is included in interest expense.

67

Table of Contents

Revenue Recognition.GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Warrants. Warrants are classified as a component of permanent equity when they are freestanding financial instruments that are legally detachable and separately exercisable from the shares of common stock with which they were issued, are immediately exercisable, do not embody an obligation for the Company to repurchase its shares, permit the holders to receive a fixed number of shares of common stock upon exercise and do not provide any guarantee of value or return.

Variable Interest Entities. The Company records revenueenters into agreements with special purpose entities (“SPEs”), some of which are variable interest entities (“VIEs”), in the ordinary course of business. A legal entity is considered a VIE if it has either a total equity investment that is insufficient to finance its operations without additional subordinated financial support or whose equity holders lack the characteristics of a controlling financial interest. The Company’s variable interests arise from contractual or other monetary interests in the saleentity. The typical condition for a controlling financial interest ownership is holding a majority of hydrocarbon products, ethanolthe voting interests of an entity; however, a controlling financial interest may also exist in entities, such as VIEs, through arrangements that do not involve controlling voting interests.

The Company consolidates a VIE if it is deemed to be the primary beneficiary. The Company determines it is the primary beneficiary if it has the power to direct the activities that most significantly impact the VIEs’ economic performance and related products, includinghas the saleobligation to absorb losses or has the right to receive benefits of corn inventory.the VIE that could potentially be significant to the VIE. The Company evaluates its relationships with its VIEs on an ongoing basis to determine whether it is the primary beneficiary. See Footnote 22 below for further information.

Revenue Recognition. The Company recognizes revenue when all ofin accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). Revenue from the following criteria are satisfied: persuasive evidence of an arrangement exists; risk of loss and title transfer to the customer; the priceCompany’s point in time product sales is fixed or determinable; and collectability is reasonably assured.

Ethanol and related products as well as hydrocarbonrecognized when products are generally shipped free on board shipping point. Collectability of revenue is reasonably assured based on historical evidence of collectability betweentransferred, or services are invoiced and control transferred. The Company has presented the Companydisclosures required by ASC 606, see Note 3, Revenues from contracts with customers and its customers. In accordance with the Company’s agreements for the marketing and sale of ethanol and related products, commissions due to marketers were deducted from the gross sales price at the time payment was remitted. Ethanol and related products sales were recorded net of commissions and shipping and handling costs.other revenues.

Revenue related to government research grants and cooperative agreements is recognized in the period during which the related costs are incurred, provided that the conditions under the awards have been met and only perfunctory obligations are outstanding. Revenues related to the lease agreements are recognized on a straight-line basis over the term of the contract.

In 2017, 2016 and 2015, C&N Ethanol Marketing, LLC accounted for approximately 76%, 71% and 71% of our consolidated revenue, respectively.  In the same years, Land O’Lakes Purina Feed LLC accounted for approximately 17%, 17% and 19% of our consolidated revenue, respectively. Both are customers of our Gevo Development/Agri-Energy segment (see Note 17). Given the production capacity compared to the overall size of the North American market and the demand for our products, the Company does not believe that a decline in a specific customer's purchases would have a material adverse long-term effect upon our financial results.

Cost of Goods SoldProduction. Cost of goods soldproduction includes costs incurred in conjunction with the operations for the production of RNG and isobutanol, at the Luverne Facility and costs directly associated with the ethanol and related products production process suchas well as costs for direct materials, direct labor and certain plant overhead costs. Costs associated with the operations for the production of isobutanol includes costs, for direct materials, direct labor,and plant utilities including natural gas and plant depreciation.wind power. Direct materials consist of dextrose for initial production of isobutanol, corn feedstock, manure feedstock, denaturant, and process chemicals. Direct labor includes compensation of personnel directly involved in production operations at the Luverne Facility. Costs of direct materials for the production of ethanol and related products consist of corn feedstock, denaturant and process chemicals. Direct labor includes compensation of personnel directly involved in the operation of the Luverne Facility.operations. Plant overhead costs primarily consist of plant utilities and plant depreciation. Cost of goods sold is mainly affected by the cost of corn and natural gas. Corn is the most significant raw material cost.utilities. The Company purchases natural gas and wind power to power steam generation in the production process and to dry the distiller’sdistillers grains, a by-product of ethanol and related products production.

Patents. All costs related to filing and pursuing patent applications are expensed as incurred as recoverability of such expenditures is uncertain. Patent-related legal expenses incurred are recorded as selling, general and administrative expense, and during the years ended December 31, 2017, 2016 and 2015 were $0.3 million, $0.2 million, and $0.9 million, respectively.

Research and Development. Research and development costs are expensed as incurred and are recorded as research and development expense in the Consolidated Statement of Operations.incurred. The Company’s research and development costs consist of expenses incurred to identify, develop, and test its technologies for the production of isobutanol and the development of downstream applications thereof. Research and development expense includes personnel costs (including stock-based compensation), consultants and related contract research, facility costs, supplies, depreciation on property, plant and equipment used in development, license fees and milestone payments paid to third parties for use of their intellectual property and patent rights and other direct and allocated expenses incurred to support the Company’s overall research and development programs.

81General and Administrative. General and administrative expenses are expensed as incurred. The Company’s general and administrative costs consist of personnel costs (including stock-based compensation), consulting and service provider expenses (including patent counsel-related costs), legal fees, marketing costs, insurance costs, occupancy-related costs, travel and relocation expenses and hiring expenses. Our corporate personnel, consisting of subject matter experts, including chemists, engineers, and sustainability experts, dedicate the majority of their time and efforts for the development of our projects. Costs incurred have not yet been allocated to the specific projects on the face of our financial statements.


Project Development Costs. Project development costs consist of consulting, preliminary engineering costs, and personnel costs, including stock-based compensation.

68

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Income Taxes. Deferred tax assets and liabilities are recognized based on the difference between the carrying amounts of assets and liabilities in the financial statements and their respective tax bases. Deferred tax assets and liabilities are measured using currently enacted tax rates in effect in the years in which those temporary differences are expected to reverse. Deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. At December 31, 2017 and 2016, based upon current facts and circumstances, the Company had recorded a valuation allowance against its deferred tax assets of $107.4 million and $139.3 million, respectively.

Stock-Based Compensation. The Company’s stock-based compensation expense includes expenses associated with share-based awards granted to employees and board members,members. Our stock-based compensation is classified as either an equity award or a liability award in accordance with U.S. GAAP. The fair value of an equity-classified award is determined at the grant date and expenses associated with awards under its employee stock purchase plan (“ESPP”). Stock-based compensation expense for all share-based payment awards granted is amortized on a straight-line basis over the requisite service period. The fair value of a liability-classified award is determined on a quarterly basis through the final vesting date and is amortized based on the grant datecurrent fair value. value of the award and the percentage of vesting period incurred to date.

The grant date fair value for stock option awards is estimated using the Black-Scholes option pricing model and the grant date fair value for restricted stock awards is based upon the closing price of the Company’s common stock on the date of grant. The Company recognizes compensation costs for share-based payment awards granted to employees net of estimatedactual forfeitures and recognizes stock-based compensation expense for only those awards expected to vest on a straight-line basis over the requisite service period of the award, which is currently the vesting term of up to four years. For performance basedthree years.

The Company accounts for stock-based employee compensation plans under the fair value recognition and measurement provisions in accordance with applicable accounting standards, which require all stock-based payments to employees, including grants of stock options and restricted stock awards, to be measured based on the grant date fair value of the awards, with the resulting expense generally recognized on a straight-line basis over the period during which the employee is required to perform service in exchange for the award.

Stock-based compensation expenses related to restricted stock awards and stock options are recorded net of actual forfeitures in our Consolidated Statements of Operations.

Liability awards are subject to variable accounting treatment, such that they are remeasured at fair value each reporting period through the Consolidated Statements of Operations. Any impact of forfeitures is based on actual forfeitures, although not affecting the fair value measurement of the awards, and are reflected at that time as well.

Income Taxes. In preparing the Consolidated Financial Statements, the Company recognizesestimates the actual amount of taxes currently payable or receivable as well as deferred tax assets and liabilities attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using currently enacted tax rates in effect in the years in which those temporary differences are expected to reverse. Deferred tax assets are be reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Changes in deferred tax assets and liabilities generally have a direct impact on earnings in the period of the changes. Where applicable tax laws and regulations are either unclear or subject to varying interpretations, it is possible that changes in these estimates could occur that materially affect the amounts of deferred income tax assets and liabilities recorded in the Consolidated Financial Statements.

Each period, we evaluate the likelihood of whether or not some portion or all of each deferred tax asset will be realized and provide a valuation allowance for those deferred tax assets for which it is more likely than not that the related benefits will not be realized. When evaluating our valuation allowance, we consider historic and future expected levels of taxable income, the pattern and timing of reversals of taxable temporary timing differences that give rise to deferred tax liabilities, and tax planning initiatives. Levels of future taxable income are affected by, among other things, production costs, interest rates, and federal and local legislation. If we determine that all or a portion of the deferred tax assets will not be realized, a valuation allowance will be recorded with a charge to income tax expense. Conversely, if we determine that we will ultimately be able to realize all or a portion of the related benefits for which a valuation allowance has been provided, all or a portion of the related valuation allowance will be reduced with a credit to income tax expense.

69

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

In addition, the calculation of income tax expense overinvolves significant management estimation and judgment involving a number of assumptions. In determining these amounts, management interprets tax legislation in each of the requisite service period.jurisdictions in which we operate and makes estimates of the expected timing of the reversal of future tax assets and liabilities. We also make assumptions about future earnings, tax planning strategies and the extent to which potential future tax benefits will be used. We are also subject to assessments by various taxation authorities which may interpret tax legislation differently, which could affect the final amount or the timing of tax payments.

The Company may from time to time be assessed interest or penalties by major tax jurisdictions, although there have been no such assessments historically with any material impact to its financial results. The Company would recognize interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying Consolidated Statements of Operations. Accrued interest and penalties would be included within the related tax liability line in the Consolidated Balance Sheets.

Prior Period Financial Statement Immaterial Adjustment. The Company has entered into agreements with Zero6 Energy Development, Inc. (“ZEDI”), a national clean energy expert that provides expertise in capital management, development, engineering, and asset management, to develop and construct facilities to provide carbon neutral power to NZ1 via the two limited liability companies: Kingsbury Country Wind Fuel, LLC (“KCWF”) and Dakota Renewable Hydrogen, LLC (“DRH”) (collectively, the “Project LLCs”), respectively, to induce the design and construction of the power generation, transmission and distribution facilities that will serve NZ1. The Project LLCs formed to govern the projects are VIEs. In determining whether the Company was the primary beneficiary of the VIEs, the Company considered both qualitative and quantitative factors regarding the nature, size and form of the involvement with the VIE, such as the role in establishing the VIEs and the ongoing rights and responsibilities; the economic interests deemed to be variable interests in the VIEs; the design of the VIEs, including the capitalization structure, subordination of interests, and payment priority. During the third quarter of 2023, the Company identified that the governance structure and operating procedures of the Project LLCs resulted in the Company having the power to control certain significant activities of the Project LLCs, as defined by Accounting Standards Codification 810 (“ASC 810”), Consolidations. Therefore, the Company is the primary beneficiary of the VIEs, and per ASC 810, must consolidate the VIEs. Prior to the third quarter of 2023, the Company did not consolidate the Project LLCs. The Company assessed the materiality of this correction on the previously issued interim and annual financial statements in accordance with SEC Staff Accounting Bulletin No. 99. The Company concluded that the changes were not material to any of the previously issued consolidated financial statements. The Company’s primary involvement with the VIEs is to fund the deposits in order to induce the contractor to design and construct the power generation, transmission and distribution facilities that will serve NZ1. These amounts funded will be either fully reimbursed upon completion of the project or used as an investment into the Project LLC. Gevo has contractual priority liens against the equipment and constructed facilities under the contracts. In December 2023 the agreements with ZEDI related to the two Project LLCs were amended to remove certain kickout rights that previously existed. As of December 2023, we have concluded that the removal of the kickout rights from the agreements has resulted in a loss of control and that, therefore, the Company is no longer the primary beneficiary of the Project LLCs, and accordingly no longer consolidates the Project LLCs. See Footnote 22.

A summary of the impact of the adjustment on the Consolidated Balance Sheets for each of the periods ended December 31, 2022, March 31, 2023, and June 30, 2023, respectively, is as follows: an increase to property, plant, and equipment of $8.3 million, $19.0 million, and $19.7 million, and a corresponding decrease in deposits and other assets of $8.3 million, $19.0 million, and $19.7 million. For the period ended March 31, 2023, a summary of the impact of the adjustment on the Consolidated Balance Sheets is as follows: an increase in trade accounts receivable, net, of $0.1 million and an increase is accounts payable and accrued liabilities of $0.1 million. For the period ended June 30, 2023, a summary of the impact of the adjustment on the Consolidated Balance Sheets is as follows: a decrease in accounts payable and accrued liabilities of $0.3 million and a corresponding decrease to deposits and other assets.

70

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Additionally, the following immaterial adjustments were made to the consolidated statements of cash flows associated with the above changes for each of the periods ended September 30, 2022, December 31, 2022, March 31, 2023, and June 30, 2023, respectively, as follows: a decrease in the net cash used in operating activities of $8.3 million, $8.3 million, $10.7 million, and $11.4 million, and a corresponding decrease in the netcash provided by investing activities reported for the periods then ended, respectively, as a result of these changes. The reclassification was made for presentation purposes and had no impact on the consolidated statements of operations and comprehensive income.

Recently Issued, Not Yet Adopted Accounting Pronouncements

Segment Reporting. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). ASU 2023-07 would enhance disclosures for significant segment expenses for all public entities required to report segment information in accordance with ASC 280. ASC 280 requires a public entity to report for each reportable segment a measure of segment profit or loss that its chief operating decision maker (“CODM”) uses to assess segment performance and to make decisions about resource allocations. The amendments in ASU 2023-07 improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more useful financial analyses. Currently, Topic 280 requires that a public entity disclose certain information about its reportable segments. For example, a public entity is required to report a measure of segment profit or loss that the CODM uses to assess segment performance and make decisions about allocating resources. ASC 280 also requires other specified segment items and amounts such as depreciation, amortization and depletion expense to be disclosed under certain circumstances. The amendments in ASU 2023-07 do not change or remove those disclosure requirements. The amendments in ASU 2023-07 also do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-07 retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact that ASU 2023-07 may have on its financial statements and related disclosures when adopted.

Income Taxes. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". ASU 2023-09 is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. A public entity should apply the amendments in ASU 2023-09 prospectively to all annual periods beginning after December 15, 2024. The Company is currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.

3. Revenues from Contracts with Customers and Other Revenue

RNG Revenue

The Company’s revenues are primarily comprised of the sale of RNG and related environmental attributes produced at the NW Iowa RNG facility under long-term contracts with customers. Revenue is recognized at a point in time when the Company transfers the product to its customer. The customer obtains control of the product upon RNG delivery into gas pipeline system, whereas the title and control for the environmental attributes are transferred to the customer subsequent to the issuance of such attributes by the relevant regulatory agency. The Company generally has a single performance obligation in our arrangements with customers. The Company’s performance obligation related to the sales of RNG and related environmental attributes are satisfied at a point in time upon delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring its products. There is no variable consideration present in the Company’s performance obligations. Consideration for each transaction is based upon quoted market prices at the time of delivery. All material contracts have payment terms of between one to three months and there are no return or refund rights.

71

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Licensing and Development Revenue

The Company’s licensing and development revenue is related to a joint development agreement with LG Chem, Ltd. ("LG Chem") to develop bio-propylene for renewable chemicals using Gevo’s Ethanol-to-Olefins ("ETO") technology. As the contractually promised intellectual properties (“IP”) are not individually distinct, the Company combined each individual IP noted in the contract into a bundle of IP (“IP Rights”) that is distinct and accounted for all of the IP Rights promised in the contract as a single performance obligation. The IP Rights granted were “functional IP rights” that have significant standalone functionality. The Company’s subsequent activities do not substantively change that functionality and do not significantly affect the utility of the IP to which the licensee has rights. The Company has no further obligation with respect to the grant of IP Rights, including no expressed or implied obligation to maintain or upgrade the technology, or provide future support or services. Licensees legally obtain control of the IP Rights upon execution of the contract. As such, the earnings process is complete and revenue is recognized upon the execution of the contract, when collectability is probable and all other revenue recognition criteria have been met.

Other Hydrocarbon Revenue

The Company recorded limited revenues from its development-scale plant, the Luverne Facility, during the year ended December 31, 2023, and 2022. These revenues were promotional in nature and from customer contracts for ethanol sales and related products and hydrocarbon revenues, which included isooctene, isooctane, and SAF. These products were sold mostly on a free-on-board shipping point basis (recognized at a point in time), were independent transactions, did not provide post-sale support or promises to deliver future goods, and were single performance obligations.

The following tables display the Company’s revenue by major source based on product type (in thousands):

    

Year Ended December 31, 

Major Goods/Service Line

2023

    

2022

Renewable natural gas commodity

 

659

 

640

Environmental attribute revenue

14,798

214

Licensing and development revenue

 

1,300

 

Other hydrocarbon revenue - ethanol, isooctane, IBA

443

321

Total operating revenue

$

17,200

$

1,175

Contract Assets and Trade Receivables. As of December 31, 2023, and 2022, there were no contract assets or liabilities as all customer amounts owed to the Company are unconditional and the Company does not receive payment in advance for its products. Accordingly, amounts owed by customers are included in “Trade accounts receivable, net” on the Company’s Consolidated Balance Sheets. In addition, due to the nature of the Company’s contracts, there are no costs incurred or to be paid in the future that qualify for asset recognition as a cost to fulfill or obtain a contract. No allowance for doubtful accounts was recorded for each of the years ended December 31, 2023, and 2022.

4. Asset Impairment

There were no impairment losses recorded during the year ended December 31, 2023.

72

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

During the year ended December 31, 2022, the Company recorded a $24.7 million impairment loss on long-lived assets, to reduce the carrying value of certain property, plant, and equipment, and a leased right of use (“ROU”) asset, at the Agri-Energy, LLC (“Agri-Energy”) segment to its fair value. The impairments recorded to date relate to the decision to suspend production at the Luverne Facility and shift the plant into an idled, care and maintenance status during the third quarter of 2022. As a result of this change in use, combined with a sustained history of operating losses, the Company assessed that indicators of impairment were present for long-lived assets within its Agri-Energy reporting segment. The Company therefore performed impairment testing and determined that the carrying amounts of certain property plant and equipment and the leased ROU asset exceeded estimated fair values. The Company estimated the fair value of these asset groups generally using a cost approach which is based on replacement or reproduction costs of the assets and is considered a Level 2 measurement and recorded a corresponding impairment loss under Operating Expenses within the Consolidated Statements of Operations.

5. Net Loss Perper Share.

Basic net loss per share is computed by dividingcalculated based on the net loss attributable to Gevo, Inc. common stockholders for the period by the weighted-averageweighted average number of common shares outstanding for the period. Diluted net loss per share is calculated based on the assumption that stock options and other dilutive securities outstanding, which have an exercise price less than the average market price of the Company’s common shares during the period, would have been exercised on the later of the beginning of the period or the date granted, and that the funds obtained from the exercise were used to purchase common shares at the average market price during the period. None of the Company’s stock options or other dilutive securities are considered to be dilutive in periods with net losses.

The effect of the Company’s dilutive securities is calculated using the treasury stock method and only those instruments that result in a reduction in net income per common share are included in the calculation. Diluted earningsnet loss per share (“EPS”) includes the dilutive effect of common stock equivalents and is computed using the weighted-average number of common stock and common stock equivalents outstanding during the reporting period. Diluted EPS for the years ending December 31, 2017, 2016, and 2015 excluded common stock equivalents because the effect of their inclusion would be anti-dilutive or would decrease the reported net loss per share. Therefore 50,373 and 69,245 of dilutive common stock equivalents have been excluded for the years ended December 31, 2023, and 2022, respectively, as the Company is in a net loss position. See Notes 16 and 21 for all outstanding options and warrants that were not included in the computation of diluted weighted average common shares outstanding, as the exercise price of the options and warrants exceeded the average price of the Company’s common stock during the reporting period, and therefore are anti-dilutive.

Basic and diluted net loss per share is calculated as follows (net loss in thousands):

    

Year Ended December 31, 

2023

    

2022

Net loss

$

(66,215)

$

(98,007)

Basic weighted-average shares outstanding

 

238,687,621

 

221,537,262

Net loss per share - basic and diluted

$

(0.28)

$

(0.44)

6. Marketable Securities

The Company’s investments in marketable securities are stated at fair value and are available for sale. During the year ended December 31, 2023, all remaining investments in marketable securities matured with no realized gain or loss. The following table summarizes the Company’s investments in marketable securities (in thousands) as of:

    

December 31, 2022

    

Amortized

    

Gross

    

Cost

Unrealized

Maturity

Basis

Losses

Fair Value

Marketable securities (current)

 

  

 

  

 

  

 

  

U.S. Treasury notes

 

Within one year

$

56,418

$

(344)

$

56,074

U.S. Government-sponsored enterprise securities

 

Within one year

 

112,030

 

(696)

 

111,334

Total marketable securities (current)

$

168,448

$

(1,040)

$

167,408

73

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

The cost of securities sold is based upon the specific identification method. Interest income from marketable securities totaled $0.8 million and $4.3 million for the years ended December 31, 2023, and 2022, respectively, and is included in “Interest and investment income” in the Consolidated Statements of Operations.

7. Restricted Cash

As of December 31, 2023, current restricted cash of $77.3 million consists of amounts held as collateral for letters of credit to provide financing support for development and construction of the NW Iowa RNG and NZ1 projects.

The Company entered into an irrevocable direct pay letter of credit (the “Bond Letter of Credit”) with Citibank N.A (“Citibank”) in April 2021 to support the 2021 Bonds (as defined below) for the development and construction of NW Iowa RNG. See Note 14, Debt, for additional information on the 2021 Bonds. The Bond Letter of Credit has a 0.5% annual fee and expires April 4, 2024 (unless terminated earlier). The Company deposited $71.2 million with Citibank as restricted cash to secure any amounts drawn under the Bond Letter of Credit. As of December 31, 2023, no amounts have been drawn under the Bond Letter of Credit.

In September 2022, the Company entered into a Pledge and Assignment agreement with Citibank to provide credit support in the form of a letter of credit (the “Power Letter of Credit”) from Citibank to a local electric utility company in order to induce the utility company to design and construct the power transmission and distribution facilities that will serve NZ1. The Company deposited $6.6 million of restricted cash in an account with Citibank to collateralize the Power Letter of Credit, which has a 0.3% annual fee and expires September 30, 2024 (unless terminated earlier). As of December 31, 2023, no amounts have been drawn under the Power Letter of Credit. In January 2024, Citibank was notified by the local electric utility company to close the letter of credit, as the Company has discontinued its relationship with the local utility, and fulfilled all obligations under the Power Letter of Credit.

The Company is entitled to receive interest income on the restricted cash, and recorded interest income of $3.4 million and $0.5 million for the years ended December 31, 2023, and 2022, respectively, included in “Other income, net” in the Consolidated Statements of Operations.

8. Prepaid and Other Current Assets

The following table sets forth securities that could potentially dilute the calculationcomponents of diluted earnings per share. This table excludes any shares that could potentially be issued in settlement of make-whole payments associated with the 2020Company’s prepaid and the 2022 Notes.other current assets (in thousands) as of:

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Warrants to purchase common stock

 

7,193,766

 

 

 

1,103,766

 

 

 

1,024,635

 

Convertible 2017 Notes

 

-

 

 

 

75,119

 

 

 

75,191

 

Convertible 2020 Notes

 

28,759,675

 

 

 

-

 

 

 

-

 

Convertible 2022 Notes

 

-

 

 

 

5,608

 

 

 

13,117

 

Outstanding options to purchase common stock

 

46,431

 

 

 

16,915

 

 

 

24,089

 

Unvested restricted common stock

 

3,093

 

 

 

8,823

 

 

 

16,413

 

Total

 

36,002,965

 

 

 

1,210,231

 

 

 

1,153,445

 

    

December 31, 

2023

    

2022

Prepaid insurance

$

568

$

911

Interest receivable

 

1,331

 

514

Prepaid feedstock

 

1,097

 

1,097

Other current assets

 

1,357

 

512

Total prepaid expenses and other current assets

$

4,353

$

3,034

9. Leases, Right-of-Use Assets and Related Liabilities

The following table sets forth additional securities transactionsCompany is party to an operating lease contract for the Company’s office and research facility in Englewood, Colorado, which expires in January 2029. The lease contains an option to extend the lease which management does not reasonably expect to exercise, so it is not included in the length of the term. The Company also has one production line piece of equipment with an operating lease that had they occurredexpires in 2017 would have further diluted the calculation for earnings/ (loss) per share:2024.

74

Date

Shares

Exchange of 2022 Notes

January 2018

780,303

Total

780,303

Recent Accounting Pronouncements

Revenue from Contracts with Customers (“ASU 2014-09”). In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers. The objectiveTable of ASU 2014-09 is to outline a new, single comprehensive model to use in accounting for revenue arising from contracts with customers. The new revenue recognition model provides a five-step analysis for determining when and how revenue is recognized, depicting the transfer of promised goods or services to customers in an amount that reflects the consideration that is expected to be received in exchange for those goods or services. ASU 2014-09 is effective for fiscal years and interim periods within those years beginning after December 15, 2016. Early adoption is permitted. On July 9, 2015, the FASB Board voted to delay the implementation of ASU 2014-09 by one year to December 15, 2017. In April 2016, the FASB issued Accounting Standards Update No. 2016-10 Revenue from Contracts with Customers, Identifying Performance Obligations and Licensing (“ASU 2016-10”) which provides additional clarification regarding  Identifying Performance Obligations and Licensing .  The new standard is required to be applied retrospectively to each priorContents

82


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. As a result of the Company’s conclusions below, there is no requirement to select a transition method, as a result of the Company determining that there is no impact upon revenue recognition, historical or otherwise, as a result of adopting ASU 2014-09.

The Company’s current and historical revenues have consisted of the following:  (a) ethanol sales and related products revenue, net; (b) Hydrocarbon revenue; and (c) grant and other revenue, which primarily has historically consisted of revenues from governmental and cooperative research grants. The following provides the Company’s initial assessment on how this standard will impact the aforementioned sources of revenue. Given the complexity of this new standard the information below is subject to change and a different conclusion may be reached in 2018, even if remote.

Ethanol sales and related products revenues. Ethanol sales and related products revenues are sold to customers on a “free-on-board, shipping point” basis. Each transaction occurs independent of any other sale, and once sold, there are no future obligations on the part of the Company to provide post-sale support or promises to deliver future goods or services. The Company has four finance leases for land under arrangements related to NW Iowa RNG. Under these contracts, the Company leases land from dairy farmers on which it has built three anaerobic digesters, and continuesrelated equipment and pipelines to sell close to 100 percent of its ethanol productioncondition raw biogas from cow manure provided by the farmers. The partially conditioned biogas is transported from the three digester sites to a single customer, representing 76%, 71%central gas upgrade system located at the fourth site that upgrades the biogas to pipeline-quality RNG for sale. These leases expire at various dates between 2031 and 71% of total revenues2050. The Company accounts for lease components separately from non-lease components for the twelve-months ended December 31, 2017, 2016 and 2015, respectively.Company’s dairy lease asset class. The Company completed its review of this customer and consistent with prior assessments, does not expect there to be any impact on howtotal consideration in the Company has and will continue to account for sales of ethanol to this customer. The Company further evaluated related products, including distiller’s grains and corn oil, and after its review, does not expect there to be any significant impact to how the Company has or will account for or disclose these revenues streams.

Hydrocarbon revenue. Hydrocarbon revenues include sales of alcohol-to-jet fuel, isooctene and isooctane andlease agreement is sold mostly on a “free-on-board, shipping point” basis. Each transaction occurs independent of any other sale, and once sold, there are no future obligations on the part of the Company to provide post-sale support or promises to deliver future goods or services. The Company has determined that there will be no material impact as to how the Company has historically recognized or will recognize revenues priorallocated to the upcoming adoption of ASU 2014-09.lease and non-lease components based on their relative standalone selling prices.

GrantThe following tables present the (i) other quantitative information and other revenues. Grant(ii) future minimum payments under non-cancelable financing and other revenues primarily have historically consisted of governmental and cooperative research grants, of which the Northwest Advanced Renewables Alliance (“NARA”) grant, funded by the United States Department of Agriculture (“USDA”), comprised the majority of those revenues since 2014. After reviewing this arrangement, the Company has concluded that this grant consists of a non-reciprocal arrangement, and therefore, does not qualify as a contract pursuant to Topic 606 “ Revenues from Contracts with Customers”, which was established with the issuance of ASU 2014-09. However, Topic 606 does stipulate revenue recognition under these circumstances, and we determined that there will be no change to revenues recognition before and after adoption of ASU 2014-09.  

Leases (“ASU 2016-02”). In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Topic 842 Leases. ASU-2016-02 requires leases to be reported on the financial statements. The objective is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Future minimum lease obligations for leases accounted for as operating leases at December 31, 2017 totaled $2.9 million. The Company is currently in the process of evaluating the impact of adoption of ASU 2016-02 on its consolidated financial statements.

Statement of Cash Flows, Classification of Certain Cash Receivable and Cash Payments (“ASU 2016-15”). In August 2016, the FASB issued Accounting Standards Update No. 2016-15,  Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments  which clarifies cash flow statement classification of eight specific cash flow issues. The purpose of ASU 2016-15 isas they relate to provide clarification and consistency for classifying the eight specific cash flow issues because current GAAP either is unclear or does not include specific guidance. The amendments in the update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The Company is currently in the process of evaluating the impact of adoption of ASU 2016-15 on its consolidated statements of cash flows.

Statement of Cash Flows – Restricted Cash (“ASU 2016-18”). In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows Restricted Cash  which standardizes the classification and presentation of changes in restricted cash on the statement of cash flows. This amendment requires that that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. This amendment is effective for public business entities for fiscal years beginning after December 15, 2017, but early adoption is permitted. This standard must be applied retrospectively for all periods presented. Adoption of this standard will materially impact the presentation of the Company’s historical statementleases (in thousands), except for weighted averages:

Years Ended December 31, 

 

2023

    

2022

 

Other Information

  

 

  

Cash paid for amounts included in the measurement of lease liabilities:

  

 

  

Operating cash flows from finance leases

$

22

$

30

Operating cash flows from operating leases

 

330

 

928

Finance cash flows from finance leases

 

2

 

2

Right-of-use asset obtained in exchange for new operating lease liabilities

 

199

 

Weighted-average remaining lease term, finance lease (months)

 

307

 

311

Weighted-average remaining lease term, operating leases (months)

 

61

 

65

Weighted-average discount rate - finance leases (1)

 

12

%  

 

12

%

Weighted-average discount rate - operating leases (1)

 

6

%  

 

5

%

(1)Our leases do not provide an implicit interest rate, and we calculate the lease liability at lease commencement as the present value of unpaid lease payments using our estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that we would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease.

Year Ending December 31, 

    

Operating Leases

    

Finance Leases

2024

$

617

$

50

2025

 

398

 

27

2026

 

367

 

25

2027

 

335

 

26

2028

 

345

 

26

2029 and thereafter

 

 

523

Total

 

2,062

 

677

Less: amounts representing present value discounts

 

231

 

445

Total lease liabilities

 

1,831

 

232

Less: current portion

 

532

 

45

Non-current portion

$

1,299

$

187

75

Table of cash flow due to the existence of approximately $2.6 million in restricted cashContents

83


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

deposits relating to the 2017 Notes (see Note 5)10. However, this standard will not materially impact the Company prospectively as a result of the release of the restricted cash in April 2017 due to an amendment to the 2017 Notes (see Note 7). 

Derivatives and Hedging (Topic 815) I. Accounting for Certain Financial Instruments with Down Round Provisions (“ASU 2017-11”).  In July 2017, the FASB issued Accounting Standards Update No. 2017-11,  Derivatives and Hedging (Topic 815) Accounting for Certain Financial Instruments with Down Round Provisions  which simplifies the accounting for certain equity-linked financial instruments and embedded features with down round features that reduce the exercise price when the pricing of a future round of financing is lower. Currently, the existence of such features require classification outside of equity and recognition of changes in the fair value of the instrument in earnings each reporting period. This standard eliminates the need to remeasure the instruments at fair value and allows classification within equity. This standard will not materially impact the Company’s accounting, as current liability classified financial instruments and embedded derivatives that require separation from the host instrument have features other than down-round provisions that require current accounting and classification.

Adoption of New Accounting Pronouncements.

Simplifying the Measurement of Inventory (“ASU 2015-11”). In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure in scope inventory at the lower of cost and net realizable value. Subsequent measurement is unchanged for inventory measured using LIFO or the retail inventory method. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company adopted this standard for the year-ending December 31, 2017. Adoption of this standard does not materially impact the measurement of the Company’s inventory.

Derivatives and Hedging (Topic 815) Contingent Put and Call Options in Debt Instruments (“ASU 2016-06”).   In March 2016, the FASB issued Accounting Standards Update No. 2016-06, Derivatives and Hedging (Topic 815) Contingent Put and Call Options in Debt Instruments . Topic 815 requires that embedded derivatives be separated from the host contract and accounted for separately as derivatives if certain criteria are met. There are two approaches for determining if the criteria are met. The objective of ASU 2016-06 is intended to resolve the diversity in practice resulting from those two approaches. The Company adopted this standard in the first quarter of 2017.  The adoption of this new standard does not materially impact the Company’s consolidated financial statements.

Compensation—Stock Compensation (‘ASU 2016-09”). In March 2016, the FASB issued Accounting Standards Update No. 2016-09, Compensation—Stock Compensation. This standard was issued as part of its Simplification Initiative. The objective of the Simplification Initiative is to identify, evaluate, and improve areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided to users of financial statements. The areas for simplification in ASU 2016-09 involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The amendments in ASU 2016-09 are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted ASU 2016-09 effective as of January 1, 2017 on a prospective basis, and prior periods have not been adjusted. The adoption of this standard does not materially impact the Company’s accounting for stock compensation.

84


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

3. Inventories

The following table sets forth the components of the Company’s inventory balances (in thousands). as of:

 

December 31,

 

 

2017

 

 

2016

 

Raw materials

 

 

 

 

 

 

 

Corn

$

189

 

 

$

108

 

Enzymes and other inputs

 

202

 

 

 

309

 

Nutrients

 

5

 

 

 

10

 

Finished goods

 

 

 

 

 

 

 

        Ethanol

 

222

 

 

 

72

 

        Isobutanol

 

1,122

 

 

 

755

 

        Jet Fuels, Isooctane and Isooctene

 

524

 

 

 

519

 

        Distiller's grains

 

59

 

 

 

-

 

Work in process - Agri Energy

 

197

 

 

 

274

 

Work in process - Gevo

 

437

 

 

 

62

 

Spare parts

 

1,405

 

 

 

1,349

 

Total inventories

$

4,362

 

 

$

3,458

 

    

December 31, 

2023

    

2022

Raw materials

 

$

104

$

168

Finished goods

 

SAF, Isooctane, Isooctene and other

 

1,167

 

1,581

Work in process

 

 

Environmental attributes

2,067

4,193

Jet fuel

 

 

51

Spare parts

 

471

 

354

Total inventories

$

3,809

$

6,347

WorkDuring the years ended December 31, 2023, and 2022, the Company recorded net realizable value adjustments of $1.9 million and $0.4 million, respectively, included in process inventory includes unfinished jet fuel, isooctane, and isooctene inventory.Cost of production in the Consolidated Statements of Operations.

4.

11. Property, Plant and Equipment

The following table sets forth the Company’s property, plant and equipment by classification (in thousands).:

 

 

 

December 31,

 

 

 

 

2017

 

 

2016

 

Construction in progress

-

 

$

479

 

 

$

293

 

Plant machinery and equipment (1)

10 years

 

 

16,284

 

 

 

15,397

 

Site improvements

10 years

 

 

7,051

 

 

 

7,050

 

Agri-Energy Retrofit asset (1)

20 years

 

 

70,842

 

 

 

70,791

 

Lab equipment, furniture and fixtures and vehicles

5 years

 

 

6,513

 

 

 

6,431

 

Demonstration plant

2 years

 

 

3,597

 

 

 

3,597

 

Buildings

10 years

 

 

2,543

 

 

 

2,543

 

Computer, office equipment and software

3 years

 

 

1,795

 

 

 

1,594

 

Leasehold improvements, pilot plant, land and support equipment

2 - 5 years

 

 

2,536

 

 

 

2,526

 

Total property, plant and equipment

 

 

 

111,640

 

 

 

110,222

 

Less accumulated depreciation and amortization

 

 

 

(41,271

)

 

 

(34,630

)

Property, plant and equipment, net

 

 

$

70,369

 

 

$

75,592

 

    

Useful Life

December 31, 

(in years)

    

2023

    

2022

Land

$

6,505

$

6,452

Plant facilities and infrastructure

 

5 to 20

 

77,329

 

76,900

Machinery and equipment

 

5 to 20

 

95,212

 

87,248

Furniture and office equipment

 

3 to 7

 

2,864

 

2,977

Software

 

3 to 6

 

1,636

 

2,217

Construction in progress

 

 

114,332

 

81,019

Total property, plant and equipment

 

 

297,878

 

256,813

Less: accumulated depreciation and amortization

 

 

(86,315)

 

(71,639)

Property, plant and equipment, net

$

211,563

$

185,174

(1)

In May 2016, certain assets of the Agri-Energy retrofit asset were reclassified from plant, machinery and equipment to the Agri-Energy retrofit asset.  

As of December 31, 2017 and 2016, the Company has zero and $0.7 million, respectively, of capital lease assets included in computer, office equipment and software. The Company recorded amortization of capital lease assets of $0.1 million during each of the years ended December 31, 2017, 2016 and 2015, as a component of depreciation and amortization in the consolidated statements of cash flows.  

The Company recorded $6.6 million, $6.7depreciation expenses of $17.6 million and $6.6$6.5 million of depreciation expense for the years ended December 31, 2017, 2016,2023, and 2015, respectively, including $6.2 million, $6.02022, respectively.

At December 31, 2023, and 2022, construction in progress included accruals of $7.0 million and $5.7$13.8 million, respectively.

Construction in progress includes $34.7 million for Gevo, $15.5 million for Agri-Energy related to a fractionation and hydrocarbon skid, $0.6 million for NW Iowa RNG and $63.5 million for NZ1 at December 31, 2023. Construction in progress includes $25.9 million for Gevo, $11.4 million for Agri-Energy, $1.0 million for NW Iowa RNG and $42.7 million for NZ1 at December 31, 2022. Construction in progress is not subject to depreciation until the assets are placed into service.

Borrowing costs. Borrowing costs directly attributable to acquisition and construction of an asset are capitalized until it is completed and ready for its intended use, and thereafter are recognized in profit or loss for the current period. The Company did not capitalize interest expense during the year ended December 31, 2023, and capitalized $0.3 million of depreciationinterest expense in costfor the year ended December 31, 2022.

76

Table of goods soldContents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

12. Intangible Assets

Identifiable intangible assets consist of patents, which management evaluates to determine whether they (i) support current products, (ii) support planned research and development, or (iii) prevent others from competing with Gevo’s products.

The following tables set forth the Company’s intangible assets by classification (in thousands) as of:

    

December 31, 2023

    

    

Identifiable

    

Weighted-

Gross Carrying

Accumulated

Intangible

Average Useful Life

Amount

    

Amortization

    

Assets, net

    

(Years)

Patents

$

4,580

$

(1,621)

$

2,959

 

7.4

Defensive assets

 

4,900

 

(1,335)

 

3,565

 

8.4

Intangible assets

$

9,480

$

(2,956)

$

6,524

 

7.9

    

December 31, 2022

    

    

Identifiable

    

Weighted-

Gross Carrying

Accumulated

Intangible

Average Useful Life

Amount

Amortization

Assets, Net

(Years)

Patents

$

4,580

$

(1,039)

$

3,541

 

7.4

Defensive assets

 

4,900

 

(750)

 

4,150

 

8.4

Intangible assets

$

9,480

$

(1,789)

$

7,691

 

7.9

The Company recorded amortization expense of $1.2 million and $1.3 million for the years ended December 31, 2017, 20162023, and 20152022, respectively.

The following table details the estimated amortization of identifiable intangible assets as of December 31, 2023 (in thousands):

Year Ending December 31, 

    

Patents

    

Defensive Assets

    

Total

2024

$

582

$

586

$

1,168

2025

 

582

 

586

 

1,168

2026

 

582

 

586

 

1,168

2027

 

582

 

586

 

1,168

2028

 

582

 

586

 

1,168

2029 and thereafter

 

49

 

635

 

684

Total intangible assets

$

2,959

$

3,565

$

6,524

85


13. Deposits and Other Assets

The following table sets forth the components of the Company’s deposits and other assets (in thousands) as of:

    

Year Ended December 31, 

    

2023

    

2022

Deposits (1)

$

166

$

276

Prepaid feedstock (2)

 

440

 

934

Equity interest (3)

 

1,500

 

1,500

Exclusivity fees (4)

 

583

 

2,522

Deposits receivable (5)

 

33,602

 

Other assets, net (6)

 

8,028

 

8,460

Total deposits and other assets

$

44,319

$

13,692

77

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

(1)Deposits for services and products.
(2)Prepaid feedstock fees, non-current, for the production of RNG.
(3)The Company directly holds a 4.6% interest in the Series A Preferred Stock of Zero6 Clean Energy Assets, Inc. (“Zero6”), formerly Juhl Clean Energy Assets, Inc., which is not a publicly listed entity with a readily determinable fair value. The Company therefore measures the securities at cost. Recent observable equity raises indicated no impairment issues. This ownership interest is also pledged as collateral against two future obligations to Rock County Wind Fuel, LLC (“RCWF”), a Zero6 subsidiary, see Note 19, Commitments and Contingencies, for additional information.
(4)Axens North America, Inc. (“Axens”) will provide certain alcohol-to-SAF technologies and services exclusively provided to the Company which may be offset against future license fees subject to the delivery of a process design package.
(5)Deposits provided to a developer of certain wind-farm projects and power utility contractor to induce to design and construct the power generation, transmission and distribution facilities that will serve NZ1, $5.5 million of which will be either reimbursed or used as an investment into wind generation facility and the remaining $28.1 million is expected to be fully reimbursed upon completion of the project. Gevo has contractual priority liens against the equipment and constructed facilities under the contracts.
(6)Payments which were allocated to the non-lease fuel supply, primarily related to sand separation systems, to support NW Iowa RNG fuel supply agreements prior to commencement of operations, being amortized over the life of the project.
5.

14. Accounts Payable and Accrued Liabilities

The following table sets forth the components of the Company’s accounts payable and accrued liabilities in the consolidated balance sheetsConsolidated Balance Sheets (in thousands).:

 

December 31,

 

 

2017

 

 

2016

 

Accounts payable - trade

$

666

 

 

$

2,611

 

Accrued legal-related fees

 

274

 

 

 

626

 

Accrued employee compensation

 

700

 

 

 

1,385

 

Accrued interest

 

434

 

 

 

359

 

Accrued production fees

 

447

 

 

 

144

 

Accrued utilities payable

 

677

 

 

 

567

 

Accrued taxes payable

 

172

 

 

 

136

 

Short-term capital lease

 

-

 

 

 

147

 

Customer deposit

 

436

 

 

 

-

 

Other accrued liabilities  *

 

205

 

 

 

218

 

Total accounts payable and accrued liabilities

$

4,011

 

 

$

6,193

 

    

Year Ended December 31, 

    

2023

    

2022

Accounts payable

$

2,718

$

5,009

Accrued liabilities

 

13,411

 

12,594

Accrued payroll and related benefits

 

6,621

 

5,105

Accrued sales and use tax

 

2

 

2,052

Total accounts payable and accrued liabilities

$

22,752

$

24,760

*

Other accrued liabilities consist of franchise taxes, audit fees, and a variety of other expenses, none of which individually represent greater than five percent of total current liabilities.

6. Embedded Derivatives15. Debt

2020 Notes Embedded Derivative2021 Bond Issuance

In June 2017,On April 15, 2021, on behalf of Gevo NW Iowa RNG, LLC, the CompanyIowa Finance Authority (the “Authority”) issued $68,155,000 of its 12% convertible senior secured notes due 2020non-recourse Solid Waste Facility Revenue Bonds (Gevo NW Iowa RNG, LLC Renewable Natural Gas Project), Series 2021 (Green Bonds) (the “2020 Notes”“2021 Bonds”) in exchange for its 12.0% convertible senior secured notes due 2017NW Iowa RNG. The bond proceeds were used as a source of construction financing alongside equity from the Company. The bonds were issued under a Trust Indenture dated April 1, 2021 (the “2017 Notes”“Indenture”) between the Authority and Citibank, N.A. as trustee (the “Trustee”). The 2020 Notes contain2021 Bonds mature April 1, 2042. The bonds bear interest at 1.5% per annum during the following embedded derivatives: (i) a Make-Whole PaymentInitial Term Rate Period, (as defined in the indenture governing the 2020 Notes (the “2020 Notes Indenture”)) upon either conversion or redemption; (ii) right to redeem the outstanding principal upon a Fundamental Change (as defined in the 2020 Notes Indenture); (iii) issuer rights to convert into a limited number of shares in any given three-month period commencing nine -months from the issuance date and dependent on the stock price exceeding 150% of the then in-effect conversion price over a ten-business day period; and (iv) holder rights to convert into either shares of the Company’s common stock or pre-funded warrants upon the election of the holders of the 2020 Notes.

Embedded derivatives are separated from the host contract and the 2020 Notes, and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. The Company has concluded that certain embedded derivatives within the 2020 Notes meet these criteria and, as such, must be valued separate and apart from the 2020 Notes as one embedded derivative and recorded at fair value each reporting period.

The Company used a binomial lattice model in order to estimate the fair value of the embedded derivative in the 2020 Notes. A binomial lattice model generates two probable outcomes, whether up or down, arising at each point in time, starting from the date of valuation until the maturity date. A lattice was initially used to determine if the 2020 Notes would be converted by the holder, called by the issuer, or held at each decision point. Within the lattice model, the following assumptions are made: (i) the 2020 Notes will be converted by the holder if the conversion value plus the holder’s Make-Whole Payment is greater than the holding value; or (ii) the 2020 Notes will be called by the issuer if (a) the stock price exceeds 150% of the then in-effect conversion price over a ten-business day period and (b) if the holding value is greater than the conversion value plus the Make-Whole Payment at the time.

Using this lattice model, the Company valued the embedded derivative using a “with-and-without method”, where the value of the 2020 Notes including the embedded derivative is defined as the “with”, and the value of the 2020 Notes excluding the embedded derivative is defined as the “without”. This method estimates the value of the embedded derivative by comparing the difference in the values between the 2020 Notes with the embedded derivative and the value of the 2020 Notes without the embedded derivative. The lattice model requires the following inputs: (i) price of Gevo common stock; (ii) Conversion Rate (as defined in the 2020 Notes Indenture); (iii) Conversion Price (as defined in the 2020 Notes Indenture); (iv) maturity date; (v) risk-free interest rate; (vi) estimated

86


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

stock volatility; and (vii) estimated credit spread for the Company.

Upon issuance on June 20, 2017, the fair value of the embedded derivative was valued at $7.0 million. As of December 31, 2017 the estimated fair value of the embedded derivatives was $5.2 million.  The Company recorded a $1.8 million gain to reflect the change in fair value of the embedded derivative in the consolidated statements of operations for the year-ended December 31, 2017. The Company recorded the estimated fair value of the embedded derivative as a component of current liabilities in the consolidated balance sheet.

The following table sets forth the inputs to the lattice model that were used to value the embedded derivatives.

 

December 31,

 

 

June 20,

 

 

2017

 

 

2017 (*)

 

Stock price

$

0.59

 

 

$

0.62

 

Conversion Rate

 

1,358.90

 

 

 

1,358.90

 

Conversion Price

$

0.74

 

 

$

0.74

 

Maturity date

March 15, 2020

 

 

March 15, 2020

 

Risk-free interest rate

 

1.89

%

 

 

1.45

%

Estimated stock volatility

 

75

%

 

 

80

%

Estimated credit spread

 

28

%

 

 

28

%

 *  The June 20, 2017 inputs represent the initial valuation of the 2020 Notes Embedded Derivative instrument that arose due to the exchange of the 2017 Notes for the 2020 Notes.

Changes in certain inputs into the lattice model can have a significant impact on changes in the estimated fair value of the embedded featured within the 2020 Notes. For example, the estimated fair value will generally decrease with: (1) a decline in the stock price; (2) decreases in the estimated stock volatility; and (3) a decrease in the estimated credit spread.

2022 Notes Embedded Derivative

In July 2012, the Company issued 7.5% convertible senior notes due July 2022 (the “2022 Notes”) which contain the following embedded derivatives: (i) rights to convert into shares of the Company’s common stock, including upon a Fundamental Change (as defined in the indenture governing the 2022 Notes (the “2022 Notes Indenture”)); and (ii) a Coupon Make-Whole Payment (as defined in the 2022 Notes Indenture) in the event of a conversion by the holders of the 2022 Notes prior to July 1, 2017.

Embedded derivatives are separated from the host contract, the 2022 Notes, and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. The Company has concluded that the embedded derivatives within the 2022 Notes meet these criteria and, as such, must be valued separate and apart from the 2022 Notes as one embedded derivative and recorded at fair value each reporting period.

The Company used a binomial lattice model in order to estimate the fair value of the embedded derivative in the 2022 Notes. A binomial lattice model generates two probable outcomes, whether up or down, arising at each point in time, starting from the date of valuation until the maturity date. A lattice was initially used to determine if the 2022 Notes would be converted, called or held at each decision point. Within the lattice model, the following assumptions are made: (i) the 2022 Notes will be converted early if the conversion value is greater than the holding value; or (ii) the 2022 Notes will be called if the holding value is greater than both (a) the Redemption Price (as defined in the 2022 Notes Indenture) and (b) the conversion value plus the Coupon Make-Whole Payment at the time. If the 2022 Notes are called, then the holders will maximize their value by finding the optimal decision between (1) redeeming at the Redemption Price and (2) converting the 2022 Notes.

Using this binomial lattice model, the Company valued the embedded derivative using a “with-and-without method”, where the value of the 2022 Notes including the embedded derivative is defined as the “with”, and the value of the 2022 Notes excluding the embedded derivative is defined as the “without”. This method estimates the value of the embedded derivative by looking at the difference in the values between the 2022 Notes with the embedded derivative and the value of the 2022 Notes without the embedded derivative. The lattice model requires the following inputs: (i) price of Gevo common stock; (ii) Conversion Rate (as defined in the 2022 Notes Indenture); (iii) Conversion Price (as defined in the 2022 Notes Indenture); (iv) maturity date; (v) risk-free interest rate; (vi) estimated stock volatility; and (vii) estimated credit spread for the Company.

87


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

As of December 31, 2017 and December 31, 2016, the estimated fair value of the embedded derivatives was zero.  Any decline in the estimated fair value of the embedded derivatives represents an unrealized gain which has been recorded as gain from change in fair value of embedded derivatives in the consolidated statements of operations. The Company recorded the estimated fair value of the embedded derivative with the 2022 Notes, net in the consolidated balance sheets.

7. Derivative Warrant Liability

The following warrants were sold by the Company:

December 2013, the Company sold warrants to purchase 71,013 shares of the Company’s common stock (the “2013 Warrants”).

August 2014, the Company sold warrants to purchase 50,000 shares of the Company’s common stock (the “2014 Warrants”).

February 2015, the Company sold Series A warrants to purchase 110,833 shares of the Company’s common stock (the “Series A Warrants”) and Series B warrants to purchase 110,833 shares of the Company’s common stock (the “Series B Warrants”).

May 2015, the Company sold Series C warrants to purchase 21,500 shares of the Company’s common stock (the “Series C Warrants”).  

December 2015, the Company sold Series D warrants to purchase 502,500 shares of the Company’s common stock (the “Series D Warrants”) and Series E warrants to purchase 400,000 shares of the Company’s common stock (the “Series E Warrants”).

April 2016, the Company soldSeries F warrants to purchase 514,644 shares of common stock (the “Series F Warrant”) and 1,029,286 Series H warrants, each to purchase one share of common stock (the “Series H Warrant”), and 328,571 pre-funded Series G warrants (“Series G Warrants”) to purchase one share of common stock, pursuant to an underwritten public offering.  

September 2016, the Company soldSeries I warrants to purchase 712,503 shares of common stock (the “Series I Warrant”) and 185,000 pre-funded Series J warrants (“Series J Warrants”) to purchase one share of common stock, pursuant to an underwritten public offering.

In February 2017, the Company sold Series K warrants to purchase 6,250,000 shares of the Company’s common stock (the “Series K Warrants”) and Series M warrants to purchase 6,250,000 shares of the Company’s common stock (the “Series M Warrants”), and pre-funded Series L warrants (the “Series L Warrants”) to purchase 570,000 shares of the Company’s common stock, pursuant to an underwritten public offering

88


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

The following sets forth information pertaining to shares issued upon the exercise of such warrants for the year ended December 31, 2017:

 

 

Issuance

Date

 

Expiration

Date

 

Exercise

Price as of December 31, 2017

 

 

Shares

Underlying

Warrants on

Issuance Date

 

 

Shares Issued

upon Warrant

Exercises as of

December 31,

2017

 

 

Shares

Underlying

Warrants

Outstanding as of

December 31,

2017 (4)

 

2013 Warrants

 

12/16/2013

 

12/16/2018

 

$

8.99

 

 

 

71,013

 

 

 

15,239

 

 

 

55,774

 

2014 Warrants

 

08/05/2014

 

08/05/2019

 

$

6.83

 

 

 

50,000

 

 

 

30,538

 

 

 

19,462

 

Series A Warrants

 

02/03/2015

 

02/03/2020

 

$

0.68

 

 

 

110,833

 

 

 

99,416

 

 

 

11,417

 

Series B Warrants

 

02/03/2015

 

08/03/2015

 

 

-

 

(1)

 

110,833

 

 

 

110,833

 

 

 

-

 

Series C Warrants

 

05/19/2015

 

05/19/2020

 

$

5.50

 

 

 

21,500

 

 

 

-

 

 

 

21,500

 

Series D Warrants

 

12/11/2015

 

12/11/2020

 

$

2.00

 

 

 

502,500

 

 

 

501,570

 

 

 

930

 

Series E Warrants

 

12/11/2015

 

12/11/2020

 

 

-

 

(1)

 

400,000

 

 

 

400,000

 

 

 

-

 

Series F Warrants

 

04/01/2016

 

04/01/2021

 

$

2.00

 

 

 

514,644

 

 

 

233,857

 

 

 

280,787

 

Series G Warrants

 

04/01/2016

 

04/01/2017

 

 

-

 

(1)

 

328,571

 

 

 

328,571

 

 

 

-

 

Series H Warrants

 

04/01/2016

 

10/01/2016

 

 

-

 

(1)

 

1,029,286

 

 

 

1,029,286

 

 

 

-

 

Series I Warrants

 

09/13/2016

 

09/13/2021

 

$

11.00

 

 

 

712,503

 

 

 

-

 

 

 

712,503

 

Series J Warrants

 

09/13/2016

 

09/13/2017

 

 

-

 

 

 

185,000

 

 

 

185,000

 

 

 

-

 

Series K Warrants

 

02/17/2017

 

2/17/2022

 

$

0.60

 

 

 

6,250,000

 

 

 

160,000

 

 

 

6,090,000

 

Series L Warrants

 

02/17/2017

 

02/17/2018

 

 

-

 

(1)

 

570,000

 

 

 

570,000

 

 

 

-

 

Series M-A Warrants

 

02/17/2017

 

11/17/2017

 

 

-

 

(1), (2)

 

2,305,000

 

 

 

1,485,000

 

 

 

-

 

Series M-B Warrants

 

02/17/2017

 

11/17/2017

 

 

-

 

(1), (3)

 

3,945,000

 

 

 

3,945,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

17,106,683

 

 

 

9,094,310

 

 

 

7,192,373

 

(1)

Warrants have either been fully exercised and/or expired as of December 31, 2017.    

(2)

In October 2017, 1,485,000 Series M warrants were repriced between $0.60 and $0.65 per warrant. Of those warrants that were repriced, all were exercised in the fourth quarter of 2017, providing proceeds of $1.0 million.

(3)

In September 2017, 3,945,000 Series M warrants were repriced to $0.60. Of those warrants that were repriced, all were exercised in the second half of 2017, providing proceeds of $2.4 million.

(4)

This table does not include 1,393 equity-classified warrants issued between 2008 through 2012, with strike prices between $17.70 and $24.45 per share.

The agreements governing the above warrants include the following terms:

certain warrants have exercise prices which are subject to adjustment for certain events, including the issuance of stock dividends on the Company’s common stock and, in certain instances, the issuance of the Company’s common stock or instruments convertible into the Company’s common stock at a price per share less than the exercise price of the respective warrants;

warrant holders may exercise the warrants through a cashless exercise if, and only if, the Company does not have an effective registration statement then available for the issuance of the shares of its common stock. If an effective registration statement is available for the issuance of its common stock, a holder may only exercise the warrants through a cash exercise;

the exercise price and the number and type of securities purchasable upon exercise of the warrants are subject to adjustment upon certain corporate events, including certain combinations, consolidations, liquidations, mergers, recapitalizations, reclassifications, reorganizations, stock dividends and stock splits, a sale of all or substantially all of the Company’s assets and certain other events; and

in the event of an extraordinary transaction (as defined in the respective warrant agreements), generally including any merger with or into another entity, sale of all or substantially all of the Company’s assets, tender offer or exchange offer, or reclassification of its common stock, in which the successor entity (as defined in the respective warrant

89


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

agreements) that assumes the warrant is not a publicly traded company, the Company or any successor entity will pay the warrant holder, at such holder’s option, exercisable at any time concurrently with or within 30 days after the consummation of the extraordinary transaction, an amount of cash equal to the value of such holder’s warrants as determined in accordance with an appropriate valuation model and the terms of the respective warrant agreement.

Based on these terms, the Company has determined that all warrants issued since 2013 (the “Warrants”) qualify as derivatives and, as such, are presented as a derivative warrant liability on the consolidated balance sheets and recorded at fair value each reporting period. The fair value of the Warrants was estimated to be $2.0 million and $2.7 million as of December 31, 2017 and December 31, 2016, respectively. The decrease in the estimated fair value of the Warrants represents an unrealized gain which has been recorded as a gain from the change in fair value of derivative warrant liability in the consolidated statements of operations.

During the twelve months ended December 31, 2017, common stock was issued as a result of exercise of Warrants as described below:

 

Twelve Months Ended

December 31, 2017

 

 

Common Stock

Issued

 

 

Proceeds

 

Series K Warrants

 

160,000

 

 

 

106,000

 

Series L Warrants

 

570,000

 

 

 

5,700

 

Series M-A Warrants

 

1,485,000

 

 

 

950,250

 

Series M-B Warrants

 

3,945,000

 

 

 

2,367,000

 

 

 

6,160,000

 

 

$

3,428,950

 

During the twelve months ended December 31, 2017, we issued 160,000 shares of common stock as a result of the exercise of Series K Warrants, 570,000 shares of common stock as a result of the exercise of Series L Warrants and 5,430,000 shares of common stock as a result of the exercise of Series M Warrants, resulting in a total proceeds of approximately $3.4 million.

In addition, in September 2017, as permitted by Section 2(a) of the Series M Warrants agreement the Board of Directors of the Company approved a voluntarily reduction of the exercise price of the Series M Warrants exercisable into 3,945,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock, for the remaining term of these warrants (The Series “M-B” Warrants). Except for the reduction in exercise price, the terms of these Series M-B Warrants remained unchanged. In September 2017, the Company issued 3,500,000 shares of common stock as a result of the exercise of these Series M-B Warrants. In the fourth quarter of 2017, the remaining 445,000 Series M-B Warrants for which the exercise price had been adjusted to $0.60 were exercised.

   In October 2017, the Board of Directors of the Company approved voluntarily reductions of the exercise price of additional Series M Warrants exercisable into 1,185,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.65 per share of common stock, and Series M Warrants exercisable into 300,000 shares of the Company’s common stock from an exercise price of $2.35 per share of common stock to $0.60 per share of common stock. These, along with the remainder of the Series M Warrants for which the original exercise price was not reduced comprise the Series M-A Warrants.   Except for the reduction in exercise price, the terms of these Series M Warrants remained unchanged. During the fourth quarter of 2017, all Series M-A warrants for which the exercise price was reduced were exercised. The remaining Series M-A warrants expired during the fourth quarter of 2017.

     As of December 31, 2017, all of the Series B, E, G, H, J and M Warrants for which the exercise price had been adjusted were fully exercised or expired.  

8. Debt

2020 Notes   

The following table sets forth information pertaining to the 2020 Notes which is included in the Company’s consolidated

90


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

balance sheets (in thousands).

 

Principal

Amount

of 2020 Notes

 

 

Debt

Discount

 

 

 

 

Debt Issue

Costs

 

 

Total 2020 Notes

 

 

2020 Notes Embedded Derivative

 

 

Total 2020 Notes and 2020 Notes Embedded Derivative

 

Balance - December 31, 2016

$

-

 

 

$

-

 

 

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Issuance of 2020 Notes and related discounts and

   issue costs

$

16,492

 

 

$

(3,009

)

 

 

 

$

(800

)

 

$

12,683

 

 

$

6,975

 

 

$

19,658

 

Amortization of debt discount

 

-

 

 

 

508

 

 

 

 

 

-

 

 

 

508

 

 

 

-

 

 

 

508

 

Amortization of debt issue costs

 

-

 

 

 

-

 

 

 

 

 

135

 

 

 

135

 

 

 

-

 

 

 

135

 

Paid-in-kind interest

 

165

 

 

 

-

 

 

 

 

 

-

 

 

 

165

 

 

 

-

 

 

 

165

 

Change in fair value of 2020 Notes embedded derivative

 

-

 

 

 

-

 

 

 

 

 

-

 

 

 

-

 

 

 

(1,751

)

 

 

(1,751

)

Balance - December 31,2017

$

16,657

 

 

$

(2,501

)

 

 

 

$

(665

)

 

$

13,491

 

 

$

5,224

 

 

$

18,715

 

On April 19, 2017, the Company entered into an Exchange and Purchase Agreement (the “Purchase Agreement”) with WB Gevo, LTD (the “Holder”) the holder of the 2017 Notes, which were issued under that certain Indenture dated as of June 6, 2014, by and among the Company, the guarantors party thereto, and Wilmington Savings Fund Society, FSB, as trustee and as collateral trustee (as supplemented, the “2017 Notes Indenture”), and Whitebox Advisors LLC, in its capacity as representative of the Holder (“Whitebox”). Pursuant to the terms of the Purchase Agreement, the Holder, subject to certain conditions, including approval of the transaction by the Company’s stockholders (which was received on June 15, 2017), agreed to exchange all of the outstanding principal amount of the 2017 Notes for an equal principal amount of the 2020 Notes, plus an amount in cash equal to the accrued and unpaid interest (other than interest paid in kind) on the 2017 Notes (the “Exchange”). Pursuant to the Purchase Agreement, the Company also granted the Holder an option (the “Purchase Option”) to purchase up to an additional aggregate principal amount of $5.0 million of 2020 Notes (the “Option Notes”), at a purchase price equal to the aggregate principal amount of such Option Notes purchased, having identical terms (other than with respect to the issue date and restrictions on transfer relating to compliance with applicable securities law) to the 2020 Notes issued, at any time on or within ninety (90) days of the closing of the Exchange. The right to purchase Option Notes expired as of September 30, 2017. On June 20, 2017, the Company completed the Exchange, terminated the 2017 Notes Indenture and cancelled the 2017 Notes.  The Company recognized an approximately $4.0 million loss which has been recorded as loss on exchange or conversion of debt within the consolidated statements of operations.

The 2020 Notes will mature on March 15, 2020 and are secured by a first lien on substantially all of the Company’s assets. The 2020 Notes bear interest at a rate equal to 12% per annum (with 2% potentially payable as PIK Interest (as defined and described below) at the Company’s option), payable on March 31, June 30, September 30, and December 31 of each year. Under certain circumstances, the Company has the option to pay a portion of the interest due on the 2020 Notes by either (a) increasing the principal amount of the 2020 Notes by the amount of interest then due or (b) issuing additional 2020 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”). In the event the Company pays any portion of the interest due on the 2020 Notes as PIK Interest, the maximum aggregate principal amount of 2020 Notes that could be convertible into shares of the Company’s common stock will be increased. Additional shares of the Company’s common stock may also become issuable pursuant to the 2020 Notes in the event the Company is required to make certain make-whole payments as provided in the 2020 Notes Indenture.

The 2020 Notes are convertible into shares of the Company’s common stock, subject to certain terms and conditions. The initial conversion price of the 2020 Notes is equal to $0.7359 per share of common stock, or 1.3589 shares of common stock per $1 principal amount of 2020 Notes (the “Conversion Price”). In addition, upon certain equity financing transactions by the Company, the Holders will have a one-time right to reset the Conversion Price (the “Reset Provision”) (i) in the first ninety (90) days following the Exchange Date, at a 25% premium to the common stock price in the equity financing and (ii) after ninety (90) and to and including one hundred eighty (180) days following the closing of the Exchange, at a 35% premium to the common stock share price in the equity financing. Following an exercise of the Reset Provision, the Holders will also have a right to consent to certain equity financings by the Company during the one hundred eighty (180) days following the closing of the Exchange.

Each Holder has agreed not to convert its 2020 Notes into shares of Company common stock to the extent that, after giving effect to such conversion, the number of shares of common stock beneficially owned by such Holder and its affiliates would exceed 4.99% of Company common stock outstanding at the time of such conversion (the “4.99% Ownership Limitation”); provided that a

91


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Holder may, at its option and upon sixty-one (61) days’ prior notice to the Company, increase such threshold to 9.99% (the “9.99% Ownership Limitation”). If a conversion of 2020 Notes by Whitebox would exceed the 4.99% Ownership Limitation or the 9.99% Ownership Limitation, as applicable, the Purchase Agreement contains a provision granting the holder a fully funded prepaid warrant for such common stock with a term of nine months, subject to a 6 month extension, which it can draw down from time to time.

Other than as set forth in the Reset Provision, the 2020 Notes do not contain any anti-dilution adjustments for future equity issuances that are below the Conversion Price, and adjustments to the Conversion Price will only generally be made in the event that there is a dividend or distribution paid on shares of the Company’s common stock, a subdivision, combination or reclassification of the Company’s common stock, or at the discretion of the Board of Directors of the Company in limited circumstances and subject to certain conditions.

Under certain circumstances, we may file one or more registration statements on Form S-3 or amend filings in order to register shares of common stock for sale or resale, as necessary in connection with the 2020 Notes.

2017 Notes   

In May 2014, the Company entered into a term loan agreement (the “Loan Agreement”) with the lenders party thereto from time to time (each, a “Lender” and collectively, the “Lenders”) and Whitebox Advisors, LLC, as administrative agent for the Lenders (“Whitebox”), with a maturity date of March 15, 2017, pursuant to which the Lenders committed to provide one or more senior secured term loans to the Company in an aggregate amount of up to approximately $31.1 million on the terms and conditions set forth in the Loan Agreement (collectively, the “Term Loan”). The first and only advance of the Term Loan in the amount of $22.8 million, net of discounts and issue costs of $1.6 million and $1.5 million, respectively, was made to the Company in May 2014. Also in May 2014, the Company and its subsidiaries entered into an Exchange and Purchase Agreement (the “Exchange and Purchase Agreement”) with WB Gevo, Ltd. and the other Lenders party thereto from time to time and Whitebox, in its capacity as administrative agent for the Lenders. Pursuant to the terms of the Exchange and Purchase Agreement, the Lenders were given the right, subject to certain conditions, to exchange all or a portion of the outstanding principal amount of the Term Loan for the Company’s 2017 Notes, which were convertible into shares of the Company’s common stock.  While outstanding, the Term Loan bore an interest rate equal to 15% per annum, of which 5% was payable in cash and 10% was payable in kind and capitalized and added to the principal amount of the Term Loan.

In June 2014, the Lenders exchanged all $25.9 million of outstanding principal amount of Term Loan for 2017 Notes, together with accrued paid-in-kind interest of $0.2 million. The terms of the 2017 Notes were set forth in an indenture by and among the Company, its subsidiaries in their capacity as guarantors, and Wilmington Savings Fund Society, FSB, as trustee (the “2017 Notes Indenture”).

On February 13, 2017, the Company and its subsidiaries, as guarantors, entered into an Tenth Supplemental Indenture (the “Tenth Supplemental Indenture”) with Wilmington Savings Fund Society, FSB, as trustee and collateral trustee, and Whitebox, relating to the 2017 Notes. The Tenth Supplemental Indenture amended the 2017 Notes Indenture to, among other things, (i) extend the maturity date of the 2017 Notes to June 23, 2017, (ii) increase the interest rate on the 2017 Notes from 10.0% to 12.0% per annum, and (iii) required the Company to pay down approximately $9.6 million in principal outstanding leaving the remaining principal balance of the 2017 Notes at approximately $16.5 million.

On June 20, 2017, the Company and the Holder exchanged all of the outstanding principal amount of the 2017 Notes for an equal principal amount of the 2020 Notes. As a result, at December 31, 2017, the outstanding principal amount of the 2017 Notes was zero.

 While the 2017 Notes were outstanding, the Company was required to maintain an interest reserve in an amount equal to 10% of the original outstanding principal amount of $26.1 million, to be adjusted on an annual basis. As of December 31, 2016, there was a balance of $2.6 million in the interest reserve account. This amount was classified as restricted deposits until the second quarter of 2017.     

2022 Notes

The following table sets forth information pertaining to the 2022 Notes which is included in the Company’s consolidated balance sheets (in thousands).   

92


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

 

Principal

Amount

of 2022 Notes

 

 

Debt

Discount

 

 

Debt Issue

Costs

 

 

Total

 

Balance - December 31, 2016

$

9,575

 

 

$

(1,307

)

 

$

(47

)

 

$

8,221

 

Amortization of debt discount

 

-

 

 

 

149

 

 

 

-

 

 

 

149

 

Amortization of debt issue costs

 

-

 

 

 

-

 

 

 

6

 

 

 

6

 

Exchange of 2022 Notes

 

(8,885

)

 

 

-

 

 

 

-

 

 

 

(8,885

)

One-time repurchase of debt

 

(175

)

 

 

-

 

 

 

-

 

 

 

(175

)

Write-off of debt discount and debt issue costs associated with

   extinguishment of debt

 

-

 

 

 

1,158

 

 

 

41

 

 

 

1,199

 

Balance - December 31, 2017

$

515

 

 

$

-

 

 

$

-

 

 

$

515

 

In July 2012, the Company sold $45.0 million in aggregate principal amount of 2022 Notes, for net proceeds of $40.9 million, after accounting for $2.7 million and $1.4 million of discounts and issue costs, respectively. The 2022 Notes bear interest at 7.5% which is to be paid semi-annually in arrears on January 1 and July 1 of each year. The 2022 Notes will mature on July 1, 2022, unless earlier repurchased, redeemed or converted. During the twelve-months ended December 31, 2017, 2016 and 2015, the Company recorded $0.2 million, $4.0 million and $3.7 million, respectively, of expense related to the amortization of debt discounts and issue costs, $1.2 million, $2.5 million, and $1.9 million respectively, of expense related to the write-off of debt discount and debt issue costs associated with extinguishment or conversion of debt; and $0.05 million and $1.2 million and $1.8 million, respectively, of interest expense related to the 2022 Notes.

The amortization of debt issue costs, debt discounts and cash interest are included as a component of interest expense in the consolidated statements of operations. The Company amortizes debt discounts and debt issue costs associated with the 2022 Notes using an effective interest rate is 1.1%. The bonds are supported by the $71.2 million Bond Letter of approximately 40% fromCredit; see Note 7, Restricted Cash. The Trustee can draw sufficient amounts on the issuanceBond Letter of Credit to pay the principal and interest until the first mandatory tender date through Julyof April 1, 2017, a five-year period, which represents2024. The bonds are callable and re-marketable on or after October 1, 2022. If the bonds have not been called and re-marketed by the first mandatory tender date, the holders can require the Company to repurchase the 2022 Notes.

The 2022 Notes are convertible at a conversion rate of 0.5856 shares of the Company’s common stock per $1,000 principal amount of 2022 Notes, subject to adjustment in certain circumstances as described in the Indenture. This is equivalent to a conversion price of approximately $1,707.65 per share of common stock. HoldersTrustee may convert the 2022 Notes at any time prior to the close of businessdraw on the third business day immediately precedingBond Letter of Credit to repay the maturity datebonds in their entirety at the purchase price. As of July 1, 2022.

If a holder elected to convert its 2022 Notes prior to July 1, 2017, such holder was entitled to receive, in addition to the consideration upon conversion, a Coupon Make-Whole Payment. The Coupon Make-Whole Payment was equal to the sum of the present values of the number of semi-annual interest payments that wouldDecember 31, 2023, no amounts have been payable on the 2022 Notes that a holder had elected to convert from the last day through which interest was paid up to but excluding July 1, 2017, computed using a discount rate of 2%. The Company could pay any Coupon Make-Whole Payment either in cash or in shares of common stock at its election. If the Company elected to pay in common stock, the stock would be valued at 90% of the average of the daily volume weighted average prices of the Company’s common stock for the 10 trading days preceding the date of conversion. Prior to 2016, the Company converted $20.1 million in outstanding 2022 Notes in return for 28,978 shares of the Company’s common stock, of which, 7,331 represented amounts oweddrawn under the Coupon Make-Whole Payment. Additionally, the Company issued 55,392 shares in exchange for the redemptionBond Letter of $2.5 millionCredit.

78

Table of the 2022 Notes. No holders of the 2022 Notes elected to convert, and the conversion period has expired.Contents

The Company had a provisional redemption right (“Provisional Redemption”) to redeem, at its option, all or any part of the 2022 Notes at a price payable in cash, beginning on July 1, 2015 and prior to July 1, 2017, provided that the Company’s common stock for 20 or more trading days in a period of 30 consecutive trading days ending on the trading day immediately prior to the date of the redemption notice exceeds 150% of the conversion price for the 2022 Notes in effect on such trading day. On or after July 1, 2017, the Company has an optional redemption right (“Optional Redemption”) to redeem, at its option, all or any part of the 2022 Notes at a price payable in cash. The price payable in cash for the Optional Redemption or Provisional Redemption is equal to 100% of the principal amount of 2022 Notes redeemed plus any accrued and unpaid interest thereon through, but excluding, the repurchase date.

The holders of the 2022 Notes had a one-time option to require the Company to repurchase on July 1, 2017 (or on the first business day following such date), at a purchase price, payable in cash, equal to one hundred percent (100%) of the principal amount of any 2022 Notes to be so purchased, plus accrued and unpaid interest. Prior to July 1, 2017, certain holders of the 2022 Notes delivered notices to the trustee of the 2022 Notes requiring the repurchase of $175,000 principal amount of the 2022 Notes, plus

93


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

accrued and unpaid interest, which was completed on July 3, 2017.

In the second half of 2016, the CompanyThe 2021 Bonds were issued 951,801 shares in exchange for the redemption of $12.8 million in outstanding 2022 Notes. In the first half of 2017, the Company issued 2,982,053 shares in exchange for $8.9 million in outstanding 2022 Notes, resulting in approximately $1.0 million loss on exchange of debt.

If a Fundamental Change (as defined in the 2022 Notes Indenture) occurs, at any time, then each holder will have the right to require the Company to repurchase all of such holder’s 2022 Notes, or any portion thereof that is an integral multiple of $1,000 principal amount, for cash at a repurchase pricepremium of 100%$0.8 million and debt issuance costs were $3.0 million. The bond debt is classified as current debt and is presented net of the principal amount of such 2022 Notes plus any accruedpremium and unpaid interest thereon through, but excluding,issuance costs, which are being amortized over the repurchase date.

If there is an Event of Default (as defined in the 2022 Notes Indenture) under the 2022 Notes, the holders of not less than 25% in principal amountlife of the outstanding notes by notice tobonds using the Company and the trustee may, and the trustee at the request of such holders shall, declare the principal amount of all the outstanding 2022 Notes and accrued and unpaid interest thereon to be due and payable immediately.  There have been no Events of Default as of December 31, 2017

In the first quarter of 2018, the Company issued 780,303 shares in exchange for the redemption of the remaining $515,000 in outstanding 2022 Notes.

9. Capital Stock

method. As of December 31, 2017,2023, and 2022, the premium balance and the debt issuance cost net of amortization were $0.1 million, $0.4 million, $0.3 million and $1.3 million, respectively.

Loans Payable 

In April 2020, the Company has authorized 250.0and Agri-Energy each entered into a loan agreement with Live Oak Banking Company, pursuant to which the Company and Agri-Energy obtained loans from the SBA PPP totaling $1.0 million and 10.0in the aggregate (the “SBA Loans”).

In April 2021, the balance of $0.5 million shares of common and preferred stock, respectively, of which there are 21.8 million shares of common stock outstanding and zero shares of preferred stock outstanding.

The holders of the Company’s common stock have one voteand $0.1 million of Agri-Energy’s loans and accrued interest obtained through the SBA PPP were forgiven. The remaining SBA Loan for Agri-Energy totals $0.3 million, bears interest at 1.0% per share. annum and matures in April 2025. Monthly payments of $8,230, including interest, began on June 5, 2021 and are payable through April 2025.

The board of directors has the authority, without action by its stockholders, to designate and issue shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. The Company’s amended and restated certificate of incorporation provides that the Company’s board of directors will be divided into three classes, with staggered three-year terms and provides that all stockholder actions must be effected at a duly called meeting of the stockholders and not by a written consent. The amended and restated certificate of incorporation also provides that only the board of directors may call a special meeting of the stockholders and requires the approval of either a majority of the directors then in office or 66 2/3% of the voting power of all then outstanding capital stock for the adoption, amendment or repeal of any provisionsummary of the Company’s amended and restated bylaws. In addition, the amendment or repeal of certain provisions oflong-term debt is as follows (in thousands) as of:

    

    

  

Year Ended December 31, 

Interest Rate

Maturity Date

    

2023

    

2022

2021 Bonds, net

 

1.5%

 

April 2042

$

67,967

$

67,223

SBA Loans

 

1.0%

 

April 2025

 

119

 

224

Equipment

 

4% to 5%

 

December 2023 to December 2024

 

32

 

94

Total debt

 

  

 

68,118

 

67,541

Less: current portion

 

  

 

(68,097)

 

(159)

Non-current portion

 

  

$

21

$

67,382

Future payments for the Company’s amended and restated certificate of incorporation requireslong-term debt are as follows (in thousands):

Year Ending December 31, 

    

Total Debt

2024

$

68,089

2025

 

29

Total debt

$

68,118

16. Stock-Based Compensation

Equity incentive plans. In February 2011, the approval of 66 2/3% of the voting power of all then outstanding capital stock.

94


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

10. Equity Incentive Plans

2006 Omnibus Securities and Incentive Plan. During 2006, the Company established the Gevo, Inc. 2006 Omnibus Securities and Incentive Plan (the “2006 Plan”). Pursuant to the 2006 Plan, the Company granted stock awards to employees and directors of the Company. Upon adoption ofCompany’s stockholders approved the Gevo, Inc. 2010 Stock Incentive Plan (as amended and restated to date, the “2010 Plan”), no further grants can be made under and the 2006Employee Stock Purchase Plan. At December 31, 2017, a total of 837 shares of Gevo common stock were reserved for issuance upon the exercise of outstanding stock option awards under the 2006 Plan.  To the extent outstanding awards under the 2006 Plan expire, or are forfeited, cancelled, settled, or become unexercisable without the issuance of shares, the shares of common stock subject to such awards will be available for future issuance under the 2010 Plan.

2010 Stock Incentive Plan. In February 2011, the Company’s stockholders approved theThe 2010 Plan which was subsequently amended in June 2013, and amended and restated in July 2015, June 2016 and November 2016, and provides for the grant of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units and other equity awards to employees and directors of the Company. Stock options grantedIn May 2023, upon approval of the shareholders at the 2023 Annual Meeting of Stockholders, the 2010 Plan was amended and restated, which increased the number of shares of common stock reserved for issuance under the 2010 Plan have an exercise price that is at least equal to the fair market value of the Company’s common stock on the date the stock option is granted and expire ten years after the date of grant.37,980,074 shares. At December 31, 2017, a total of 45,594 shares of Gevo common stock were reserved for issuance upon the exercise of outstanding stock option awards under the 2010 Plan, and an additional 133,6072023, 13,613,130 shares were available for grant.

Employee Stock Purchase Plan. In February 2011, the Company’s stockholders approved the ESPP. The offering periods for the ESPP are from January 1 to June 30 and from July 1 to December 31 of each calendar year. The Company has reserved 4,285 shares of common stock forfuture issuance under the ESPP,2010 Plan.

Stock-based compensation expense. The Company records stock-based compensation expense during the requisite service period for share-based payment awards granted to employees and non-employees.

79

Table of which 3,802 shares as of December 31, 2017 are available for future issuance. The purchase price of the common stock under the ESPP is 85% of the lower of the fair market value of a share of common stock on the first or last day of the purchase period.Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

11. Stock-Based Compensation

Stock-Based Compensation Expense. The following table sets forth the Company’s stock-based compensation expense (in thousands).

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Stock options and ESPP awards

 

 

 

 

 

 

 

 

 

 

 

Research and development

$

37

 

 

$

62

 

 

$

131

 

Selling, general and administrative

 

122

 

 

 

321

 

 

 

401

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock awards

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

12

 

 

 

116

 

 

 

576

 

Selling, general and administrative

 

17

 

 

 

143

 

 

 

1,467

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

70

 

 

 

28

 

 

 

10

 

Selling, general and administrative

 

163

 

 

 

216

 

 

 

62

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock-based compensation

$

421

 

 

$

886

 

 

$

2,647

 

Determining Fair Value of Share-Based Payment Awards. The following table sets forth the Black-Scholes option pricing model assumptions and resulting grant date fair value for stock options granted.  

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Risk-free interest rate

 

2.01

%

 

 

1.49

%

 

 

1.62

%

Expected dividend yield

None

 

 

None

 

 

None

 

Expected volatility factor

 

119.00

%

 

 

106.70

%

 

 

106.89

%

Expected option life (in years)

 

5.77

 

 

 

5.77

 

 

 

5.77

 

Weighted average grant date fair value

$

0.86

 

 

$

5.66

 

 

$

35.40

 

95


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Due to the Company’s limited history of grant activity, the expected life of options granted was estimated using the “simplified method” in accordance with SEC Staff Accounting Bulletin 110, where the expected life equals the arithmetic average of the vesting term and the original contractual term of the options. The volatility factor was determined based upon management’s estimate using inputs from comparable public companies. The risk-free interest rate assumption is determined based upon observed interest rates appropriate for the expected term of the Company’s employee stock options. The dividend yield assumption is based on the Company’s history of dividend payouts.

An annual forfeiture rate is estimated at the time of grant for all share-based payment awards, and revised, if necessary, in subsequent periods if the actual forfeiture rate differs from the Company’s estimate. Forfeitures have been estimated by the Company based upon historical and expected forfeiture experience. Estimated forfeiture rates used for the periods presented were from 0% to 5%.indicated (in thousands):

    

Year Ended December 31, 

2023

    

2022

Equity Classified Awards

 

  

 

  

Cost of production

$

59

$

(25)

General and administrative

 

15,204

 

14,342

Other

 

1,824

 

2,618

Total equity classified awards

 

17,087

 

16,935

Total stock-based compensation

$

17,087

$

16,935

Stock Option Award Activityoption award activity. Stock option activity under the Company’s optionstock incentive plans at December 31, 2017 and changes during the year ended December 31, 20172023, were as follows.follows:

    

    

    

Weighted-

    

Average

Weighted-

Remaining

Average

Contractual

Aggregate

Number of

Exercise

Term

Intrinsic

Options

    

Price (1)

    

(years)

    

Value

Options outstanding at December 31, 2022

 

5,945,321

$

4.65

9.1

 

$

Granted

 

3,368,717

$

1.69

 

  

 

$

Canceled or forfeited

 

(1,204,915)

$

4.06

 

  

 

$

Exercised

 

$

 

  

 

$

Options outstanding at December 31, 2023

 

8,109,123

$

3.51

 

8.8

$

Options vested and expected to vest at December 31, 2023

 

3,046,060

$

4.80

 

8.0

$

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

 

 

 

 

Number of

 

 

Exercise

 

 

Term

 

 

Aggregate

 

 

Options

 

 

Price

 

 

(years)

 

 

Intrinsic Value

 

Options outstanding at December 31, 2016

 

16,915

 

 

$

289.73

 

 

 

 

 

 

$

-

 

Granted

 

60,000

 

 

 

1.01

 

 

 

 

 

 

 

 

 

Canceled or forfeited

 

(30,484

)

 

 

1.01

 

 

 

 

 

 

 

 

 

Exercised

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2017

 

46,431

 

 

$

106.19

 

 

 

8.25

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at December 31, 2017

 

29,013

 

 

$

165.47

 

 

 

7.85

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and expected to vest at December 31, 2017

 

46,431

 

 

$

106.19

 

 

 

8.25

 

 

$

-

 

(1)Exercise price of options outstanding range from $1.15 to $876 as of December 31, 2023. The higher end of the range is due to the impact of several reverse stock splits during the years 2015 to 2018.

During the year ended December 31, 2023, 3.0 million stock options vested. As of December 31, 2023, the total unrecognized compensation expense, net of actual forfeitures, relating to stock options was $8.6 million, which is expected to be recognized over the remaining weighted-average period of approximately 1.9 years.

The aggregate intrinsic values infollowing table sets forth the table above representweighted average Black-Scholes option pricing model assumptions (no dividends were expected) and resulting grant date fair value for the total pre-tax intrinsic values (the difference between the closing price of Gevo’s common stock on the last trading day of the 2017 calendar year and the exercise price, multiplied by the number of in-the-money stock option shares) that would have been received by the option holders had all in-the-money outstanding stock options been exercised on December 31, 2017. The total intrinsic value of options exercisedgranted during the years ended December 31, 2017, 2016,2023, and 2015 was zero. 2022:

The following table summarizes information associated with outstanding and exercisable stock options at December 31, 2017.

Year Ended December 31, 

   

2023

    

2022

 

Risk-free interest rate

 

4.30

%

2.90

%

Expected volatility factor

 

153

%

134

%

Expected option life (years)

 

6.0

 

6.0

Weighted-average fair value

$

1.41

$

2.18

 

 

Options Outstanding

 

 

Options Exercisable

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

Weighted-

 

 

Average

 

Range of

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

Average

 

 

Remaining

 

Exercise

 

Number of

 

 

Average Exercise

 

 

Contractual Life

 

 

Number of

 

 

Exercise

 

 

Contractual Life

 

Prices

 

Options

 

 

Price

 

 

in Years

 

 

Options

 

 

Price

 

 

in Years

 

$0.00 to $51.00

 

 

43,968

 

 

$

14.03

 

 

 

8.65

 

 

 

26,550

 

 

$

18.35

 

 

 

8.49

 

$105.00 to $147.00

 

 

80

 

 

$

144.90

 

 

 

0.00

 

 

 

80

 

 

$

144.90

 

 

 

0.00

 

$264.00 to $438.00

 

 

586

 

 

$

368.79

 

 

 

0.33

 

 

 

586

 

 

$

368.79

 

 

 

0.33

 

$462.00 to $1,845.00

 

 

801

 

 

$

715.51

 

 

 

1.89

 

 

 

801

 

 

$

715.51

 

 

 

1.89

 

$2,331.00 to $3,426.00

 

 

637

 

 

$

2,938.98

 

 

 

0.29

 

 

 

637

 

 

$

2,938.98

 

 

 

0.29

 

$3,801.00 to $5,742.00

 

 

360

 

 

$

4,556.47

 

 

 

1.69

 

 

 

360

 

 

$

4,556.47

 

 

 

1.69

 

 

 

 

46,431

 

 

$

106.19

 

 

 

8.25

 

 

 

29,013

 

 

$

165.47

 

 

 

7.85

 

96


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

As of December 31, 2017, $0.1 million of total unrecognized compensation cost related to stock options is expected to be recognized as an expense by the Company in the future over a weighted-average period of approximately one year.

There is a maximum contractual term of 10ten years for the share options. The Company settles stock option exercises with newly issued common shares. No tax benefits were realized by the Company in connection with these exercises as the Company maintains net operating loss carryforwards and has established a valuation allowance against the entire tax benefit.

Restricted Stock.Stock. The Company periodically grants restricted stock awards to employees and directors. The vesting period for restricted stock awards granted may be based upon a service period or based upon the attainment of performance objectives. The Company recognizes stock-based compensation over the vesting period, generally two to three to six years, for awards that vest based upon a service period. For performance based restricted stock awards, the Company recognizes expense over the requisite service period.

80

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Non-vested restricted stock awards at December 31, 20172023, and changes during the year ended December 31, 20172023, were as follows.  follows:

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

Number of

 

 

Grant-Date

 

 

Shares

 

 

Fair Value

 

Non-vested at December 31, 2016

 

8,823

 

 

$

47.51

 

Granted

 

-

 

 

 

-

 

Vested

 

(5,730

)

 

 

49.50

 

Canceled or forfeited

 

-

 

 

 

-

 

Non-vested at December 31, 2017

 

3,093

 

 

$

43.80

 

    

    

Weighted-

Average

Number of

Grant-Date

Shares

Fair Value

Outstanding at December 31, 2022

 

5,254,457

$

3.94

Granted

 

4,208,021

$

1.49

Vested and issued

 

(2,415,824)

$

4.08

Canceled or forfeited

 

(887,313)

$

3.39

Non-vested at December 31, 2023

 

6,159,341

$

2.30

The total fair value of restricted stock that vested during the years ended December 31, 2017, 20162023, and 20152022, was $0.2 million, $0.3$9.8 million and $1.4$10.2 million,, respectively. As of December 31, 2017,2023, the total unrecognized compensation expense, net of estimatedactual forfeitures, relating to restricted stock awards was $0.1$10.3 million, which is expected to be recognized over athe remaining weighted-average period of approximately one year.

12. Gevo Development

Gevo, Inc. currently owns 100% of the outstanding equity interests of Gevo Development.

Gevo, Inc. made capital contributions to Gevo Development of $8.9 million, $12.3 million, and $7.9 million, respectively, during the years ended December 31, 2017, 2016, and 2015.

The following table sets forth (in thousands) the net loss incurred by Gevo Development (including Luverne after September 22, 2010, the closing date of the acquisition) which has been fully allocated to Gevo, Inc.’s capital contribution account based upon its capital contributions (for the period prior to September 2010) and 100% ownership (for the period after September 22, 2010).

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Gevo Development Net Loss

$

(12,653

)

 

$

(12,983

)

 

$

(12,294

)

The accounts of Agri-Energy are consolidated within Gevo Development as a wholly owned subsidiary which is then consolidated into Gevo, Inc.1.8 years. As of December 31, 20172023, Gevo Development does not have any assets that can be used only to settle obligations of Gevo Development.

As previously disclosed, in June 2011, we entered into an Isobutanol Joint Venture Agreement (the “Joint Venture Agreement”) between our wholly-owned subsidiary, Gevo Development and Redfield Energy, LLC (“Redfield”), under which we agreed to work with Redfield to Retrofit Redfield’s ethanol production facility located near Redfield, South Dakota for the commercial production of isobutanol.  During the fourth quarter of 2017, we entered into an Agreement with Redfield, pursuant to which we and Redfield agreed to terminate the Joint Venture Agreement in all respects.  Therethere are no termination fees or other obligations of either party in connection with such termination.unvested liability-classified restricted stock awards.

97


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

13.17. Income Taxes

There is no provision for income taxes because the Company has incurred operating losses since inception. As of December 31, 2017,2023, the Company hadhas a federal and state net operating loss carryforwardscarryover of approximately $359.2$201.2 million and $336.7$138.7 million, respectively, which may be usedavailable to offset future taxable income.income for income tax reporting purposes. The Company also hadremaining federal research and development tax creditnet operating loss carryovers do not expire. Of our state net operating loss carryovers, $137.1 million would expire between the years 2027-2043

We periodically evaluate our net operating loss carryforwards and other federal tax creditwhether certain changes in ownership have occurred that would limit our ability to utilize a portion of our net operating loss carryforwards which aggregatepursuant to $3.5 million at December 31, 2017. These carryforwards expire at various times through 2037 and may be limited in their annual usage by Section 382 of the Internal Revenue Code Section 382. An ownership change may occur, for example, as amended, relating toa result of trading in our stock by significant investors as well as issuance of new equity. As a result of ownership changes.changes in prior years, a portion of our net operating losses have been limited.

The following table sets forth the tax effects of temporary differences that give rise to significant portions of the Company’s net deferred tax assets (in thousands).  :

December 31, 

    

2023

    

2022

Deferred tax assets, net:

 

  

 

  

Net operating loss carryforwards

$

48,638

$

40,511

Operating lease assets

 

(405)

 

(371)

Operating lease liabilities

 

545

 

410

Depreciation

 

11,421

 

9,145

Stock compensation

 

2,530

 

2,027

Business interest expense

 

1,110

 

1,033

Capitalized research cost

 

7,332

 

3,334

Other temporary differences

 

820

 

691

Deferred tax assets

 

71,991

 

56,780

Valuation allowance

 

(71,991)

 

(56,780)

Net deferred tax assets

$

$

 

December 31,

 

2017

 

 

2016

 

 

Deferred tax assets, net:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

$

100,631

 

 

$

133,514

 

 

Research and other credits

 

3,482

 

 

 

3,482

 

 

Other temporary differences

 

3,266

 

 

 

2,319

 

 

Deferred tax assets - before valuation allowance

 

107,379

 

 

 

139,315

 

 

Valuation allowance

 

(107,379

)

 

 

(139,315

)

 

Net deferred tax assets - after valuation allowance

$

-

 

 

$

-

 

 

81

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminated the option to deduct research and development expenditures in the current year and requires taxpayers to amortize them over five years pursuant to Internal Revenue Code Section 174. The Company recognizes uncertainmandatory capitalization requirement increases the deferred tax positions net, against any operating losses or applicable research credits as they arise.  Currently, there are no uncertain tax positions recognized atasset for Capitalized Research Costs by $3.6 million for the year ended December 31, 2017. The Company has2023.

ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not to occur. Based on management’s review of both the positive and negative evidence, which includes our historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting results, we have concluded that it is not more likely than not that we will be able to realize all of our U.S. deferred tax assets. Therefore, we have provided a full valuation allowance on itsagainst deferred tax assets at December 31, 20172023 and 2016, as management believes it is more likely than not that the related deferred tax asset will not be realized. The reported amount of income tax expense differs from the amount that would result from applying domestic federal statutory tax rates to pretax losses, primarily because of changes in the valuation allowance.2022, respectively.

The following table sets forth reconciling items from income tax computed at the statutory federal rate.  rate:

Year Ended December 31,

 

2017

 

 

2016

 

 

2015

 

Year Ended December 31, 

    

2023

    

2022

Federal income tax at statutory rate

 

35.0

%

 

 

35.0

%

 

 

35.0

%

 

21.0

%  

21.0

%

State income taxes, net of federal benefits

 

7.5

%

 

 

2.9

%

 

 

5.4

%

 

6.8

%  

1.6

%

Research and other credits

 

0.0

%

 

 

(5.8

%)

 

 

(1.2

%)

Impact of change in statutory tax rates

 

(183.8

%)

 

 

0.0

%

 

 

0.0

%

Permanent deductions

 

7.5

%

 

 

(18.0

%)

 

 

(4.0

%)

Officers compensation limit

 

(1.8)

%  

(1.2)

%

Stock based compensation

(2.5)

%  

%

Other permanent

(0.2)

%  

(1.0)

%

Valuation allowance

 

133.8

%

 

 

(14.1

%)

 

 

(35.2

%)

 

(23.3)

%  

(20.4)

%

Effective tax rate

 

0.0

%

 

 

(0.0

%)

 

 

0.0

%

 

%  

%

Accounting literature regarding liabilities for unrecognized tax benefits provides guidance for the recognition and measurement in financial statements of uncertain tax positions taken or expected to be taken in a tax return. The Company’s evaluation was performed for the tax periods from inception to December 31, 2017, which remain2023. The Company is subject to examination by major tax jurisdictions as offor the years ended December 31, 2017.2018 to 2022.

The Company may from time to time be assessed interestrecognizes uncertain tax positions net, against any operating losses or penalties by majorapplicable research credits as they arise. Currently, there are no uncertain tax jurisdictions, although there have been no such assessments historically, with any material impact to its financial results. The Company would recognize interest and penalties

98


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

related to unrecognized tax benefits within the income tax expense line in the accompanying consolidated statements of operations.  Accrued interest and penalties would be included within the related tax liability line in the consolidated balance sheets.

In December 2017, the federal government of the United States of America passed the “Tax Cuts and Jobs Act”. The Company has evaluated the impact, if any, on the Company’s financial statements, including tax disclosures. As ofpositions recognized at December 31, 2017, the Company does not consider the new tax reform to materially impact to the Company’s financial statements except for certain reductions in the estimated valuation of net operating loss carryforwards2023 and the associated offsetting valuation allowance.  2022, respectively.

14.18. Employee Benefit Plan

The Company’s employees participate inCompany sponsors the Gevo, Inc. 401(k) Plan (the “401(k) Plan”). under Section 401(k) of the Internal Revenue Code. Subject to certain eligibility requirements, the 401(k) Plan covers substantially all employees beginning the month after three months of service with quarterly entry dates.employment. Employee contributions are deposited by the Company into the 401(k) Plan and may not exceed the maximum statutory contribution amount. The Company may makeBeginning January 1, 2023, the 401(k) Plan was amended to include matching and/or discretionary contributions to the 401(k) Plan. Effective January 2013,Plan, with the Company elected to cease providing an employer match.

15. Commitmentsmatching 100% of the employee’s contributions that are not over 3% of compensation, plus 50% of contributions which are over 3% but are not over 5% of compensation. The matching contributions will be made in shares of the Company’s common stock and Contingencies

Leases. Duringvest immediately. For the year ended December 31, 2012,2023, accrued matching contributions to the Company entered into a six year software license agreement.401(k) Plan was $0.7 million, equivalent to approximately 0.7 million shares of common stock, to be remitted to participants in Q1 2024. The Company concluded that the software license agreement qualifies as a capital lease. Accordingly, at December 31, 2017 and 2016, the Company had capital lease liabilities of zeroand $0.1 million included in accounts payable and accrued liabilities and other long-term liabilities, respectively on its consolidated balance sheet.

The Company hasdid not provide an operating lease for its office, research, and production facility in Englewood, Colorado (the “Colorado Facility”) with a term expiring in July 2021. The Company also maintains a corporate apartment in Colorado, which has a lease term expiringemployer match during the next 12 months. The Company maintains an operating lease for rail cars Luverne Facility, with the lease term expiring in July 2020.

Rent expense for the yearsyear ended December 31, 2017, 20162022.

19. Commitments and 2015 was $1.6 million, $1.7 million,Contingencies

Legal Matters. From time to time, the Company has been and $1.6 million, respectively.may again become involved in legal proceedings arising in the ordinary course of its business. The Company recognizes rent expenseis not presently a party to any litigation and is not aware of any pending or threatened litigation against the Company that it believes could have a material adverse effect on its business, operating leasesresults, financial condition or cash flows.

82

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

State Tax Audit. During the year ended 2023, the Company was notified of a pending sales and use tax audit by the South Dakota Department of Revenue for the period covering January 2021 through December 2023. Although the final resolution of the Company’s sales and use tax audit is uncertain, based on current information, in the opinion of the Company’s management, the ultimate disposition of these matters will not have a straight-line basis.material adverse effect on the Consolidated Balance Sheets, Statements of Operations, or Liquidity.

The table below shows the future minimum payments under non-cancelable operating leases and capital leases at December 31, 2017 (in thousands).

 

Operating Leases

 

2018

$

1,421

 

2019

 

907

 

2020

 

394

 

2021

 

200

 

2022

 

-

 

Thereafter

 

-

 

Total

$

2,922

 

Indemnifications. In the ordinary course of its business, the Company makes certain indemnities under which it may be required to make payments in relation to certain transactions. As of December 31, 2017and 2016,2023, and 2022, the Company did not have any liabilities associated with indemnities.

In addition, the Company as permitted under Delaware law and in accordance with its amended and restated certificate of incorporation and amended and restated bylaws, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company’s request in such capacity.limitations. The duration of these indemnifications, commitments, and guarantees varies and, in certain cases, is indefinite. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. No such losses have been recorded to date.

Environmental Liabilities. The Company’s operations are subject to environmental laws and regulations adopted by various governmental authorities in the jurisdictions in which it operates. These laws require the Company to investigate and remediate the

99


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

effects of the release or disposal of materials at its locations. Accordingly, the Company has adopted policies, practices and procedures in the areas of pollution control, occupational health and the production, handling, storage and use of hazardous materials to prevent material environmental or other damage, and to limit the financial liability which could result from such events. Environmental liabilities are recorded when the Company’s liability is probable, and the costs can be reasonably estimated. No environmental liabilities have been recorded as of December 31, 2017.2023.

Fuel Supply Commitment. The Company has three long-term fuel supply contracts to source feedstock for the anaerobic digesters at the NW Iowa RNG project. These contracts provide an annual amount of feedstock to be used in the production of RNG.

Zero6 Commitments. In September 2022, the Company entered into a development agreement with Zero6 to construct and operate a wind project for the provision of electric energy for NZ1. Pursuant to the agreement, the Company has committed to pay Zero6 total development charges of $8.6 million, comprised of advanced development fee payments of $0.9 million, certain reimbursable costs of $1.2 million, and $6.5 million upon completion of the project. The Company is not contractually obligated for the specified development charges until certain milestones are met in future periods, and upon completion of the project. Further, the Company has committed to fund certain discretionary, budgeted costs associated with long lead equipment and engineering services for NZ1, totaling an estimated $36.0 million. The amount is expected to be fully reimbursed upon completion of the project. Gevo has contractual priority liens against the equipment and constructed facilities under the contracts. See Footnote 22 below for further information.

16.Additionally, the Company’s investment in Zero6, see Note 13 above, is pledged separately as collateral for two commitments for the purchase of wind electricity for the Luverne Facility, as well as the purchase of 100% of RCWF’s renewable energy credits. Gevo has a commitment to purchase all of RCWF’s electricity. The portion not used by the Luverne Facility is charged to the Company at a lower price.

83

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

The estimated commitments as of December 31, 2023, and thereafter are shown below (in thousands):

December 31, 

2029 and

    

2024

    

2025

    

2026

    

2027

    

2028

    

thereafter

    

Total

Fuel Supply Payments

$

3,193

$

2,699

$

1,718

$

2,060

$

2,202

$

26,061

$

37,933

Zero6 Commitment

 

36,221

 

7,149

 

 

 

 

 

43,370

Renewable Energy Credits

 

128

 

128

 

129

 

128

 

128

 

1,455

 

2,096

Electricity Above Use (Est.)

 

447

 

 

 

 

 

 

447

Total

$

39,989

$

9,976

$

1,847

$

2,188

$

2,330

$

27,516

$

83,846

20. Fair Value Measurements and Fair Value of Financial Instruments

Accounting standards define fair value, outline a framework for measuring fair value, and detail the required disclosures about fair value measurements. Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. Standards establish a hierarchy in determining the fair market value of an asset or liability. The fair value hierarchy has three levels of inputs, both observable and unobservable. Standards require the utilization of the highest possible level of input to determine fair value.

Level 1 – inputs include quoted market prices in an active market for identical assets or liabilities.

Level 2 – inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data.

Level 3 – inputs are unobservable and corroborated by little or no market data.

100


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

These tables present theThe carrying value and fair value, by fair value hierarchy, of ourthe Company’s financial instruments excluding cash and cash equivalents, accounts receivable and accounts payable; as carrying value approximately fair value due to their short-term nature; at December 31, 20172023, and 2016, respectively2022, are as follows (in thousands).:

    

Fair Value Measurements at December 31, 2023

Quoted

Prices in

Active

Significant

Markets for

Other

Significant

Fair Value at

Identical

Observable

Unobservable

December 31, 

Assets

Inputs

Inputs

 

2023

    

(Level 1)

    

(Level 2)

    

(Level 3)

Cash and cash equivalents (1)

$

298,349

$

298,349

$

$

Fair Value Measurements at December 31, 2022

Quoted

Prices in

Active

Significant

Markets for

Other

Significant

Fair Value at

Identical

Observable

Unobservable

December 31, 

Assets

Inputs

Inputs

    

2022

    

(Level 1)

    

(Level 2)

    

(Level 3)

Cash and cash equivalents (1)

$

237,125

$

237,125

$

$

Marketable securities

 

$

167,408

$

167,408

$

$

 

 

 

 

 

Fair Value Measurements at December 31, 2017 (In thousands)

 

 

Fair Value at

December 31, 2017

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs (Level 3)

 

Recurring:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Warrant Liability

$

1,951

 

 

$

-

 

 

$

-

 

 

$

1,951

 

2020 Notes Embedded Derivative Liability

 

5,224

 

 

 

-

 

 

 

-

 

 

 

5,224

 

Total Recurring Fair Value Measurements

$

7,175

 

 

$

-

 

 

$

-

 

 

$

7,175

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonrecurring

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corn and finished goods inventory

$

1,916

 

 

$

189

 

 

$

1,727

 

 

$

-

 

 

$

1,916

 

 

$

189

 

 

$

1,727

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value Measurements at December 31, 2016 (In thousands)

 

 

Fair Value at

December 31, 2016

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs (Level 3)

 

Recurring:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivative Warrant Liability

$

2,698

 

 

$

-

 

 

$

1,884

 

 

$

814

 

2017 Notes

 

25,769

 

 

 

-

 

 

 

-

 

 

 

25,769

 

Total Recurring Fair Value Measurements

$

28,467

 

 

$

-

 

 

$

1,884

 

 

$

26,583

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonrecurring

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corn and finished goods inventory

$

1,327

 

 

$

108

 

 

$

1,219

 

 

$

-

 

 

$

1,327

 

 

$

108

 

 

$

1,219

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)Cash and cash equivalents includes $283.2 million and $200.7 million invested in U.S. government money market funds as of December 31, 2023, and 2022, respectively.

84

 

 

Fair Value Measurements Using Significant Unobservable Inputs

(Level 3) (in thousands)

 

 

 

Derivative Warrant Liability

 

 

2017 Notes

 

 

2020 Embedded Derivative Liability

 

Opening Balance

 

$

814

 

 

$

25,769

 

 

$

-

 

Transfers into Level 3

 

 

1,884

 

 

 

-

 

 

 

-

 

Transfers out of Level 3

 

 

-

 

 

 

-

 

 

 

-

 

Total (gains) or losses for the period

 

 

 

 

 

 

 

 

 

 

 

 

Included in earnings

 

 

(5,101

)

 

 

339

 

 

 

(1,751

)

Included in other comprehensive income

 

 

-

 

 

 

-

 

 

 

-

 

Purchases, issues, sales and settlements

 

 

 

 

 

 

 

 

 

 

 

 

Purchases

 

 

-

 

 

 

-

 

 

 

-

 

Issues

 

 

5,671

 

 

 

-

 

 

 

6,975

 

Sales

 

 

-

 

 

 

-

 

 

 

-

 

Settlements

 

 

(1,317

)

 

 

(26,108

)

 

 

-

 

Closing balance

 

$

1,951

 

 

$

-

 

 

$

5,224

 

Table of Contents

101


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Fair Value Methodology

Inventories. The Company records its corn inventory at fair value only when the Company’s cost of corn purchased exceeds the market value for corn. The Company determines the market value of corn and dry distiller’s grain based upon Level 1 inputs using quoted market prices. The Company records its ethanol, isobutanol and hydrocarbon inventory at market using Level 2 inputs.   

2017 Notes.  The Company had estimatedno transfers of assets or liabilities between fair value hierarchy levels during the years ended December 31, 2023, and 2022.

For the 2021 Bonds, the fair valuevalues are estimated using the Black-Derman-Toy interest rate lattice framework. The effective maturity of the 2017 2021 Bonds was assumed to be April 1, 2024 (three years from issuance) with repayment of 100% of principal on that date. The impact of the Company’s optional redemption feature, effective October 1, 2022, is appropriately captured by the Black-Derman-Toy interest rate lattice. The carrying values and estimated fair values of the 2021 Bonds as of December 31, 2023, are summarized as follows (in thousands):

    

Carrying

    

Estimated

Value

Fair Value

2021 Bonds

$

67,967

$

67,916

21. Shareholders’ Equity

Share Issuances

In February 2018, the Company commenced an at-the-market offering program, which allows it to sell and issue shares of its common stock from time to time. In 2021, the at-the-market offering program was amended to provide a total capacity of $500.0 million. As of December 31, 2023, the Company has remaining capacity to issue up to approximately $360.6 million of common stock under the at-the-market offering program.

Subsequently, in January 2024 the Company filed an updated Form S-3, which included a base prospectus which covers the offer, issuance and sale of up to an aggregate of $750.0 million of the registrant’s common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts and units and an at-the-market offering prospectus supplement covering the offering, issuance and sale by the registrant of up to a maximum aggregate offering price of $500.0 million of the Company’s common stock that may be issued and sold under an at-the-market-offering agreement.

In June 2022, the Company completed a registered direct offering (“the June 2022 Offering”) of an aggregate of 33,333,336 shares of the Company’s common stock at a price of $4.50 per share, accompanied by Series 2022-A warrants to purchase an aggregate of 33,333,336 shares of the Company’s common stock (each, a “Series 2022-A Warrant”) pursuant to a securities purchase agreement with certain institutional and accredited investors. The Series 2022-A Warrants are exercisable for a term of five years from the date of issuance at an exercise price of $4.37 per share. As of December 31, 2023, none of the Series 2022-A Warrants had been exercised.

The net proceeds to the Company from the June 2022 Offering were $139.2 million, after deducting placement agent’s fees, advisory fees and other offering expenses payable by the Company, and assuming none of the Series 2022-A Warrants issued in the June 2022 Offering are exercised for cash. The Company intends to use the net proceeds from the June 2022 Offering to fund capital projects, working capital and for general corporate purposes.

Warrants

In addition to the Series 2022-A Warrants, the Company has warrants outstanding that were issued in conjunction with a registered direct offering in August 2020 (the “Series 2020-A Warrants”). The Company evaluated the Series 2022-A Warrants and Series 2020-A Warrants for liability or equity classification and determined that equity treatment was appropriate because both the Series 2022-A Warrants and Series 2020-A Warrants do not meet the definition of liability instruments.

85

Table of Contents

GEVO, INC.

Notes to be $25.8 million at December 31, 2016, utilizing a binomial lattice model. Consolidated Financial Statements (Continued)

The Company derecognized the liability when it exchanged the 2017 Notes for the 2020 Notes on June 20, 2017,Series 2022-A Warrants and the obligation now is accounted forSeries 2020-A Warrants are classified as a component of equity because they are freestanding financial instruments that are legally detachable and separately exercisable from the 2020 Notesshares of common stock with which they were issued, are immediately exercisable and related 2020 Note Embedded Liability.

2020 Notes.  The Company has estimated the fair value of the 2020 Notes to be $13.5 million at June 20, 2017,will expire five years from the date of issuance, do not embody an obligation for the Company exchangedto repurchase its shares, and permit the 2017 Notes for the 2020 Notes, utilizingholders to receive a binomial lattice model. The Company has elected to account for the 2020 Notes using the amortized cost method and reported at $13.5 million, netfixed number of debt discount and issuance costs at December 31, 2017.

2020 Notes Embedded Derivative. The Company had estimated the fair valueshares of the embedded derivative on a stand-alone basis to be $5.2 million at December 31, 2017 basedcommon stock upon Level 3 inputs. See Note 6, Embedded Derivatives and Derivative Warrant Liabilities, for the fair value inputs used to estimate the fair value of the 2020 Notes with and without the embedded derivative and the fair value of the embedded derivative.

2022 Notes Embedded Derivative. The Company had estimated the fair value of the embedded derivative on a stand-alone basis to be $0 million at December 31, 2017 and December 31, 2016, respectively, based upon Level 3 inputs. See Note 6, Embedded Derivatives and Derivative Warrant Liabilities, for the fair value inputs used to estimate the fair value of the 2022 Notes with and without the embedded derivative and the fair value of the embedded derivative.

Derivative Warrant Liability. Prior to 2017, the Company estimated the fair value ofexercise. In addition, the Series A, Series F2022-A Warrants and Series K warrants using a Monte-Carlo model (Level 3). For all other warrants the Company valued these using a standard Black-Scholes model (Level 2). However, beginning in the first quarter 2017, the2020-A Warrants do not provide any guarantee of value or return. The Company valued the Series F2022-A Warrants and KSeries 2020-A Warrants at issuance using a Monte-Carlo model (Level 3) and other warrants usingthe Black-Scholes models comprised of some inputs requiring the use of Monte-Carlo models (Level 3).option pricing model. The Company has estimated the fair value at the issuance date of the derivative warrant liabilitySeries 2022-A Warrants was $92.9 million with the key inputs to be $2.0the valuation model including a weighted average volatility of 151.1%, a risk-free rate of 2.86% and an expected term of five years. The fair value at the issuance date of the Series 2020-A Warrants was $8.3 million aswith the key inputs to the valuation model including a weighted average volatility of December 31, 2017.130%, a risk-free rate of 0.30% and an expected term of five years.

While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

On February 17, 2022, the remaining Series K warrants expired with 7,126 unexercised warrants.

.The following table sets forth information pertaining to shares issued upon the exercise of warrants:

.

 

 

 

 

Shares

 

Shares

 

 

 

 

Issued upon

 

Underlying

 

 

Shares

 

Warrant

 

Warrants

 

Exercise

 

Underlying

 

Exercises as

 

Outstanding

Price as of

 

Warrants on

 

of

 

as of

Issuance

Expiration

December 31, 

Issuance

 

December 31, 

 

December 31, 

    

Date

    

 Date

    

2023

    

Date

    

2023

    

2023

Series 2020-A Warrants (1)

 

7/6/2020

 

7/6/2025

$

0.60

 

30,000,000

 

29,914,069

 

85,931

Series 2022-A Warrants (1)

 

6/8/2022

 

6/7/2027

$

4.37

 

33,333,336

 

 

33,333,336

Total Warrants

 

63,333,336

 

29,914,069

 

33,419,267

(1)Equity-classified warrants.

No warrants were exercised during the year ended December 31, 2023. During the year ended December 31, 2022, common stock was issued as a result of the exercise of warrants as shown below (dollars in thousands):

    

Common Stock

    

 Issued

Proceeds

Series 2020-A Warrants

4,677

$

3

Share Repurchase Program

17. SegmentsOn May 30, 2023, the Board authorized a stock repurchase program, under which the Company may repurchase up to $25 million of its common stock. The primary goal of the repurchase program is to allow the Company to opportunistically repurchase shares, while maintaining its ability to fund development projects. Under the stock repurchase program, the Company may repurchase shares from time to time in the open market or through privately negotiated transactions. The timing, volume and nature of stock repurchases, if any, will be in the Company’s sole discretion and will be dependent on market conditions, applicable securities laws, and other factors. The stock repurchase program may be suspended or discontinued at any time and does not have an expiration date.

The Company did not repurchase any shares of common stock under the stock repurchase program during the years ended December 31, 2023, and 2022.

86

Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

22. Variable Interest Entities

The Company has entered into agreements with various SPEs to facilitate the development and construction of facilities to provide carbon neutral power to NZ1. These SPEs are structured as a limited liability companies.

Nonconsolidated VIEs

During September 2022 and February 2023, the Company entered into agreements with Zero6 Energy Development, Inc. (“ZEDI”), a national clean energy expert that provides expertise in capital management, development, engineering, and asset management, to develop and construct facilities to provide carbon neutral power to NZ1 via the two Project LLCs: Kingsbury County Wind Fuel, LLC (“KCWF”) and Dakota Renewable Hydrogen, LLC (“DRH”), respectively. In December 2023 the agreements with ZEDI related to the two Project LLCs were amended to remove certain kickout rights that previously existed.

Each Project LLC is currently funded via advances for certain long lead equipment items from Gevo. The Company has made certain refundable project advances indirectly to the Project LLCs via ZEDI, to induce ZEDI to design and construct the power generation, transmission and distribution facilities that will serve NZ1.

Each Project LLC is a VIE, and the Company holds an implicit variable interest in each Project LLC. As of December 2023, we have concluded that the removal of the kickout rights from the agreements has resulted in a loss of control and that, therefore, the Company is no longer the primary beneficiary of the Project LLCs. The Project LLCs are a VIE because their equity is insufficient to maintain its on-going collateral requirements without additional financial support from the Company.

There was no gain or loss recognized as a result of the deconsolidation of the Project LLCs. We have recognized $33.6 million in Deposits and other assets related to advances made to the Project LLCs which are reimbursable upon the achievement or failure to achieve certain milestones. Such amounts represent our maximum exposure to loss as a result of our involvement with the Project LLCs.

23. Segments

Operating segments are defined as components of an entity for which discrete financial information is available that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s Chief Executive Officer is the CODM. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. As such, management has determined that we have two operatingthe Company has organized its operations and activities into three reportable segments: (i) Gevo Inc. segment; and (ii) Gevo Development/Agri-Energy segment; (iii) Renewable Natural Gas segment. We organize our business segments based on the nature of the products and services offered through each of our consolidated legal entities. Transactions between segments are eliminated in consolidation.

Gevo Segmentsegment. OurThe Gevo segment is responsible for all research and development activities related to the future production of isobutanol, includingSAF, commercial opportunities for other renewable hydrocarbon products, such as hydrocarbons for gasoline blendstocks and diesel fuel; ingredients for the development of our proprietary biocatalysts, the productionchemical industry, such as ethylene and sale of renewable jetbutenes; plastics and materials; and other fuels, our Retrofit process and the next generation of chemicals and biofuels that will be based on our isobutanol technology. Ourchemicals. The Gevo segment also develops, maintains and protects ourits intellectual property portfolio, develops future markets for our isobutanol and provides corporate oversight services.services, and is responsible for development and construction of our Net-Zero Projects and Verity.

Gevo Development/Agri-Energy segment. Our Gevo Development/The Agri-Energy segment is currently responsible for the operation of ourthe Company’s Luverne Facility, and the development and optimization of the production of isobutanol, ethanol isobutanol and related products.

10287


Table of Contents

GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

Renewable Natural Gas segment. The Renewable Natural Gas segment produces-pipeline quality methane gas captured from dairy cow manure.

Year Ended December 31, 2023

    

    

    

Renewable

    

Gevo

Agri-Energy

Natural Gas

Consolidated

Revenues

$

1,743

$

$

15,457

$

17,200

Depreciation and amortization

$

(1,799)

$

(10,503)

$

(6,705)

$

(19,007)

Loss from operations

$

(64,955)

$

(12,785)

$

(4,095)

$

(81,835)

Interest income

$

18,957

$

$

$

18,957

Interest expense

$

(354)

$

(16)

$

(1,791)

$

(2,161)

Acquisitions of property, plant, and equipment

$

43,907

$

4,154

$

6,394

$

54,455

Year Ended December 31, 2022

Renewable

    

Gevo

    

Agri-Energy

    

Natural Gas

    

Consolidated

Revenues

$

81

$

240

$

854

$

1,175

Depreciation and amortization

$

(1,573)

$

(6,002)

$

(312)

$

(7,887)

Loss from operations

$

(58,427)

$

(40,171)

$

(4,088)

$

(102,686)

Interest income

$

6,118

$

$

$

6,118

Interest expense

$

(436)

$

1

$

(732)

$

(1,167)

Acquisitions of property, plant, and equipment

$

45,272

$

4,091

$

34,714

$

84,077

December 31, 2023

Renewable

    

Gevo

    

Agri-Energy

    

Natural Gas

    

Consolidated

Total assets

$

519,994

$

28,818

$

101,510

$

650,322

December 31, 2022

Renewable

    

Gevo

    

Agri-Energy

    

Natural Gas

    

Consolidated

Total assets

$

573,057

$

34,440

$

93,251

$

700,748

The Company’s chief operating decision maker is provided

24. Subsequent Events.

On February 29, 2024, the Company received notice from Nasdaq that the Company was not in compliance with and reviewsNasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the financial resultsminimum bid price of each ofits common stock had been below $1.00 per share for the Company’s consolidated legal entities, Gevo, Inc., Gevo Development, LLC, and Agri-Energy, LLC.previous 30 consecutive business days. The Company organizes itshas 180 calendar days, or until August 27, 2024, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the minimum bid price of our common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business segments based ondays during the nature ofcompliance grace period. In the products and services offered through each of its consolidated legal entities. All revenue is earned, and all assets are held, in the U.S.

 

Year Ended December 31,

 

 

2017

 

 

2016

 

 

2015

 

Revenues from external customers:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

1,097

 

 

$

2,425

 

 

$

2,911

 

Gevo Development / Agri-Energy

 

26,439

 

 

 

24,788

 

 

 

27,226

 

Consolidated

$

27,536

 

 

$

27,213

 

 

$

30,137

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

(10,603

)

 

$

(11,045

)

 

$

(19,723

)

Gevo Development / Agri-Energy

 

(12,679

)

 

 

(12,940

)

 

 

(12,204

)

Consolidated

$

(23,282

)

 

$

(23,985

)

 

$

(31,927

)

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

2,951

 

 

$

7,789

 

 

$

8,147

 

Gevo Development / Agri-Energy

 

-

 

 

 

48

 

 

 

96

 

Consolidated

$

2,951

 

 

$

7,837

 

 

$

8,243

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization expense:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

473

 

 

$

738

 

 

$

856

 

Gevo Development / Agri-Energy

 

6,168

 

 

 

6,009

 

 

 

5,717

 

Consolidated

$

6,641

 

 

$

6,747

 

 

$

6,573

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisitions of plant, property and equipment:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

120

 

 

$

350

 

 

$

7

 

Gevo Development / Agri-Energy

 

1,786

 

 

 

5,588

 

 

 

1,457

 

Consolidated

$

1,906

 

 

$

5,938

 

 

$

1,464

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

 

 

 

2017

 

 

2016

 

 

 

 

 

Total assets:

 

 

 

 

 

 

 

 

 

 

 

Gevo

$

87,507

 

 

$

110,072

 

 

 

 

 

Gevo Development / Agri-Energy

 

149,758

 

 

 

156,749

 

 

 

 

 

Intercompany eliminations (1)

 

(148,412

)

 

 

(154,497

)

 

 

 

 

Consolidated (2)

$

88,853

 

 

$

112,324

 

 

 

 

 

(1)

Includes intercompany sales of $0.4 and $0.2 million, respectively for hydrocarbon sales.

��

(2)

All other significant non-cash items relate to the activities of Gevo

18. Subsequent Events

At-The-Market Offering Agreement

On February 13, 2018,event the Company entered into an At-The-Market Offering Agreement (the “Sales Agreement”)does not regain compliance with H.C. Wainwright & Co., LLC (the “Agent”), which provides for the issuance and sale from time to timeMinimum Bid Price Requirement by August 27, 2024, the Company of up to $5,000,000 of shares of common stock, par value $0.01 per share (the “Shares”). The Shares have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to our Registration Statement on Form S-3 (File No. 333-211370). Sales of the Shares, if any, may be made by any method permitted by law deemed to beeligible for an “at-the-market offering” as defined in Rule 415(a)(4)additional 180-calendar day compliance period.

88

Table of the Securities Act, including sales made directly on or through the Nasdaq Capital Market or any other existing trading market for the Shares, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailingContents

103


GEVO, INC.

Notes to Consolidated Financial Statements (Continued)

market prices and/or any other method permitted by law.  The Company intends to use the net proceeds from this offering to fund working capital and for other general corporate purposes, which may include the repayment of outstanding indebtedness.

Eco-Energy Ethanol and Isobutanol Purchase and Marketing Agreement

During the first quarter of 2018, Agri-Energy, entered into an Ethanol and Isobutanol Purchase and Marketing Agreement (the “Agreement”) with Eco-Energy, LLC (“Eco-Energy”), which provides for the sale and marketing of ethanol produced at the Luverne Facility. Pursuant to the Agreement, Eco-Energy will purchase ethanol for its own use or account, or purchase ethanol to sell and market to third parties, at market prices at the time of a purchase order for the sale of the ethanol. Agri-Energy will also pay Eco-Energy a marketing fee for any product sold to third parties under the terms of the Agreement. Agri-Energy may also sell isobutanol to Eco-Energy under the terms of the Agreement, however, Agri-Energy is under no obligation to sell any isobutanol to Eco-Energy.

Exchange of 2022 Notes

See Note 8 “Debt” for disclosure of the exchange of the 2022 Notes for shares of the Company’s common stock in the first quarter of 2018.


Item 9.

Changes in and Disagreements with AccountantsAccountants on Accounting and Financial Disclosure

None.

Item 9A.

Item 9A.Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms,regulations, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on their evaluation, as of December 31, 2017, our Chief Executive Officer and Principalour Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2017.2023.

Remediation of Material Weakness

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. In connection with the preparation of the Company’s consolidated financial statements for the three and nine months ended September 30, 2023, management identified a material weakness related to the ineffective design of internal controls to identify and evaluate the existence of, and accounting for, variable interest entities (“VIEs”). This material weakness resulted in the failure to timely identify two potential VIEs requiring consolidation at the time the Company entered into the agreements. This material weakness resulted in a prior period adjustment to our consolidated financial statements as of and for the period ended September 30, 2023.

In order to remediate the material weakness, management implemented the following procedures during the year ended December 31, 2023:

The design and operating effectiveness of the Company’s internal controls covering contract reviews and analysis were evaluated and new processes and procedures were introduced to ensure new and historical agreements are properly reviewed for the existence of potential VIEs.
A comprehensive review of contracts the Company is party to was performed to ensure proper VIE accounting conclusions were reached.
Management engaged expert, third-party advisory services to assist in supporting management’s analysis and processes, as well as further strengthen the precision of management’s review controls for the assessment of potential VIEs.

During the fourth quarter of fiscal 2023, the Company completed its testing of the implemented controls. Based on the foregoing remediation activities and testing of controls, management concluded that the material weakness has been fully remediated as of December 31, 2023.

89

Table of Contents

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Principalour Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth inInternal Control—Integrated Framework (2013 framework) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based upon the results of the evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2017.2023.

Changes in Internal Control Over Financial Reporting

ThereExcept for additional control improvements implemented, stemming from the remediation of the material weakness discussed above, there were no changes in our internal control over financial reporting during the quarter ended December 31, 20172023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.Other Information

During our last fiscal quarter, the below directors and/or officers, as defined in Rule 16a-1(f), adopted, modified or terminated a “Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K. The Rule 10b5-1 trading arrangements were each intended to satisfy the affirmative defense in Rule 10b5-1(c)(1).

Item 9B.

Name and Title

Other InformationAction

Date

Duration of Plan

Total Number of Shares of Common Stock to be Purchased or Sold

Patrick Gruber

Chief Executive Officer

Terminate

November 15, 2023

June 30, 2023 to November 15, 2023

Up to 2,067,374

Paul Bloom

Chief Carbon Officer and Chief Innovation Officer

Terminate

December 8, 2023

June 30, 2023 to December 8, 2023

Up to 358,175

As previously disclosed,No other directors or officers, as defined in June 2011, we entered into an Isobutanol Joint Venture Agreement (the “Joint Venture Agreement”) with Redfield Energy, LLC (“Redfield”)Rule 16a-1(f), under which we agreed to work with Redfield to Retrofit Redfield’s  ethanol production facility located near Redfield, South Dakota for the commercial productionadopted, modified and/or terminated a “Rule 10b5-1 trading arrangement,” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of isobutanol.  On November 5, 2017, we entered into an Agreement with Redfield, pursuant to which we and Redfield agreed to terminate the Joint Venture Agreement in all respects.  There are no termination fees or other obligationsRegulation S-K, during our last fiscal quarter.

90

Table of either party in connection with such termination.Contents


Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

None.

PART

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

The information required by this item will be included in theis incorporated by reference to our definitive proxy statement for our 2018the 2024 annual meeting of stockholders or an amendment to this Report to be filed with the SEC within 120 days after our fiscal year ended December 31, 2017,2023.

We have a written code of business conduct and ethics in place that applies to all of our directors, officers and employees, including our principal executive officer, principal financial officer, and principal accounting officer. A copy of our code of ethics is incorporated into this Reportavailable on our website: https://investors.gevo.com/corporate/corporate-governance/. We are required to disclose certain changes to, or waivers from, that code for our senior financial officers. We intend to use our website as a method of disseminating any change to, or waiver from, our code of ethics as permitted by reference.applicable SEC rules.

Item 11.

Executive Compensation

The information required by this item will be included in theis incorporated by reference to our definitive proxy statement for our 2018the 2024 annual meeting of stockholders or an amendment to this Report to be filed with the SEC within 120 days after our fiscal year ended December 31, 2017, and is incorporated into this Report by reference.2023.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item will be included in theis incorporated by reference to our definitive proxy statement for our 2018the 2024 annual meeting of stockholders or an amendment to this Report to be filed with the SEC within 120 days after our fiscal year ended December 31, 2017, and is incorporated into this Report by reference.2023.

Item 13.

Certain Relationships and Related Transactions, and Director Independence

The information required by this item will be included in theis incorporated by reference to our definitive proxy statement for our 2018the 2024 annual meeting of stockholders or an amendment to this Report to be filed with the SEC within 120 days after our fiscal year ended December 31, 2017, and is incorporated into this Report by reference.2023.

Item 14.

Principal Accountant Fees and Services

The information required by this item will be included in theis incorporated by reference to our definitive proxy statement for our 2018the 2024 annual meeting of stockholders or an amendment to this Report to be filed with the SEC within 120 days after our fiscal year ended December 31, 20172023.

91

Table of Contents

, and is incorporated into this Report by reference.

PART IV


PART IV

Item 15.

Exhibits, and Financial Statement Schedules

(a)(1) Financial Statements

The following consolidated financial statementsConsolidated Financial Statements are included:

Page

Report of Independent Registered Public Accounting Firm

71

55

Consolidated Balance Sheets

72

57

Consolidated Statements of Operations

73

58

Consolidated Statements of Comprehensive Income (Loss)

59

Consolidated Statements of Stockholders’ Equity

74

60

Consolidated Statements of Cash Flows

75

61

Notes to Consolidated Financial Statements

78

63

(a)(2) Financial Statement Schedules

All financial statement schedules have been omitted because they are not applicable or are not required, or because the information required to be set forth therein is included in the consolidated financial statementsConsolidated Financial Statements or notes thereto.


(a)(3) Exhibits

 

 

 

 

Incorporated by Reference

 

 

Exhibit

No.

 

Description

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

Filed

Herewith

3.1

 

Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

10-K

 

001-35073

 

March 29, 2011

 

3.1

 

 

3.2

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

8-K

 

001-35073

 

June 10, 2013

 

3.1

 

 

3.3

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

8-K

 

001-35073

 

July 9, 2014

 

3.1

 

 

3.4

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

8-K

 

001-35073

 

April 22, 2015

 

3.1

 

 

3.5

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

8-K

 

001-35073

 

January 6, 2017

 

3.1

 

 

3.6

 

Amended and Restated Bylaws of Gevo, Inc.

 

10-K

 

001-35073

 

March 29, 2011

 

3.2

 

 

4.1

 

Form of the Gevo, Inc. Common Stock Certificate.

 

S-1

 

333-168792

 

January 19, 2011

 

4.1

 

 

4.2

 

Fifth Amended and Restated Investors’ Rights Agreement, dated March 26, 2010.

 

S-1

 

333-168792

 

August 12, 2010

 

4.2

 

 

4.3†

 

Stock Issuance and Stockholder’s Rights Agreement, dated July 12, 2005, by and between Gevo, Inc. and California Institute of Technology.

 

S-1

 

333-168792

 

August 12, 2010

 

4.3

 

 

4.4

 

Amended and Restated Warrant to purchase shares of Common Stock issued to CDP Gevo, LLC, dated September 22, 2010.

 

S-1

 

333-168792

 

October 1, 2010

 

4.4

 

 

4.6

 

Plain English Warrant Agreement No. 0647-W-01, dated August 5, 2010, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

S-1

 

333-168792

 

October 1, 2010

 

4.11

 

 

4.7

 

Plain English Warrant Agreement No. 0647-W-02, dated August 5, 2010, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

S-1

 

333-168792

 

October 1, 2010

 

4.12

 

 

4.8

 

Plain English Warrant Agreement No. 0647-W-03, dated October 20, 2011, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

8-K

 

001-35073

 

October 26, 2011

 

10.7

 

 

4.9

 

First Amendment to Plain English Warrant Agreement, relating to Warrant Number 0647-W- 01, dated December 11, 2013, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

8-K

 

001-35073

 

December 12, 2013

 

4.1

 

 

4.10

 

First Amendment to Plain English Warrant Agreement, relating to Warrant Number 0647-W- 02, dated December 11, 2013, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

8-K

 

001-35073

 

December 12, 2013

 

4.2

 

 

4.11

 

First Amendment to Plain English Warrant Agreement, relating to Warrant Number 0647-W- 03, dated December 11, 2013, by and between Gevo, Inc. and TriplePoint Capital LLC.

 

8-K

 

001-35073

 

December 12, 2013

 

4.3

 

 

4.12

 

Common Stock Warrant, issued to Genesis Select Corporation, dated June 6, 2013.

 

10-Q

 

001-35073

 

August 14, 2013

 

4.9

 

 

Incorporated by Reference

Exhibit
No.

   

Description

   

Form

   

File No.

   

Filing Date

   

Exhibit

   

Filed
Herewith

3.1

Amended and Restated Certificate of Incorporation of Gevo, Inc.

10-K

001-35073

February 24, 2022

3.1

3.2

Second Amended and Restated Bylaws of Gevo, Inc.

8-K

001-35073

November 24, 2021

3.1

4.1

Form of Gevo, Inc. Common Stock Certificate.

S-1

333-168792

January 19, 2011

4.1

4.2

Form of Series 2020-A Warrant.

8-K

001-35073

July 8, 2020

4.1

4.3

Form of Series 2022-A Warrant.

8-K

001-35073

June 8 2022

4.1

4.4

Description of Securities.

10-K

001-35073

February 24, 2022

4.3

10.1#

Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan.

8-K

001-35073

May 25, 2023

10.1

10.2#

Form of Restricted Stock Unit Agreement under the Amended and Restated 2010 Stock Incentive Plan.

S-1

333-168792

January 19, 2011

10.15

10.3#

Form of Restricted Shares Award Agreement under the Amended and Restated 2010 Stock Incentive Plan.

10-Q

001-35073

August 8, 2018

10.7

10.4#

Form of Stock Option Award Agreement under the Amended and Restated 2010 Stock Incentive Plan.

10-Q

001-35073

August 8, 2018

10.6


92

 

 

 

 

Incorporated by Reference

 

 

Exhibit

No.

 

Description

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

Filed

Herewith

4.13

 

Common Stock Unit Warrant Agreement, dated December 16, 2013, by and between Gevo, Inc. and the American Stock Transfer & Trust Company, LLC.

 

8-K

 

001-35073

 

December 12, 2013

 

4.1

 

 

4.14

 

Exchange and Purchase Agreement, dated April 19, 2017, by and among Gevo, Inc., the guarantors party thereto, the holders named in Schedule I thereto, and Whitebox Advisors LLC, in its capacity as representative of the holders.

 

8-K

 

001-35073

 

April 20, 2017

 

4.1

 

 

4.15

 

Indenture, dated June 20, 2017, by and among Gevo, Inc., the guarantors party thereto, and Wilmington Savings Fund Society, FSB, as trustee and collateral trustee.

 

8-K

 

001-35073

 

June 20, 2017

 

4.1

 

 

4.16

 

Registration Rights Agreement, dated June 20, 2017, by and among Gevo, Inc. and the investors named therein.

 

8-K

 

001-35073

 

June 20, 2017

 

4.2

 

 

4.17

 

Common Stock Unit Warrant Agreement, dated August 5, 2014, by and between Gevo, Inc. and the American Stock Transfer & Trust Company, LLC.

 

8-K

 

001-35073

 

August 6, 2014

 

4.1

 

 

4.18

 

2015 Common Stock Unit Series A Warrant Agreement, dated August 5, 2014, by and between Gevo, Inc. and the American Stock Transfer & Trust Company, LLC.

 

8-K

 

001-35073

 

February 4, 2015

 

4.1

 

 

4.19

 

2015 Common Stock Unit Series C Warrant Agreement, dated May 19, 2015, by and between Gevo, Inc. and the American Stock Transfer & Trust Company LLC.

 

8-K

 

001-35037

 

May 20, 2015

 

4.1

 

 

4.20

 

Form of Series D Warrant to Purchase Common Stock.

 

8-K

 

001-35037

 

December 15, 2015

 

4.1

 

 

4.21

 

Form of Amendment No. 1 to Series D Warrant.

 

8-K

 

001-35037

 

June 13, 2016

 

4.3

 

 

4.22

 

Form of Series F Warrant to Purchase Common Stock.

 

8-K

 

001-35037

 

April 5, 2016

 

4.1

 

 

4.23

 

Form of Series I Warrant to Purchase Common Stock.

 

8-K

 

001-35037

 

September 15, 2016

 

4.1

 

 

4.24

 

Form of Series K Warrant to Purchase Common Stock.

 

8-K

 

001-35037

 

February 22, 2017

 

4.1

 

 

10.1†

 

Ethanol Purchasing and Marketing Agreement, dated April 1, 2009, by and between C&N Ethanol Marketing Corporation and Agri-Energy, LP.

 

S-1

 

333-168792

 

November 4, 2010

 

10.26

 

 

10.2†

 

License Agreement, dated July 12, 2005, by and between Gevo, Inc. and the California Institute of Technology, as amended.

 

S-1

 

333-168792

 

November 4, 2010

 

10.6

 

 

10.3

 

Amendment No. 4, dated October 1, 2010, to the License Agreement, by and between Gevo, Inc. and the California Institute of Technology, dated July 12, 2005.  

 

S-1

 

333-168792

 

October 21, 2010

 

10.10

 

 


 

 

 

 

Incorporated by Reference

 

 

Exhibit

No.

 

Description

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

Filed

Herewith

10.6#

 

Gevo, Inc. 2006 Omnibus Securities and Incentive Plan.

 

S-1

 

333-168792

 

August 12, 2010

 

10.11

 

 

10.7#

 

Form of Stock Option Agreement under the 2006 Omnibus Securities and Incentive Plan.

 

S-1

 

333-168792

 

August 12, 2010

 

10.13

 

 

10.8#

 

Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan.

 

10-Q

 

001-35073

 

November 14, 2016

 

10.4

 

 

10.9#

 

Form of Restricted Stock Unit Agreement under the 2010 Stock Incentive Plan.

 

S-1

 

333-168792

 

January 19, 2011

 

10.15

 

 

10.10#

 

Form of Restricted Stock Award Agreement under the 2010 Stock Incentive Plan.

 

10-K

 

001-35073

 

March 29, 2011

 

10.21

 

 

10.11#

 

Form of Stock Option Award Agreement under the 2010 Stock Incentive Plan.

 

10-K

 

001-35073

 

March 29, 2011

 

10.22

 

 

10.12#

 

Gevo, Inc. Employee Stock Purchase Plan.

 

S-8

 

333-172771

 

March 11, 2011

 

4.7

 

 

10.13#

 

Gevo, Inc. Executive Health Management Plan.

 

10-Q

 

001-35073

 

November 2, 2011

 

10.1

 

 

10.14#

 

Form of Indemnification Agreement between Gevo, Inc. and its directors and officers.

 

S-1

 

333-168792

 

January 19, 2011

 

10.33

 

 

10.15#

 

Employment Agreement, dated June 4, 2010, by and between Gevo, Inc. and Patrick Gruber.

 

S-1

 

333-168792

 

November 4, 2010

 

10.14

 

 

10.16#

 

Amendment Agreement, dated December 21, 2011, by and between Gevo, Inc. and Patrick Gruber.

 

8-K

 

001-35073

 

December 27, 2011

 

10.1

 

 

10.17#

 

Second Amendment Agreement, dated February 16, 2015, by and between Gevo, Inc. and Patrick Gruber.

 

8-K

 

001-35073

 

February 17, 2015

 

10.1

 

 

10.18#

 

Employment Agreement, dated June 4, 2010, by and between Gevo, Inc. and Christopher Ryan.

 

S-1

 

333-168792

 

November 4, 2010

 

10.16

 

 

10.19#

 

Offer Letter, dated April 10, 2014, by and between Gevo, Inc. and Mike Willis.

 

10-K

 

001-35073

 

April 15, 2014

 

10.38

 

 

10.20#†

 

Transaction Bonus Agreement, dated September 6, 2016, by and between Gevo, Inc. and Mike Willis.

 

10-K

 

001-35073

 

March 31, 2017

 

10.20

 

 

10.21#

 

Offer of Employment Letter, dated December 21,2015, for Geoffrey T. Williams, Jr.

 

10-Q

 

001-35073

 

May 9, 2017

 

10.1

 

 

10.22#

 

Change of Control Agreement for Geoffrey T. Williams, Jr., dated February 18, 2016.

 

10-Q

 

001-35073

 

May 9, 2017

 

10.2

 

 

10.23†

 

Lease of Space, dated September 13, 2012, between Hines REIT 345 Inverness Drive, LLC and Gevo, Inc.

 

10-K

 

001-35073

 

March 26, 2013

 

10.48

 

 

10.24†

 

Price Risk Management, Origination and Merchandising Agreement, dated June 1, 2015, by and between Agri-Energy, LLC and FCStone Merchant Services, LLC.

 

10-Q

 

001-35073

 

August 7, 2015

 

10.3

 

 

10.25

 

Grain Bin Lease Agreement, dated June 1, 2015, by and between Agri-Energy, LLC and FCStone Merchant Services LLC.

 

10-Q

 

001-35073

 

August 7, 2015

 

10.4

 

 


 

 

 

 

Incorporated by Reference

 

 

Exhibit

No.

 

Description

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

Filed

Herewith

10.26

 

Unsecured Guaranty Agreement, dated June 1, 2015, by Gevo, Inc. in favor of FCStone Merchant Services, LLC.

 

10-Q

 

001-35073

 

August 7, 2015

 

10.5

 

 

10.27†

 

First Amendment to Grain Bin Lease Agreement, dated December 21, 2017, Agri-Energy, LLC and FCStone Merchant Services, LLC.

 

 

 

 

 

 

 

 

 

X

10.28†

 

First Amendment to Price Risk Management, Origination and Merchandising Agreement, dated December 21, 2017, Agri-Energy, LLC and FCStone Merchant Services, LLC.

 

 

 

 

 

 

 

 

 

X

10.29†

 

Settlement Agreement and Mutual Release, dated August 22, 2015, by and among Gevo, Inc., Butamax Advanced Biofuels, LLC, E.I. du Pont de Nemours & Company and BP Biofuels North America LLC.

 

10-Q

 

001-35073

 

November 5, 2015

 

10.2

 

 

10.30†

 

Patent Cross-License Agreement, dated August 22, 2015, by and between Gevo, Inc. and Butamax Advanced Biofuels LLC.

 

10-Q

 

001-35073

 

November 5, 2015

 

10.3

 

 

10.31†

 

Joint Development Agreement, dated November 6, 2015, by and between Gevo, Inc. and Praj Industries Ltd.

 

8-K

 

001-35073

 

November 10, 2015

 

10.1

 

 

10.32†

 

Development License Agreement, dated November 6, 2015, by and between Gevo, Inc. and Praj Industries Ltd.

 

8-K

 

001-35073

 

November 10, 2015

 

10.2

 

 

10.33†

 

Supplemental Agreement (to Joint Development Agreement), dated November 16, 2017, by and between Gevo, Inc. and Praj Industries Ltd.

 

8-K

 

001-35073

 

November 21, 2017

 

10.1

 

 

10.34†

 

Supplemental Agreement (to Development License Agreement), dated November 16, 2017, by and between Gevo, Inc. and Praj Industries Ltd.

 

8-K

 

001-35073

 

November 21, 2017

 

10.2

 

 

10.35†

 

Joint Development Agreement, dated February 1, 2016, by and between Gevo, Inc. and Porta Hnos S.A.

 

8-K

 

001-35073

 

February 5, 2016

 

10.1

 

 

10.36†

 

Commercial License Agreement, dated February 1, 2016, by and between Gevo, Inc. and Porta Hnos S.A.

 

8-K

 

001-35073

 

February 5, 2016

 

10.2

 

 

10.37

 

First Amendment to Lease, effective December 11, 2015, between Hines REIT 345 Inverness Drive, LLC.

 

10-K

 

001-35073

 

March 30, 2016

 

10.62

 

 

10.38

 

Form of Securities Purchase Agreement, dated June 10, 2016, by and between Gevo, Inc. and each purchaser identified therein.

 

8-K

 

001-35073

 

June 13, 2016

 

10.1

 

 

10.39

 

Form of Exchange Agreement.

 

8-K

 

001-35073

 

September 9, 2016

 

10.3

 

 

10.40†

 

Supply Agreement, effective May 15, 2017, by and between Gevo, Inc. and HCS Holding GmbH.

 

8-K

 

001-35073

 

May 4, 2017

 

10.1

 

 

21.1

 

List of Subsidiaries.

 

S-1

 

333-168792

 

October 1, 2010

 

10.10

 

 

 

23.1

 

Consent of Grant Thornton  LLP.

 

 

 

 

 

 

 

 

 

X


Table of Contents

Incorporated by Reference

Exhibit
No.

Description

Form

File No.

Filing Date

Exhibit

Filed
Herewith

10.5#

Form of Stock Appreciation Rights Award Agreement under the Amended and Restated 2010 Stock Incentive Plan.

10-Q

001-35073

August 8, 2018

10.8

Exhibit

No.

Description

Form

File No.

Filing Date

Exhibit

Filed

Herewith

31.110.6#

Gevo, Inc. Employee Stock Purchase Plan.

S-8

333-172771

March 11, 2011

4.7

10.7#

Gevo, Inc. Executive Health Management Plan.

10-Q

001-35073

November 2, 2011

10.1

10.8#

Form of Indemnification Agreement between Gevo, Inc. and its directors and officers.

S-1

333-168792

January 19, 2011

10.33

10.9#

Employment Agreement, dated June 4, 2010, by and between Gevo, Inc. and Patrick Gruber.

S-1

333-168792

November 4, 2010

10.14

10.10#

Amendment Agreement, dated December 21, 2011, by and between Gevo, Inc. and Patrick Gruber.

8-K

001-35073

December 27, 2011

10.1

10.11#

Second Amendment Agreement, dated February 16, 2015, by and between Gevo, Inc. and Patrick Gruber.

8-K

001-35073

February 17, 2015

10.1

10.12#

Employment Agreement, dated June 4, 2010, by and between Gevo, Inc. and Christopher Ryan.

S-1

333-168792

November 4, 2010

10.16

10.13#

Offer Letter, dated November 9, 2019, by and between Gevo, Inc. and L. Lynn Smull.

8-K

001-35073

November 15, 2019

10.1

10.14#

Offer Letter, dated February 16, 2021, by and between Gevo Inc. and Paul Bloom.

10-Q

001-35073

May 14, 2021

10.6

10.15†

At-The-Market Offering Agreement, dated January 16, 2024, between Gevo, Inc. and H.C. Wainwright & Co., LLC.

S-3

333-276515

January 16, 2024

1.2

10.16+

Master Framework Agreement, dated August 13, 2020, by and between Gevo, Inc. and Praj Industries Ltd.

8-K

001-35073

August 18, 2020

10.1

10.17+

Base Contract for Sale and Purchase of Natural Gas, dated July 22, 2021, by and between Gevo NW Iowa RNG, LLC, BP Canada Energy Marketing Corp. and BP Products North America Inc.

8-K

001-35073

August 9, 2021

10.1

10.18+

Special Provisions Attached to and Forming Part of the Base Contract for Sale and Purchase of Natural Gas dated July 22, 2021, by and between Gevo NW Iowa RNG, LLC, BP Canada Energy Marketing Corp. and BP Products North America Inc.

8-K

001-35073

August 9, 2021

10.2

93

Table of Contents

Incorporated by Reference

Exhibit
No.

   

Description

   

Form

   

File No.

   

Filing Date

   

Exhibit

   

Filed
Herewith

10.19+

Biogas Supply Addendum – Vehicle Fuel Segment-Supply Side, dated July 22, 2021, by and between Gevo NW Iowa RNG, LLC, BP Canada Energy Marketing Corp. and BP Products North America Inc.

8-K

001-35073

August 9, 2021

10.3

10.20+

Transaction Confirmation relating to the Base Contract, by and between Gevo NW Iowa RNG, LLC and BP Canada Energy Marketing Corp.

8-K

001-35073

August 9, 2021

10.4

10.21+††

Asset Purchase Agreement, date September 21, 2021, between Butamax Advanced Biofuels LLC and Danisco US Inc., and Gevo, Inc.

8-K

001-35073

September 23, 2021

10.1

10.22

Bond Financing Agreement, dated as of April 1, 2021, by and between Gevo NW Iowa RNG, LLC and the Iowa Finance Authority.

8-K

001-35073

April 15, 2021

10.1

10.23++

Letter of Credit Reimbursement Agreement, dated as of April 1, 2021, by and between Gevo, Inc. and Citibank, N.A.

8-K

001-35073

April 15, 2021

10.2

10.24+

Fuel Supply Agreement, dated March 16, 2022, by and between Gevo, Inc. and Delta Air Lines, Inc.

8-K

001-35073

March 22, 2022

10.1

10.25+

Fuel Supply Agreement, dated March 18, 2022, by and between Gevo, Inc. and British Airways plc.

8-K

001-35073

March 21, 2022

10.1

10.26+

Fuel Supply Agreement, dated July 18, 2022, by and between Gevo, Inc. and American Airlines, Inc.

8-K

001-35073

July 22, 2022

10.1

10.27++

First Amended and Restated Transaction Confirmation, by and between Gevo NW Iowa RNG, LLC BP Canada Energy Marketing Corp, and BP Products North America Inc.

10-Q

001-35073

August 8, 2022

10.2

10.28#

Gevo, Inc. Change in Control Severance Plan

8-K

001-35073

December 2, 2022

10.1

10.29+

Master Framework Agreement for Ethanol to Jet Collaboration, dated September 22, 2021, by and between Axens North America, Inc. and Gevo, Inc.

10-Q

001-35073

August 10, 2023

10.1

10.30+

Amended and Restated Fuel Supply Agreement, dated March 15, 2023, by and between Gevo, Inc. and Kolmar Americas, Inc.

10-Q

001-35073

March 15, 2023

10.1

94

Table of Contents

Incorporated by Reference

Exhibit
No.

Description

Form

File No.

Filing Date

Exhibit

Filed
Herewith

10.31+

Side Agreement, dated May 5, 2023, by and between Axens North America, Inc. and Gevo, Inc.

10-Q

001-35073

August 10, 2023

10.2

10.32+

Technology Access Agreement, dated May 5, 2023, by and among Gevo, Inc., Phillips 66 Company and Archer-Daniels-Midland Company

10-Q

001-35073

August 10, 2023

10.3

10.33+

Extension Agreement to the Master Framework Agreement for ETJ Collaboration, dated December 11, 2023, by and between Gevo, Inc. and Axens North America, Inc.

8-K

001-35073

December 13, 2023

10.1

10.34

Amendment No. 1 to Fuel Sales Agreement, dated December 2, 2022, by and between Gevo, Inc. and Delta Air Lines, Inc.

X

10.35

Amendment No. 2 to Fuel Sales Agreement, dated November 27, 2023, by and between Gevo, Inc. and Delta Air Lines, Inc.

X

10.36

Amendment No. 1 to Fuel Sales Agreement, dated December 12, 2023, by and between Gevo, Inc. and British Airways plc

X

10.37+

Amendment No. 1 to Fuel Sales Agreement, dated December 13, 2023, by and between Gevo, Inc. and American Airlines, Inc.

X

21.1

List of Subsidiaries.

X

23.1

Consent of Grant Thornton LLP.

X

31.1

Section 302 Certification of the Principal Executive Officer.

X

31.2

Section 302 Certification of the Principal Financial Officer.

X

32.1

32.1 *

Section 906 Certifications of the Principal Executive Officer and the Principal Financial Officer.

*

97

Gevo, Inc. Compensation Recovery Policy

X

101

101.INS

Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data Files Pursuant to Rule 405 of Regulation S-T: (i) Consolidated Balance Sheets at December 31, 2017 and December 31, 2016, (ii) Consolidated Statements of Operations for each ofFile because its XBRL tags are embedded within the three years in the period ended December 31, 2017, (iii) Consolidated Statements of Stockholders’ Equity for each of the three years in the period ended December 31, 2017, (iv) Consolidated Statements of Cash Flows for each of the three years in the period ended December 31, 2017; and (iv) Notes to the Consolidated Financial Statements.Inline XBRL document)

X

95

Table of Contents

Incorporated by Reference

Exhibit
No.

Description

Form

File No.

Filing Date

Exhibit

Filed
Herewith

101.SCH

Inline XBRL Taxonomy Extension Schema

X

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

X

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

X

01.LAB

Inline XBRL Taxonomy Extension Label Linkbase

X

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

X

104

Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

Certain portions have been omitted pursuant to a confidential treatment request. Omitted information has been filed separately with the SEC.

+

Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed.

++

Confidential portions of the exhibit have been redacted from the filed version of the exhibit and are marked with a ***

††

Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to supplementally furnish copies of any omitted schedules to the Securities and Exchange Commission upon request.

#

Indicates a management contract or compensatory plan or arrangement.

*

Furnished herewith

(b) Exhibits

See Item 15(a)(3) above.

(c) Financial Statement Schedules

See Item 15(a)(2) above.

Item 16.

Form 10K-Summary10-K Summary

None.

96


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Gevo, Inc.

(REGISTRANT)

By:

/s/ Bradford K. TowneAlisher Nurmat

Bradford K. Towne

ChiefAlisher Nurmat, CPA
Vice President of Accounting Officerand Treasurer
(Principal Accounting Officer)

Date: March 28, 20187, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

Signatures

Signatures

Title

Title

Date

/s/ PATRICK R. GRUBER

Chief Executive Officer (Principal Executive Officer)

and Director

March 28, 20187, 2024

Patrick R. Gruber, Ph.D.

/s/ Bradford k. towne

/s/ L. LYNN SMULL

Chief AccountingFinancial Officer (Principal Financial Officer)

March 7, 2024

L. Lynn Smull

/s/ ALISHER NURMAT

Vice President of Accounting and

Treasurer (Principal Accounting Officer)

March 28, 20187, 2024

Bradford K. TowneAlisher Nurmat, CPA

/s/ RUTH I. DREESSENWILLIAM H. BAUM

Chairperson of the Board of Directors

March 28, 20187, 2024

Ruth DreessenWilliam H. Baum

/s/ GARY W. MIZE

Director

March 28, 20187, 2024

Gary W. Mize

/s/ Andy MarshANDREW J. MARSH

Director

March 28, 20187, 2024

AndyAndrew J. Marsh

/s/ Johannes Minho rothJAIME GUILLEN

Director

March 28, 20187, 2024

Johannes Minho RothJaime Guillen

/s/ WILLIAM H. BAUMCAROL J. BATTERSHELL

Director

March 28, 20187, 2024

William BaumCarol J. Battershell

/s/ ANGELO AMORELLI

Director

March 7, 2024

Angelo Amorelli

/s/ MARY KATHRYN ELLET

Director

March 7, 2024

Mary Kathryn Ellet

113

97